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Abstract  
 
Background 
Musculoskeletal pain is a major burden on society. Research in adults has identified risk factors 
associated with musculoskeletal pain onset, however at present evidence for risk factors in 
children and adolescents is limited. 
Aims 
Identify potential risk factors for musculoskeletal pain onset in children and adolescents from 
current literature, and generate specific hypotheses to be tested using existing cohort data. 
Methods 
A systematic review was conducted to summarize existing evidence of risk factors for 
musculoskeletal pain onset in children and adolescents. Two child and adolescent prospective 
cohort datasets and a local primary care consultation database were used to test hypotheses 
using logistic and survival regression analysis.  
Results 
The systematic review found evidence that sleep problems and psychological symptoms 
(internalizing and externalizing) were associated with musculoskeletal pain onset with added 
evidence of potential effect modifiers. For sleep problems, analysis within a prospective cohort 
showed higher odds (OR 1.35, 95%CI 0.84, 2.16) for musculoskeletal pain onset, but this 
association was significant only for chronic pain onset (OR 2.22, 95%CI 1.43, 3.44), with evidence 
of effect modification by gender (association was stronger in boys). Testing within a primary care 
cohort showed a 49% increased hazard of sleep consultations with musculoskeletal consultations. 
In a cohort of adolescents musculoskeletal pain was not significantly associated with internalizing 
symptoms (OR 1.43, 95%CI 0.96, 2.12), however a significant association was found for 
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externalizing symptoms (adjusted OR 1.99, 95% CI 1.28, 3.10), with evidence of effect 
modification by pubertal status and screen time use. Testing in a primary care cohort revealed a 
39% increased hazard for musculoskeletal consultations. 
Conclusions 
Potential risk factors (sleep and psychological symptoms) and effect modifiers were identified for 
(chronic) musculoskeletal pain onset within child and adolescent population and primary care 
samples. Future work is required to explore mechanisms explaining these associations, and 
develop appropriate interventions. 
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Chapter one. Introduction 
 
The central aim of this thesis is to explore and describe the epidemiology of child and adolescent 
musculoskeletal pain, and identify risk factors for the onset of musculoskeletal pain in this 
population. This introduction chapter outlines current knowledge on musculoskeletal pain 
relevant to the aims of the thesis, including information on: the history of the understanding of 
pain, the conceptual definition of pain, the impact and consequences of musculoskeletal pain, the 
prevalence and incidence of musculoskeletal pain, and risk factors for musculoskeletal pain onset 
in adults. Finally, the chapter discusses areas of the literature where knowledge on the onset of 
musculoskeletal pain is currently lacking and where further research is needed. 
 
1.1 History and definition of pain 
1.1.1 Early theories and the biomedical model 
Pain may be simply considered as an adaptive signal that is hardwired within human beings to 
protect from physical damage and activate the responses necessary for survival (i.e. flight or fight 
system, avoidance of danger) (Main, Sullivan, & Watson, 2007; Simons, Elman, & Borsook, 2014). 
Over the course of many years however, the understanding of pain has been interpreted in many 
different ways (See Figure 1.1). Early civilisation attributed pain to the effect of Gods or evil 
spirits, this thinking was intertwined with religious and cultural thought and beliefs, other early 
documented explanations were focused more on internal causes such as disequilibrium of bodily 
fluids and also pain was interpreted as an emotion or sensation originating in the heart (Allan & 
Waddell, 1989; Main et al., 2007). Coming forward in time to the last few centuries, different 
theories have been used to explain pain and the experience of pain. In 1664, Descartes 
importantly proposed a link between body and mind, and described pain as a perception that 
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exists in the brain (Moayedi & Davis, 2013). According to Descartes’ theory, a sensory cue (e.g. 
nociception from tissue damage) would travel up the spinothalamic tract, which operates as 
hollow tube where “animal spirits” would flow to transmit both sensory and motor information to 
the brain and then the brain would act to transmit action from the nerves to the muscles in order 
to avoid further pain (Main et al., 2007; Moayedi & Davis, 2013). This theory assumed that there 
was a direct relationship between the pain sensation and the amount of tissue damage, in effect a 
balance between severity of damage and severity of experience (Main et al., 2007). Following 
Descartes’ theory, Bell (1811) advanced the Specificity Theory of pain, suggesting that the brain is 
a heterogeneous structure and the nerves within consist of heterogeneous bundles of neurons 
with different specialized functions. Each dedicated fibre would therefore lead to a particular 
sensory region of the brain, thus suggesting a specific pain “pathway” (Moayedi & Davis, 2013). 
However, both Descartes’ and Bell’s theories had significant shortcomings, such as the evidence 
of variation of pain perception from individuals when a fixed measurable controlled level of 
nociception is applied, and also phenomenon such as phantom limb pain, which is clearly not 
linked to actual peripheral nociception (Main et al., 2007). Despite these shortcomings the 
Specificity Theory of pain became the predominant theory, and was further supported and 
modified by the work of von Frey (1894-1896), who proposed four somatosensory modalities, 
therefore distinguishing different dimensions of pain (i.e. cold, heat, pain and touch), and 
Sherrington (1903-1906), who described the specificity of response of the neurons to different 
stimuli and proposed the framework of nociception (Moayedi & Davis, 2013). These early theories 
of pain share the dualistic point of view that considers the body as separate from the mind 
(Gatchel, Peng, Peters, Fuchs, & Turk, 2007). These theories have largely underpinned the 
“biomedical“ point of view, much aligned to the development of medicine in the 19th and 20th 
century, which, in terms of the understanding of pain experience, focused only on the 
neurophysiological components of pain (Bendelow, 2013). The biomedical model considered pain 
only as a signal of the presence of damage or of an ongoing disease, and as something that could 
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be described within biological parameters (Engel, 1977). Within this model, only the nociceptive 
aspect of pain was contemplated (Bendelow, 2013). Following the tenets of this model, pain can 
be defined as a sensation that is provoked by the interaction of different systems that are present 
at the neuraxis level (Manchikanti, Singh, Datta, Cohen, & Hirsch, 2009). This definition embraces 
two types of pain: nociceptive pain “usually elicited by the activation of specific receptors, by 2 
types of peripheral nociceptors connected with C- and A-delta fibres”, and neuropathic pain, 
which is the consequence of “injury to sensory fibres or from damage to the central nervous 
system” (Manchikanti et al., 2009). 
 
1.1.2 The biopsychosocial model of pain 
In the second part of the 20th century, some authors proposed a distinction between disease, 
which is intended as biological damage that occurs to the body, and illness, which represents how 
disease is experienced (Gatchel et al., 2007). As a consequence of this line of thinking, it is 
possible to draw an analogy where nociception is comparable to the disease, and pain to the 
illness (Gatchel et al., 2007). According to this point of view, pain should be considered as an 
illness, where the subjective experience of pain is the result of the interconnection between body 
(biological), psychology (perception and experience) and culture (social influence), rather than 
being purely the result of organic biological damage (Bendelow, 2013; Gatchel et al., 2007). 
Therefore, in opposition to the biomedical model, a “biopsychosocial” model was developed, 
which could embrace the full experience of pain (Engel, 1977). According to the biopsychosocial 
model, in addition to the medical model of disease (i.e. tissue damage as an explanation for the 
experience of pain), other factors such as the psychological status and social interactions and 
context (for example the relationship of the patient with the physician within a health care 
system) are accounted for, and all these factors are considered in equal measure (Engel, 1977). 
This biopsychosocial approach was further supported by the Gate Control Theory of pain 
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proposed by Melzack and Wall in 1965. According to this theory, nociceptive sensory information 
arrives at the dorsal horn in the spinal cord from myelinated A fibres and unmyelinated C fibres. 
This information undergoes a modulation which may stimulate the opening or closing of the 
spinal “gates” located in the dorsal horn that regulate the transmission of the impulses to the 
nervous system and to the brain (Main et al., 2007; Waddell, 2004). This modulation depends on 
the balance of activity of large nerve fibres (which close the gate) and small nerve fibres (which 
open the gate), as well as other impulses coming from the central nervous system (i.e. top down 
processing), including psychological factors such as emotions and beliefs (Main et al., 2007; 
Waddell, 2004). Importantly according to this model, the brain (inclusive of cognitive and 
emotional processes) has an active role in pain processing, and this gives explanation to the 
persistence of pain after tissue healing, and the experience of pain in presence of non-noxious 
stimulus or no perceived stimulus (Gatchel et al., 2007; Melzack, 1999). A further advance of the 
biopsychosocial approach led to the neuromatrix theory of pain. According to this theory, pain is 
produced by a neurosignature of a genetically determined widespread network of neurons, called 
“neuromatrix”, which consists of loops that involve the thalamus, cortex and limbic system that 
cyclically process the sensory input, again highlighting central top down processing components 
that direct how pain is experienced (Melzack, 1999). Within this model the brain is not only 
involved in the processing and modulation of the nociceptive stimulus, but it can also generate a 
sensory experience even in the absence of a nociceptive input, such as in the case of phantom 
limb pain (Melzack, 1999). The biopsychosocial theoretical paradigm is now generally accepted 
within the field of pain research (Gatchel et al., 2007; Roditi & Robinson, 2011), and has led to 
current definitions of pain inclusive of these non-biomedical factors. For example according to the 
International Association for the Study of Pain, pain is “An unpleasant sensory and emotional 
experience associated with actual or potential tissue damage, or described in terms of such 
damage” (http://www.iasp-pain.org/Taxonomy#Pain). From this definition, which also takes into 
account the emotional aspect of pain, it follows that the nature of pain is subjective and 
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potentially unique for each individual (Gatchel et al., 2007; Main, Richards, & Fortune, 2000; 
Roditi & Robinson, 2011). There are many types of pain symptoms including headache, cancer 
pain, neuropathic pain, visceral pain and finally musculoskeletal pain (Roditi & Robinson, 2011). 
Among these conditions, musculoskeletal pain is the most common type of pain experienced 
(Dieppe, 2013), with considerable consequences on both the individual and society (see Section 
1.3). The characteristics and different types of musculoskeletal pain are described in the following 
paragraph.  
 
 
Figure 1.1 Theories of pain during history 
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1.2 Musculoskeletal pain  
The musculoskeletal system consists of different components (muscles, spine, joints, bones, 
nerves, ligaments and tendons) that work together to support body structure (Carlson & Carlson, 
2011; Dieppe, 2013). Therefore musculoskeletal pain can be understood as a broad umbrella term 
that includes the pain experience related to these components (Dieppe, 2013). Musculoskeletal 
pain is common and experienced by almost everyone during their lifetime and, due to its high 
prevalence and impact on society (please refer to Section 1.3 and 1.4), is a major health and social 
concern worldwide (Dieppe, 2013). Musculoskeletal pain is experienced in many different body 
regions, and is often defined depending on the body region affected (e.g. spinal pain, low back 
pain, neck pain, knee pain, shoulder pain, foot/ankle pain, hand pain, limb pain, joint pain and 
widespread pain). Musculoskeletal pain is also understood in terms of its duration, with three 
suggested categories: acute (musculoskeletal pain that lasts up to four weeks), sub-acute 
(musculoskeletal pain that lasts between four and twelve weeks) or chronic musculoskeletal pain 
(musculoskeletal pain that lasts more than twelve weeks), these definitions have been created to 
assist in clinical treatment guidelines, for example to identify people who have not recovered 
within an expected normal recovery time (Qaseem, Wilt, McLean, & Forciea, 2017). 
Musculoskeletal pain may be also described and assessed in terms of pain severity, by considering 
pain intensity, emotional distress, activity limitations and functional limitations associated with 
pain (for example impact on daily activities, work, school), impact on overall health, impact on 
sleep, all of which conceptualise the subjective pain experience (i.e. sensory, affective and 
evaluative components of pain) (Dieppe, 2013; Kamaleri, Natvig, Ihlebaek, Benth, & Bruusgaard, 
2008; Legault, Cantin, & Descarreaux, 2014; Melzack, 1975, 1983; Treede et al., 2015). In the next 
section, the impact of musculoskeletal pain is outlined.  
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1.3 Impact of musculoskeletal pain 
There are several consequences linked to the experience of musculoskeletal pain. In accordance 
to the biopsychosocial model of pain that has been described previously in this chapter, the 
consequences of musculoskeletal pain can be classified in biopsychosocial domains. These 
consequences are outlined below as physical and physiological consequences, psychological affect 
and consequences, and social and economic consequences. 
 
1.3.1 Physical and physiological consequences of musculoskeletal pain  
Musculoskeletal pain can have several physical and physiological consequences. Potential 
physiological changes and symptoms associated with pain presence include dysfunction of the 
sympathetic nervous system (which may lead to tachycardia, hyperventilation, cold sweats, 
blurred vision, abdominal pain, extreme pallor, nausea, dizziness, feeling weak) (Clinch & 
Eccleston, 2009). In addition, individuals with musculoskeletal pain may change their posture as a 
coping and avoidance strategy, or damage to the musculoskeletal structure may alter posture. 
This may ultimately lead to a disequilibrium of the musculoskeletal system in the long-term 
(Clinch & Eccleston, 2009). Another potential consequence is hypersensitivity to pain. Research 
has shown that in the acute phase of musculoskeletal pain a change of the neuronal architecture 
may occur, with changes in the dorsal horn neurones that are in the pathway of transmission of 
pain signals to the brain. This may eventually result in central sensitization, where pain is 
amplified (hyperalgesia) and innocuous stimuli is experienced as painful (allodynia), thus 
intensifying pain perception and making individuals hypersensitive to pain (Voscopoulos & Lema, 
2010). There are also specific mechanisms that can be influenced by pain, for example pain can 
affect the function of the hypothalamus-pituitary-adrenal (HPA) axis, which is the system involved 
in the survival response to stress (Gupta & Silman, 2004; Kaplow et al., 2013; McBeth et al., 2007). 
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In normal circumstances, the activation of the HPA axis in reaction to stress begins with the 
release of the corticotrophin-releasing hormone (CRH) from the hypothalamus, which stimulates 
the anterior pituitary to produce the adrenocorticotropic hormone (ACTH) and ultimately leads to 
the production of cortisol (Gupta & Silman, 2004). During a period of prolonged stress or pain, the 
HPA axis may become hyperactive, leading to the production of high levels of cortisol (Bergman, 
2005; Generaal et al., 2014; McBeth et al., 2007). Following this hyperactive period, the HPA axis 
may become hypoactive with low levels of CRH, which in turn may lower the ACTH levels, 
consequently down-stimulating cortisol production (Generaal et al., 2014; Kaplow et al., 2013; 
McBeth et al., 2007). As a result of this hypo-active HPA axis status, individuals may become more 
sensitive to stressful life-events, and consequently more vulnerable to the impact of 
musculoskeletal pain (the stress diathesis hypothesis). In addition, the presence of pain can affect 
sleep patterns and sleep hygiene, which can result in the experience of fatigue and changes to 
pain sensitivity and tolerance thresholds (Clinch & Eccleston, 2009; Dueñas, Ojeda, Salazar, Mico, 
& Failde, 2016; Mourão, Blyth, & Branco, 2010; Tüzün, 2007). Prolonged exposure to pain (e.g. 
chronic pain) can also induce physical disuse of the musculoskeletal system, which may occur 
when an individual avoids the performance of activities for a long period of time (Leeuw et al., 
2007; Waddell, 2004). This may lead to loss of function, functional limitation and disability 
(Waddell, 2004).  
 
1.3.2 Psychological consequences associated with pain 
There are many psychological factors associated with musculoskeletal pain. Such factors include 
emotional arousal, distress, and depressive and anxiety symptoms (Henschke, Kamper, & Maher, 
2015; Tüzün, 2007; Waddell, 2004); for example evidence shows the prevalence of depression 
and anxiety is significantly higher in persons with chronic pain compared to levels in the general 
population (Roditi & Robinson, 2011; Tüzün, 2007) and that musculoskeletal pain is more 
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common in those with depression (Goesling, Clauw, & Hassett, 2013). One of the key pain related 
psychological concepts that has led to the explanation of the development of chronic 
musculoskeletal pain is pain-catastrophizing (i.e. misinterpreting pain, worrying about pain, pain 
anxiety, and having negative thoughts about the possibility to cope with pain). Research has 
demonstrated that pain catastrophizing is robustly associated with poor prognosis once someone 
has musculoskeletal pain, and may account for pain-associated disability more than pain itself 
(Keefe, Rumble, Scipio, Giordano, & Perri, 2004; Leeuw et al., 2007; Quartana, Campbell, & 
Edwards, 2009; Waddell, 2004). Catastrophizing, which may develop as an adaptive response to 
pain, may lead to fear-avoidance behaviours (i.e. avoiding movements or limiting activities which 
are believed to increase pain). This may consequently contribute to the persistence or 
exacerbation of pain through the processes and principles of classical and operant conditioning 
(e.g. avoidance of pain by restricting movement, and the intrinsic rewards of avoidance such as 
relief leading to greater efforts to avoid pain in the future) (Keefe et al., 2004; Leeuw et al., 2007; 
Vlaeyen & Linton 2000; Waddell, 2004). There are other key factors directly related to the pain 
experience. These include illness behaviour (i.e. how the individual expresses and communicates 
pain and how this information is interpreted and acted upon by other individuals), hypervigilance 
(i.e. tendency of increased awareness of bodily symptoms misinterpreted as pain), misbeliefs 
about pain (e.g. that pain indicates physical damage), altered motivation (e.g. passive coping 
strategies to avoid pain), anhedonia (i.e. inability to feel pleasure), and the impairment of 
cognitive skills such as concentration, attention and memory (Clinch & Eccleston, 2009; Leeuw et 
al., 2007; Mourão et al., 2010; Simons et al., 2014; Tüzün, 2007; Waddell, 2004). Broader 
consequences involve mood disturbance (i.e. lower mood in individuals with musculoskeletal 
pain), coping, self-efficacy and locus of control (i.e. the individual’s confidence in the ability to 
control pain can influence coping responses to pain), as well as general health and a lower quality 
of life perceived by the individuals with pain (Campbell, Bishop et al., 2013; Clinch & Eccleston, 
2009; Dieppe, 2013; Dueñas et al., 2016; Henschke et al., 2015; Keefe et al., 2004; Mourão et al., 
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2010). Finally, compared to people without pain, those with chronic pain show a higher 
vulnerability regarding neuroticism, fear of failure and social isolation (Merlijn et al., 2003).  
 
1.3.3 Social and economic consequences of musculoskeletal pain 
Musculoskeletal pain also has social consequences. For example, as society is shaped upon the 
needs of persons who are fully able-bodied (Waddell, 2004), and musculoskeletal pain may 
involve a certain degree of disability or functional limitations (Section 1.3.1), the person with 
musculoskeletal pain may experience a number of social disadvantages (Waddell, 2004). These 
include limitations on the activities (daily, leisure or strenuous activities) to which the individual is 
able to participate (Dieppe, 2013; Krismer & van Tulder, 2007) and fewer social contacts due to 
the reduction in the time available for family and friends (Dueñas et al., 2016; Tüzün, 2007). As a 
consequence this can lead to social isolation (Waddell, 2004) and affect the social development of 
the person with pain, and the level of social support they receive, which can then impact on the 
perception of pain and how the individual copes with pain (Campbell, Wynne-Jones, & Dunn, 
2011). For example people with pain have less frequent peer relationships than their pain-free 
counterparts (Clinch & Eccleston, 2009), poorer capacity of carrying out normal social activities 
and have restrictions in engaging in daily activities or work activities (Saastamoinen, Leino-Arjas, 
Laaksonen, Martikainen, & Lahelma, 2006). Also, because of the uncertainty of their health status, 
it may be complicated for people with pain to arrange social activities (Dueñas et al., 2016). 
Additionally, pain has an impact on the familial structure. Families in which there is one or more 
persons suffering from musculoskeletal pain may modify their lifestyle in order to cope with the 
person in pain (Waddell, 2004) and evidence shows the impact of pain at a family and partner 
level, for example a change in roles (e.g. partner has to take on increased duties) leading to 
increased stress, anger and frustration at the family member who has pain (Strunin & Boden, 
2004). In addition, persons within the family can have a more limited social life and experience 
11 
 
anxiety and depression as a consequence of their relative who is suffering pain (Clinch & 
Eccleston, 2009; Dueñas et al., 2016). Moreover, research has shown that overall relationship 
quality between couples can be affected when one partner has pain, with evidence that it can 
increase and decrease relationship quality (Vivekanantham, Campbell, Mallen, & Dunn, 2014). In 
addition, research also shows that pain behaviours can be influenced by partners’ reactions, some 
reactions increasing the likelihood of future pain behaviours (e.g. solicitous responses) whilst 
others can increase depression and anxiety (e.g. negative responses from partners), all of which 
demonstrate the complexities of the reciprocal dynamics at a family level when pain is present 
(Campbell, Jordan, & Dunn, 2012; Leonard, Cano, & Johansen, 2006; Waddell, 2004). 
Musculoskeletal pain is also linked to economic costs for both the individual and society. Overall, 
the economic burden of pain is significant, with both direct (direct healthcare, hospitalization, 
medications, outpatient visits, diagnostic tests, assistive devices, alternative therapies) and 
indirect (number of work days lost, productivity loss, employee retraining, administrative 
expenses, disability allowance and unemployment benefits in adults) costs to be considered 
(Breivik, Eisenberg, & O’Brien, 2013; Hoy, Brooks, Blyth, & Buchbinder, 2010; Krismer & van 
Tulder, 2007; Manchikanti et al., 2009). For example it has been estimated that individuals who 
have a back pain condition have overall healthcare expenses 60% higher than those who do not 
suffer of back pain (Manchikanti et al., 2009), and that back pain is one of the main reasons for 
sick leave and work loss (21-43% productivity loss in individuals with pain, with higher 
percentages with increasing severity of pain) (Dueñas et al., 2016). Overall, the mean annual cost 
of chronic pain has been estimated at $560-635 billion in the US (of which $11.6-12.7 billion is the 
cost of lost productivity, 2010 figures), being higher than the costs associated with cancer, 
diabetes and heart disease, and as 3-10% of gross domestic product in Europe in 2008 (Breivik, 
Eisenberg, & O’Brien, 2013; Gaskin & Richard, 2012; Institute of Medicine (US) Committee on 
Advancing Pain Research, Care, 2011). In the UK, the direct cost associated with back pain was 
estimated as £1632 million (1998 figures) (Maniadakis & Gray, 2000). In addition, the impact of 
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musculoskeletal pain can be conceptualised by means of another measure that accounts for the 
years an individual loses due to disability; disability-adjusted life years (DALYs). This measure is 
composed by the sum of the years lived with disability (YLD) and years lost due to premature 
mortality (YLL) (Murray et al., 2012). The proportion of the global disability-adjusted life years 
(DALYs) due to musculoskeletal pain was 4.7% in 1990 and has risen to 6.8% in 2010 (Murray et 
al., 2012). Moreover, low back pain, neck pain and other musculoskeletal disorders rank first, 
fourth and sixth among the leading causes of years lived with disability (YLDs) (Vos et al., 2012). 
Altogether this evidence clearly show the social and economic impact due to musculoskeletal 
pain. 
 
1.3.4 Summary of the impact of musculoskeletal pain 
In this section, the impact of musculoskeletal pain has been outlined. Physical and physiological 
consequences (e.g. change in posture, central sensitization, change in the HPA axis functioning, 
change in sleep patterns), psychological consequences (e.g. anxiety, depression, pain 
catastrophizing, fear-avoidance behaviours), and social (e.g. restriction in social activities, burden 
on the family environment) and economic consequences (e.g. direct healthcare expenses, work 
days lost, productivity loss) have been described. In the following section, the prevalence and 
incidence of musculoskeletal pain are outlined. 
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1.4 Prevalence and incidence of musculoskeletal pain  
In this section epidemiological data representing the prevalence and incidence of musculoskeletal 
pain are reported. In the context of musculoskeletal pain, the term “prevalence” refers to the 
proportion of the population who report the experience of musculoskeletal pain in a determined 
time-period (e.g. lifetime, 1-year, point) while “incidence” is the proportion of new cases of 
musculoskeletal pain that occur over a certain period of time among all the individuals at risk (i.e. 
within a cohort study it would be those within the population without musculoskeletal pain at 
baseline who subsequently report musculoskeletal pain). Some aspects regarding the prevalence 
and incidence of musculoskeletal pain should be underlined. The prevalence and incidence of pain 
are influenced by factors such as the case-definition and the time-period considered (Cimmimo, 
Ferrone, & Cutolo, 2011; McBeth & Jones, 2007). For example, the prevalence or incidence would 
be higher if a longer interval of time was used, for example a 1-year period prevalence or 
incidence rate would be higher than a 1-month period prevalence or incidence rate because of 
the inclusion of more cases with musculoskeletal pain over the longer time period. This is shown 
in the text below, where estimates for the prevalence or incidence of musculoskeletal pain are 
higher if longer intervals are used (Table 1.1 and Table 1.2). Likewise, if less or more stringent 
case-definitions for musculoskeletal pain occurrence are used the prevalence or incidence can 
change. For example the estimate of chronic widespread pain differs depending on which criteria 
are used (e.g. ACR 1990 criteria, which requires bilateral pain, above and below the waist, in the 
axial skeleton present for at least 3 months, will always include more of the population compared 
to a more stringent Manchester definition, which requires pain in at least two sections of two 
contralateral limbs and in the axial skeleton for at least 3 months) (Henschke et al., 2015; Hunt, 
Silman, Benjamin, McBeth, & Macfarlane, 1999; Mourão et al., 2010). Such differences are also 
found based on the definition of the amount or severity of pain (e.g. to be counted one would be 
required to have a certain “amount” of pain or the pain would have to have a certain impact), and 
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on how long the period of pain would have to last (e.g. more than a day, more than a week, more 
than a month).   
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1.4.1 Prevalence of musculoskeletal pain 
A scoping search of published reviews was performed and figures for the prevalence of 
musculoskeletal pain are shown in Table 1.1. Several of the identified reviews report on the 
prevalence of low back pain, neck pain and chronic widespread pain or fibromyalgia. In 
comparison, less information was present regarding the prevalence of pain in the shoulder, knee, 
ankle/foot or lower limbs (See Table 1.1). The most prevalent conditions were low back pain and 
neck pain. From reviews on back pain the evidence suggests that point prevalence (i.e. at the time 
of assessment) is estimated at approximately 20% with a large range between 4% and 60%, and 1 
year period prevalence rates at 40% with a range from 36% to 85%. Reasons for the large 
variation in estimated prevalence rates are due to different definitions used between studies, also 
different populations have been studied, for example general population, workers, clinical 
samples. Similar estimates were reported for the 1-year prevalence of neck pain in several 
reviews (median 37.2%; range 12-75%). Regarding knee pain, the mean 1-year prevalence 
reported in a review was 25.0% (range 6.5-28%). Figures on shoulder pain reported in two reviews 
were similar regarding the 1-month prevalence (range 19-33%). Several authors reported on the 
prevalence of chronic widespread pain, with estimates ranging from 0 to 24% depending on the 
definition used; however, most of the estimates among the 23 studies included in a recent 
systematic review were between 10% and 15% (Mansfield, Sim, Jordan, & Jordan, 2016). Lower 
figures were reported for the prevalence of fibromyalgia (range 0.1-11%). 
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Table 1.1 Prevalence of musculoskeletal pain in adults 
Study Period Site Figure 
Miranda et al., 2012 - Chronic musculoskeletal pain 14.1-85.5% A 
McBeth & Jones, 2007 Lifetime Back pain 51-84% 
 1-year Back pain 36-67% 
 1-month Back pain 31-42% 
 Point Back pain 13-30% 
Louw et al., 2007 Lifetime Back pain 62% (range 56-74%) 
 1-year Back pain 50% (range 40-72%) 
 Point Back pain 32% (range 16-59%) 
Garcia et al., 2014 - Low back pain 31.3% B 
  Low back pain 16.7% (range 9.1-20.3%) C 
  Low back pain 31.5% (range 27.7-33.6%) D 
  Low back pain 65% (range 50.0-80.8%) E 
Woolf & Pfleger, 2003 1-year Low back pain 58-84% 
 Point Low back pain 4-33% 
Hoy et al., 2012 
 
 
 
Johansson et al., 2017  
 
Manchikanti et al., 2009 
Lifetime 
1-year 
1-month 
Point 
1-year 
1-year 
1-year 
Low back pain 
Low back pain 
Low back pain 
Low back pain 
Mid back pain 
Low back pain 
Chronic low back pain 
38.9% 
38.0% 
30.8% 
18.3% 
15% 
43% 
15-45% 
 Point Chronic low back pain 30% 
Henschke et al., 2015 - Chronic low back pain 5.9-11% 
Miranda et al., 2012 - Chronic Low back pain 5.1-65.2% A 
Meucci et al., 2015 - Chronic low back pain 4.2% (Subjects aged 24-39) 
  Chronic low back pain 19.6% (Subjects aged 20-59) 
  Chronic low back pain 25% (Subjects aged >60) 
Miranda et al., 2012 - Lower limb pain 50% A 
Peat et al., 2001 1-year Knee pain 25.0% (range 6.5-28%) 
Thomas et al., 2011 Point Foot/ ankle pain 20% (Subjects aged >45) 
Manchikanti et al., 2009 1-year Neck pain 12.1-71.5% 
Fejer et al., 2006 Lifetime Neck pain 48.5% (range 14.2-71.0%) 
 1-year Neck pain 37.2% (range 16.7-75.1%) 
 6-month Neck pain 29.8% (range 6.9-54.2%) 
 1-month Neck pain 23.3% (range 15.4-41.1%) 
 1-week Neck pain 12.5% (range 1.4%-19.5%) 
 Point Neck pain 7.6% (range 5.9-22.2%) 
Hogg-Johnsons et al., 2008 1-year Neck pain 12.1-71.5% 
 1-month Neck pain 15.4-45.3% 
 1-week Neck pain 12-14% 
Johansson et al., 2017  1-year Neck pain 32% 
Reid et al., 2011 Lifetime Chronic neck pain 5% 
McBeth & Jones, 2007 
Luime et al., 2004 
1-month 
Point 
1-month 
1-year 
Lifetime 
Shoulder pain 
Shoulder pain 
Shoulder pain 
Shoulder pain 
Shoulder pain 
20-33% 
6.9-26% 
19-31% 
5-47% 
7-67% 
A Systematic review conducted on elderly Brazilian populations 
B Overall pooled estimate 
C Miners, oil workers and university administrative officials 
D Nurses, senior citizens, transit bus drivers, workers enrolled in a physical rehabilitation program and 
university employees 
E Truck drivers, seamstresses, sitting workers, coffee sack loaders, obese population, pregnant women, 
sawyers, homemakers, nurses 
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Table 1.1 Prevalence of musculoskeletal pain in adults 
Study Period Site Figure 
Gran, 2003 - Chronic widespread pain 0.0-13.2% 
McBeth and Jones, 2007 - Chronic widespread pain 7-22% 
Cimmino et al., 2011 - Chronic widespread pain 11.4-24% 
Mourão et al., 2010 - Chronic widespread pain 4.2-13.3% 
Shipley, 2010 - Chronic widespread pain 10% 
Mansfield et al., 2016 - Chronic widespread pain 0-24% 
McBeth and Jones, 2007 - Fibromyalgia 1-11% 
Mourão et al., 2010 - Fibromyalgia 0.7-7.3% 
Shipley, 2010 - Fibromyalgia 2% 
Reid et al., 2011 - Fibromyalgia 2.9% 
Gran, 2003 - Fibromyalgia 0.1-3.3% 
A Systematic review conducted on elderly Brazilian populations 
B Overall pooled estimate 
C Miners, oil workers and university administrative officials 
D Nurses, senior citizens, transit bus drivers, workers enrolled in a physical rehabilitation program and 
university employees 
E Truck drivers, seamstresses, sitting workers, coffee sack loaders, obese population, pregnant women, 
sawyers, homemakers, nurses 
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1.4.2 Incidence of musculoskeletal pain 
In this scoping search, rates of the incidence of musculoskeletal pain were identified (Table 1.2). 
As with the evidence presented on prevalence, variation in estimates are wide depending on a 
number of factors (time frame, definition, first ever episode or new episode). For back pain, 
estimates for the 1-year incidence ranged from 1.5% up to 36% (Hoy et al., 2010), with a recent 
systematic review providing a pooled estimate (26%-27%) for community and occupational 
settings (Taylor, Goode, George, & Cook, 2014). Other reviews reported on the incidence for knee 
pain or patellofemoral pain (25%, time-frame not specified) (Callaghan & Selfe, 2007), and on the 
1-year incidence estimate for neck pain (14.6-17.9%), shoulder pain (0.9-2.5%), chronic 
musculoskeletal pain (8.3%) and fibromyalgia (0.6%) (Cimmimo, Ferrone, & Cutolo, 2011; Gran, 
2003; Hogg-Johnson et al., 2008; Luime et al., 2004). 
  
Table 1.2 Incidence of musculoskeletal pain in adults 
Study Period Site Figure 
Hoy et al., 2010 1-year Low back pain 6.3-15.4% A 
 1-year Low back pain 1.5-36% B 
Taylor et al., 2014 - Low back pain 26% A 
 - Low back pain 27% B 
Woolf & Pfleger, 2003 
Johansson et al., 2017  
Meucci et al., 2015 
Callagahan & Selfe, 2007 
Hogg-Johnsons et al., 2008 
Luime et al., 2004 
1-year 
1-month 
1-year 
- 
1-year 
1-year 
Low back pain 
Mid back pain 
Chronic low back pain 
Knee pain 
Neck pain 
Shoulder pain 
2.8% 
0.4-0.7% 
10.8% 
25% (range 3-40%) 
14.6 -17.9% 
0.9-2.5% 
Cimmino et al., 2011 1-year Chronic widespread pain 8.3% 
Gran, 2003 1-year Fibromyalgia 0.6% 
A First-ever episode of low back pain 
B Populations pain-free at baseline in community and occupational settings 
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1.4.3 Summary of prevalence and incidence figures for musculoskeletal pain 
An extensive body of information on the prevalence and incidence of musculoskeletal conditions 
has been shown in Sections 1.4.1 and 1.4.2 above. Despite the wide variability of the estimates 
reported, (due to variation on population, age, setting, definition, and duration), the figures 
reported indicate that musculoskeletal pain is common in adults, with high prevalence and 
incidence rates in the general population. In the next section the risk factors for the onset of 
musculoskeletal pain are outlined. 
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1.5 Risk factors for the onset of musculoskeletal pain 
Evidence for factors associated with the onset of musculoskeletal pain are summarized in this 
section. A scoping search of recent reviews that report on risk factors for the onset of 
musculoskeletal pain in adults was performed to complement the full systematic review on 
factors in childhood and adolescence within the next chapter. A brief description of the 
association for potential risk factors with pain in different body sites is given below (Section 1.5.1 - 
1.5.4). For ease of reading and interpretation, risk factors will be described corresponding to the 
biopsychosocial model of pain (i.e. biological factors, psychological factors and social factors). 
Only the evidence of the presence of an association is reported but not the size of effect. Most 
reviews report on risk factors for low back pain as most of the research has focused on this 
condition, although information on risk factors relative to other body sites is presented where 
available. Evidence is presented as a positive effect (+) if the factor is shown to increase risk, a 
negative sign (-) was assigned if there was no association, and a hash sign (#) if the evidence for 
that factor was mixed. 
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1.5.1 Biological factors 
1.5.1.1 Age  
The effect of age on musculoskeletal pain has been explored and reported in many reviews (Table 
1.3). As can be seen from the evidence within Table 1.3 the majority of evidence suggest an 
association of greater risk of musculoskeletal pain onset with increasing age. Though there is 
some suggestion that this is not linear and that this relationship decreases after the 6th decade of 
life (Cimmimo et al., 2011; Hoy et al., 2010; McBeth & Jones, 2007). 
 
 
 
  
Table 1.3 Risk factors for musculoskeletal pain in adults – Age 
Risk factor Review Pain site Effect 
Age Henschke et al.,2015 Musculoskeletal pain # 
 McBeth & Jones, 2007 Musculoskeletal pain + 
 Hoy et al., 2010 Musculoskeletal pain + 
 Krismer & van Tulder, 2007 Low back pain + 
 Manchikanti et al., 2009 
Dionne et al., 2006 
Low back pain 
Low back pain 
+ 
# 
 Manchikanti et al., 2009 Neck pain + 
 Hogg-Johnsons et al., 2008 Neck pain # 
 Bergman, 2005 Chronic widespread pain + 
 Mourão et al., 2010 Chronic widespread pain + 
 Cimmino et al., 2011 Chronic widespread pain + 
 Larsson et al., 2012 Chronic widespread pain + 
 Mourão et al., 2010 Fibromyalgia + 
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1.5.1.2 Female gender 
Several reviews (Table 1.4) indicate female gender to be a risk factor for musculoskeletal pain in 
general (Henschke et al., 2015; Hoy et al., 2010; McBeth & Jones, 2007), and chronic widespread 
pain and fibromyalgia more specifically (Bergman, 2005; Cimmimo et al., 2011; Gran, 2003; 
Larsson, Björk, Börsbo, & Gerdle, 2012; Mourão et al., 2010). However there was also evidence of 
mixed findings for both back pain (Louw, Morris, & Grimmer-Somers, 2007; Manchikanti et al., 
2009), and neck pain (Hogg-Johnson et al., 2008; Manchikanti et al., 2009). In summary, the 
majority of the evidence suggests that female gender is a risk factor for the development of 
musculoskeletal pain. This may be partly explained by physical or physiological differences 
between males and females, but also by differences in pain perception and sex-role expectancies 
which may encourage the reporting of pain in females compared to males (Fillingim, 2000). 
 
 
 
  
Table 1.4 Risk factors for musculoskeletal pain in adults – Female gender 
Risk factor Review Pain site Effect 
Female gender Henschke et al.,2015 Musculoskeletal pain + 
 McBeth & Jones, 2007 Musculoskeletal pain + 
 Hoy et al., 2010 Musculoskeletal pain + 
 Louw et al., 2007 Low back pain + 
 Manchikanti et al., 2009 Low back pain # 
 Manchikanti et al., 2009 Neck pain + 
 Hogg-Johnsons et al., 2008 Neck pain # 
 Gran, 2003 Chronic widespread pain + 
 Bergman, 2005 Chronic widespread pain + 
 Mourão et al., 2010 Chronic widespread pain + 
 Cimmino et al., 2011 Chronic widespread pain + 
 Larsson et al., 2012 Chronic widespread pain + 
 Gran, 2003 Fibromyalgia + 
 Mourão et al., 2010 Fibromyalgia + 
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1.5.1.3 Physical and mechanical factors 
Three reviews were identified that reported information on the association between physical 
factors and musculoskeletal pain (Table 1.5). Factors associated with risk of low back pain are disc 
degeneration (but not in neck pain, (Manchikanti et al., 2009) and behaviours such as limping or 
lifting heavy weights. 
 
 
 
  
Table 1.5 Risk factors for musculoskeletal pain in adults – Physical and mechanical 
factors 
Risk factor Review Pain site Effect 
Physical and 
mechanical factors 
Leboeuf-Yde, 2004 
Taylor et al., 2014 
Low back pain 
Low back pain 
# 
+ 
 Manchikanti et al., 2009 Low back pain + 
 Manchikanti et al., 2009 Neck pain - 
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1.5.1.4 Presence of other pain symptoms 
A number of reviews have shown that previous experience of pain or pain in other body sites are 
risk factors for the onset of low back pain (Louw et al., 2007; Taylor et al., 2014), neck pain (Hogg-
Johnson et al., 2008) and chronic widespread pain (Bergman, 2005; Mourão et al., 2010) (Table 
1.6). Finally, the number of pain sites at baseline was reported as a risk factor for the transition 
from chronic regional pain to chronic widespread pain in another systematic review (Larsson et 
al., 2012). The evidence provided by these reviews suggest a link between the presence of other 
pain symptoms or previous experience of pain and the onset of musculoskeletal pain or the 
transition to widespread pain. 
 
 
Table 1.6 Risk factors for musculoskeletal pain in adults – Presence of other pain 
symptoms 
Risk factor Review Pain site Effect 
Presence of other  Taylor et al., 2014 Low back pain + 
Pain symptoms Louw et al., 2007 Low back pain + 
 Hogg-Johnsons et al., 2008 Neck pain + 
 Bergman, 2005 Chronic widespread pain + 
 Mourão et al., 2010 Chronic widespread pain + 
 Larsson et al., 2012 Chronic widespread pain + 
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1.5.1.5 Physical activity 
There is conflicting results on the effect of physical activity on musculoskeletal pain (Table 1.7). 
Some evidence suggests that increases in physical activity decrease the risk for low back pain and 
neck pain onset, however engagement in vigorous sport activities has been shown to have a 
negative effect on the musculoskeletal health (Hildebrandt, Bongers, Dul, van Dijk, & Kemper, 
2000). Conversely, a recent meta-analysis reported no effect of physical activity on the onset of 
low back pain, and a protective effect for the development of chronic low back pain (Shiri & Falah-
Hassani, 2017). This is in contrast with another review that reported a significant effect for the 
onset of low back pain among those who regularly participated in sports (Taylor et al., 2014). 
Engagement in regular physical activity may be an effective preventive strategy for non-specific 
low back pain according to other authors (Krismer & van Tulder, 2007). Finally, another review 
reported low physical activity as a risk factor for chronic widespread pain (Cimmimo et al., 2011). 
At present the evidence is mixed, but suggestive that moderate levels of physical activity may be 
protective for musculoskeletal pain or chronic musculoskeletal pain. 
 
 
  
Table 1.7 Risk factors for musculoskeletal pain in adults – Physical activity 
Risk factor Review Pain site Effect 
Physical activity Hildebrandt et al., 2000 Musculoskeletal pain # 
 Taylor et al., 2014 Low back pain + 
 Shiri et al., 2017 Low back pain - 
 Krismer & van Tulder, 2007 Low back pain - 
 Cimmino et al., 2011 Chronic widespread pain + 
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1.5.1.6 Obesity 
Seven reviews report findings on the association between BMI categories and musculoskeletal 
pain (Table 1.8). Four reviews reported that obesity or having a higher BMI is a risk factor for 
incident low back pain or chronicity of low back pain, also for chronic widespread pain and 
fibromyalgia (Hoy et al., 2010; Mourão et al., 2010; Shiri, Karppinen, Leino-Arjas, Solovieva, & 
Viikari-Juntura, 2010a; Weigl, Cieza, Cantista, Reinhardt, & Stucki, 2007). However, another 
literature review reported that the association between obesity and low back pain did not show a 
dose-response pattern and was not present in monozygotic twins who were dissimilar in body 
weight, suggesting no evidence for causality or a potential genetic interaction effect (Leboeuf-
Yde, 2004). This is supported by two reviews that reported mixed evidence for an association 
between BMI and low back pain (Manchikanti et al., 2009; Taylor et al., 2014). Based on the 
evidence of these reviews, obesity or higher BMI is likely to be associated with musculoskeletal 
pain, but the associations reported may be the due to other underlying factors associated to the 
development of musculoskeletal conditions. It may be therefore that higher BMI alone is not 
sufficient to cause the development of the condition, but when present together with other 
factors it may contribute to the development of musculoskeletal pain and to its chronicity.  
 
 
Table 1.8 Risk factors for musculoskeletal pain in adults – Obesity 
Risk factor Review Pain site Effect 
Obesity Shiri et al., 2010 Low back pain + 
 Taylor et al., 2014 Low back pain # 
 Weigl et al., 2007 Low back pain + 
 Hoy et al., 2010 Low back pain + 
 Leboeuf-Yde, 2004 Low back pain # 
 Manchikanti et al., 2009 Low back pain # 
 Mourão et al., 2010 Chronic widespread pain + 
 Mourão et al., 2010 Fibromyalgia + 
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1.5.1.7 Smoking  
Another factor suspected to be related to the onset of musculoskeletal pain is smoking (Table 
1.9). Several reviews report on smoking as a risk factor for the onset of low back pain (Abate, 
Vanni, Pantalone, & Salini, 2013; Louw et al., 2007; Manchikanti et al., 2009; Shiri, Karppinen, 
Leino-Arjas, Solovieva, & Viikari-Juntura, 2010), chronic widespread pain (Bergman, 2005; 
Cimmimo et al., 2011; Gran, 2003) and neck pain (Hogg-Johnson et al., 2008; Manchikanti et al., 
2009). The association between smoking and pain may be explained by the thousands of 
compounds that are present in cigarette smoke, with several of them resulting in physiological 
effects (Shi, Weingarten, Mantilla, Hooten, & Warner, 2010), such as changes in the 
neuroendocrine system that alter the perception of pain and increase the degeneration of bone 
(Holley et al., 2013; Shi et al., 2010). Smoking could also be responsible for an increased time of 
curing and the alteration of bone metabolism but is also a proxy marker for other factors such as 
deprivation and poor health behaviour in general (Abate et al., 2013; Holley et al., 2013; Shi et al., 
2010).  
 
 
Table 1.9 Risk factors for musculoskeletal pain in adults – Smoking 
Risk factor Review Pain site Effect 
Smoking Shiri et al. 2010 Low back pain + 
 Leboeuf-Yde, 2004 Low back pain # 
 Louw et al., 2007 Low back pain + 
 Abate et al. 2013 Low back pain + 
 Manchikanti et al., 2009 Low back pain + 
 Manchikanti et al., 2009 Neck pain + 
 Hogg-Johnsons et al., 2008 Neck pain + 
 Gran, 2003 Chronic widespread pain + 
 Bergman, 2005 Chronic widespread pain + 
 Cimmino et al., 2011 Chronic widespread pain + 
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1.5.1.8 Sleep problems 
Sleep problems (e.g. problems falling asleep, waking up during the night, non-restorative sleep) 
are another factor suspected to be related to musculoskeletal pain onset, and the results of 5 
reviews show a consistent link between sleep problems and musculoskeletal pain onset (Table 
1.10). However, there is evidence of variation across different types of musculoskeletal 
conditions, for example sleep disorders were indicated as a risk factor for chronic musculoskeletal 
pain (Bergman, 2005; Cimmimo et al., 2011; Mourão et al., 2010), and for incident low back pain 
(Taylor et al., 2014). Finally, a recent review investigated the bidirectional association between 
sleep and pain, both in prospective and experimental research. Findings showed that sleep 
problems are more likely to precede pain in contrast to pain as a predictor of sleep problems 
(Finan, Goodin, & Smith, 2013). Possible mechanisms that may explain the association between 
sleep and musculoskeletal pain include an augmented production of cytokine and inflammatory 
mediators, moreover sleep problems may increase the muscular tension, potentially making 
individuals more vulnerable to muscular problems (Auvinen et al., 2010; Bonvanie, Oldehinkel, 
Rosmalen, & Janssens, 2016; Irwin, Olmstead, & Carroll, 2016). Other factors involved in the 
association between sleep and musculoskeletal pain are disturbances of the sleep architecture 
and genetic factors (Kelly, Blake, Power, O’keeffe, & Fullen, 2011; Moldofsky, 2001; Zhang et al., 
2012). According to the above mentioned reviews, all the evidence suggests an association 
between sleep problems and musculoskeletal pain. 
 
Table 1.10 Risk factors for musculoskeletal pain in adults – Sleep problems 
Risk factor Review Pain site Effect 
Sleep problems Taylor et al., 2004 
Finan et al., 2013 
Low back pain 
Musculoskeletal pain 
+ 
+ 
 Bergman, 2005 Chronic widespread pain + 
 Cimmino et al., 2011 Chronic widespread pain + 
 Mourão et al., 2010 Chronic widespread pain + 
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1.5.1.9 Familial and Genetic factors 
Some reviews report on the role of familial and genetic factors on the onset and heritability of 
musculoskeletal pain (Table 1.11). According to a review, genetic factors explain the association 
between disc degeneration and low back pain, which therefore could be heritable (Manchikanti et 
al., 2009). In three systematic reviews on twin studies of pain, the heritability estimate of 
musculoskeletal pain was approximately 50% for chronic widespread pain, and approximately 
35% for back pain and neck pain (Hogg-Johnson et al., 2008; Mourão et al., 2010; Nielsen, 
Knudsen, & Steingrímsdóttir, 2012). Another two systematic reviews report that family history of 
pain is a risk factor for the onset of chronic widespread pain and the transition from chronic 
regional pain to chronic widespread pain (Bergman, 2005; Larsson et al., 2012). Despite the 
reported genetic link for musculoskeletal pain, it is still difficult to identify definitive unique 
genetic markers for pain, for example previous research has shown that at least 358 genes are 
likely to be involved with pain or analgesia, and so currently research is quite a way off from 
identifying a specific pain genotype (Mogil, 2009, 2012). 
 
 
 
  
Table 1.11 Risk factors for musculoskeletal pain in adults – Familial and genetic factors 
Risk factor Review Pain site Effect 
Familial and Genetic  Manchikanti et al., 2009 Low back pain + 
factors Nielsen et al., 2012 
 
Hogg-Johnsons et al., 2008 
Nielsen et al., 2012 
Low back pain 
Neck pain 
Neck pain 
Chronic widespread pain 
+ 
+ 
+ 
+ 
 Bergman, 2005 Chronic widespread pain + 
 Larsson et al., 2012 Chronic widespread pain + 
 Mourão et al., 2010 Chronic widespread pain + 
 Mourão et al., 2010 Fibromyalgia + 
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1.5.2 Psychological factors 
There is a large body of evidence suggesting a relationship between psychological factors (e.g. 
depression, anxiety, stress and somatization) and musculoskeletal pain onset (Table 1.12). Several 
reviews report on psychological factors such as depression, anxiety, stress, poor mental 
behaviours, mental distress, emotional problems, mood/emotions, cognitive functioning, pain 
behaviour, passive coping strategies, somatization, catastrophizing, social isolation, panic 
disorders and familial mood disorders as risk factors for the onset of low back pain, neck pain, 
musculoskeletal pain, knee pain, chronic musculoskeletal pain or fibromyalgia (Bergman, 2005; 
Cimmimo et al., 2011; Gran, 2003; Hogg-Johnson et al., 2008; Hoy et al., 2012; Krismer & van 
Tulder, 2007; Manchikanti et al., 2009; McBeth & Jones, 2007; Mourão et al., 2010; Phyomaung et 
al., 2014; Pinheiro et al., 2015; Taylor et al., 2014; Weigl et al., 2007).  
 
Table 1.12 Risk factors for musculoskeletal pain in adults – Psychological factors 
Risk factor Review Pain site Effect 
Psychological  McBeth & Jones, 2007 Musculoskeletal pain + 
variables Taylor et al., 2004 Low back pain + 
 Krismer & van Tulder, 2007 Low back pain + 
 Pinheiro et al., 2015 Low back pain + 
 Weigl et al., 2007 Low back pain + 
 Hoy et al., 2010 Low back pain + 
 Manchikanti et al., 2009 Low back pain + 
 Phyomaung et al., 2014 Knee pain # 
 Manchikanti et al., 2009 Neck pain + 
 Hogg-Johnsons et al., 2008 Neck pain + 
 Gran, 2003 Chronic widespread pain + 
 Bergman, 2005 Chronic widespread pain + 
 Cimmino et al., 2011 Chronic widespread pain + 
 Mourão et al., 2010 Chronic widespread pain + 
 Gran, 2003 Chronic widespread pain + 
 Mourão et al., 2010 Fibromyalgia + 
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1.5.3 Social factors 
1.5.3.1 Socioeconomic status 
Many reviews have reported on the association between socioeconomic status and 
musculoskeletal pain onset (Table 1.13). Two systematic reviews reported a relationship between 
socioeconomic factors (including perceived inadequacy of income, lower social status, low 
educational status, low income, social class) and incident low back pain (Manchikanti et al., 2009; 
Taylor et al., 2014). With regard to neck pain, the evidence for an association with socioeconomic 
status is mixed (Manchikanti et al., 2009). Several indicators of low socioeconomic status (e.g. 
lower education, low income, being an immigrant, separated, divorced, widowed, disabled, and 
lower-level employee or manual worker, unemployment) were reported as risk factors for chronic 
widespread pain and fibromyalgia in other reviews (Bergman, 2005; Cimmimo et al., 2011; Gran, 
2003; Mourão et al., 2010). Whilst there is accord on the social factors associated with 
musculoskeletal pain, one review suggests that rather than a direct risk factor, factors like 
socioeconomic status may be a risk marker, with other factors (e.g. psychosocial factors) linked to 
the onset of musculoskeletal pain (McBeth & Jones, 2007).  
 
  
Table 1.13 Risk factors for musculoskeletal pain in adults – Socioeconomic status 
Risk factor Review Pain site Effect 
Low socioeconomic  McBeth & Jones, 2007 Musculoskeletal pain + 
status Taylor et al., 2004 Low back pain + 
 Manchikanti et al., 2009 Low back pain + 
 Manchikanti et al., 2009 Neck pain # 
 Bergman, 2005 Chronic widespread pain + 
 Gran, 2003 Chronic widespread pain + 
 Cimmino et al., 2011 Chronic widespread pain + 
 Mourão et al., 2010 Chronic widespread pain + 
 Gran, 2003 Fibromyalgia + 
 Mourão et al., 2010 Fibromyalgia + 
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1.5.3.2 Ethnicity 
Four reviews (Table 1.14) reported a relationship between an individuals’ ethnicity and 
musculoskeletal pain, with non-Caucasians groups (e.g. African-American, Hispanic, South Asian, 
American Indians and Alaska Natives) more at risk compared to Caucasian groups (Cimmimo et 
al., 2011; Jimenez, Garroutte, Jundu, Morales, & Buchwald, 2012; Manchikanti et al., 2009; 
McBeth & Jones, 2007). Explanations involve cultural differences in the conceptualisation of pain 
and the measurement of pain (Jimenez, Garroutte, Jundu, Morales, & Buchwald, 2012; 
Manchikanti et al., 2009). However, similar to the link of socioeconomic status, ethnicity may be a 
risk marker rather than a risk factor (McBeth & Jones, 2007). In summary, according to this body 
of literature non-Caucasian individuals may be at higher risk of experiencing musculoskeletal pain, 
although it is not clear yet if this is a direct consequence of the ethnicity or of other underlying 
associated factors. 
 
 
Table 1.14 Risk factors for musculoskeletal pain in adults – Ethnicity 
Risk factor Review Pain site Effect 
Ethnicity Jimenez et al. 2012 Musculoskeletal pain + 
 McBeth & Jones, 2007 Musculoskeletal pain + 
 Manchikanti et al., 2009 Neck pain + 
 Cimmino et al., 2011 Chronic widespread pain + 
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1.5.3.3 Work and occupational factors 
Table 1.15 shows 10 reviews that studied the link between various work factors and 
musculoskeletal pain. The evidence is mixed due to the high level of variation in the factors 
measured, and the differing types of employment. Key factors that appear involved in the link 
between employment and musculoskeletal pain onset are low levels of job satisfaction and 
support at work, and the physical and ergonomic aspects of the job. Based on this evidence, it 
appears that work does have a role on the onset of musculoskeletal pain, however there is no 
clear consensus yet on what the specific factors may be. 
 
 
   
Table 1.15 Risk factors for musculoskeletal pain in adults – Work and occupational 
factors 
Risk factor Review Pain site Effect 
Working Taylor et al., 2004 Low back pain + 
 Hoy et al., 2010 Low back pain + 
 Krismer & van Tulder, 2007 Low back pain + 
 Manchikanti et al., 2009 Low back pain + 
 Campbell et al., 2013 Low back pain # 
 Leboeuf-Yde, 2004 
Kwon et al., 2011 
Low back pain 
Low back pain 
- 
# 
 Ariens et al., 2001 Neck pain + 
 Manchikanti et al., 2009 Neck pain + 
 Hogg-Johnsons et al., 2008 Neck pain + 
 Cimmino et al., 2011 Chronic widespread pain + 
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1.5.3.4 Alcohol consumption 
Two reviews reported on the association between alcohol consumption and the onset of 
musculoskeletal pain (Table 1.16). The evidence from these reviews is mixed. One review 
reported an association between alcohol consumption and self-reported low back pain, but not in 
a dose-response relationship, and the association was not present when controlling for 
monozygotic twins who were discordant for alcohol consumption (Leboeuf-Yde, 2004). In another 
systematic review only one among 18 retrospective and longitudinal studies reported a clear 
association between alcohol consumption and low back pain (Ferreira, Pinheiro, Machado, & 
Ferreira, 2013). This suggests that the evidence that alcohol consumption is a factor associated 
with the onset of musculoskeletal pain is inconclusive. However, more research is needed to 
confirm that alcohol consumption does not contribute to the onset of musculoskeletal pain. 
 
Table 1.16 Risk factors for musculoskeletal pain in adults – Alcohol consumption 
Risk factor Review Pain site Effect 
Alcohol 
consumption 
Leboeuf-Yde, 2004 
Ferreira et al., 2013 
Low back pain 
Low back pain 
# 
# 
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1.5.4 Summary of the risk factors for musculoskeletal pain in adults 
In the previous sections the potential risk factors for the onset of musculoskeletal pain in adults 
have been described. According to the body of evidence from different reviews (whose 
conclusions may be partly based on findings reported from the same studies), there are some 
factors which seem to be predictive of the onset of musculoskeletal pain in adults. These factors 
are female gender, higher age, ethnicity, physical and mechanical factors, psychological factors, 
sleep problems and previous history of musculoskeletal pain or the presence of musculoskeletal 
pain in other body sites. Other factors have less conclusive support and therefore further research 
is needed to clarify how socioeconomic status, physical activity, smoking, obesity, familial and 
genetic factors, work-related factors and alcohol consumption potentially influence the onset of 
musculoskeletal pain. In the next section the rationale for investigating musculoskeletal pain in 
children and adolescents is outlined, followed by a description of prevalence and incidence figures 
for musculoskeletal pain in children and adolescents. 
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1.6 Rationale for investigating musculoskeletal pain in children and adolescents 
The nature and understanding of musculoskeletal pain and how it is experienced has changed 
over time. In the past musculoskeletal pain has been understood as an episodic condition, the 
experience seen as discrete episodes of pain interceded by pain free periods, with these pain free 
periods reducing in frequency and length as chronicity takes hold (Axen & Leboeuf-Yde, 2013; 
Dunn, Hestbaek, & Cassidy, 2013). However a strong body of research that has investigated the 
course of musculoskeletal pain over time (using innovative statistical techniques such as latent 
class trajectories and latent class growth analysis) has emerged to show that, in adults, the 
patterns or trajectories of pain over time are relatively stable and not episodic in nature, for 
example people with high levels of pain severity are much more likely to have this trajectory over 
time compared to those with a low level of pain or no pain (Dunn, Jordan, & Croft, 2006; Dunn, 
Campbell, & Jordan, 2013; Lemeunier, Leboeuf-Yde, & Gagey, 2012). A recent systematic review 
identified eight articles that reported on the trajectories of low back pain (the most common 
musculoskeletal pain condition in adults), and showed that low back pain status at baseline was 
highly predictive of the trajectory of low back pain later in life (Lemeunier, Leboeuf-Yde, & Gagey, 
2012). Specifically, individuals without low back pain at baseline were more likely to be free of low 
back pain at follow-up, whereas the opposite was found for those with pain at baseline. When 
movement to other trajectory groups occurred (e.g. movement of an individual from one pain 
trajectory classification to another), it was towards neighbouring groups in terms of pain intensity 
or frequency rather than an episodic “pain to pain free”, or vice versa, over time (Lemeunier et 
al., 2012). Giving more credence to the stability of pain trajectories, one recent study carried out a 
long term trajectory analysis over a period of 7 years in those who had consulted for back pain in 
primary care. The study was completed in two parts, in the first part pain trajectories were 
calculated using latent class analysis over a period of 6 months (using monthly measures of pain 
intensity), and four trajectories were identified; individuals with persistent severe pain, with 
fluctuating pain, with mild persistent pain, and no pain. The cohort was followed up 7 years later 
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and again trajectories calculated over a period of 6 months (monthly measures), and the findings 
show that the majority of individuals remained within their original trajectory cluster with little 
evidence of movement. Only 11% of individuals moved to groups of a different severity of pain 
(fluctuating group), thus suggesting that the pattern of episodic pain, and even increasing pain or 
recovering pain is not common (Dunn, Jordan, et al., 2006; Dunn, Campbell, et al., 2013). Given 
the growing evidence that adult pain patterns are relatively stable over time, raises the question 
of when might these stable patterns actually begin? One study (Dunn, Jordan, Mancl, Drangsholt, 
& Le Resche, 2011) considered if stability is found in a younger population. They carried out a 
trajectory study in adolescents (monthly measures over a period of 3 years) and the findings show 
some distinct differences in trajectory clusters compared to the findings in adult populations. In 
line with findings in adults, trajectories were identified for persistent pain, fluctuating pain, 
persistent mild pain and no pain, however there was also evidence of “emerging” trajectories in 
this age group (i.e. trajectories of increasing pain, low to high to low pain, and those of recovering 
pain), suggesting perhaps the starting points for trajectory development and that the origins of 
long term musculoskeletal pain trajectories may begin in childhood and adolescence (Dunn et al., 
2011; Dunn, Hestbaek, et al., 2013). Further support for this hypothesis has come from other 
prospective studies, which showed that musculoskeletal pain in adolescence is predictive of 
musculoskeletal pain in adulthood (Brattberg, 2004; Harreby, Neergaard, Hesselsôe, & Kjer, 1995; 
Hestbaek, Leboeuf-Yde, Kyvik, & Manniche, 2006). As the evidence base for the emergence of 
“pain trajectories” within children and adolescents has grown, there is an ever increasing need to 
understand the beginnings of pain, and what factors are involved in these beginnings (i.e. risk 
factors). One drawback within research of these beginnings in adult populations is the actual 
identification of “first ever” musculoskeletal pain. As outlined above, musculoskeletal pain is very 
common, and in adults there is high likelihood that individuals have experienced periods of pain 
before. This prior experience of pain may shape how they respond to future pain (e.g. 
maladaptive coping, fear-avoidance behaviour, psychological distress), making the identification 
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of incident risk factors difficult. It may be that the way in which we respond to pain in early life 
sets the model to how we might respond as adults. Therefore, there is a need to understand the 
factors involved in the prediction of musculoskeletal pain onset in children and adolescents, as 
this potentially reduces the chance of the influence of previous experience of musculoskeletal 
pain. Such information on incident risk factors can then be used to give greater understanding to 
the forming of long term pain trajectories in adulthood. This information could then help develop 
appropriate interventions designed for groups of children/adolescents at high risk of long term 
pain, potentially averting significant individual and societal burden. Another advantage to the 
study of musculoskeletal pain onset in children and adolescents is the opportunity to compare 
differences in risk factors to those in adults, this may also reveal specific and important factors 
unique to children and adolescents. In the following section, estimates of the prevalence and 
incidence of musculoskeletal pain in children and adolescents are described. 
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1.7 Musculoskeletal pain in children and adolescents 
In this section, estimates reported in several reviews regarding the prevalence (Section 1.7.1) and 
incidence (Section 1.7.2) of musculoskeletal pain in children and adolescents, are presented.  
 
1.7.1 Prevalence of musculoskeletal pain in children and adolescents 
Estimates of the prevalence of musculoskeletal pain are reported in Table 1.17. As can be seen 
within Table 1.17 there is a wide range of estimates dependent on pain type, body site, time-
frame and in what population, which creates considerable heterogeneity. Taking the evidence 
together around 1-2% of children and adolescents have chronic disabling pain, with a higher level 
(up to 50% of those referring to primary care) for recurrent pain. In addition, Table 1.17 shows 
that low back (1-year prevalence 33%, range 4-51%) and neck pain (1-year prevalence range 15.8-
71.5%) are the most prevalent. Lower rates were reported for limb pain (2 - 24%), chronic 
widespread pain (7.5%) and fibromyalgia which was estimated to have the lowest prevalence (≤ 
3%). In addition, the period of sharp increase in prevalence rates of musculoskeletal pain seems to 
be between the age of 12 and 15 (Hill & Keating, 2009), and by the age of 18 the prevalence 
values are similar to those reported in adults (Jeffries, Milanese, & Grimmer-Somers, 2007). 
 
 
Table 1.17 Prevalence of musculoskeletal pain in children and adolescents 
Study Period Site Figure 
Clinch & Eccleston, 2009 - Chronic disabling pain 1-2% 
Holm et al., 2012 - Pain >3 months 87% A 
  Pain >12 months 48% A 
  Recurrent pain 50% A 
King et al., 2011 - Musculoskeletal pain 4-40% 
De Inocencio, 2004 - Musculoskeletal pain 1.6-11.2% A  
A Percentage of children among those who referred to primary care for musculoskeletal pain 
B Rates for 100 encounters due to musculoskeletal pain 
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Table 1.17 Prevalence of musculoskeletal pain in children and adolescents 
Study Period Site Figure 
Hoy et al., 2012 - Low back pain 20-30% 
McBeth & Jones, 2007 - Low back pain 8-44% 
Calvo-Muñoz et al., 2013 Lifetime 
1-year 
1-week 
Low back pain 
Low back pain 
Low back pain 
39.9% 
33.6% 
17.7% 
 
Louw et al., 2007 
Point 
Lifetime 
Low back pain 
Low back pain 
12% 
36% (range 28-52%) 
 1-year Low back pain 33% (range 14-51%) 
 Point Low back pain 12% (range 10-14%) 
Garcia et al., 2014 - Low back pain 19.5% 
Jeffries et al., 2007 Lifetime Low back pain 7-72% 
 1-year Low back pain 7-50.8% 
 1-month Low back pain 9.8-36% 
 1-week Low back pain 9.5-35% 
 Point Low back pain 1-38.5% 
Johansson et al., 2017 1-month Mid back pain 13-35% 
 1-month Low back pain 4-36% 
Hill & Keating, 2009 Lifetime Low back pain 9-60% 
 1-year Low back pain 4-48% 
 Point Low back pain 1-49% 
Henschke et al., 2015 1-month Low back pain 9.8-36.0% 
King et al., 2011 1-month Chronic Back pain 18-24% 
Fuglkjaer et al., 2017 1-year Lower limb pain 5.8-10.9% 
 1-week Lower limb pain 4.1-19% 
Smith et al., 2014  Lower limb pain 24% 
Henschke et al., 2014  Lower limb pain 1.72-5.33% (boys) B 
  Lower limb pain 1.85-4.40% (girls) B 
Fuglkjaer et al., 2017 1-year Upper limb pain 4.8-5.1% 
 1-week Upper limb pain 0.5-7% 
Henschke et al., 2014  Upper limb pain 1.30-4.55% (boys) B 
  Upper limb pain 1.38-3.26% (girls) B 
Henschke et al., 2014  Spine/trunk pain 0.63-2.91% (boys) B 
  Spine/trunk pain 0.60-2.06% (girls) B 
Briggs et al., 2009 Lifetime Thoracic/spine pain 15.6–19.5% 
 1-year Thoracic/spine pain 4.2–9.7% 
 Point Thoracic/spine pain 4-41% 
Manchikanti et al., 2009 1-year Neck pain 34.5-71.5% 
Fejer et al., 2006 1-year Neck pain 15.8-22.1% 
 6-month Neck pain 6-45% 
 1-month Neck pain 6.9% 
Hogg-Johnsons et al., 2008 1-year Neck pain 34.5-71.5% 
 1-month Neck pain 4.5-8.5% 
 1-week Neck pain 8% 
Jeffries et al., 2007 Lifetime Neck pain 3-21% 
Johansson et al., 2017 1-month Neck pain 5-15% 
Henschke et al., 2015 1-month Multiple pain 16% (range 12.1-35.7%) 
Mourão et al., 2010 - Chronic widespread pain 7.5% 
Mourão et al., 2010 - Fibromyalgia 0.1-3.2% 
Gran, 2003 - Fibromyalgia 1.2% 
A Percentage of children among those who referred to primary care for musculoskeletal pain 
B Rates for 100 encounters due to musculoskeletal pain 
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1.7.2 Incidence of musculoskeletal pain in children and adolescents 
Compared to estimates of prevalence, less information is available in the literature about the 
incidence of musculoskeletal pain in children and adolescents. Eight reviews highlight evidence of 
1-year incidence for general musculoskeletal pain (38%), low back pain (figures ranging from 
11.8% to 33%), upper back pain (6%-35%), mid back pain (49.8%, 2-year incidence), lower limb 
pain (16%), upper limb pain (13.3%), neck pain (21-28%) and chronic widespread pain (7.7%) (see 
Table 1.18). The wide variance in the estimates reported is due to the difference in body sites 
considered, case definition used and number of studies included in the reviews.  
 
 
 
Table 1.18 Incidence of musculoskeletal pain in children and adolescents 
Study Period Site Figure 
McBeth & Jones, 2007 1-year Musculoskeletal pain 38% 
Hill & Keating, 2009 1-year Low back pain 15-23% 
Henschke et al., 2015 1-year Low back pain 11.8-33% 
McBeth & Jones, 2007 1-year Low back pain 17.2% 
Jeffries et al., 2007 
Briggs at al., 2009 
1-year 
1-year 
Low back pain 
Upper Back pain 
11.8-33% 
6.7-35.3% 
Johansson et al., 2017  
 
2-year 
3-month 
Mid back pain 
Mid back pain 
49.8% 
3.5-3.9% 
Fuglkjaer et al., 2017 1-year Lower limb pain 16% 
Fuglkjaer et al., 2017 1-year Upper limb pain 13.3% 
Jeffries et al., 2007 1-year Neck pain 28.4% 
Hogg-Johnsons et al., 2008 1-year Neck pain 21.3% 
McBeth & Jones, 2007 1-year Chronic widespread pain 7.7% 
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1.7.3 Summary of musculoskeletal pain research in children and adolescents 
Overall estimates of the prevalence and incidence of musculoskeletal pain in children and 
adolescents show how common pain is and that actually the proportion of older children and 
adolescents who experience musculoskeletal pain approaches the values reported for adults. This 
is supported by the literature that reported a sharp increase in prevalence rates of 
musculoskeletal pain in young populations between the age of 12 and 15 (Hill & Keating, 2009), 
with prevalence values reaching adult levels by the age of 18 (Dissing et al., 2017; Jeffries et al., 
2007). As discussed in Section 1.6 above, there is a need for more research on musculoskeletal 
pain in young populations, firstly because children and adolescents should not be regarded as 
“small adults”, but as a population with different physiology and psychosocial development, who 
may therefore have differences in susceptibility to the effects of risk factors compared to adults 
or indeed have specific and unique risk factors not generally experienced by adults (Hestbaek, 
Leboeuf-Yde, & Kyvik, 2006). Secondly because the identification of unique risk factors within 
child and adolescent populations may help to understand the nature of the onset of 
musculoskeletal pain that then leads to the development of high risk for adult musculoskeletal 
pain. However, while research carried out in adult populations on the risk factors for the onset of 
musculoskeletal pain is extensive, as outlined previously in this chapter (Section 1.5), currently 
little is known about potential risk factors for the onset of musculoskeletal pain in children and 
adolescents (at the time of writing this thesis). Therefore, a comprehensive systematic review on 
the risk factors for the onset of musculoskeletal pain in children and adolescents was performed, 
which is outlined in the next chapter.  
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Chapter two. Systematic review on the risk factors for the onset 
of musculoskeletal pain in children and adolescents 
 
2.1 Introduction 
As described in chapter 1 (Section 1.6), there is a need to understand factors that predict 
musculoskeletal pain onset in children and adolescents, and the reasons are many: children and 
adolescents are a distinct population different from adults, musculoskeletal pain in children and 
adolescents is common, there is a paucity of existing literature in this population, children and 
adolescents are less likely to have a history of musculoskeletal pain compared to adults (and 
therefore be less likely to be influenced by previous pain), patterns of pain (trajectories) over time 
appear different and potentially are emerging within the child and adolescent period, and that 
childhood and adolescent pain is linked to later adulthood pain. Whilst previous reviews on the 
risk factors for the onset of musculoskeletal pain in children and adolescents have been published 
(Jones & Macfarlane, 2005; King et al., 2011; Lardon, Leboeuf-Yde, Le Scanff, & Wedderkopp, 
2014; Leboeuf-Yde, 2004; Manchikanti et al., 2009; McBeth & Jones, 2007; Paulis, Silva, Koes, & 
Van Middelkoop, 2014; Prins, Crous, & Louw, 2008; Shiri et al., 2010b; Sitthipornvorakul, 
Janwantanakul, Purepong, Pensri, & Van Der Beek, 2011), the focus of these previous reviews has 
been limited and restricted. For example, these reviews have not provided a broad scope of risk 
factors across a range of musculoskeletal conditions. They have focused only on specific risk 
factors such as puberty, obesity, smoking or physical activity, or they focused only on specific body 
sites (e.g. low back pain). Consequently, no review has been carried out on a broad range of 
potential risk factors for the onset of musculoskeletal pain across a range of body sites. This 
chapter aims to systematically review up-to-date evidence of published literature on the risk 
factors for musculoskeletal pain in children and adolescents. A description of the methods used to 
carry out the systematic review together with the results, the discussion of the results, and a 
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comparison with previous reviews is outlined in the following sections. As part of the 
development of this review chapter, it was decided to conduct a separate systematic review (using 
the same methodology as this chapter) with a narrowed focus on the relationship of sleep 
problems with musculoskeletal pain onset in children and adolescents. This review was recently 
published (Andreucci, Campbell, & Dunn, 2017) and a copy of the paper can be found in appendix 
I. 
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2.2 Materials and Methods 
2.2.1 Inclusion criteria 
Articles meeting the inclusion criteria were considered regardless of the language of publication, 
publication status and date of publication in order to reduce the risk of publication bias. 
Translations of articles were attempted whenever possible (in particular of articles published in 
German). The inclusion criteria regarding the study population, outcomes, setting and study 
design are described below. 
2.2.1.1 Study population 
Studies had to report on individuals aged from 6 to 19 years old. This age range was chosen 
because the age of six has been reported to be the starting point for children to use the word 
“pain” (Stanford, Chambers, & Craig, 2005; von Baeyer, 2006) and children younger than 5 years 
of age have a tendency to use only the extremes of the scales used to assess pain (Stinson, 
Kavanagh, Yamada, Gill, & Stevens, 2006; von Baeyer, 2006). The age of nineteen was chosen as 
this is defined as the start of adulthood by the WHO 
(http://www.who.int/hiv/pub/guidelines/arv2013/intro/keyterms/en/). 
2.2.1.2 Outcomes 
Studies had to report data on musculoskeletal pain presence as the outcome. No limitations in 
terms of dimensions and characteristics of musculoskeletal pain were applied (i.e. articles 
reporting on musculoskeletal pain in any body site and of any duration and severity were 
included). The use of any type of self-reported pain measure was eligible. 
2.2.1.3 Setting 
The studies had to be conducted in the general population, school or primary care setting as the 
aetiology of musculoskeletal pain from specific conditions treated in secondary care (e.g. juvenile 
idiopathic arthritis, cancer pain) is likely to be different. 
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2.2.1.4 Study design 
To be included studies had to employ prospective cohort designs. These study designs are the 
most suitable to identify the onset of musculoskeletal pain compared to other study designs 
where confidence of temporal causality is reduced (i.e. cross-sectional studies). 
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2.2.2 Exclusion criteria 
The following exclusion criteria were applied: 
 Studies with a sample size ≤30. Studies with low sample sizes are less likely to provide 
reliable (precise) estimates, less likely to identify potentially important associations with 
statistical significance, and may be more likely to be subject to reporting bias (Hennekens 
& Buring, 1987). 
 Studies conducted in populations composed of only adult individuals, since the research 
question focused on individuals aged 6 - 19. Studies on populations composed of both 
adults and children, when separate data from children could be retrieved, were included. 
If data on children were not shown, the study was excluded. 
 Studies where the pain was not self-reported by the children but it was reported by the 
parents, as a difference in the reporting of musculoskeletal pain between parents and 
children has been observed (Haraldstad, Sørum, Eide, Natvig, & Helseth, 2011; Sundblad, 
Saartok, & Engström, 2006). 
 Randomized controlled trials were excluded, since the primary focus is on the 
effectiveness of one or more interventions, and the risk of musculoskeletal pain onset in 
the absence of preventative intervention may not be reported. Moreover, randomized 
controlled trials often employ stringent selection criteria which can compromise 
generalizability. 
 Studies of populations with specific diseases or conditions where pain was assessed and 
reported but was a result of the disease or underlying condition (e.g. cancer pain). 
 Studies where translation was not possible.  
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2.2.3 Data Sources and Searches 
The search was carried out by using the OVID interface. The OVID interface includes the following 
databases (accessed on the 20th of November 2014, further updated on the 8th of November 2016 
for the published review (Andreucci et al., 2017)): 
 Medline 
 PsycINFO 
 EMBASE 
 AMED 
 HMIC 
For each database a combination of specific keywords relating to “children”, “musculoskeletal 
problems” and “risk factors” was used (Please see appendix II for a full breakdown of search 
terms). 
 
2.2.4 Study selection 
Potentially eligible studies were those who reported data on the risk factors for the onset of new 
episodes of musculoskeletal pain in children and adolescents. Searches were carried out and the 
number of references from each database was recorded and references were imported into 
“Refworks” a reference management database. A number of stages were used to select studies to 
the review. The first stage of selection of the articles concerned only the screening of the titles. 
Articles were rejected for inclusion if they clearly showed no relation to the inclusion criteria 
based on the title (e.g. non pain study, study on adults). The second stage involved the screening 
of abstracts, and articles were rejected if they showed no relation to the inclusion criteria based 
on information provided on the abstract (e.g. study that was not prospective in design or age at 
follow-up was over 19 years old). Then the full-text of articles were examined for eligibility. The 
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number of articles remaining after each stage was recorded. Each phase was carried out by one 
reviewer (Alessandro Andreucci) and sub-samples (20%) were cross-checked (Paul Campbell) for 
consistency. Any disagreements were resolved through consensus meetings mediated by a third 
reviewer (Kate M Dunn). Finally, all articles that met the inclusion criteria were included for data 
extraction and analysis.  
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2.2.5 Data extraction 
From each paper, data were extracted by Alessandro Andreucci and a random sub-sample (20%) 
of articles was cross-checked with Paul Campbell. The extraction was performed by using a data 
extraction form created by Alessandro Andreucci in Microsoft Excel, using the headings shown in 
Table 2.1. 
 
 
Table 2.1 Data extraction  form 
Item 
Article title 
Authors 
Date 
Country 
Aim of the study 
Study design 
Study setting 
Inclusion/exclusion criteria of the study 
Recruitment procedures used 
N° of participants 
Age range 
Sex ratio 
Ethnicity 
Response rate 
Information about non-responders 
Pain definition 
Pain location 
Exposures analyzed 
Questionnaire used 
Prevalence 
Incidence 
Length of follow-up 
Statistical analyses 
Results 
Conclusions 
Notes 
51 
 
2.2.6 Quality assessment 
There is no agreed gold standard quality assessment tool for observational studies, and a wide 
array of measures exist within the literature (Mallen, Peat, & Croft, 2006; Shamliyan, Kane, & 
Dickinson, 2010). A measure was chosen that encompasses the main components of study quality 
and the assessment of risk of bias, and is based on previous reviews with a similar focus to this 
current review, i.e. prospective cohort studies, focusing on musculoskeletal pain (Mallen, Peat, 
Thomas, Dunn, & Croft, 2007; Shraim, Mallen, & Dunn, 2013). The quality assessment tool 
included 15 items relative to both internal and external validity (Mallen et al., 2007; Shraim et al., 
2013). The criteria that composed the quality assessment tool are shown in Table 2.2. Each item 
was scored positive (+) if it was found as satisfactorily presented and valid, negative (–) if absent, 
or (na) if it was found as not applicable. A point was given if the item was positive, while in the 
other two cases no one point was given. It follows that the highest possible score was 15. The 
quality of the articles was rated as ‘high’ if 11-15 items were fulfilled; ‘moderate’ if 6-10 items 
were fulfilled, and ‘low’ if 1-5 or no items were fulfilled, following methodology used previously 
(Shraim, 2013). The quality of each paper was assessed by Alessandro Andreucci and sub-samples 
(20%) were cross-checked with Paul Campbell for consistency. 
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Table 2.2 Quality assessment checklist 
Item 
A. Clearly defined study objective 
B. Appropriate design for study question 
C. Inclusion and exclusion criteria clear and appropriate 
D. Representative sample (and comparison) 
E. Sample size calculation presented 
F.  Appropriate selection of outcome 
G. Appropriate measurement of outcome 
H. Standardised collection of data 
I.  Adequate length of follow-up for research question 
J.  Baseline participation >70% (all groups) 
K. Losses and dropouts <20% 
L.  Adequate description of losses and completers 
M. Appropriate analysis of outcomes measured 
N. Numerical description of important outcomes given 
O. Adjusted and unadjusted calculations provided (with confidence interval if appropriate) 
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2.2.7 Evidence Synthesis  
To increase confidence in the assumption of causality a number of factors (e.g. consistency of 
evidence, temporality, dose-response, theoretical plausibility, size of effect) were considered 
following previous guidance (Bhopal, 2002). For example, the choice of prospective design gives 
greater confidence in the temporal relationship, and another key factor is the consistency of 
evidence, and whether the evidence is at risk of bias. To assess the strength of evidence a “levels 
of evidence” approach was used following previous methodology (see Table 2.3, references of 
previous use (Campbell et al., 2011; Licht-Strunk, van der Windt, van Marwijk, de Haan, & 
Beekman, 2007)). The levels of evidence assessment considers the consistency of the reported 
associations for each risk factor, and also gives greater weighting to findings of higher quality and 
lower risk of bias. As Table 2.3 outlines, the strength of evidence was determined by the 
consistency of findings and the quality of the evidence. In addition, a best evidence approach was 
used, where only high quality studies were included. This approach allowed to assess if the 
consistency and direction of associations between risk factors and musculoskeletal pain onset 
reported in studies with a low risk of bias (based on the study quality assessment) were similar to 
evidence from all eligible studies. Whilst a statistical assessment of evidence for each risk factor 
would be additionally informative (e.g. meta-analysis), inspection of the extracted data showed 
high levels of heterogeneity in terms of the measurements for the risk factors and 
musculoskeletal pain, and therefore a meta-analysis was not performed. 
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Table 2.3 Levels of evidence for association of risk factors and musculoskeletal pain 
Level of evidence 
Statistical significant associations 
Strong Consistent associations found in at least two high quality studies 
Moderate Consistent associations found in one high quality study and at least one 
medium or two low quality studies 
Weak Associations found in at least two medium or three low quality studies 
Inconclusive Associations found in less than three medium/low quality studies  
Inconsistent Inconsistent findings irrespective of study quality 
Associations without statistical significance 
Inconclusive Weak, non-significant associations found in at least two studies 
Insufficient Only one study available, presenting a weak non-statistical association, 
irrespective of study quality  
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2.3 Results 
2.3.1 Selection of the studies 
The search strategy identified more than 35,000 publications across all 5 databases. The selection 
procedure finally resulted in the selection of 37 studies meeting the eligibility criteria (Figure 2.1). 
  
Figure 2.1 Flowchart showing the process of selection of the studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Records identified through database 
searching (n = 35167) 
13927 MEDLINE 
923 PsycINFO 
19972 EMBASE 
311 AMED 
34 HMIC 
 
 
Additional records identified by 
private contact with experts (n = 93) 
Records after screening 
of the titles (n = 2393) 
 
Full-text articles assessed 
for eligibility (n = 156) 
Full-text articles excluded  
(n = 119) because of: 
1. Age (14) 
2. Athletes (25) 
3. No translation (4) 
4. Review (2) 
5. Cross-sectional or 
RCT (74) 
 
Records excluded based 
on the abstract (n = 2237) 
 
Studies included in 
evidence synthesis  
(n =37) 
Records after duplicates removed 
(n =30655) 
Records excluded because 
clearly not eligible from 
the title (n = 28262) 
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2.3.2 Study Characteristics 
Included studies were from 13 different countries and the study populations ranged from 76 to 
2951 individuals. The samples were recruited from schools or school settings in 22 studies and 
from the general population in 16 articles (one study reported information about 2 cohorts of 
children, of which one was recruited at school and another one from general population). Not one 
study was based in a primary care setting. Some cohorts were reported in more than one article. 
A cohort of Canadian high school students was reported in 5 studies (Feldman, Rossignol, Shrier, 
& Abenhaim, 1999; Feldman, Shrier, Rossignol, & Abenhaim, 2001, 2002a, 2002b; Shrier, 
Ehrmann-Feldman, Rossignol, & Abenhaim, 2001). Two English studies (Harrison, Wilson, & 
Munafo, 2014; Tobias, Deere, Palmer, Clark, & Clinch, 2013) reported data from the Avon 
Longitudinal Study of Parents and Children (ALSPAC). Two other studies (Jones, Silman, & 
Macfarlane, 2003; Jones, Watson, Silman, Symmons, & Macfarlane, 2003) reported data from a 
cohort of children of Northwest England. Finally, 6 studies were drawn from the Northern Finland 
Birth Cohort (Auvinen et al., 2010; Jussila et al., 2014; Mikkonen et al., 2008, 2012, 2013; 
Paananen et al., 2010) while 4 studies were drawn from a cohort in southern Finland (El-
Metwally, Salminen, Auvinen, MacFarlane, & Mikkelsson, 2007; Mikkelsson et al., 2008; 
Mikkelsson, Sourander, Salminen, Kautiainen, & Piha, 1999; Ståhl et al., 2008).  
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2.3.3 Methodological Quality 
Twenty-six articles (70%) out of 37 were defined as high quality and 11 (30%) as medium quality. 
All the studies reported a clearly defined objective (Quality indicator A). Moreover, in all the 
studies the collection of data was standardized (Quality indicator H) and the outcome was 
selected appropriately (Quality indicator F) and the length of follow-up was adequate (e.g. Quality 
indicator I). However, more variability was found for other quality indicators. One of these was 
the study design (Quality indicator B), with 1 study using a case-control design nested within a 
prospective cohort study, and 4 studies in which musculoskeletal pain was assessed only at 
follow-up (i.e. no assessment of the presence of pain at baseline). In 7 (19%) articles the 
inclusion/exclusion criteria (Quality indicator C) were not clear and appropriate or were not 
reported at all. In 4 studies (11%) the sample was not representative (Quality indicator D), being 
composed of only males, being a case-control subsample or a selective subsample of the initial 
cohort. Only 2 studies (5%) reported a sample size calculation (Quality indicator E). In 2 studies 
(5%) the outcome was considered as not appropriately measured (Quality indicator G). In 18 
studies (49%) the criteria “baseline participation >70%” (Quality indicator J) was not met or no 
information was present. In 20 studies (54%) the criteria “losses and dropouts <20%” (Quality 
indicator K) was not met or no information was present. In addition, in 16 (43%) articles those lost 
to follow-up and completers were not described adequately or no information was provided 
(Quality indicator L). Six (16%) studies did not meet the criteria “appropriate analysis of outcomes 
measured“ (Quality indicator M), as information on the analysis performed was not described 
clearly, or only univariable analysis was carried out, or the comparison group also included 
children with musculoskeletal pain at baseline. In 6 (16%) articles there was no information on the 
effect of the risk factors on outcome (i.e. effect size of result) (Quality indicator N), only a 
descriptive of the level of statistical significance (yes/no) of the association was provided. Finally, 
5 (14%) studies reported only unadjusted analyses. The average total score of the studies was 
11.54 (score range 7 – 14). 
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2.4 Overall findings 
The results for potential risk factors for the onset of musculoskeletal pain were grouped in eight 
domains based on the extracted data: 
 Anthropometric measures (BMI, High growth spurt and other anthropometric features) 
 Psychological domain (Conduct problems, depression and other psychological variables)  
 Sleep (Quantity and quality of sleep) 
 Day-time tiredness  
 Physical activity (Amount of physical activity and type of physical activity) 
 Sedentary activity (Watching TV, playing computer and other kind of sedentary activities) 
 Smoking (Being a regular smoker and number of cigarettes smoked) 
 Other risk factors (Puberty, parental pain and alcohol consumption) 
 
A description of the results for each domain is provided below.  
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2.4.1 Anthropometric measures 
The anthropometric measures domain includes different subdomains that are further described 
below: 
 Body Mass Index (BMI) 
 High growth spurt 
 Other anthropometric measures 
 
2.4.1.1 Body Mass Index (BMI) and musculoskeletal pain 
Ten studies, of which 7 (70%) were of high quality and 3 (30%) of medium quality, reported on the 
association between BMI and onset of musculoskeletal pain (Table 2.4). Overall, one study 
reported a significant association, one reported an inconsistent association and eight no 
significant associations, indicating inconsistent evidence for the association of BMI with onset of 
musculoskeletal pain. When conducting the best evidence synthesis (i.e. including only high 
quality studies), one study reported an inconsistent association and six studies no significant 
associations. These findings suggest that current evidence indicates that it is unlikely that there is 
evidence for a strong or significant association between BMI and musculoskeletal pain onset.  
 
 
 
  Table 2.4 BMI and musculoskeletal pain 
Study Area of assessment Association Quality 
Jones, Watson, et al., 2003 
Szpalski et al., 2002 
Mikkonen et al., 2013 
Nissinen et al., 1994 
Salminen et al., 1995 
Back x 
+ 
# 
x 
x 
High 
Medium 
High 
High 
Medium 
Feldman et al., 2002a 
Brink et al., 2009 
Neck/upper limb x 
x 
High 
Medium 
Feldman et al., 2002b 
Jussila et al., 2014 
Musculoskeletal x 
x 
High 
High 
Paananen et al., 2010 Multisite x High 
+ significant association with musculoskeletal pain onset 
x no significant association 
# inconsistent association 
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2.4.1.2 Height, high growth spurt and musculoskeletal pain  
Overall, ten studies have described the relationship between height or high growth spurt and 
musculoskeletal pain (Table 2.5). Seven (70%) of these studies were of high quality while 3 (30%) 
were of medium quality. Three studies reported inconsistent association and 7 only reported non-
significant associations with pain onset. The best evidence synthesis, which included only studies 
of high quality, again showed that 3 studies reported inconsistent associations and 4 reported 
only non-significant associations, resulting in inconsistent evidence for an association between 
height or high growth spurt and the onset of musculoskeletal pain. Given the direction of the 
evidence toward non significance, the conclusion is that an association is unlikely. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 2.5 Height, high growth spurt and musculoskeletal pain 
Study Area of assessment Association Quality 
Feldman et al., 2001 
Janssens et al., 2011 
Jones, Watson, et al., 2003 
Salminen et al., 1995 
Szpalski et al., 2002 
Nissinen et al., 1994 
Back # 
x 
# 
x 
x 
# 
High 
High 
High 
Medium 
Medium 
High 
Feldman et al., 2002a 
Brink et al., 2009 
Neck/upper limb x 
x 
High 
Medium 
Shrier et al., 2001 Lower limb x High 
Feldman et al., 2002b Musculoskeletal x High 
+ significant association with musculoskeletal pain onset 
x no significant association 
# inconsistent association 
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2.4.1.3 Other anthropometric measures and musculoskeletal pain  
Overall, 17 studies explored the association between anthropometric characteristics and the 
onset of musculoskeletal pain (Table 2.6). Nine (53%) of these studies were of high quality and 8 
(47%) of medium quality. Among the several anthropometric characteristics investigated, 9 
significant findings, 10 inconsistent associations and 36 non-significant associations were 
reported. When using a best evidence synthesis, 2 significant associations, 3 inconsistent 
associations and 18 non-significant associations remain. No consistent evidence of association 
was found across the several anthropometric characteristics reported, and for each characteristic 
found as having an effect on musculoskeletal pain (i.e. low lumbar extension strength, disc 
degeneration, disc protrusion, Scheuermann-type changes, painful palpation of spinous 
processes, awkward trunk posture), the significant finding reported was from only one single 
study. Therefore, the strength of evidence of association found is limited. Considering where 
comparisons can be made across studies, the findings on joint hypermobility overall suggest 
inconsistent evidence of association, although some significant findings for specific body sites (i.e. 
shoulder, knee, ankle/foot) were reported in one study (Tobias et al., 2013). 
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Table 2.6 Other anthropometric measures and musculoskeletal pain 
Study Measurement of exposure Area of 
assessment 
Association Quality 
Tobias et al., 2013 
Sjolie et al., 2001 
 
Burton et al., 1996 
Feldman et al., 2001 
 
 
 
 
Newcomer & Sinaki, 1996 
Salminen et al., 1995 
 
 
 
 
 
Nissinen et al., 1994 
 
 
 
 
 
 
Szpalski et al., 2002 
 
Mikkonen et al., 2012 
Smith et al., 2008 
Joint hypermobility 
Low lumbar extension strength 
Lumbar mobility/ extension strength 
Lumbar sagittal flexibility 
Low Quadriceps flexibility 
Low Hamstrings flexibility 
Low Sit-and-reach flexibility  
Schober lumbar flexion 
Abdominal strength 
Back strength 
Disc degeneration 
Disc protrusion 
Muscular atrophy 
Spinal mobility 
Trunk muscle strength 
Scheuermann-type changes 
Kyphosis 
Increase of kyphosis 
Lordosis 
Increase of lordosis 
Hump size 
Gain of hump size 
Static profile of the spine 
Painful palpation of spine processes 
Awkward trunk posture 
Sway Posture 
Flat Posture 
Hyperlordotic Posture 
Back x 
+ 
# 
x 
# 
# 
x 
x 
x 
# 
+ 
+ 
x 
x 
x 
+ 
x 
x 
x 
x 
# 
x 
x 
+ 
+ 
# 
# 
# 
Medium 
High 
 
Medium 
High 
 
 
 
 
Medium 
Medium 
 
 
 
 
 
High 
 
 
 
 
 
 
Medium 
 
High 
Medium 
Ståhl et al., 2008 
Tobias et al., 2013 
 
 
Brink et al., 2009 
Joint hypermobility 
 
 
 
Head tilt angle 
Cervical angle 
Shoulder pro- and retraction angle 
Thoracic angle 
Extreme cervical and thoracic angle 
Neck/upper limb x 
x Neck 
x Upper arm 
+ Shoulder 
x 
# 
x 
x 
# 
High 
Medium 
 
 
Medium 
Tobias et al., 2013 
 
 
 
 
Shrier et al., 2001 
Joint hypermobility 
 
 
 
 
Low flexibility  
 
Lower limb 
 
 
x Lower leg 
x Hip 
x Thigh 
+ Knee 
+ Ankle foot 
x lower limb 
x hip 
x knee 
x leg 
x ankle/foot 
Medium 
 
 
 
 
High 
Tobias et al., 2013 Joint hypermobility Wrist/hand 
Elbow 
x 
x 
Medium 
+ significant association with musculoskeletal pain onset      
x no significant association     
# inconsistent association 
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Table 2.6 Other anthropometric measures and musculoskeletal pain 
Study Measurement of exposure Area of assessment Association Quality 
El-Metwally et al., 2007 
Tobias et al., 2013 
Joint hypermobility 
 
Musculoskeletal 
 
x 
x 
High 
Medium 
Mikkelsson et al., 2008 
Tobias et al., 2013 
Mikkelsson et al., 1999 
Joint hypermobility 
 
Tender point count 
Pain threshold 
Multisite 
 
x 
x 
x 
x 
High 
Medium 
High 
+ significant association with musculoskeletal pain onset      
x no significant association     
# inconsistent association 
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2.4.2 Psychological factors 
2.4.2.1 Psychological factors and musculoskeletal pain 
Seventeen articles concerning psychological risk factors were found and 13 (76%) were of high 
quality while 4 (24%) were of medium quality. Twenty significant associations, 10 inconsistent 
associations and 25 non-significant associations were reported for a range of psychological risk 
factors (Table 2.7). When only the studies of high quality were included, 10 significant 
associations, 10 inconsistent associations and 20 no significant associations were reported. 
Among the different psychological factors assessed, inconsistent evidence of association for the 
onset of musculoskeletal pain was found for depression (two significant associations, one 
inconsistent association and three non-significant associations), though the direction of effect did 
suggest a trend of increasing depression and musculoskeletal pain onset. Inconsistent evidence of 
association for the onset of musculoskeletal pain was found for anxiety (one inconsistent 
association and three non-significant associations). Similarly, evidence of association was 
inconsistent for stress or coping with stress (one inconsistent association and two non-significant 
associations), self-efficacy (one inconsistent association and one non-significant association), and 
for pain catastrophizing and somatosensory amplification (inconsistent associations from one high 
quality study). For child self-esteem, one high quality and one medium quality study reported 
three non-significant associations, indicating inconclusive evidence of association, although 
examination of the studies showed a trend of decreased likelihood for the onset of 
musculoskeletal pain with higher levels of self-esteem. For internalizing (i.e. anxiety, depressed 
mood) and externalizing symptoms (i.e. behavioural disorders, oppositional and conduct 
disorders), five high quality studies reported 4 significant associations, 2 inconsistent associations 
and one non-significant association across all body sites. Study results suggest that increasing 
levels of internalizing / externalizing symptoms are likely risk factors of the onset of 
musculoskeletal pain. Two studies of high quality reported on factors that can be included within 
the internalizing and externalizing psychological domain, such as conduct problems, hyperactivity, 
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emotional problems and peer problems. For conduct problems, two studies reported significant 
associations suggesting strong evidence of association between these potential risk factors and 
incident musculoskeletal pain, although both studies were drawn from the same cohort. For 
hyperactivity, emotional problems and peer problems the two high quality studies reported only 
non-significant associations (direction of association towards an increase likelihood for the onset 
of musculoskeletal pain), suggesting inconclusive evidence of association. A couple of studies 
reported on a range of psychological and behavioural factors. One medium quality study reported 
inconclusive evidence of association (increasing trend toward increased likelihood of 
musculoskeletal pain onset) for being bullied, reaction to bullying, fear of schoolmates, loneliness, 
difficulties to make friends, feeling of being an outsider, nervousness, difficulties verbalizing 
feelings and difficulties talking to mother or to father. Similarly one high quality study reported 
non-significant associations for satisfaction with life, critical life events, financial strain and playing 
time, and one inconsistent association (significant increased likelihood in girls, non-significant 
decreased likelihood in boys) for quarrelling in the family.   
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Table 2.7 Psychological factors and musculoskeletal pain 
Study Measurement of exposure Area of assessment Association Quality 
Barke et al., 2014 
 
 
 
Stanford et al., 2008 
Gill et al., 2014 
 
Larsson & Sund, 2007 
Jones, Watson, et al., 2003 
 
 
 
 
Gill et al., 2014 
Brattberg, 1994 
 
 
 
 
 
 
 
 
 
Szpalski et al., 2002 
Stanford et al., 2008 
Gill et al., 2014 
Pain catastrophizing 
Somatosensory amplification 
Dysfunctional stress coping 
Anxiety sensitivity  
Anxiety/depression 
Depression  
Internalizing/externalizing 
Internalizing/externalizing 
Conduct problems 
Hyperactivity 
Emotional problems 
Peer problems 
Prosocial behaviour 
Low perceived self-efficacy 
Being bullied 
Passive reaction to bullying 
Fear of schoolmates 
Loneliness 
Difficulties to make friends 
Feeling of being an outsider 
Nervousness 
Difficulties verbalizing feelings 
Difficulties talking to mother 
Difficulties talking to father 
Mental health status 
Child self-esteem 
Back 
 
# 
# 
# 
# 
x 
# 
# 
+ 
+ 
x 
x 
x 
x 
# 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
x 
x 
x 
High 
 
 
 
Medium 
High 
 
High 
High 
 
 
 
 
High 
Medium 
 
 
 
 
 
 
 
 
 
Medium 
Medium 
High 
Larrsson & Sund, 2007 
Shrier et al., 2001 
Feldman et al., 2002a 
Brink et al., 2009 
 
Gill et al., 2014 
 
 
 
Internalizing/externalizing 
Mental health status 
 
Depression 
Anxiety 
Depression  
Internalizing/externalizing 
Low perceived self-efficacy 
Child self-esteem 
Limb 
Lower limb 
Neck/upper limb 
+ 
+ 
+ 
x 
x 
+ 
+ 
x 
x 
High 
High 
High 
Medium 
 
High 
 
 
 
El-Metwally et al., 2007 
Jussila et al., 2014 
Depression 
Internalizing/externalizing 
Musculoskeletal x 
+ 
High 
High 
+ significant association with musculoskeletal pain onset        
x no significant association        
# inconsistent association 
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Table 2.7 Psychological factors and musculoskeletal pain 
Study Measurement of exposure Area of assessment Association Quality 
Kröner-Herwig et al., 2011 
 
  
 
 
 
 
 
Mikkelsson et al., 2008 
Mikkelsson et al., 1999 
Kroner-Herwig et al., 2011 
Paananen et al., 2010 
Jones, Silman, et al., 2003 
 
Satisfaction with life 
Critical life events 
School Stress 
Financial strain 
Playing time 
Quarreling in the family 
Dysfunctional stress coping  
Anxiety sensitivity 
Depression  
Depression  
Internalizing/externalizing 
Internalizing/externalizing 
Conduct problems 
Hyperactivity 
Emotional problems 
Peer problems 
Prosocial behaviour 
Multisite 
 
x 
x 
x 
x 
x 
# 
x 
x 
+ 
x 
# 
x 
+ 
x 
x 
x 
# 
High 
 
 
 
 
 
 
 
High 
High 
High 
High 
High 
 
+ significant association with musculoskeletal pain onset        
x no significant association        
# inconsistent association 
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2.4.3 Sleep 
2.4.3.1 Sleep and musculoskeletal pain 
The association between sleep patterns (both sleep quality and quantity) and the onset of 
musculoskeletal pain was assessed in ten studies, of which eight were of high and two of medium 
quality (Table 2.8). Overall two significant, five inconsistent and five non-significant associations 
were reported in the studies. When taking into consideration only the high quality studies, one 
significant, five inconsistent and four non-significant associations were reported. It should be 
noted that one of these studies (Auvinen et al., 2010) reported inconsistent associations in more 
than one body site. Seven studies reported two significant, one inconsistent and six non-
significant associations for sleep quality, and direction of associations suggests that low sleep 
quality is associated with increased likelihood of the onset of musculoskeletal pain. Five studies 
reported one significant, two inconsistent and four non-significant associations for sleep quantity, 
and direction of association between sleep quantity and the onset of musculoskeletal pain was 
inconsistent. Overall the results suggest that the evidence of an association between both sleep 
quality or quantity and the onset of musculoskeletal pain is inconsistent. However, when pain site 
and sex is considered there was strong evidence of an association between low sleep quality and 
the onset of neck pain (in girls). 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.8 Sleep and musculoskeletal pain 
Study Area of assessment Association Quality 
Auvinen et al., 2010 
Szpalski et al., 2002 
Brattberg, 1994 
Back 
Back 
Back 
# 
x 
+ 
High 
Medium 
Medium 
Auvinen et al., 2010 
Ståhl et al., 2008 
Neck 
Neck 
# 
+ 
High 
High 
Auvinen et al., 2010 Shoulder # High 
El-Metwally et al., 2007 
Jussila et al., 2014 
Musculoskeletal 
Musculoskeletal 
x 
# 
High 
High 
Mikkelson et al., 2008 
Mikkelsson et al., 1999 
Paananen et al., 2010 
Harrison et al., 2014 
Multisite 
Multisite 
Multisite 
Multisite 
x 
x 
x 
# 
High 
High 
High 
High 
+ significant association with musculoskeletal pain onset 
x no significant association 
# inconsistent association 
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2.4.4 Day-time tiredness 
2.4.4.1 Day-time tiredness and musculoskeletal pain 
The effect of day-time tiredness on the onset of musculoskeletal pain was assessed in 6 studies, of 
which 5 were of high quality (Table 2.9). Two significant associations, three inconsistent 
associations and three non-significant associations (two from a high quality and one from a 
medium quality study) were reported in the studies. Overall the evidence of association between 
day-time tiredness and musculoskeletal pain is inconsistent, although examination of the 
direction of associations reported in the studies showed an increased likelihood of the onset of 
musculoskeletal pain with increasing levels of day-time tiredness. In addition, strong evidence of 
association for the onset of neck pain in girls was reported, indicating a high likelihood of neck 
pain onset in girls reporting day-time tiredness.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 2.9 Day-time tiredness and musculoskeletal pain 
Study Area of assessment Association Quality 
Szpalski et al., 2002 
Auvinen et al., 2010 
Back 
Back 
x 
# 
Medium 
High 
Ståhl et al., 2008 
Auvinen et al., 2010 
Neck 
Neck 
+ 
# 
High 
High 
Auvinen et al., 2010 Shoulder # High 
El-Metwally et al., 2007 Musculoskeletal + High 
Mikkelsson et al., 2008 
Jones, Silman, et al., 2003 
Multisite 
Multisite 
x 
x 
High 
High 
+ significant association with musculoskeletal pain onset 
x no significant association 
# inconsistent association 
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2.4.5 Physical activity 
2.4.5.1 Physical activity and musculoskeletal pain  
The effect of physical activity on the onset of musculoskeletal pain was assessed in 20 studies, of 
which 14 (70%) were of high quality and 6 (30%) of medium quality (Table 2.10). Two significant 
associations, six inconsistent associations and 14 non-significant associations were reported in the 
studies. When looking at the best evidence (i.e. only the high quality studies), one significant 
association, four inconsistent associations and nine non-significant associations were reported. 
According to the levels of evidence used in this review, the evidence of association between 
physical activity and musculoskeletal pain is inconsistent overall. In addition, inspection of the 
direction of associations of studies showed inconsistent likelihood of the onset of musculoskeletal 
pain with increasing levels of physical activity (i.e. some studies showed an increase likelihood, 
while other studies showed a decrease likelihood). This, together with the high proportion of non-
significant findings suggests that overall an association is unlikely. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.10 Physical activity and musculoskeletal pain 
Study Area of assessment Association Quality 
Balagué et al., 2010 
Feldman et al., 2001 
Jones, Watson et al., 2003 
Salminen et al., 1995 
Szpalski et al., 2002 
Wedderkopp et al., 2009 
Burton et al., 1996 
Sjoile et al., 2001 
Brattberg, 1994 
Back 
 
+ 
x 
# 
x 
x 
# 
# 
+ 
x 
Medium 
High 
High 
Medium 
Medium 
Medium 
Medium 
High 
Medium 
El-Metwally et al., 2007 
Jussila et al., 2014 
Feldman et al., 2002b 
Sundblad et al., 2008 
Musculoskeletal 
 
# 
# 
x 
x 
High 
High 
High 
High 
Kröner-Herwig et al., 2011 
Mikkelsson et al., 2008 
Paananen et al., 2010 
Wedderkopp et al., 2009 
Jones, Silman, et al., 2003 
Multisite 
 
x 
x 
x 
x 
# 
High 
High 
High 
Medium 
High 
Ståhl et al., 2008 
Wedderkopp et al., 2009 
Feldman et al, 2002a 
Neck x 
x 
x 
High 
Medium 
High 
Shrier et al., 2001 Lower limb x High 
+ significant association with musculoskeletal pain onset 
x no significant association 
# inconsistent association 
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2.4.6 Sedentary activity 
2.4.6.1 Sedentary activity and musculoskeletal pain  
The association between sedentary activity and musculoskeletal pain was explored in 9 studies, of 
which 7 were of high and 2 of medium quality (Table 2.11). Nine associations were reported in the 
studies, of which one was significant, two were inconsistent associations and six were non-
significant associations. Both the significant and the inconsistent associations were from high 
quality studies, while two out of six of the non-significant associations were from medium quality 
studies. Overall the evidence of association between sedentary activity and musculoskeletal pain 
in the different body sites is inconsistent, and inspection of the direction of association is also 
inconsistent (i.e. studies showed both an increased likelihood and a decreased likelihood for the 
onset of musculoskeletal pain).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 2.11 Sedentary activity and musculoskeletal pain 
Study Area of assessment Association Quality 
Jones, Watson, et al., 2003 
Szpalski et al., 2002 
Sjolie et al., 2001 
Back 
 
x 
x 
x 
High 
Medium 
High 
Brink et al., 2009 Upper quadrant x Medium 
Jussila et al., 2014 
Sundblad et al., 2008 
Musculoskeletal 
 
# 
+ 
High 
High 
Paananen et al., 2010 
Jones, Silman et al., 2003 
Kröner-Herwig et al., 2011 
Multisite 
 
x 
x 
# 
High 
High 
High 
+ significant association with musculoskeletal pain onset 
x no significant association 
# inconsistent association 
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2.4.7 Smoking 
2.4.7.1 Smoking and musculoskeletal pain  
The association between smoking and the onset of musculoskeletal pain was assessed in 10 
studies of which nine were of high quality and one of medium quality (Table 2.12). Overall one 
significant association, four inconsistent associations and eight non-significant associations were 
reported in the studies. The best evidence synthesis (i.e. using only the high quality studies), 
showed four inconsistent associations and eight non-significant associations. Noteworthy, five 
studies were drawn from the same cohort (Feldman et al., 1999, 2001, 2002a, 2002b; Shrier et al., 
2001); two of these studies reported inconsistent associations for the onset of back pain (Feldman 
et al., 1999, 2001), while the three other studies reported non-significant associations for 
neck/upper limb pain, lower limb pain and musculoskeletal pain (Feldman et al., 2002a, 2002b; 
Shrier et al., 2001). One of these studies (Feldman et al., 1999) reported on multiple body sites 
(back pain, neck/upper limb pain, lower limb pain). According to the levels of evidence used in 
this review, the association between smoking and the onset of musculoskeletal pain is 
inconsistent. Further inspection of the direction of associations of the studies showed a trend for 
increased likelihood of the onset of musculoskeletal pain in smokers compared to non-smokers, 
but with different results between genders (i.e. increased likelihood in girls, inconsistent in boys) 
in the only study where analysis were stratified by levels of cigarette smoking (Mikkonen et al., 
2008). Overall these findings suggest that there is no evidence for an important or significant 
association between smoking and the onset of musculoskeletal pain. 
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Table 2.12 Smoking and musculoskeletal pain 
Study Area of assessment Association Quality 
Feldman et al., 2001 
Feldman et al., 1999 
Gill et al., 2014 
Mikkonen et al., 2008 
Brattberg, 1994 
Back 
Back 
Back 
Back 
Back 
# 
# 
# 
# 
+ 
High 
High 
High 
High 
Medium 
Feldman et al., 2002a  
Gill et al., 2014 
Feldman et al., 1999 
Neck/Upper limb 
Neck/Upper limb 
Neck/Upper limb 
x 
x 
x 
High 
High 
High 
Feldman et al., 1999 
Shrier et al., 2001 
Lower limb 
Lower limb 
x 
x 
High 
High 
Feldman et al., 2002b 
Jussila et al., 2014 
Musculoskeletal 
Musculoskeletal 
x 
x 
High 
High 
Paananen et al., 2010 Multisite x High 
+ significant association with musculoskeletal pain onset 
x no significant association 
# inconsistent association 
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2.4.8 Other risk factors 
2.4.8.1 Other risk factors and musculoskeletal pain  
Five articles reported on the association between other risk factors such as puberty, parental 
pain, or alcohol consumption and the onset of musculoskeletal pain (Table 2.13). One study of 
high quality reported a statistically significant association between pubertal status and back pain 
in a cohort of American and Dutch children, resulting in inconclusive evidence according to the 
levels of evidence used. Three articles of medium quality reported one significant association, one 
inconsistent association and one non-significant association between parental pain and the onset 
of musculoskeletal pain, and the evidence of association is therefore inconsistent. One high 
quality study reported an inconsistent association between alcohol consumption and the onset of 
musculoskeletal pain, the evidence of association with the onset of musculoskeletal pain is 
therefore inconsistent.  
 
 
 
 
   
Table 2.13 Other risk factors and musculoskeletal pain 
Study Measurement of exposure Area of assessment Association Quality 
Janssens et al., 2011 
Szpalski et al., 2002 
Brattberg, 1994 
Balagué et al., 2010 
Pubertal status 
Parental pain 
Back + 
x 
# 
+ 
High 
Medium 
Medium 
Medium 
Jussila et al., 2014 Alcohol consumption  Musculoskeletal # High 
+ significant association with musculoskeletal pain onset 
x no significant association 
# inconsistent association 
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2.5 Discussion 
2.5.1 Summary of main findings 
The aim of this systematic review was to identify potential risk factors for the onset of 
musculoskeletal pain in children and adolescents. Thirty-seven studies, of which 26 (70%) were 
assessed at being of high quality and 11 (30%) of medium quality were identified, reported on 
children and adolescents from 13 different countries (study population range 76 - 2951 
individuals). In summary, none of the factors identified were supported by consistent, high quality 
evidence of a statistically significant association across the range of body sites according to the 
best evidence synthesis. However, there was evidence of statistically significant and potentially 
important associations when considering sub populations based on body site location and 
individual characteristics (e.g. sex). For example, there was a strong evidence of an association 
between low quality of sleep and day-time tiredness and the onset of neck pain, although this 
finding was only in girls. Furthermore, there was a consistent evidence for an association between 
conduct problems and the onset of musculoskeletal pain, although this evidence was based on 
two studies drawn from the same cohort. With regard to psychological factors (i.e. internalizing 
and externalizing symptoms), the evidence of association with the onset of musculoskeletal pain 
was inconsistent overall. However, inspection of the direction of associations of the studies 
suggest that increasing levels of internalizing and externalizing symptoms are likely risk factors for 
the onset of musculoskeletal pain. The evidence reported for both sleep problems and 
internalizing and externalizing symptoms is also supported by the proportion of significant and 
mixed findings found across the body sites (7/12 significant and mixed findings for sleep 
problems, 6/7 for internalizing and externalizing symptoms), although this did not result in an 
overall consistent evidence of association using the levels of evidence criteria. Regarding other 
potential risk factors assessed, no consistent evidence of association was found for any of the 
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body sites when examined singularly, and the proportion of significant and mixed findings were 
lower and therefore less consistent. 
   
2.5.2 Comparison with other reviews 
As mentioned in section 2.1 a number of systematic reviews have been carried out previously, 
however the individual focus of these previous reviews was narrower than the broad aims of this 
review. In addition, two other recent reviews that report information on risk factors for the onset 
of musculoskeletal pain in children and adolescents have since been published (Huguet et al., 
2016; Kamper, Henschke, Hestbaek, Dunn, & Williams, 2016). Evidence from these reviews was 
integrated in the discussion for completeness. 
 
2.5.2.1 Anthropometric measures 
Findings relative to anthropometric measures were reported in three reviews. Two reviews 
reported an association between anthropometric factors (i.e. disc degeneration, upper lumbar 
pathology, muscular tightness) and back pain (Kamper, Henschke et al., 2016; Leboeuf-Yde, 2004), 
which is consistent with the findings for these specific anthropometric factors reported in this 
systematic review. Another review reported no evidence of association between joint 
hypermobility and the onset of musculoskeletal pain (Huguet et al., 2016) and this fits with the 
majority of evidence found in this review. Three reviews reported inconsistent evidence of 
association between taller height or high growth spurt and the onset of musculoskeletal pain 
(Huguet et al., 2016; Jones & Macfarlane, 2005; Kamper, Henschke et al., 2016). This is in 
accordance with the inconsistent evidence of association found in this systematic review, 
although the majority of the findings in this review were non-significant. Four reviews report that 
BMI is not prospectively associated with the onset of musculoskeletal pain (Huguet et al., 2016; 
Jones & Macfarlane, 2005; Kamper, Henschke et al., 2016; Paulis et al., 2014), and one reports 
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that the association between BMI and low back pain was not present in a dose-response 
relationship and was not observed in monozygotic twins (Leboeuf-Yde, 2004). This in accordance 
with results of this systematic review and seems to confirm that BMI is not a risk factor for the 
onset of musculoskeletal pain in children and adolescents. 
 
2.5.2.2 Psychological factors 
A number of reviews (Huguet et al., 2016; Jones & Macfarlane, 2005; Kamper, Henschke et al., 
2016; King et al., 2011; McBeth & Jones, 2007; Prins et al., 2008) reported on the association 
between various psychological factors and the onset of musculoskeletal pain. Overall, evidence 
from these reviews is in line with results of this systematic review, which reported several 
significant findings for the association between psychological factors and the onset of 
musculoskeletal pain. Specifically, psychological factors such as internalizing and externalizing 
symptoms were found to be likely associated with the onset of musculoskeletal pain in children 
and adolescents. 
 
2.5.2.3 Sleep 
One recent review (Kamper, Henschke et al., 2016) reported that sleep problems are predictive of 
musculoskeletal pain onset, although this evidence came from only one study (Auvinen et al., 
2010), which was also identified and included within this systematic review. The addition of other 
studies within this systematic review showed a greater level of inconsistency, although strong 
evidence for certain subgroups and body locations was found (i.e. neck pain in girls). This overall 
inconsistency may be explained by heterogeneity across studies in pain locations and measures 
used for both sleep and musculoskeletal pain, which makes the comparison of associations less 
clear, and suggests that there is a need for more research specifically focused on sleep as a risk 
factor for musculoskeletal pain in children. As mentioned at the beginning of this chapter a 
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subsequent systematic review was carried out by me and my supervisors, the findings of this 
review suggest that there is no general support that sleep factors are associated with 
musculoskeletal pain onset, however (as outlined in this chapter) some evidence exists for certain 
musculoskeletal body areas at higher risk and that some sub groups (e.g. gender) may be more at 
risk, therefore more empirical research is required (Andreucci et al., 2017). 
 
2.5.2.4 Physical activity 
Five reviews reported on the effect of physical activity on musculoskeletal pain. Three reviews did 
not identify any prospective evidence for an association (Jones & Macfarlane, 2005; Kamper, 
Henschke et al., 2016; Sitthipornvorakul et al., 2011). Differently, a review reported inconsistent 
evidence of association between physical activity and the onset of back pain, but included studies 
also on young adults and athletes (Huguet et al., 2016). Another review reported inconsistent 
results when physical activity was self-reported, but no association when physical activity was 
evaluated with an objective measurement (Leboeuf-Yde, 2004). Overall these results are in line 
with the results found by this systematic review, where most findings were inconsistent or non-
significant and inspection of the direction of associations showed inconsistency in the likelihood 
of the onset of musculoskeletal pain with increasing levels of physical activity. This may be 
explained by the differences in measures used to assess physical activity and is in agreement with 
the proposed j-shaped relationship between physical activity and musculoskeletal pain (i.e. 
moderate levels of physical activity may be protective, but high levels of physical activity may 
increase the likelihood of musculoskeletal pain) (Jones & Macfarlane, 2005). 
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2.5.2.5 Sedentary activity 
In accordance with the results of this systematic review, two reviews (Jones & Macfarlane, 2005; 
Kamper, Henschke et al., 2016) reported no evidence of prospective association between high 
levels of sedentary activity and musculoskeletal pain. 
 
2.5.2.6 Smoking 
Three reviews report an association between being a regular smoker and the onset of back pain 
or musculoskeletal pain (Huguet et al., 2016; Kamper, Henschke et al., 2016; Shiri et al., 2010b). 
This is in contrast with the results of this systematic review, which found inconsistent associations 
for back pain onset, but non-significant associations for other body sites. The association between 
smoking and musculoskeletal pain may be attributable to other factors such genetic components 
(Leboeuf-Yde, 2004), or smoking may be a marker of other factors such as psychological problems 
or unhealthy behaviours (e.g. sleep problems, lack of physical activity), which may be responsible 
for the onset of musculoskeletal pain (Mikkonen et al., 2008). 
 
2.5.2.7 Pubertal status  
A review reported on a link between being in a more advanced pubertal status and back pain 
onset, which may be due to the hormonal change that occur during puberty (Lardon, Leboeuf-
Yde, Le Scanff, & Wedderkopp, 2014). However the majority of studies identified in that review 
were cross-sectional, and only one study was prospective (Janssens et al., 2011). This prospective 
study was also included in this current systematic review, and the results from that study showed 
that those adolescents who were in a more advanced pubertal status at baseline were at an 
increased likelihood for the onset of back pain (Janssens et al., 2011). In conclusion the evidence 
of pubertal status as a risk factor for musculoskeletal pain onset is currently inconclusive, but this 
finding suggests that puberty may be a risk factor for the onset of back pain and therefore more 
research is needed on this factor.  
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2.5.2.8 Alcohol consumption 
A review by Leboeuf-Yde has reported evidence for an association between alcohol consumption 
and the onset of back pain in adolescents, which did not show a dose-relationship trend though 
and was not present when assessed in monozygotic twins. This suggests that the association 
found may explained by other unknown factors, and therefore alcohol is unlikely a risk factor for 
back pain (Leboeuf-Yde, 2004). In this systematic review inconsistent results were found in one 
study for the association between alcohol consumption and musculoskeletal pain onset, with a 
significant increased likelihood of musculoskeletal pain onset in girls but not in boys.  
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2.5.3 Strengths and weaknesses of this systematic review 
2.5.3.1 Search strategy and selecting studies 
There are several strengths of this systematic review. First, in order to include the widest range of 
literature, five databases were systematically searched without any language or time restrictions, 
which led to the identification of a higher number of prospective cohort studies as compared to 
other systematic reviews within the literature. Second, this systematic review covered a broader 
range of risk factors and body sites, a much broader scope compared to other systematic reviews. 
Third, to obtain the best evidence on the risk factors for the onset of musculoskeletal pain, only 
prospective cohort studies were included. This choice of study design enables a more confident 
estimate of incidence of the onset of musculoskeletal pain and the temporal sequence between 
the risk factor and musculoskeletal pain. In addition, the risk of recall bias when measuring 
exposure to risk factors, that is large with retrospective or case–control studies, is minimized with 
the use of prospective cohort studies (Delgado-Rodriguez & Llorca, 2004). However, there are also 
some limitations. First, despite the comprehensive search strategy used, none of the identified 
studies was carried out in South America, Africa, or Asia, therefore results of this systematic 
review may be not generalizable to these different social/cultural environments. Second, 
language bias is another potential limitation because papers in a language different from English 
are less likely to be published or be within the databases searched (grey literature). Whilst no 
language restrictions were applied in this systematic review, so for example three papers 
produced in German were translated (they did not meet the inclusion criteria), four additional 
papers were excluded (one paper in Swedish, one paper in Norwegian, one paper in Czech, one 
paper in Finnish) due to unavailability of translators. In addition, studies that do not find evidence 
of risk are less likely to be published and, whilst the reference lists of the included papers were 
searched for further published literature, alternative sources such as registers for unpublished 
studies and databases for PhD theses were not explored. Also, a meta-analysis of study findings 
was not possible, due to the high heterogeneity in definitions used in the included studies for 
82 
 
both the risk factors and musculoskeletal pain (e.g. presence, frequency, time period), which also 
limited comparability. Finally, not one of the studies identified within this systematic review was 
carried out in a primary care setting, which signifies the lack of knowledge on risk factors for the 
onset of musculoskeletal pain for children and adolescents who specifically seek healthcare.  
 
2.5.3.2 Evidence synthesis and quality appraisal 
The review made use of a previously published approach to defining levels of evidence, allowing 
conclusions to be systematically based both on results found and on the quality of studies. The 
use of numerical thresholds to define study quality helped to distinguish between studies 
providing low versus high quality evidence for the association between potential risk factors and 
the onset of musculoskeletal pain. However, an acknowledged limitation of the use of a total 
score for study quality is that it can obscure major flaws that are assessed by one criterion only, 
and key elements of bias are weighted in the same way as other aspects of study quality that do 
not indicate bias. For example low response rate is scored in the same way as failure to report a 
power calculation, clearly the latter being less impactful on the assessment of quality and bias 
(Shamliyan, Kane, & Dickinson, 2010). However, some important flaws were identified in the 
quality assessment process. For example, in the studies where musculoskeletal pain was assessed 
only at follow-up it was not possible to know if the subjects already had musculoskeletal pain at 
inception of the study. This then limits the inference of causality, and may have affected 
(confounded) the estimates reported, leading to an overestimation of the association found. In 
addition, in some studies the criteria for appropriate analysis of outcomes measured was not met 
or only unadjusted analyses were performed. This may have led to an overestimation of the 
association found compared to the estimate of the true association, because part of the effect 
may be due to other factors. In studies where the criteria “baseline participation >70%” and 
“losses and dropouts <20%” was not met, non-response bias or attrition bias may have occurred if 
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there was a difference in characteristics between those who participated and those who did not, 
or those who completed the study at follow-up and those who did not (Delgado-Rodriguez & 
Llorca, 2004). The use of levels of evidence to assess the strength of evidence for a risk factor had 
other limitations. For example, if one study reported findings relative to different levels of 
exposure to a risk factor, with more than one significant finding for different levels of that 
exposure but a non-significant finding for another level of the exposure, then the association 
would be regarded as mixed. In addition, if only one non-significant association from one study 
was present along with a number of significant findings from some studies, then the evidence of 
association would be regarded as inconsistent. Consequently, those factors that were investigated 
by fewer studies, or for which analyses were not stratified by levels of exposure, would be more 
likely to be assessed as having a strong evidence of association if significant findings were 
reported. To overcome this potential limitation, the overall proportion of significant and mixed 
findings vs. non-significant findings was taken into consideration, as well as the use of a best 
evidence synthesis that only considered high quality studies, and the inspection of the direction of 
associations. Another limitation is that if more than one study drawn from the same cohort report 
findings for the same body site, then the same result would be counted more than one time in 
terms of the overall count. This was the case for the evidence of association between smoking 
and the onset of back pain for example, as two articles reported findings drawn from the same 
cohort (Feldman et al., 1999, 2001), and between smoking and the onset of neck/upper limb pain 
(Feldman et al., 1999, 2002a). However, this limitation was taken into consideration and discussed 
in the evaluation of evidence (Section 2.4.7.1), and in review of the evidence and conclusions 
reported, the exclusion of one of the two studies would not have changed the evidence of 
associations. Finally, studies with a smaller sample size are more likely to have high variability in 
findings (i.e. low precision), and the detection of a statistically significant effect would not be 
possible without a sufficient sample size (Hennekens & Buring, 1987). Therefore, it may be 
possible that true associations were not detected because studies were underpowered, although 
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attempts were made to overcome this by only including studies with sample sizes above 30 
participants. 
 
2.5.4 Potential risk factors identified within the review and implications for my thesis  
In the light of the findings (consistency of evidence) reported in this systematic review, two risk 
factors were identified that require further investigation. These two factors are: sleep (i.e. sleep 
problems), and psychological (i.e. internalizing and externalizing) symptoms. The rationale for 
investigation of these two risk factors is outlined below, including the description of further 
additional criteria that support the selection of these risk factors, such as consistency with 
research conducted in adults, theoretical plausibility, and evidence of dose-response identified in 
some studies included in the review, which taken together may indicate potential for causation. 
 
2.5.4.1 Sleep problems 
Sleep problems in children and adolescents are common, as between 25% and 40% experience at 
least one type of sleep problem during childhood and adolescence (Dosi, Figura, Ferri, & Bruni, 
2015; Meltzer, Plaufcan, Thomas, & Mindell, 2014). Strong evidence of association for the onset 
of neck pain in children with low sleep quality (although only in girls) was found in this systematic 
review. Also, a larger proportion of studies reported significant or inconsistent findings rather 
than non-significant findings with trends showing an elevated level of risk, suggesting an element 
of consistency overall and specifically consistency for neck pain. In addition, in terms of coherence 
with the wider literature there is evidence in support of this hypothesis from studies carried out in 
adult populations where evidence of risk is more established (Gupta et al., 2007; McBeth, Lacey, 
& Wilkie, 2014; Mork & Nilsen, 2012; Onen, Alloui, Gross, Eschallier, & Dubray, 2001). There is 
also theoretical plausibility with evidence of potential mechanisms that may explain the 
association between sleep and musculoskeletal pain, as introduced in Section 1.5.1.8. For 
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example increased production of cytokine and inflammatory mediators has been observed in 
individuals with sleep problems, moreover sleep problems may increase muscular tension, 
potentially leading to musculoskeletal pain. In addition, studies within the systematic review that 
explored the effect of increasing levels of sleep problems showed a dose-response pattern of 
association with musculoskeletal pain (Auvinen et al., 2010; Harrison et al., 2014). This underlines 
that there is a need to systematically investigate the association between sleep quality and the 
onset of musculoskeletal pain in children. 
 
2.5.4.2 Psychological symptoms  
The 1-year prevalence of psychological symptoms in childhood and adolescence is 25% 
(Merikangas, Nakamura, & Kessler, 2009). Most of the studies within the review conceptualised 
psychological and behavioural problems within the domains of externalizing symptoms and 
internalizing symptoms. These domains represent a conceptualised discrimination in children and 
adolescents (Forns, Abad, & Kirchner, 2011) between problems that are outer-directed (e.g. 
behavioural actions, conduct disorders) which affect the surrounding environment (externalizing) 
and distress related problems (anxiety, depressed mood) which are inner directed (internalizing). 
Hereafter I will refer to psychological problems within these domains which have been shown to 
be common during childhood and more so adolescence (Corley, Beltz, Wadsworth, & Berenbaum, 
2015; Downing & Bellis, 2009; Graber, 2013; Pinyerd & Zipf, 2005). A high number of significant 
and inconsistent findings for internalizing and externalizing symptoms (trends showing increased 
odds) were reported in this systematic review, together with strong evidence of an association of 
conduct problems (which are part of the externalizing symptoms construct) with pain. This 
suggests that internalizing and externalizing symptoms may potentially be linked with the onset of 
musculoskeletal pain. In support of this, a body of research in adults suggests that psychological 
factors are predictive of the onset of musculoskeletal pain (Gupta et al., 2007; McBeth & Jones, 
86 
 
2007; Pinheiro et al., 2015; Taylor et al., 2014). In addition, a dose-response association with 
musculoskeletal pain was reported in studies within the systematic review that explored the 
effect of increasing levels of factors pertaining to the internalizing and externalizing constructs 
(Jones, Silman, et al., 2003; Jones, Watson, et al., 2003). This PhD study will investigate if specific 
psychological and behavioural problems such as internalizing and externalizing symptoms are 
predictive of the onset of musculoskeletal pain in adolescents. 
 
2.6 Summary 
This chapter has outlined the design and results of a systematic review on risk factors for the 
onset of musculoskeletal pain in children and adolescents. In the following chapter the aim and 
specific objectives of this thesis will be outlined. 
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Chapter three. Aim and objectives of the PhD 
 
3.1 Aim 
The overall aim of this thesis is to identify potential risk factors for the onset of musculoskeletal 
pain in children and adolescents from the current literature (Chapter 2), and where appropriate to 
do so (i.e. factors identified as requiring further investigation), generate hypotheses and test 
those hypotheses using existing cohort data. 
3.2 Specific objectives 
Two potential risk factors for the onset of musculoskeletal pain in children and adolescents were 
identified in the systematic review performed within this thesis (Section 2.4): the presence of 
sleep problems and the presence of psychological symptoms. This evidence has led to the 
development of the objectives that are investigated within this thesis, as outlined below. 
Specific objectives addressed are: 
1. To investigate whether sleep problems are a risk factor for the onset of musculoskeletal 
pain in children. 
2. To investigate whether psychological symptoms are risk factors for the onset of 
musculoskeletal pain in adolescents. 
3. To investigate whether sleep problems and psychological symptoms are associated with 
consultation for musculoskeletal pain in children and adolescents within a primary care 
setting. 
The rationale for the investigation of objectives 1 and 2 has been outlined in Section 2.5.4. In the 
following sections each of the research objectives are explained in more detail, including the 
factors selected as potential confounders and for testing for potential effect modification. 
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3.3 Objective number 1 - Investigation of sleep problems as a risk factor for the onset 
of musculoskeletal pain in children 
The aim of the investigation of this objective is to investigate the association between sleep 
problems and the onset of musculoskeletal pain in children in more detail. Informed by the results 
of the systematic review (chapter 2) and additional research in adults, the selection of potential 
confounders to be included in the analysis (Section 3.3.1) and the variables explored for effect 
modification (Section 3.3.2) will be justified below. 
 
3.3.1 Selection of potential confounders 
Analysis of the association between sleep problems and the onset of musculoskeletal pain may be 
subject to influence from potential confounders. Previous studies have indicated that low levels of 
physical activity may be associated with low sleep quality (Aguilar, Vergara, Velasquez, & Garcia-
Hermoso, 2015) and may also be predictive of the onset of musculoskeletal pain (Wedderkopp, 
Kjaer, Hestbaek, Korsholm, & Leboeuf-Yde, 2009). Psychological symptoms are associated with 
sleep problems (i.e. the association between sleep problems and depression is bidirectional) 
(Campbell, Tang, et al., 2013; Coulombe, Reid, Boyle, & Racine, 2011; Pieters et al., 2014) as well 
as with the onset of musculoskeletal pain in children (Jones, Silman, et al., 2003; Jones, Watson, 
et al., 2003; Jussila et al., 2014). Therefore analysis will be adjusted for these potential 
confounders.  
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3.3.2 Rationale for investigating effect modification 
Potential effect modifiers of the association between sleep and musculoskeletal pain in children 
were identified. The rationale for the investigation of potential modification effect is described 
below. 
  
3.3.2.1 Gender 
Literature clearly shows gender differences in the rates of sleep problems and reports of pain;  
adult females report poorer sleep quality and more pain than males (Fillingim, 2000; Mallampalli 
& Carter, 2014; Zhang & Wing, 2006), boys are more likely than girls to have sleep problems or 
receive a diagnosis for sleep disorders (Archbold, Pituch, Panahi, & Chervin, 2002; Meltzer, 
Johnson, Crosette, Ramos, & Mindell, 2010), girls may become at increased risk of sleep problems 
compared to boys after the beginning of puberty (Bonvanie et al., 2016; Knutson, 2005). Thus, 
while it is clear that gender differences are present, it is still not clear which gender is potentially 
at higher risk for both sleep problems and musculoskeletal pain, and whether differences 
between genders change at different life stages (e.g. puberty). Two of the studies identified 
within the review explored gender differences in the association between sleep problems and 
musculoskeletal pain. Results suggest that low sleep quality is predictive of the onset of neck pain 
in girls, but not in boys (Section 2.4.3.1). However, one of these studies focused on individuals of 
an older age range (16-18 years old) (Auvinen et al., 2010), and the other study (Ståhl et al., 2008) 
included a sleep measure that was part of a broader assessment that included other 
psychosomatic symptoms, which may have biased their reported results. Therefore, further 
investigation is needed to assess potential gender effects on the association between sleep and 
musculoskeletal pain.  
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3.3.2.2 Puberty 
Puberty and pubertal status may modify the association between sleep and musculoskeletal pain. 
During puberty a change in the secretion of hormones (i.e. melatonin) and in the circadian 
regulation system occurs, which affects the sleep-wake pattern, and may cause sleep problems 
(Carskadon & Tarokh, 2014; Dahl & Lewin, 2002). Furthermore, changes in the psychosocial 
context occur during pubertal development that can affect the sleep of children. This includes a 
change in bedtime routine and sleep duration, the increased use of technology in bed, and 
engagement in social activities later in the evening all of which can disrupt sleep patterns 
(Carskadon & Tarokh, 2014; Carskadon, 2011). In addition, as shown in the systematic review an 
association between advanced pubertal stage and musculoskeletal pain was reported (Section 
2.5.2.7). Based on this evidence it is reasonable to hypothesize that the association between sleep 
problems and musculoskeletal pain may be modified by pubertal status, with a stronger 
association expected for later pubertal stages compared to pre-pubertal children.  
 
 
3.3.2.3 Screen time 
Another potential modifier of the association between sleep and musculoskeletal pain is screen 
time. Children are commonly exposed to high levels of artificial lights through computers, 
televisions and smartphones (Hale & Guan, 2015). This exposure to screen time is suspected to 
influence sleep patterns by decreasing the secretion of melatonin necessary for falling asleep 
(Aguilar et al., 2015; Hale & Guan, 2015; Higuchi, Motohashi, Liu, & Maeda, 2005), and as outlined 
for pubertal effects in the above section, this screen time behaviour may increase with age. 
Therefore, it may be postulated that the association between sleep problems and musculoskeletal 
pain is modified by the levels of exposure to screen time, with the association expected to be 
stronger in those reporting increasing levels of screen time. 
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3.4 Objective number 2 - Investigation of psychological symptoms as a risk factor for 
the onset of musculoskeletal pain in adolescents 
The aim of this objective is to further investigate the association between psychological 
symptoms and the onset of musculoskeletal pain in adolescents, taking account of the influence 
of potential confounders and exploring potential effect modification by the same factors as 
introduced in section 3.3.2. The selection of potential confounders (Section 3.4.1) and justification 
of potential effect modifiers (Section 3.4.2) is outlined below. 
 
3.4.1 Selection of potential confounders 
The association between psychological symptoms and the onset of musculoskeletal pain may be 
confounded by several factors. Psychological symptoms are associated with cigarette use and 
substance use (Colder et al., 2013; King, Iacono, & McGue, 2004). In addition, several associations 
between smoking and back pain onset were reported in the studies identified within the review 
(Brattberg, 1994; Feldman et al., 1999, 2001; Gill, Davis, Smith, & Straker, 2014; Mikkonen et al., 
2008). Sleep problems are also associated with psychological symptoms in adolescence 
(Campbell, Tang, et al., 2013; Coulombe et al., 2011; Pieters et al., 2014) and may be predictive of 
the onset of musculoskeletal pain (Section 2.4.3). Similarly, low levels of physical activity may be 
predictive of the onset of musculoskeletal pain (Wedderkopp et al., 2009). In addition, physically 
inactive adolescents are at higher risk of psychological symptoms compared to normally active 
individuals (Monshouwer, Have, van Poppel, Kemper, & Vollebergh, 2013). Therefore, potential 
confounders that will be considered within the analysis of the association between psychological 
symptoms and the onset of musculoskeletal pain will be smoking, marijuana use, drug use, 
physical activity, and the presence of sleep problems.  
  
92 
 
3.4.2 Rationale for investigating effect modification 
Potential effect modifiers of the association between psychological symptoms and 
musculoskeletal pain were identified. Rationale for testing the potential effect modification is 
described below. 
 
3.4.2.1 Gender 
Literature reports the presence of a gender imbalance on the prevalence of psychological 
symptoms, with higher risk of internalizing symptoms in girls and of externalizing symptoms in 
boys (Maughan, Rowe, Messer, Goodman, & Meltzer, 2004; Merikangas et al., 2009). Studies 
identified within the systematic review showed mixed evidence for gender in the association 
between psychological symptoms and the onset of musculoskeletal pain. Further analysis is 
therefore required to investigate the influence of gender on the association between 
psychological symptoms and onset of musculoskeletal pain.  
 
3.4.2.2 Puberty 
Pubertal timing is linked to the development of psychological symptoms in adolescents, as those 
who develop earlier or later compared to their peers are at higher risk of psychological symptoms 
(Graber, 2013; Kaltiala-Heino, Marttunen, Rantanen, & Rimpela, 2003; Mendle, 2014). In addition, 
being in a more advanced pubertal stage is suspected to be linked with musculoskeletal pain 
(Janssens et al., 2011; Lardon et al., 2014). It is therefore reasonable to hypothesize a difference 
in the association between psychological factors and the onset of musculoskeletal pain depending 
on the pubertal timing of adolescents. Accordingly, the potential effect modification of puberty on 
this association will be assessed.  
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3.4.2.3 Screen time 
High levels of screen time are associated with psychological symptoms such as depression, 
anxiety, emotional and behavioural problems (Cao et al., 2011; Kremer et al., 2014; Mundy, 
Canterford, Olds, Allen, & Patton, 2017; Wu, Tao, Zhang, Zhang, & Tao, 2015). Thus, it may be 
postulated that the association between psychological symptoms and the onset of 
musculoskeletal pain is modified by the levels of exposure to screen time, with higher odds in 
those individuals with increased levels of screen time. This will be assessed by investigating the 
potential effect modification of screen time. 
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3.5 Objective number 3 - Investigation of sleep problems and psychological symptoms 
as risk factors for the onset of musculoskeletal pain in children and adolescents 
within a primary care setting 
The rationale for the investigation of objective number 1 (i.e. investigation of sleep problems as a 
risk factor for the onset of musculoskeletal pain in children) and objective number 2 (i.e. 
investigation of psychological symptoms as a risk factor for the onset of musculoskeletal pain in 
adolescents) has been outlined in section 2.5.4. In comparison to the body of evidence of research 
regarding the association between sleep problems, psychological symptoms and the onset of 
musculoskeletal pain in children and adolescents in general population samples, currently there is 
no research within primary care populations as shown in the systematic review. This is a 
substantial omission given that health care resources are directed here. Therefore, the 
investigation of sleep problems and psychological symptoms as risk factors for the onset of 
musculoskeletal pain will be replicated in a primary care dataset. The importance of investigating 
the objectives of this thesis in both general population and primary care datasets is outlined 
below. 
 
3.5.1 Importance of investigating the objectives in both general population and primary care 
datasets 
The analysis of the investigation of the objectives of this thesis will take place using two distinct 
populations. Firstly, analysis will be carried out in two general population samples (child and 
adolescents) (Childhood to Adolescence Transition Study and Avon Longitudinal Study of Parents 
and Children). The aim is for the results to be representative of the influence of the risk factors on 
musculoskeletal pain onset in children and adolescents in the general population. This approach is 
informative from a “public health” viewpoint where potential risk factors could be identified and 
changed at a population level (e.g. a public media campaign to reduce sleep problems via a 
reduction in screen time use to lower the risk of musculoskeletal pain onset). The second 
95 
 
approach will study these risk factors within a population of children and adolescents who seek 
healthcare both for the risk factors and musculoskeletal pain. Here the argument is more strongly 
related to the potential for intervention within a specific target population (e.g. children/ 
adolescents seeking healthcare for sleep problems or psychological symptoms). This dual 
approach addresses the concept termed the “iceberg of disease” theory. According to this theory, 
a disease may metaphorically be represented as an iceberg, where the cases that are recognized 
by the healthcare system are those at the tip of the iceberg, whereas the bottom of the iceberg 
represents the majority of cases, which are not detected by the healthcare system (Bhopal, 2002). 
Taking only one approach, either general or healthcare populations, may miss the fact that those 
who generally seek healthcare are more likely to have more severe symptoms and outcomes than 
those who do not consult (Bhopal, 2002; Campbell & Roland, 1996). The advantages of this dual 
strategy is that comparisons can be made between the two samples, which can generate greater 
understanding of the risk factors of musculoskeletal pain onset in specific groups of children and 
adolescents and point to individuals and groups who are at high risk. For example, analysis within 
general population samples may show different results regarding the strength of risk factors and 
the influence of effect modifiers. This may consequently have different implications for the 
potential for prevention or treatment. Certainly the evidence shows that despite the high 
proportion of sleep, psychological and behavioural problems reported by children and 
adolescents in the general population (Section 2.5.4.1 and 2.5.4.2), only 4% of children are 
actually given a diagnosis for sleep problems (Meltzer et al., 2010), and approximately only 10% of 
those with a mental health disorder are seen in a specialist mental health service (Kramer & 
Garralda, 2000). This appears to indicate a higher level of severity within the consultation and 
healthcare seeking population.  
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3.6 Thesis outline 
In this section, a brief overview of the content of the following chapters is outlined. 
 
 Methods chapter (Chapter 4) 
Within this chapter the choices related to study design, methods and approach to the 
analysis are described, together with a brief description of the datasets used for the 
analyses. An analysis plan will be presented for each objective. 
 The association of sleep problems with musculoskeletal pain onset in children: 
description of the Childhood to Adolescence Transition Study (CATS) cohort (Chapter 5) 
Within this chapter a description of the CATS dataset together with the descriptive 
analysis of the CATS dataset is provided. 
 The association of sleep problems with musculoskeletal pain onset in children: results of 
the Childhood to Adolescence Transition Study (CATS) cohort (Chapter 6) 
Within this chapter the results of the analysis of the association between sleep problems 
and the onset of musculoskeletal pain using data from the CATS cohort is provided 
together with a discussion of the results (thesis objective 1). 
 The association of psychological symptoms with musculoskeletal pain onset in 
adolescents: description of the Avon Longitudinal Study of Parents and Children 
(ALSPAC) cohort (Chapter 7) 
Within this chapter a description of the ALSPAC dataset together with the descriptive 
analysis of the ALSPAC dataset is provided. 
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 The association of psychological symptoms with musculoskeletal pain onset in 
adolescents: results of the Avon Longitudinal Study of Parents and Children (ALSPAC) 
cohort (Chapter 8) 
Within this chapter the results of the analysis of the association between psychological 
symptoms and the onset of musculoskeletal pain using data from the ALSPAC cohort is 
provided together with a discussion of the results (thesis objective 2). 
 The association of sleep and psychological symptoms with musculoskeletal pain onset in 
children and adolescents in primary care: description of the Consultations in Primary 
Care Archive (CiPCA) cohort (Chapter 9) 
Within this chapter a description of the CiPCA dataset together with the descriptive 
analysis of the CiPCA dataset is provided. 
 The association of sleep and psychological symptoms with musculoskeletal pain onset in 
children and adolescents in primary care: results of the Consultations in Primary Care 
Archive (CiPCA) cohort (Chapter 10) 
Within this chapter the results of the analysis of the association of both sleep and 
psychological symptoms with new episodes of musculoskeletal pain consultation using 
data from CiPCA is presented together with a discussion of the results (thesis objective 3). 
 Discussion (Chapter 11) 
In this chapter, a discussion and reflection upon the overall results of this thesis is 
outlined. Potential future implications resulting from the findings of this thesis are 
discussed.  
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3.7 Summary 
In this chapter, the aims and objectives of this thesis have been outlined, along with a description 
of the confounders included in the analysis, and the rationale for investigating potential effect 
modifiers. The importance of using both general population datasets and a primary care dataset 
to investigate the objectives has been discussed. A description of the contents of the following 
chapters of the thesis has been provided. In the following chapter, a description of the methods 
that will be used to investigate the objectives of this thesis along with a brief description of the 
datasets that will be used for the investigation of each objective will be outlined. 
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Chapter four. Methods chapter 
 
4.1 Introduction 
This chapter outlines the rationale for the choice of research design and the analysis methods 
within this thesis. Justification will be provided for the design and analysis approaches taken in 
light of alternative methods. The chapter will briefly cover the range of designs used in 
epidemiological research (Section 4.2), reasons for the particular choice of datasets within this 
thesis (Section 4.3 - 4.4), as well as the analysis approach and the methods for assessment of 
missing data and potential risk of bias due to missing data (Section 4.5). Finally, the analysis plan 
for each research question is outlined (Section 4.6). 
 
4.2 Available study designs for epidemiological studies 
A range of study designs can be used within epidemiological research (please see Figure 4.1, from 
(Grimes & Schulz, 2002). These can be broadly classified as experimental or observational designs, 
depending on whether the exposure is assigned by the researcher or not, respectively (Grimes & 
Schulz, 2002). There are two types of experimental designs, depending on the way exposures have 
been allocated to participants: randomized controlled trials or non-randomised controlled trials. 
Observational designs can also be classified into two main categories, depending on the objective 
of the study: analytical and descriptive study designs. Analytical study designs are performed 
when the objective is to investigate an association between an exposure and outcome, while 
descriptive study designs are performed when the objective is to describe the exposure and the 
outcome. Analytical designs include case-control studies, cohort studies and cross-sectional 
studies (Grimes & Schulz, 2002).  
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Figure 4.1. Types of epidemiological studies 
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4.3 Suitable study design with regard to the aim of this thesis 
The aim of this thesis is to investigate risk factors for the onset (incidence) of musculoskeletal pain 
in children and adolescents identified from the general population or primary care consultation 
records (Section 3.1). This will be achieved by estimating both the incidence of musculoskeletal 
pain and the strength of association between exposure and outcome, which will be the main 
outcomes of the analyses included within the thesis. The incidence estimates the risk of onset of a 
condition (i.e. the new cases) within the population at risk in a specific period of time (Bhopal, 
2002; Mourão et al., 2010). Therefore, in this thesis the incidence will be calculated as the number 
of new cases (i.e. those who report musculoskeletal pain at follow-up) among those at risk (i.e. 
those without musculoskeletal pain at baseline). Estimating incidence is important as this provides 
an indication of the risk of developing musculoskeletal pain within each of the samples included in 
this thesis. By comparing the incidence between those exposed and those unexposed to a certain 
risk factor, it is possible to determine which group is at higher risk of developing the disease and 
identify the potential causes of a disease (Bhopal, 2002). The strength of association is described 
through association measures (e.g. relative risk, odds ratio), which represent the ratio of the risk 
in those exposed compared to those unexposed to the risk factor (Bhopal, 2002). Given the aim of 
the thesis, which is to investigate the association between sleep problems, psychological 
symptoms and the onset of musculoskeletal pain, the analytical study design was considered the 
most suitable to address the thesis objectives. A description of analytical study designs, along with 
their strengths and limitations, and the reasons for selecting the cohort design are outlined in the 
following sections. 
  
102 
 
4.4 Description, strengths and limitations of study designs for investigating risk 
factors of disease onset 
4.4.1 Cohort study design 
A cohort study design is where exposures to the risk factor of interest are measured in individuals 
still at risk of getting the disease (i.e. who are free from the disease at baseline), and individuals 
are classified depending on their exposure status. Subsequently, individuals are followed-up over 
time to observe who develops the disease, and the incidence of the disease between the 
exposure groups is compared (Grimes & Schulz, 2002) (see Figure 4.2). Cohort designs can be 
classified into two types: prospective cohort studies and retrospective cohort studies. In 
prospective cohort studies, the study population is defined prior to the occurrence of the 
outcome, exposures to risk factors are assessed and participants are prospectively followed up 
over time. Differently, in the retrospective cohort study both the outcome and the exposure have 
already occurred. The study population is defined retrospectively based on existing data, and 
exposures and outcome can be assessed at the same time (Hennekens & Buring, 1987) (Figure 
4.3).  
 
Figure 4.2. Cohort study1 
 
 
 
 
 
 
                                                          
1 Exposures can be measured on categories that differ from the binary system represented in the figure 
such as categorical, ordinal or numerical/continuous scales 
Cohort study 
Exposed group Non-exposed group 
Disease No disease Disease No disease 
Follow-up  
103 
 
 
Figure 4.3. Prospective and retrospective cohort study 
Past Present Future 
   
   
   
   
   
   
   
   
 
 
4.4.2 Case-control study design 
The case-control study design also enables the investigation of an association between exposure 
and the outcome. However, differently from cohort studies, case-control studies start with the 
selection of the cases (i.e. those with the disease) who are matched to control individuals without 
the disease. When the cases and the controls are defined, then exposures to risk factors are 
measured retrospectively in time (Levin, 2006b).  
 
4.4.3 Cross-sectional studies 
The cross-sectional study design is a study design where both the exposure and the outcome are 
measured at the same point in time. This study design provides prevalence estimates and it is 
usually performed to give a description of the exposures and/or the outcome within a population 
(Levin, 2006a). However, this design can be also used to assess what factors are associated with an 
outcome but are not able to estimate risk (incidence of the outcome), and cannot establish 
whether the exposure occurred before the outcome (Hennekens & Buring, 1987).  
 
Prospective cohort study 
Retrospective cohort study 
TIME 
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4.4.4 Strengths and limitations of the analytical study designs 
In the following section the strengths and limitations of the analytical study designs are outlined, 
including the different types of bias which can affect analytical study designs (described in Section 
4.4.4.4). For example, studies may be affected by selection bias (i.e. the study population does not 
represent the source population) and information bias (i.e. bias in the measurement of the 
variable). In addition, the investigation of an association between a risk factor and outcome in 
epidemiological studies may be affected by the potential influence of confounding. A more 
detailed description of confounders is outlined in Section 4.5.3.  
 
4.4.4.1 Cohort studies 
Cohort studies (both prospective and retrospective studies) present several strengths. The first is 
that they enable estimation of the incidence of an outcome (for a definition please see Section 
4.3). Another advantage is that with the cohort study design it is possible to determine the 
temporal sequence between the exposure and the outcome. This provides greater confidence 
regarding the inference of causality (i.e. the exposure is potentially causing the development of 
the outcome) over study designs that measure both the exposure and outcome at the same time 
(i.e. cross-sectional studies) (Grimes & Schulz, 2002; Hennekens & Buring, 1987). Also, with the 
cohort design participant enrolment can be based on the presence or absence of the exposure, 
which allows an accurate assessment of sample size for the analysis (i.e. enough individuals in 
both the exposed and non-exposed groups) (Hennekens & Buring, 1987). For this reason, cohort 
designs are suitable for the investigation of rare exposures. However, cohort studies also present 
some limitations, which can vary between prospective and retrospective cohort studies. A 
limitation of prospective cohort studies is cost and time, outcomes can take many years to occur, 
there is a need to ensure participants keep involved, and if the outcome is rare there is a need for 
large samples (Grimes & Schulz, 2002). Conversely, retrospective cohort designs are generally less 
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costly and less time-consuming than prospective cohort designs because all the information about 
exposures and outcome is already present. Indeed, routinely collected data (e.g. healthcare 
records, registers) are usually employed in retrospective studies, which allows the assessment of 
outcomes with a normally longer latency time compared to prospective cohort designs 
(Hennekens & Buring, 1987). The use of a retrospective design presents other limitations however. 
This design depends on available data (on past exposures as well as subsequent outcomes) from 
existing cohorts (for example, routinely collected healthcare data). Data are also likely to have 
been collected for purposes different from the one investigated, information regarding the 
variables of interest may be incomplete or lacking in comparison to a purposeful design cohort 
study (Hennekens & Buring, 1987).  
 
4.4.4.2 Case-control studies 
Case-control study designs present some strengths and limitations. Strengths of case-control 
designs are that they may be chosen when the outcome of interest is rare, those with the 
outcome can be readily identified and matched to controls, therefore in terms of time and cost 
they are more efficient compared to cohort designs (Levin, 2006b). However, there are some 
limitations linked to the use of case-control studies. For example it is impossible to estimate the 
incidence of the disease with this study design. This is because this study design compares cases 
with the outcome with a selection of controls, and it is usually not possible to reconstruct the 
population the cases and controls were derived from (Levin, 2006b). Another limitation is the 
selection of the cases, which may be incident (those who are recently diagnosed with the disease) 
or prevalent (existing cases who experienced the disease at any time). Incident cases are 
preferable because they provide more reliability on the temporal sequence between the exposure 
and the outcome. Conversely, with prevalent cases the exposure may have occurred after the 
outcome and may also have changed as a consequence of the outcome (Levin, 2006b). For 
example, if prevalent cases with musculoskeletal pain were selected, there would be less 
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confidence on the assessment of sleep problems as an exposure because sleep problems may 
have been influenced as a consequence of musculoskeletal pain presence, therefore the 
temporality of the association is less clear. Another limitation concerns the selection of controls, 
who should be free of the outcome, and arise from the same source population as the cases 
originated from (Levin, 2006b). A less accurate selection of controls may lead to bias if, for 
example, controls are excluded because they have a condition associated with the exposure, but 
cases with the same condition are included (Delgado-Rodriguez & Llorca, 2004). In case-control 
studies, confounding (which affects all types of design) is often dealt with by matching the cases 
with the controls using information regarding known confounders (Levin, 2006b). Matching for a 
variable that is only associated with the exposure but not with the disease can lead to 
overmatching, which would ultimately result in an underestimation of the association (Delgado-
Rodriguez & Llorca, 2004). Finally, this study design may not be the best choice to investigate the 
effect of risk factors that are rare as this would require identification and selection of a large 
number of cases and controls (Levin, 2006b). 
 
4.4.4.3 Cross-sectional studies 
Cross-sectional designs present a strength in terms of efficiency, as exposures and outcome are 
assessed at the same time, which makes this design relatively inexpensive and quick to complete 
compared to other designs (Hennekens & Buring, 1987; Levin, 2006a). However, as only one time 
point is included in this study design, it is not possible to determine the temporal sequence 
between the exposure and the outcome, therefore inferences of causality cannot be made (Levin, 
2006a). Another key limitation linked to the use of only one time point is that this does not allow 
to estimate the incidence, but only the prevalence (Levin, 2006a). Suppose that one wanted to 
investigate the association between sleep problems and musculoskeletal pain using a cross-
sectional study. In this case, a higher prevalence of sleep problems might be found, but this might 
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be the consequence of musculoskeletal pain rather than the cause. Therefore, this might result in 
an overestimation of the association between sleep problems and musculoskeletal pain onset. 
 
4.4.4.4 Bias of analytical studies 
Analytical designs may be affected by bias. A common type of bias is selection bias, which may 
occur when the selected sample does not represent the target population, which may affect 
cohort, cross-sectional and case-control designs. For example in cohort (and cross sectional) 
designs selection bias may arise due to the effect of either selective non-participation at the start 
of the study (participation bias) or selective loss to follow-up (attrition bias, cohort designs only) 
(Delgado-Rodriguez, 2004). For example, those who decide to participate in a study may have 
different characteristics as compared to those who decide not to participate, as they may be 
healthier or have poorer health. If these characteristics are associated with the probability of the 
outcome, then the estimate of the association would be biased (either overestimation or 
underestimation). Attrition bias is a primary concern of cohort studies, especially if follow-up 
extends over multiple months or years. If the proportion of loss to follow-up is substantial (>30%), 
and individuals lost to follow-up were at a different risk to experience the outcome as compared 
to those that completed the study, this can produce biased estimates and can compromise the 
accuracy of the estimates of the study findings (Hennekens & Buring, 1987). As reported in 
Section 4.4.4.2, in case-control studies overmatching (which is a type of selection bias) can occur, 
or selection bias may arise because of an inappropriate selection of controls. In addition, hospital-
based case-control studies may be affected by Berkson’s bias, which is a specific type of selection 
bias that may occur when cases and controls have a different probability of hospitalization that is 
linked to the exposure (Bhopal, 2002; Delgado-Rodriguez & Llorca, 2004; Levin, 2006b).  
Another major type of bias is misclassification, which result in information bias and can affect all 
analytical study designs. For example, in retrospective cohort studies there is risk of information 
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bias if knowledge of the outcome influences the classification of individuals into the exposed and 
non-exposed groups or vice versa, resulting in misclassification of either the exposure or the 
outcome (Hennekens & Buring, 1987). Similarly, the case-control study design is prone to recall 
bias, which is a form of information bias leading to misclassification of the exposure (Levin, 
2006b). For example, individuals who experience musculoskeletal pain may be more likely to recall 
a certain exposure that may be suspected to be linked to pain compared to controls (Delgado-
Rodriguez & Llorca, 2004). Cross-sectional designs as well are likely to be affected by 
misclassification (information) bias, due to the concurrent assessment of both exposures and 
outcomes, as the responder may report more often exposures that are related to the outcome 
(Levin, 2006a). Misclassification can be non-differential or differential. Non-differential 
misclassification, which occurs when individuals are evenly misclassified among exposure or 
outcome groups, will result in underestimation (i.e. weakened association) between the exposure 
and the outcome (Hennekens & Buring, 1987). This may happen for example when the objective 
is to classify those with high and low levels of physical activity. If only the number of days per 
week of physical activity are used as the criterion but not the type or intensity of physical activity, 
then those individuals that exercise strenuously but only few days a week may be wrongly 
allocated to the low levels of physical activity group, which may lead to an underestimation of the 
association with musculoskeletal pain. Differential misclassification, which occurs when 
individuals are unevenly misclassified among groups of the exposure or the outcome, may 
produce either no effect difference, an overestimation, or an underestimation of the true 
association. This may happen for example when the outcome is more often detected in the group 
of exposed individuals as compared to non-exposed because those exposed are more likely to 
seek medical attention and subsequently be diagnosed with the disease / outcome of interest 
(Hennekens & Buring, 1987). This would lead to an overestimation of the association between 
exposure and outcome.  
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4.4.5 Choice of study design 
As reported in Section 4.3, in order to investigate the objectives of this thesis, two parameters 
need to be obtained: the incidence of the outcome and the strength of association between 
exposure and outcome. From the range of epidemiological (analytical) designs the prospective 
cohort design was considered to be best suited to obtain these parameters. Prospective cohorts 
allow the calculation of incidence, which is an estimate of the proportion of individuals who are 
free of the outcome at baseline and develop the outcome during the period of observation 
(follow-up) (Section 4.3). In addition, prospective cohort studies provide stronger evidence for a 
temporal association between risk factors and the onset of the disease, and are less susceptible to 
information bias (e.g. recall bias, and misclassification of the outcome) compared to the other 
study designs. A brief description of the three cohorts (two general population samples and a 
cohort identified from routinely collected electronic primary care data) used to investigate the 
objectives of this thesis are outlined in the following section. 
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4.4.6 Datasets identified for testing the objectives 
The objectives of this thesis (described in Section 3.2) will be addressed using data from cohort 
studies conducted in general population samples and a Primary Care dataset. The cohort that will 
be used to investigate objective number 1 is the Childhood to Adolescence Transitions Study 
(CATS), the cohort that will be used to investigate objective number 2 is the Avon Longitudinal 
Study of Parents and Children (ALSPAC), and the cohort that will be used to investigate objective 
number 3 is the Consultations in Primary Care Archive (CiPCA). A brief overview of these cohorts 
is described below. For a fuller description of the CATS dataset, the ALSPAC dataset, and the 
CiPCA dataset please refer to Chapter 5, Chapter 7 and Chapter 9, respectively. The description of 
the cohorts will be followed by a description of the methods for the analysis that will be 
performed together with the analysis plan, all of which is outlined in the following sections. 
 
 
Childhood to Adolescence Transitions Study (CATS) 
CATS is a population-based cohort study that includes Australian schoolchildren who were 9 years 
old at baseline and were followed up for 4 years with assessment each year. Data collection 
included suitable measures for sleep problems, musculoskeletal pain (assessed as a binary 
variable, presence/absence of musculoskeletal pain) and the potential effect modifiers and 
confounders described in Section 3.3.1 and 3.3.2 for the investigation of objective number 1. In 
the analysis within this thesis, only data up to the first year of follow-up will be used. 
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Avon Longitudinal Study of Parents and Children (ALSPAC) 
ALSPAC is a birth-cohort of English children and adolescents followed-up from birth up to the age 
of 21. Data collection for this cohort included suitable measures for psychological symptoms (in 
this case internalizing and externalizing symptoms), musculoskeletal pain (assessed as a binary 
variable, presence/absence of musculoskeletal pain) and the potential effect modifiers and 
confounders described in Section 3.4.1 and 3.4.2 for the investigation of objective number 2. In 
the analysis, only data collected when children were 13 (baseline) and 17 years old (follow-up) will 
be used as these correspond to the times of measurement of the exposure and outcome. 
 
Consultations in Primary Care Archive (CiPCA) 
CiPCA includes routinely collected data regarding consultations, prescriptions and referrals for 
patients registered with 13 general practices in North Staffordshire, England. This dataset includes 
coded consultations for sleep problems, psychological symptoms and musculoskeletal pain, which 
will be used to investigate both objectives. However, CiPCA does not include adequate 
information for the inclusion of the selected potential effect modifiers, and therefore effect 
modification will not be studied in objective 3. This analysis allows for a continued period of time 
for analysis and consultation data from year 2005 to year 2012 will be used. 
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4.5 Analysis  
4.5.1 Descriptive analysis 
A descriptive analysis of baseline characteristics will be performed in all datasets. Proportions (or 
percentages) will be presented for categorical variables and means and standard deviations for 
continuous data.  
 
4.5.2 Regression methods 
In epidemiological studies, the presence of a statistical association between variables is 
investigated, most often one or more exposures (independent variable) with an outcome 
(dependent variable) (Alexopoulos, 2010). For example, the statistical association between sleep 
problems (independent variable) and the onset of musculoskeletal pain (dependent variable) will 
be assessed for objective number 1. This can be investigated by means of regression analysis, 
which is a suitable method to predict the value of the dependent variable based on the value of 
the independent variable (Bland, 2015). Both univariable and multivariable regression analysis will 
be performed to estimate the association between risk factors (i.e. sleep problems, psychological 
symptoms) and the onset of musculoskeletal pain. Univariable analysis provides the crude 
estimate of association between only one risk factor entered in the model (e.g. sleep problems) 
and the outcome (e.g. musculoskeletal pain). However, the estimate provided by univariable 
analysis does not take into account the influence of potential confounders (for a description of 
confounders please refer to Section 4.5.3) (Bland, 2015). Conversely, multivariable analysis allows 
more than one independent variable to be entered in the model, which makes it possible to take 
into account the influence of potential confounders (Bland, 2015). Several multivariable regression 
methods are available (Bagley, White, & Golomb, 2001). The choice of the regression method to 
be used depends on the characteristic of the outcome data (i.e. continuous, binary, categorical, 
count, time-to-event data) (Bland, 2015). A description of all the regression methods is beyond 
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the scope of this thesis. Regression methods that were considered suitable for the analysis based 
on the nature of the data are outlined in the following sections. 
 
4.5.2.1 Logistic regression 
Logistic regression is the suitable method to model the relationship between one or more 
independent categorical or continuous exposures and a binary dependent outcome (for example 
the presence or absence of musculoskeletal pain) (Bland, 2015; Peng, Lee, & Ingersoll, 2002). 
Logistic regression is a model based on the use of the logit of the proportion as the dependent 
variable, which is the natural logarithm of the odds (Bland, 2015; Peng et al., 2002). This thesis 
addresses two main objectives within two prospective population-based cohort datasets. Within 
those datasets the outcome (musculoskeletal pain) is binary and there is a single time point from 
exposure to outcome with the need to adjust for potential confounder variables (Section 3.3.1 and 
3.4.1). Therefore, logistic regression using odds ratio (OR) and 95% Confidence Interval is the most 
appropriate statistical method. The concept underlying the use of the odds ratio is that 
significantly higher odds of outcome will be observed in the exposed group as compared to the 
non-exposed group, if the exposure is a risk factor for the outcome (Bhopal, 2002). Conversely, 
significantly lower odds will be observed in the exposed group as compared to the non-exposed 
group, if the exposure is a protective factor for the outcome. 
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4.5.2.2 Survival analysis 
Survival analysis is a suitable method for the analysis of time-to-event outcomes (i.e. data that 
take into account the time before the occurrence of an event) (Bland, 2015). Taking into 
consideration the nature of the data of the primary care dataset (CiPCA) with the outcome being 
time to consultation for a musculoskeletal pain problem, survival analysis was considered the 
most suitable method. There are two major methods to conducting the survival analysis: Kaplan-
Meier survival curves and the Cox-regression analysis. Kaplan-Meier survival curves method 
comprises the creation of a “life table”, which includes the probability of the event (hazard) 
conditional on still being at risk of the outcome (survival) for each time interval. This information is 
used to plot a graph (Kaplan-Meier survival curve) showing the probability of survival over time in 
those still at risk of the outcome (Bland, 2015). Survival curves can be plotted separately for 
exposed and non-exposed group with the difference between two survival curves being tested 
with the logrank test (Bland, 2015). Kaplan-Meier survival curves take account of individuals who 
are observed for only part of the study by censoring their data. The term “censored data” refers 
both to those individuals who are observed only for part of the study because they do not 
complete the study and to those individuals who do not experience the outcome before the end 
of follow-up (Bland, 2015). The assumption underlying censored data is that censored individuals 
have the same probability to experience the event after censoring as those with observed data 
(Bland, 2015). The magnitude of the difference between the two groups can be expressed using 
hazard ratio. The hazard ratio is the ratio between the hazard of the event given the presence of 
the exposure variable and the hazard of the event given the absence of the exposure variable (i.e. 
the baseline hazard, which is the hazard of the event when all exposure variables are set to zero). 
The association between a risk factor and a time-to-event outcome can be estimated by means of 
Cox-regression analysis. As with the Kaplan-Meier survival curves method, also for Cox-regression 
the assumption is made that the probability of censored individuals to experience the event after 
the censoring is the same of that of the observed individuals. In addition, another assumption that 
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is made is the proportional hazards assumption, which assumes that the hazard ratio for the two 
groups being compared is constant across the time period of follow-up. This assumption can be 
tested by means of the proportional hazards assumption test, either graphically (i.e. using Kaplan-
Meier plots) or analytically (i.e. Schoenfeld residuals test) (Bland, 2015). This test should be run 
before performing the Cox regression analysis. With the Kaplan-Meier plots the assumption is met 
if the survival curves do not cross each other, while with the Schoenfeld residuals test the 
assumption is met in case of a non-significant P value (P>0.05). 
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4.5.3 Confounders 
As outlined previously this study will consider the influence of potential confounders on the 
association between risk factors and onset of musculoskeletal pain. A confounding variable can 
confound the estimate of the association (either producing an overestimation or underestimation 
or changing the direction of the association) (Hennekens & Buring, 1987). Confounding occurs 
when populations being compared differ for other characteristics that are distributed differently 
among the populations, and these differences confound (fully or partly explain) the association 
(Bhopal, 2002). For example, one objective of this thesis is to assess the effect of sleep problems 
on the development of musculoskeletal pain. The crude association can initially be estimated by 
means of univariable logistic regression analysis, which will provide an estimate of the odds of 
developing musculoskeletal pain in those with sleep problems relative to those without sleeping 
problems. However, this crude estimate would not take into account the effect of other factors 
that may influence the association, such as psychological and behavioural problems (e.g. those 
with sleep problems may also be more likely to have psychological and behavioural problems, 
which in turn may also have a relationship with the outcome). This means that the univariable 
analysis does not give an indication of the true independent association. Therefore, adjusting the 
analysis for potential confounders gives greater accuracy to the estimation of the association. 
Confounding can be positive or negative. Positive confounding occurs when the estimate of the 
association is an overestimation or underestimation that produces a value further away from the 
null compared to the true association. Conversely, negative confounding occurs when the estimate 
of the association is a value that is closer to the null compared to the true association (Hennekens 
& Buring, 1987). For a justification of the confounding variables selected for the analyses in this 
thesis please refer to Section 3.3.1 and 3.4.1. 
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4.5.4 Analysis of effect modification 
Analysis of effect modification will be performed within this thesis. Briefly this thesis will test 
whether gender, pubertal status, and screen time use modify the relationships between the 
exposure and outcome, for a full explanation of the rationale supporting the investigation of effect 
modification please refer to Section 3.3.2 and 3.4.2. An effect modifier is a variable that influences 
the magnitude or direction of the association between a risk factor and the outcome (Hennekens 
& Buring, 1987). The modification effect can be qualitative, which occurs when there is a change 
in the direction of the association, or quantitative, which occurs when the strength of the 
association depends on the levels of the effect modifier (Kamangar, 2012). The modification effect 
can be assessed by means of a statistical interaction test in combination with stratified analysis, 
which are briefly described in the following paragraphs.  
 
4.5.4.1 Interaction test 
An interaction test can be performed to assess the presence of a statistically significant 
modification effect. The interaction test requires that an interaction term is created and entered 
in the regression model in addition to the risk factor and the potential effect modifier as 
independent variables (Kamangar, 2012). The interaction term is a variable created from the 
product term of the exposure and the potential effect modifier (Kamangar, 2012). For example, 
when investigating if screen time is an effect modifier of the association between sleep problems 
and the development of musculoskeletal pain, the interaction term would be a variable that 
represents the product term of sleep problems multiplied by levels of screen time. A statistically 
significant interaction is present if the association of the interaction term with outcome is 
statistically significant, over and beyond the independent effects of the risk factor and the effect 
modifier (Bland, 2015). The interaction term indicates a difference in the magnitude of the 
association (between sleep problems and onset of musculoskeletal pain) in individuals with the 
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effect modifier versus those without the effect modifier (e.g. children with low and high levels of 
screen time). 
 
4.5.4.2 Stratified analysis  
Whilst interaction tests are useful, the results can be hard to interpret in terms of the actual 
magnitude of effect modification (as it will be a combination of the size of effect for the 
interaction term and the change in effect for both the risk factor and modifier). So in addition to 
an interaction test, stratification can be performed to observe actual differences in the magnitude 
or direction of the association between the exposure and the outcome across strata of the effect 
modifier (Hennekens & Buring, 1987). For example, it is possible to stratify the analysis of the 
association between sleep problems and the development of musculoskeletal pain by levels of 
screen time to describe the associations within these strata (i.e. separate regression models per 
strata of the modifier). If the observed risk differs in direction between strata (i.e. for one strata 
the OR is > 1 and for another strata the OR is <1), then the effect modification would be 
qualitative. Otherwise, if there is a difference of risk and each strata shows the same direction of 
association but the magnitude varies across strata (i.e. for one stratum the OR is 1.80 and for 
another stratum the OR is 3.20), then the effect modification would be quantitative.  
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4.5.5 Missing data 
In epidemiological studies, the occurrence of missing data in a dataset is a common problem. 
Missing data can affect the validity of the findings because of limitations in the representativeness 
of the sample, the potential for generating biased estimates for the association, and reduction of 
statistical power (Kang, 2013). A reduction in statistical power will increase the probability of type-
II error, which occurs when a false null hypothesis is retained instead of being rejected (i.e. true 
associations are missed because they are not detected with statistical significance) (Hennekens & 
Buring, 1987). In the following sections, the sources of missing data, patterns of missing data 
along with the available methods to deal with missing data in the analysis will be outlined. 
 
4.5.5.1 Sources of missing data 
The sources of missing data are many. For example, individuals may decide not to take part in the 
study (baseline non-response), may be lost to follow-up, may decide not to answer a particular 
question, or information may be missing for other reasons as in the case of data missing by design 
or due to data entry. In the case of baseline non-response, if individuals who respond and take 
part at baseline are different from the target population (i.e. responders and those who did not 
respond), then missing data can lead to selection bias (Delgado-Rodriguez & Llorca, 2004). In 
addition, selection bias may occur when data are missing due to loss to follow-up (where 
individuals drop out of the study over time), which is common in cohort studies (see Section 
4.4.4.4). Loss to follow-up can result in a biased estimate of the association if the values for the 
exposure and outcome variables differ between individuals lost to follow-up and those who 
completed the study (Delgado-Rodriguez & Llorca, 2004). Missing data can be broadly categorized 
in two groups: unit non-response and item non-response. Unit non-response refers to missing 
information for a whole unit of analysis (a participant). For example, this may happen because it 
was not possible to contact an individual, or because the individual could not attend the clinic for 
120 
 
examination (de Leeuw, Hox, & Huisman, 2003; Pedersen et al., 2017). Differently, in case of item 
non-response the individuals have participated in the study but information on a particular item 
or measure are missing (de Leeuw et al., 2003). Missing data for an item can be categorised as: 
data missing by design, data missing after a point in the questionnaire (partial non-response) and 
data missing for some items for some respondents. Data missing by design occurs when different 
individuals are asked different subset of questions (e.g. an ongoing cohort recruitment where 
additional questions have been added to the baseline questionnaire, only those who participate 
after this change will have this data). Partial non-response may happen because the individual has 
no time to respond to the last part of the questionnaire after a time point during the interview, or 
where pages and sections are missing, perhaps due to printing error or a website crash (de Leeuw 
et al., 2003). Differently, data missing for some items for some respondents may occur 
purposefully, for example when questions concern sensitive topics (e.g. drug consumption, 
criminality, disclosure of abuse), where the individual prefers to avoid the question. Alternatively, 
non-response may occur because the individual was not provided with a suitable response option 
for a question. Finally, data may be missing for some items because of errors in data entry (de 
Leeuw et al., 2003).  
 
4.5.5.2 Patterns of missing data and methods to deal with missing data 
Missing data can be investigated by looking at the patterns within the dataset. Patterns of missing 
data can be categorized in three different groups: data missing completely at random (MCAR), 
missing at random (MAR) and missing not at random (NMAR) (Bland, 2015). Data are missing 
completely at random (MCAR) when the missingness is not related to the characteristics of the 
individual in the study, for example when data are missing because of flaws in the questionnaires 
used in the study (e.g. a printing error in a proportion of questionnaires sent to participants), or 
because the individual forgot to answer to some items or dropped-out from the study because 
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moving to another area, and this is unrelated to the research topic. When data are MCAR the 
estimate of the association is unbiased, although there may be a loss of power due to missing data 
(Kang, 2013).  
Data are missing at random (MAR) when the missingness is related to the individual in the study 
but it is independent from the variable for which the information is missing, and can be estimated 
from other information available about the individual (Bland, 2015). For example information on a 
variable (e.g. sleep problems) may be missing because the child was ill on that day and therefore 
the assessment of that variable could not take place, but the level of sleep problems may be 
estimated based on other data collected in this child or from other children in the cohort. Data are 
missing not at random (NMAR) when the missingness is due to the characteristic of the variable 
for which the information is missing (Bland, 2015). For example, information on a sensitive item 
(e.g. smoking) is not reported because the child/adolescent does not want to reveal their smoking 
status. In case of missing data, the patterns of missingness should be explored and described, and 
information about the percentage of non-response for each variable at each time-point of the 
study should be reported. In addition, the baseline characteristics of those who completed the 
study should be described and compared to those who were lost to follow-up to assess the risk of 
selection bias due to attrition. Several approaches can be undertaken to deal with missing data, 
depending on the pattern of missing data:  
 Complete-case analysis (i.e. omitting individuals with missing data and analysing only 
observations with complete data). It provides unbiased estimates if the data are MCAR, 
but is considered not efficient and will lead to a loss of power and lower precision of 
estimates (Bland, 2015; Kang, 2013; Pedersen et al., 2017).  
 Using the sample mean (i.e. the mean of the variable from the observed cases in the 
sample is used to replace missing data). This method can be used when data are MCAR, 
but produces conservative estimates (Bland, 2015) and an underestimation of standard 
errors (Kang, 2013). 
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 Replacing the missing data with the last observation in time of an individual before the 
occurrence of missing data. This method can be used for MCAR and MAR missing data, 
but it is likely to produce biased estimates (Bland, 2015; Kang, 2013; Pedersen et al., 
2017). 
 Imputation approaches using regression in which new estimated values are entered in 
place of missing data (Kang, 2013) by predicting the value of the missing data through a 
regression method, using information available on other variables (Kang, 2013). Two 
imputation methods are available: single imputation and multiple imputation. With the 
simple imputation method the process is carried out only one time. Differently, the 
multiple imputation method implies the creation of more than one dataset (a rule of 
thumb is that the number of datasets should be equal to the percentage of missing data) 
with imputed data in place of missing data. Subsequently, these datasets are analysed 
and, by pooling the results (regression coefficients) of the single analyses of the datasets, 
a single overall estimate is produced together with a more realistic estimate of its 
variability (Bland, 2015; Kang, 2013; Pedersen et al., 2017). Multiple imputation can be 
used under the MCAR and MAR assumption to produce valid estimates (Bland, 2015). 
 
4.5.5.3 Analyses to explore the patterns of missing data 
In case of missing data within the thesis, the patterns of missingness will be explored and reported 
for both the CATS and the ALSPAC dataset (missingness cannot be measured within the CiPCA 
dataset because only individuals with full registration status for the whole study period were 
included). The percentage of individuals with missing data on any of the variables at baseline will 
be described, in order to understand the potential impact of missing data on sample size and 
precision. The effect of loss to follow-up will be assessed by describing the baseline sample 
characteristics of those individuals that completed the study, which will be compared to the 
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baseline characteristics of those who were lost to follow-up (Section 5.3 for the CATS dataset and 
7.3 for the ALPSAC dataset). 
 
4.5.5.4 Little’s test of MCAR 
The patterns of missing data will be explored and described (Section 4.5.5.3). In addition, Little’s 
test of MCAR provides the opportunity to test the assumption that data are missing completely at 
random (MCAR). The null-hypothesis to be tested is that data are missing completely at random, 
which means that a significant test result (p<0.05) indicates that data are not missing completely 
at random. When performing this test, all the variables included in the model (i.e. variables with 
missing values and the other covariates) are to be used (Newton et al., 2010). 
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4.6 Analysis Plan 
In this section the analysis plan for the investigation of objectives 1, 2 and 3 will be outlined. 
Information regarding the sample used for analysis, the measures and definitions of exposures, 
potential confounders, effect modifiers and musculoskeletal pain, including cut-points used, will 
be outlined in chapter 5, 7, and 9 respectively, as well as the imputation methods used to deal 
with missing data. 
 
4.6.1 Investigation of sleep problems as a risk factor for the onset of musculoskeletal pain in 
children (CATS dataset) 
The aim of objective 1 is to investigate whether children with sleep problems are at a greater 
likelihood for the onset of musculoskeletal pain compared to those without sleep problems, and 
whether this association is influenced by potential effect modifiers such as gender, screen time 
and pubertal status. Given the availability of data on musculoskeletal pain duration, a secondary 
aim is to assess whether sleep problems are associated with an increase in odds for the onset of 
chronic musculoskeletal pain (i.e. musculoskeletal pain lasting > 3 months) and if this association is 
influenced by the same potential effect modifiers cited above (Section 3.3.1). In order to achieve 
this objective the following analyses will be performed: 
 Baseline descriptive analysis, to describe the sample characteristic (Section 5.4).  
 Exploration and description of the patterns of missing data in order to assess the potential 
risk of bias due to non-response and loss to follow-up (Section 5.3). 
 Calculation of the incidence of musculoskeletal pain cases at follow-up in children without 
musculoskeletal pain at baseline (Section 6.2.1) 
 Logistic regression analysis using odds ratio (OR) and 95% Confidence Interval (95% CI) to 
estimate the association between sleep problems and the onset of musculoskeletal pain 
at follow-up (Section 6.2.2). Both unadjusted and adjusted (psychological symptoms, and 
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regular participation in individual and team sport) estimates will be presented. 
 Potential effect modification (by gender, pubertal status and screen time) of the 
association between sleep problems and the onset of musculoskeletal pain will be 
investigated using interaction tests and examined via stratified analysis. 
 The same analysis process as outlined above will be performed to assess the association 
between sleep problems and chronic musculoskeletal pain onset at follow-up (Section 
6.2.3 and 6.2.4)  
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4.6.2 Investigation of psychological symptoms as risk factors for the onset of musculoskeletal 
pain in adolescents (ALSPAC dataset) 
The aim of objective 2 is to investigate whether adolescents with psychological (internalizing and 
externalizing) symptoms are at a greater likelihood for the onset of musculoskeletal pain, and 
whether this association is influenced by potential effect modifiers including gender, screen time 
and pubertal status (Section 3.4.1). Given the presence of data on musculoskeletal pain duration 
within this dataset, a secondary aim is to assess whether children with psychological (internalizing 
and externalizing) symptoms are at increased odds for the onset of chronic musculoskeletal pain 
(i.e. musculoskeletal pain lasting > 3 months), and if this association is influenced by the same 
potential effect modifiers cited above. In order to achieve these objectives, the following analysis 
will be performed: 
 Baseline descriptive analysis, in order to describe the sample characteristic (Section 7.4). 
 Exploration and description of the patterns of missing data in order to assess the potential
 risk of bias due to non-response and loss to follow-up (Section 7.3). 
 Calculation of the incidence of musculoskeletal pain cases at follow-up in adolescents 
without musculoskeletal pain at baseline (Section 8.2.1) 
 Logistic regression analysis using odds ratio (OR) and 95% Confidence Intervals (95% CI) to 
estimate the association between psychological (internalizing and externalizing) symptoms 
and the onset of musculoskeletal pain at follow-up (Section 8.2.2 and 8.3.2). Both 
unadjusted and adjusted (physical activity, smoking, marijuana use, drug use) estimates 
will be presented. 
 Potential effect modification (by gender, pubertal status and screen time) of the 
association between psychological (internalizing and externalizing) symptoms and the 
onset of musculoskeletal pain will be investigated using interaction tests and examined via 
stratified analysis.  
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 The same analysis process as outlined above will be performed to assess the association 
between psychological (internalizing and externalizing) symptoms and chronic 
musculoskeletal pain onset at follow-up (Section 8.4 and 8.5). 
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4.6.3 Investigation of sleep problems and psychological symptoms as risk factors for the 
onset of musculoskeletal pain in children and adolescents within a primary care setting  
The aim of the objective 3 is to investigate whether children and adolescents who present to 
primary care for sleep problems and psychological symptoms are at increased likelihood for 
subsequent consultation for a musculoskeletal condition. This objective will be explored within the 
CiPCA dataset. The association between sleep problems and psychological symptoms (two 
separate analyses) with consultations for musculoskeletal conditions will be investigated. Analysis 
will be repeated for the association of these factors with persistent musculoskeletal conditions 
(i.e. more than one consultation for a musculoskeletal condition within a 3 month period, defined 
as a proxy marker of chronic musculoskeletal pain). The following analysis will be performed: 
1. Baseline descriptive analysis, in order to describe the sample characteristic (Section 9.2).  
2. Calculation of the frequency of consultations for musculoskeletal conditions and 
persistent musculoskeletal conditions during the 2-year follow-up period in individuals 
without a consultation for musculoskeletal pain conditions at baseline (Section 10.1.1 and 
10.2.1). 
3. Testing of the proportional hazard assumption (i.e. the ratio of risk for the occurrence of a 
consultation for musculoskeletal conditions is constant between the two groups being 
compared across the time period of follow-up) by means of the Schoenfeld residuals test 
(Section 10.1.2.1 and 10.2.2.1). 
4. Graphical description of time to incident consultation for musculoskeletal pain conditions 
according to the exposure (i.e. sleep problems and psychological symptoms) by means of 
Kaplan-Meier plots (Section 10.1.2.2 and 10.2.2.2). 
5. Survival analysis by means of Cox regression to estimate the association between sleep 
problems and psychological symptoms (two separate analyses) and time to onset of 
musculoskeletal pain, expressed as hazard ratio (HR) and 95% Confidence Interval of the 
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exposure (Section 10.1.2.3 and 10.2.2.3). Both unadjusted estimates and the estimates 
adjusted for potential confounders of the association (i.e. year of index date, age at index 
date, gender, practice and number of consultations) will be presented. 
6. The same analysis process as outlined above will be performed to assess the association 
between sleep problems and psychological symptoms (two separate analyses) and time to 
persistent musculoskeletal conditions, expressed as hazard ratio (HR) and 95% Confidence 
Interval (Section 10.1.3 and 10.2.3). 
 
 
4.7 Chapter summary 
This chapter described epidemiological study designs and the analysis method that will be 
performed to address the objectives of this thesis. Theoretical explanations for the chosen study 
design (i.e. prospective cohort study) and the choice of analysis have been provided (Section 4.4 
and 4.5). Descriptive analysis of all cohorts will be carried out, and results will be presented in 
Chapter 5, 7 and 9. Results of the regression analysis will be presented in Chapter 6, 8 and 10. For 
all datasets, analyses of missing data will be carried out in order to assess how the missingness of 
data may have influenced the estimates of the association, with results being presented in the 
relevant results chapters. The remainder of this thesis will now outline the description, analysis, 
results and discussion for each objective.
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Chapter five. The association of sleep problems with 
musculoskeletal pain onset in children: description of the 
Childhood to Adolescence Transition Study (CATS) cohort 
 
In this chapter, a description of the CATS cohort and of the measures included within the cohort 
are outlined, followed by a description of missing data within this cohort, and the non-responder 
analysis for missing data. Finally, the descriptive findings of the cohort will be reported and 
discussed. 
 
5.1 Design and recruitment 
The Childhood to Adolescence Transition Study (CATS) dataset was made available via 
engagement of Prof. Kate Dunn with the research team who set up the cohort (Prof. George 
Patton, Prof. Susan Sawyer and Dr. Lisa Mundy). The CATS is a longitudinal prospective cohort 
study that aims to assess how the emotional, psychological, behavioural and learning 
development of children is affected by the hormonal changes that occur during puberty (Mundy 
et al., 2013). The cohort includes information from schoolchildren and their parents who reside 
within the metropolitan area of Melbourne, Australia. Children were 8-9 years old (grade 3) at 
baseline and data were collected annually for 4 years since February 2012 until year 2015. In this 
current study, only data from baseline to the first year of follow-up (2013) were used, and will 
hereafter be referred to as baseline and follow up. The recruitment consisted of a random 
selection of primary schools from a stratified cluster sample (strata based on Government, 
Catholic, Independent School type) of all the primary schools within the Metropolitan Melbourne 
area. The schools had to have 10 or more children enrolled in grade 3 to be selected. Both parents 
and children were required to give consent to take part, and a small incentive was used to 
encourage children participation (children were given a prize for returning the consent form). A 
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flow-chart (Figure 5.1) shows the process of recruitment of children and parents within CATS. A 
description of participants and non-participants to the study is outlined in Section 5.1.1.  
 
5.1.1 Description of baseline participants and non-participants 
Figure 5.1 (Mundy et al., 2013) shows the description of participants and non-participants to the 
study. Forty-three, out of 101 schools, that were approached agreed to participate in the study. 
Of the 58 schools who refused, the main reason for refusal was that they were too busy. Of the 43 
schools who agreed to take part (2289 students), 1239 (54%) students and their parents agreed to 
participate. Of those who did not agree (n = 1050), the main reasons were no response or 
parental refusal (see Figure 5.1). Of the students and parents who agreed to participate, 1194 
(96%) students and 1221 (99%) parents took part in the data collection at baseline. Among the 45 
children who did not take part in data collection at baseline, 35 children were absent, and 10 
children did not take part for other unspecified reasons (Mundy et al., 2013). 
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Figure 5.1. Flowchart of recruitment of participants to the study (Mundy et al., 2013)  
 
 
  
Eligible schools approached: 101 
73 (72%) Government 
20 (20%) Catholic 
8 (8%)     Independent 
Schools recruited into study: 43 (43%) 
30 (70%) Government 
9 (21%)   Catholic 
4 (9%)     Independent 
Mean school year size  = 53 
School year range       = 18 to 173 
  
Students attending recruited schools: 2289 
  
Students consented: 1239 (54%) 
  
Students participating at baseline: 
1194 (96%) 
1194 (96%) Questionnaire 
1190 (96%) Anthropometry 
1167 (94%) Saliva 
Students not participating: 45 (4%) 
       35 (3%) Absent 
       10 (1%) Other 
 
 
 
Parent report at baseline:  
1221 (99%) 
1217 (98%) Questionnaire P1   
939   (76%) Questionnaire P2 
        
 
 
School refused 58 (57%) 
43 (74%) Government 
11 (19%) Catholic 
4 (7%)     Independent 
Reasons for refusal: 
26 (44%) Too busy/bad time 
  9 (16%) No explanation 
  8 (14%) Participating in another study  
   6 (10%) No response from principal 
   5   (9%) Rejected by school forum 
   4   (7%) Not suitable for school 
            
 
 
 
 
 
        
        
 
 
Students lost to study: 1050 (46%) 
624 (59%) No response 
399 (38%) Parent refused consent 
  19   (2%) Incomplete consent form 
    8   (1%) Moved out of sampling   
                  frame 
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5.2 Study measures 
This cohort contains suitable measures to test the research hypothesis that children with sleep 
problems are at increased odds for the onset of musculoskeletal pain and that this relationship 
may be influenced by potential effect modifiers such as gender, screen time and pubertal status 
(Section 3.3.1). Measures self-reported by children were collected by means of an iPad APP, and 
from parents using self-report questionnaires (part 1 and part 2) (Kosola et al., 2017). A research 
assistant was present during the administration of the measures at schools, and read the 
questions aloud in order to help students with low literacy in using the iPad APP (Kosola et al., 
2017). The variables included in the study are described below. Strengths and limitations of these 
measures will be discussed in Section 6.3.2. 
 
5.2.1 Outcome measure 
5.2.1.1 Musculoskeletal pain  
Pain status was assessed at baseline and follow-up through the question “Thinking back over the 
PAST MONTH, have you had any pain or pains, which have lasted for a WHOLE DAY or LONGER?”. 
This pain question has been used in previous child cohort studies (Jones, Silman, et al. 2003; 
Jones, Watson, et al. 2003). According to the answer (Yes/No), participants were classified as 
“having pain” or “not having pain” respectively. In the case where the response was “yes”, the 
children were asked a further question on duration; “When did the pain start?”. Possible 
responses were “less than three months ago” and “more of three months ago”, the latter giving 
an indication of chronic pain status.  
 
5.2.1.2 Pain manikin 
Following the questions relative to pain status, a pain manikin was used to assess a total of 17 
different pain sites in the front and the back of the body: head, neck/throat, thoracic spine, upper 
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back, lumbar spine, lower back, chest, abdomen, shoulder, elbow, forearm, hand, buttock, thigh, 
knee, shin/calf, and foot (for a graphical description of the body sites please see appendix III; the 
presence of pain in either one side or both sides of a body site was counted as a single site). This 
measure consists of a drawing of a blank body manikin and the participant has to indicate the 
extent and distribution of the pain. Such methods have been shown to be valid and reliable for 
the identification of pain sites in adult populations and in children from the age of 8 years (Hamill, 
Lyndon, Liley, & Hill, 2014; Kosola et al., 2017; Lacey, Lewis, Jordan, Jinks, & Sim, 2005; Margolis, 
Chibnall, & Tait, 1988). The different body sites (excluding those relative to the head and the 
abdomen), together with the answers to the questions relative to pain status and pain duration 
(Section 5.2.1.1), were used to create variables that represented the presence of musculoskeletal 
pain or chronic musculoskeletal pain. Musculoskeletal pain was entered in the analysis as a binary 
variable with values of 1 and 0, according to the presence or absence of self-reported 
musculoskeletal pain respectively. Chronic musculoskeletal pain was entered in the same format, 
according to the self-reported start of musculoskeletal pain “more than three months ago” or 
“less than three months ago” respectively. 
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5.2.2 Predictor measure 
5.2.2.1 Sleep problems 
Sleep problems in children were assessed at baseline through a single self-report question taken 
from the Symptom Checklist-90 (SCL-90) scale (Derogatis, Lipman, & Covi, 1973) for the child to 
self-report. The question was “How often you have been bothered by trouble sleeping in the last 
month?” 
 Never 
 Almost never 
 Sometimes  
 Often 
 Almost always 
 
Sleep problems was entered in the analysis as a binary variable with values of 1 or 0 according to 
the frequency of sleep problems, respectively: sleep problems (often/ almost always) and no 
sleep problems (Never/almost never/sometimes) following previous methodology (Schubert et 
al., 2002). 
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5.2.3 Effect modifiers measures 
5.2.3.1 Gender  
The child’s gender was reported by the parents in the questionnaire at baseline. Gender was 
entered in the analysis as a binary variable with values of 1 or 0 according to gender, male or 
female respectively. 
 
5.2.3.2 Screen time  
Screen time (i.e. time that the children daily spent watching the TV, playing videogames and using 
the computer) was assessed at baseline through the following parent-reported questions: 
 On school days, how many hours does your child spend watching TV or DVDs, on the TV 
or on the computer? 
 On weekend days, how many hours does your child spend watching TV or DVDs, on the 
TV or on the computer? 
 On school days, how many hours does your child spend playing videogames, either on the 
computer or on consoles like XBox or Playstation?  
 On weekend days, how many hours does your child spend playing videogames, either on 
the computer or on consoles like XBox or Playstation?  
 On school days, how many hours does your child spend using the computer for email, 
schoolwork, internet access or chat?  
 On weekend days, how many hours does your child spend using the computer for email, 
schoolwork, internet access or chat?  
These questions are adapted from questionnaires of the Longitudinal Study of Australian Children 
and the Lodz Electronic Aggression Prevalence Questionnaire (LEAPQ) scale (Mundy et al., 2013). 
Total screen time in the weekdays was calculated by multiplying by 5 each estimate (i.e. TV or 
DVDs, Computer or consoles, internet and e-mail use) of screen time gathered from questions 
relative to the weekdays. Total screen time in the weekend was calculated by multiplying by 2 
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each estimate (i.e. TV or DVDs, Computer or consoles, internet and e-mail use) of screen time 
gathered from questions relative to the weekend. The estimate of total screen time in the 
weekdays was added to the estimate of total screen time in the weekend in order to obtain the 
total weekly screen time score. Average daily screen time was calculated by dividing total screen 
time weekly by 7. Then percentages of children with high screen time were calculated (“high 
screen time” was considered as screen time >2 hours/day on average), in agreement with 
American Academy of Pediatrics guidelines (American Academy of Pediatrics, 2013). This 
approach of setting the cut-off of 2 hours/day for high and low levels of screen time has already 
been used before (Kremer et al., 2014). Screen time was entered in the analysis as a binary 
variable with values of 1 or 0 according to the amount of screen time (>2 hours/day or ≤2 
hours/day, respectively).  
 
5.2.3.3 Puberty  
Information to assess pubertal development was parent-reported and was gathered through the 
Pubertal Development Scale (PDS) at baseline. The PDS produces a measure that can be used 
either continuously (score that ranges from 5 to 19) or with a categorical classification in 5 stages 
(pre-pubertal/ beginning pubertal/ mid-pubertal/ advanced pubertal / post-pubertal). 
The PDS has been used previously (Simon, Wardle, Jarvis, Steggles, & Cartwright, 2003), and has 
been shown to be suitable for school-based surveys (Bond et al., 2006), with reports of validity 
and reliability (Petersen, Crockett, Richards, & Boxer, 1988). Within the CATS cohort the pubertal 
characteristics included in the PDS (growth spurt, body hair growth, skin changes, voice 
deepening, breast development, and finally growing hair on face in boys, and menstruation in 
girls) were used to calculate the pubertal score. A score was given to each of the characteristics 
according to whether the characteristic had already started to develop or not (1 = has not started 
yet; 2 = has barely started; 3 = has definitely started; 4 = seems complete; for menstruation 1 = 
No; 4 = Yes). The sum of these scores formed the pubertal score and allowed the 5 stages 
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categorization of pubertal status in children used in the analysis. Pubertal status was entered in 
the analysis as a binary variable with values of 1 or 0 according to pubertal stage: advanced 
puberty (mid-pubertal/ advanced pubertal / post-pubertal) or early puberty (pre-pubertal/ 
beginning pubertal) respectively. This categorization of the PDS has been used previously (Simon 
et al. 2003). 
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5.2.4 Confounders 
5.2.4.1 Physical activity  
Physical activity was assessed at baseline through the parent-reported question “In the last 12 
months has your child regularly participated in any of the following activities (outside school 
hours, even if organised by the school)? (Team sport/ Individual sport)”. Possible answers were 
“yes” or “no”. This question was adapted from the Longitudinal Study of Australian Children 
(Vella, Cliff, Magee, & Okely, 2014). Two binary variables were created for physical activity and 
entered in the analysis, one for the assessment of team sports and one for individual sports. Both 
variables had values of 1 or 0 according to the regular participation or not in the specific sport 
activity assessed, respectively. 
 
5.2.4.2 Smoking 
The experience of cigarette smoking in children was assessed at baseline through the question 
“Have you ever smoked cigarettes?”. Possible options were “Never / 1 or 2 times / 3 to 5 times / 6 
to 9 times / 10 or more times”. This question was adapted from Monitoring the Future and the 
CDC Youth Risk behaviour survey (Glaser, Van Horn, Arthur, Hawkins & Catalano, 2005; Mundy et 
al., 2013). Smoking status was entered in the analysis as a categorical variable with 5 categories 
according to the answer to the question relative to smoking. 
 
5.2.4.3 Alcohol use 
Alcohol use was assessed at baseline through the question “Have you ever had more than just a 
few sips of an alcoholic drink (like beer, wine, spirits or pre-mixed drinks such as Bacardi Breezers 
or UDL’s)?”. Five possible answers were present (Never / 1 or 2 times / 3 to 5 times / 6 to 9 times/ 
10 or more times). This question was adapted from Monitoring the Future and the CDC Youth Risk 
behaviour survey (Glaser et al. 2005; Mundy et al., 2013). Alcohol consumption was entered in 
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the analysis as a categorical variable with 5 categories according to the answer to the question 
relative to alcohol consumption. 
 
5.2.4.4 Psychological symptoms  
Psychological symptoms were reported by the parents at baseline, and these symptoms were 
assessed using the Strengths and Difficulties Questionnaire (SDQ). The SDQ has been shown to be 
valid and suitable for the assessment of behavioural and emotional disorders for children aged 4 
to 16 years (Goodman, Lamping, & Ploubidis, 2010; Goodman, 1997; Mundy et al., 2013). The 
SDQ is a 25-item questionnaire with five subscales: emotional symptoms, peer problems, conduct 
problems, hyperactivity and prosocial scale (Goodman, 1997). Each subscale includes 5 questions 
that are rated on a 3-point scale (“Not true” = 0, “Somewhat true” = 1, “Certainly true” = 2), and 
therefore each subscale produces a score that ranges from 0 to 10. Subscales relative to 
difficulties (emotional symptoms, peer problems, conduct problems, hyperactivity) can also be 
combined to produce a total difficulties score, which ranges from 0 to 40 (Goodman, 1997). This 
tool has been used in studies with similar cohorts, for example on adolescents within the Avon 
Longitudinal Study of Parents and Children (ALSPAC) cohort (Edwards et al., 2014; Huisman et al., 
2010). The items included in each subscale of the Strengths and Difficulties Questionnaire are 
shown in appendix IV. Psychological symptoms were entered in the analysis as a continuous 
variable, with values reflecting the total difficulties score.   
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5.3 Selection of children for analysis and missing data 
The following sections outline a description of the process of selection of children used in the 
analysis (Section 5.3.1), and description of missing data present in the study. Investigation of 
missing data that originated from item non-response to the questionnaire is outlined in Section 
5.3.2. Investigation of missing data that originated from loss to follow-up is outlined in Section 
5.3.3. 
 
5.3.1 Selection of children for analysis 
At baseline 1194 students took part in the data collection. The self-report question on 
musculoskeletal pain presence at baseline was completed by 1190 children (99%), of which 718 
(60%) reported musculoskeletal pain presence and 472 (40%) no musculoskeletal pain presence. 
Furthermore, 181 (15%) reported chronic musculoskeletal pain presence and 1,009 (85%) no 
chronic musculoskeletal pain presence at baseline. A description of the process of selecting 
subgroups used in the analysis is provided in Figure 5.2 and Figure 5.3. 
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Figure 5.2. Flowchart describing the selection of the children for the analysis of the onset of 
musculoskeletal pain 
  
441 children musculoskeletal pain-free 
at baseline and with data on 
musculoskeletal pain at follow-up 
1239 children/parents consented  
1194 completed baseline questionnaire 
1190 completed musculoskeletal pain question at baseline 
Number of complete observations 
present for each variable: 
 Alcohol (99%) 
 Smoking (99%) 
 Team sport (65%) 
 Individual sport (67%) 
 Total difficulties (97%) 
 Puberty (74%) 
 Screen time (77%) 
472 children musculoskeletal 
pain-free at baseline 
718 children with 
musculoskeletal pain at baseline 
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Figure 5.3. Flowchart describing the selection of the children for the analysis of the onset of 
chronic musculoskeletal pain 
  
944 children chronic musculoskeletal 
pain-free at baseline and with data on 
chronic musculoskeletal pain at follow-up 
1239 children/parents consented  
1194 completed baseline questionnaire 
1190 completed musculoskeletal pain question at baseline 
181 children with chronic 
musculoskeletal pain at baseline 
Number of complete observations 
present for each variable: 
 Alcohol (99%) 
 Smoking (99%) 
 Team sport (65%) 
 Individual sport (67%) 
 Total difficulties (97%) 
 Puberty (71%) 
 Screen time (76%) 
1,009 children chronic 
musculoskeletal pain-free at baseline 
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5.3.2 Missing data for baseline variables  
The association between sleep problems in children at baseline and the onset of musculoskeletal 
pain or chronic musculoskeletal pain at follow-up was assessed in the group of children who were 
without musculoskeletal pain at baseline (N= 472; results shown in Section 6.2.2) and without 
chronic musculoskeletal pain at baseline (N=1,009; results shown in Section 6.2.4), respectively. 
Missing data was detected for some baseline variables. Reasons for missing data include non-
completion of the questionnaire and questionnaire design, for example the parental 
questionnaire consisted of two parts and some parents (8.5%) were sent a shorter version. 
Proportions of complete data and missing data for each variable at baseline were explored and 
results are shown in Table 5.1. Information on missingness is important in order to understand 
the patterns of missing data and how this could potentially affect the analysis and results. 
Therefore, all variables included in the analysis were inspected for missingness. As some variables 
(team sport and individual sport) were not included in the short version of the questionnaire, the 
proportion of missing data for these variables was much higher (See Table 5.1).  
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Table 5.1 Percentage of Complete data Vs. Missing data at baseline  
Children without musculoskeletal pain at baseline 
 Complete data, n (%) Missing data, n (%) 
Physical characteristics   
Gender 472 (100%) 
349 (74%) 
- 
123 (26%) Pubertal score 
Sleep problems   
Trouble sleeping 468 (99%) 4 (1%) 
Psychological characteristics   
Total difficulties 460 (97%) 12 (3%) 
Lifestyle Characteristics   
Screen time  363 (77%) 
471 (99%) 
471 (99%) 
308 (65%) 
317 (67%) 
109 (23%) 
1 (1%) 
1 (1%) 
164 (35%) 
155 (33%) 
Smoking 
Alcohol  
Team sport  
Individual sport  
Children without chronic musculoskeletal pain at baseline 
 Complete data, n (%) Missing data, n (%) 
Physical characteristics   
Gender 1,009 (100%) - 
Pubertal score 714 (71%) 295 (29%) 
Sleep problems   
Trouble sleeping 1,002 (99%) 7 (1%) 
Psychological characteristics   
Total difficulties 980 (97%) 29 (3%) 
Lifestyle Characteristics   
Screen time  766 (76%) 243 (24%) 
Smoking 1,008 (99%) 1 (1%) 
Alcohol  
Team sport  
Individual sport  
1,007 (99%) 
660 (65%) 
673 (67%) 
2 (1%) 
349 (35%) 
336 (33%) 
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Differences in baseline characteristics between children with complete data and those with 
missing data (i.e. the group with missing data for team sport, individual sport, puberty and screen 
time) were inspected. Results show that those with complete data were slightly more likely to be 
boys, reported slightly more sleep problems and slightly lower scores for psychological symptoms 
compared to those with missing data, though the differences are generally small (e.g. < 10% 
difference, Table 5.2).  
 
  
Table 5.2 Baseline characteristics of those with Complete data Vs. Missing 
data among children without musculoskeletal pain at baseline 
 Complete data, n (%) Missing data, n (%) 
Physical characteristics   
Gender 
Male 
 
127 (47.0%) 
143 (53.0%) 
 
81 (40.1%) 
121 (59.9%) Female 
Sleep problems 
Trouble sleeping   
No – (Never/ Almost never/ sometimes) 204 (76.4%) 162 (80.6%) 
Yes – (Often/ Almost always) 63 (23.6%) 39 (19.4%) 
Psychological characteristics   
Mean score 8.1 ± 5.3 8.5 ± 5.5 
Lifestyle Characteristics   
Smokers 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
 
269 (100.0%) 
- 
- 
- 
- 
 
200 (99.0%) 
2 (1.00%) 
- 
- 
- 
Alcohol users 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
 
192 (71.4%) 
57 (21.2%) 
13 (4.8%) 
3 (1.1%) 
4 (1.5%) 
 
147 (72.8%) 
39 (19.3%) 
12 (5.9%) 
1 (0.5%) 
3 (1.5%) 
147 
 
In the group without chronic musculoskeletal pain at baseline, children with complete data 
reported slightly more sleep problems, slightly lower scores for psychological symptoms and 
slightly higher proportions of alcohol use, compared to those with missing data, again the 
differences are small (e.g. < 10% difference, Table 5.3). 
 
  
  
Table 5.3 Baseline characteristics of those with Complete data Vs. Missing 
data among children without chronic musculoskeletal pain at baseline 
 Complete data, n (%) Missing data, n (%) 
Physical characteristics   
Gender 
Male 
 
275 (46.6%) 
315 (53.4%) 
 
187 (44.6%) 
232 (55.4%) Female 
Sleep problems 
Trouble sleeping   
No – (Never/ Almost never/ sometimes) 380 (65.0%) 295 (70.7%) 
Yes – (Often/ Almost always) 205 (35.0%) 122 (29.3%) 
Psychological characteristics   
Mean score 7.9 ± 5.1 8.6 ± 5.8 
Lifestyle Characteristics   
Smokers 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
 
585 (99.3%) 
3 (0.5%) 
1 (0.2%) 
- 
- 
 
412 (98.3%) 
6 (1.4%) 
1 (0.3%) 
- 
- 
Alcohol users 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
 
360 (61.1%) 
157 (26.7%) 
45 (7.6%) 
14 (2.4%) 
13 (2.2%) 
 
285 (68.2%) 
93 (22.3%) 
21 (5.0%) 
7 (1.7%) 
12 (2.9%) 
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5.3.3 Missing data due to loss to follow-up at 1-year 
The total number of children available at follow-up for the analysis of musculoskeletal pain onset 
was 441, indicating 31 children (7%) were lost to follow up (See Figure 5.2). The differences in 
baseline characteristics between children lost to follow-up and still present at follow-up 
(completers) were assessed. The proportion of girls in those lost to follow-up was higher (61.3% 
vs. 55.5%), and children lost to follow-up were more likely to be in the mid/advanced pubertal 
status (18.7% vs. 12.3%), had higher psychological symptoms scores (11.2 vs. 8.1), and were less 
likely to perform team sports (53.3% vs. 58.8%) and individual sports (40.0% vs. 72.2%) than 
completers (See Table 5.4). The total number of children available at follow-up for the analysis of 
chronic musculoskeletal pain onset was 944, indicating 65 children (6%) were lost to follow up 
(See Figure 5.3). Children lost at follow-up had higher psychological symptoms scores (10.1 vs. 
8.1), were more likely to have high levels of screen time (>2 hours/day; 82.9% vs. 77.6%), and less 
likely to perform team sports (58.3% vs. 63.4%) and individual sports (48.0% vs. 73.5%) than 
completers (See Table 5.5). For a discussion of the possible effect of missing data due to loss to 
follow-up please refer to Section 5.5.2. 
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Table 5.4 Baseline values of completers vs. loss to follow-up among 
children without musculoskeletal pain 
Total Completers Lost to follow-up 
 441 (93.4%) 31 (6.6%) 
Sleep problems Completers Lost to follow-up 
Yes 95 (21.7%) 7 (23.3%)  
No 343 (78.3%) 23 (76.7%)  
Potential effect modifier Completers Lost to follow-up 
Gender (N %) 
Boys 
Girls 
 
 
196 (44.4%) 
245 (55.5%) 
 
12 (38.7%) 
19 (61.3%) 
 
Puberty 
Pre-Early puberty 
Mid-Advanced puberty 
 
Screen time 
Screen time >2 hours 
Screen time ≤2 hours 
 
292 (87.7%) 
41 (12.3%) 
 
 
279 (80.9%) 
66 (19.1%) 
 
13 (81.3%) 
3 (18.7%) 
 
 
15 (83.3%) 
3 (16.7%) 
 
Potential confounder Completers Lost to follow-up 
Psychological symptoms score 8.1 ± 5.3 11.2 ± 6.4  
Smokers 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
Alcohol user 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
Physical activity 
Team sport (Yes) 
Team sport (No) 
Individual sport (Yes) 
Individual sport (No) 
 
438 (99.5%) 
2 (0.5%) 
- 
- 
- 
 
316 (71.8%) 
90 (20.5%) 
23 (5.2%) 
4 (0.9%) 
7 (1.6%) 
 
170 (58.0%) 
123 (42%) 
218 (72.2%) 
84 (27.8%) 
 
31 (100%) 
- 
- 
- 
- 
 
23 (74.2%) 
6 (19.4%) 
2 (6.4%) 
- 
-  
 
8 (53.3%) 
7 (46.7%) 
6 (40.0%) 
9 (60.0%) 
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Table 5.5 Baseline values of completers vs. loss to follow-up among 
children without chronic musculoskeletal pain 
Total Completers Lost to follow-up 
 944 (93.6%) 65 (6.4%) 
Sleep problems Completers Lost to follow-up 
Yes 305 (32.5%) 22 (34.4%)  
No 633 (67.5%) 42 (65.6%)  
Potential effect modifier Completers Lost to follow-up 
Gender (N %) 
Boys 
Girls 
 
 
434 (45.9%) 
510 (54.1%) 
 
28 (43.1%) 
37 (56.9%) 
 
Puberty 
Pre-Early puberty 
Mid-Advanced puberty 
 
Screen time 
Screen time >2 hours 
Screen time ≤2 hours 
 
620 (87.2%) 
91 (12.8%) 
 
 
567 (77.6%) 
164 (22.4%) 
 
28 (87.5%) 
4 (12.5%) 
 
 
29 (82.9%) 
6 (17.1%) 
 
Potential confounder Completers Lost to follow-up 
Psychological symptoms score 8.1 ± 5.3 10.1 ± 6.4  
Smokers 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
Alcohol user 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
Physical activity 
Team sport (Yes) 
Team sport (No) 
Individual sport (Yes) 
Individual sport (No) 
 
934 (99.1%) 
7 (0.7%) 
2 (0.2%) 
- 
- 
 
601 (63.8%) 
237 (25.2%) 
61 (6.5%) 
18 (1.9%) 
25 (2.6%) 
 
403 (63.4%) 
233 (36.6%) 
476 (73.5%) 
172 (26.5%) 
 
63 (96.9%) 
2 (3.1%) 
-  
- 
-  
 
44 (67.7%) 
13 (20.0%) 
5 (7.7%) 
3 (4.6%) 
-  
 
14 (58.3%) 
10 (41.7%) 
12 (48.0%) 
13 (52.0%) 
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5.4 Results of descriptive analyses 
Descriptive analyses of the baseline of the Childhood to Adolescence Transition Study (CATS) 
dataset were performed. The results of these analyses are shown in the following sections. 
 
5.4.1 Baseline characteristics of the total sample 
Baseline descriptive analyses of the total sample are outlined in Table 5.6. Approximately 60% of 
children reported having had musculoskeletal pain that lasted one day or more in the last month, 
with similar proportions between boys and girls, and approximately 15% of children reported 
chronic musculoskeletal pain (musculoskeletal pain lasting >3 months), again with similar 
proportions between boys and girls. Figures on sleep problems show that just over 35% of 
children reported sleep problems, with similar proportions between boys and girls. More girls 
(54%) than boys (46%) were present in the sample. Girls were on average in a more advanced 
pubertal development stage compared to boys (21% and 3% in the mid/advanced pubertal stage, 
respectively). The average number of hours of screen time per day in children was 3.3, with 
similar values between boys and girls (3.4 h/day vs 3.3 h/day). Accordingly, for around 78% of 
children the average screen time was > 2 h/day. Also, more boys had average values of screen 
time > 2 h/day than girls (81% vs. 75%, respectively). With regard to potential confounders, the 
average psychological symptoms score was 8.4 ± 5.5, and it was higher in boys compared to girls 
(8.9 ± 5.8 vs. 7.9 ± 5.1). Approximately 99% of children reported that they had never smoked 
before, and only 16 children had smoked 1 or more times. Among these children, more boys 
(2.4%) than girls (0.5%) reported having smoked before. Approximately 37% of children (45% boys 
and 31% of girls) had already had more than just one sip of alcohol, even if most of them for only 
1 or 2 times. Outside school hours, 64% of children engaged in team sports, with more boys (74%) 
than girls (54%), while around 73% of children engaged regularly in individual sports, with no 
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gender differences. In the following sections, descriptive analyses of the baseline characteristics 
of children without musculoskeletal pain and without chronic musculoskeletal pain are outlined. 
 
 
Table 5.6 Baseline characteristics of the total sample 
Age Boys Girls Overall 
Mean (±SD) 9.0 ± 0.4 9.0 ± 0.4 9.0 ± 0.4 
Musculoskeletal pain Boys Girls Overall 
Yes 339 (62.0%) 379 (58.9%) 718 (60.3%) 
No 208 (38.0%) 264 (41.1%) 472 (39.7%) 
Chronic musculoskeletal pain Boys Girls Overall 
Yes 84 (15.4%) 96 (14.9%) 180 (15.1%) 
No 462 (84.6%) 547 (85.1%) 1,009 (84.9%) 
Sleep problems Boys Girls Overall 
Yes 185 (34.1%) 230 (35.8%) 415 (35.1%) 
No 357 (65.9%) 412 (64.2%) 769 (64.9%) 
Potential effect modifier Boys Girls Overall 
Gender (N %) 572 (46.2%)  667 (53.8%) 1,239 
Puberty 
Pubertal score 
Pubertal stages 
Pre-Early puberty 
Mid-Advanced puberty 
 
Screen time 
Screen time (mean) 
Screen time >2 hours 
Screen time ≤2 hours 
 
1.3 ± 0.3 
 
403 (96.6%) 
14 (3.4%) 
 
 
3.4 ± 1.8 
345 (81.2%) 
80 (18.8%) 
 
1.4 ± 0.4 
 
373 (78.5%) 
102 (21.5%) 
 
 
3.3 ± 1.7 
370 (74.9%) 
124 (25.1%) 
 
1.4 ± 0.4 
 
776 (87.0%) 
116 (13.0%) 
 
 
3.3 ± 1.8 
715 (77.8%) 
204 (22.2%) 
Potential confounder Boys Girls Overall 
Psychological symptoms score 8.9 ± 5.8 7.9 ± 5.1 8.4 ± 5.5 
Smokers 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
Alcohol user 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
Physical activity 
Team sport (Yes) 
Team sport (No) 
Individual sport (Yes) 
Individual sport (No) 
 
533 (97.6%) 
10 (1.8%) 
2 (0.4%) 
1 (0.2%) 
- 
 
299 (54.9%) 
150 (27.5%) 
56 (10.3%) 
18 (3.3%) 
22 (4.0%) 
 
275 (74.3%) 
95 (25.7%) 
273 (73.4%) 
99 (26.6%) 
 
642 (99.5%) 
3 (0.5%) 
- 
- 
- 
 
445 (68.9%) 
159 (24.6%) 
26 (4.0%) 
7 (1.1%) 
9 (1.4%) 
 
229 (54.3%) 
193 (45.7%) 
319 (73.5%) 
115 (26.5%) 
 
1,175 (98.6%) 
13 (1.1%) 
2 (0.2%) 
1 (0.1%) 
- 
 
744 (62.5%) 
309 (25.9%) 
82 (6.9%) 
25 (2.1%) 
31 (2.6%) 
 
504 (63.6%) 
288 (36.4%) 
592 (73.4%) 
214 (26.6%) 
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5.4.2 Baseline characteristics of children with musculoskeletal pain 
Baseline descriptive analyses of children with musculoskeletal pain are outlined in Table 5.7. 
Figures on sleep problems show that approximately 44% of children reported sleep problems, 
with similar proportions between boys and girls. There were more girls (53%) than boys (47%) 
with musculoskeletal pain. Approximately 22% of girls were in a mid/advanced pubertal stage 
(mid pubertal, late pubertal or post-pubertal stage) compared to only 3% of boys. Boys had 
slightly higher average number of hours of screen time per day than girls (3.3 h/day vs 3.2 h/day, 
respectively), and approximately 76% of children (79% of boys vs. 73% of girls) had an average of 
screen time of > 2 h/day. The average psychological symptoms score was 8.5 ± 5.6 and it was 
higher in boys compared to girls (9.1 ± 6.0 vs. 8.0 ± 5.0). Approximately 98% of children reported 
that they had never smoked before, and 14 children smoked 1 or more times. Approximately 44% 
of children (52% boys and 37% of girls) had already had more than just one sip of alcohol, even if 
most of them for only 1 or 2 times. Outside school hours, 68% of children engaged in team sports, 
with more boys (78%) than girls (59%), and 75% of children engaged regularly in individual sports, 
with no gender differences. 
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Table 5.7 Baseline characteristics of children with musculoskeletal pain 
Sleep problems Boys Girls Overall 
Yes 140 (41.8%) 173 (45.8%) 313 (43.9%) 
No 195 (58.2%) 205 (54.2%) 400 (56.1%) 
Potential effect modifier Boys Girls Overall 
Gender (N %) 
Puberty 
Pubertal score 
Pubertal stages 
Pre-Early puberty 
Mid-Advanced puberty 
 
Screen time 
Screen time (mean) 
Screen time >2 hours 
Screen time ≤2 hours 
339 (47.2%) 
 
1.3 ± 0.3 
 
239 (96.8%) 
8 (3.2%) 
 
 
3.3 ± 1.6 
197 (79.1%) 
52 (20.9%) 
379 (52.8%) 
 
1.5 ± 0.4 
 
215 (77.6%) 
62 (22.4%) 
 
 
3.2 ± 1.7 
211 (73.5%) 
76 (26.5%) 
718 
 
1.4 ± 0.4 
 
454 (86.6%) 
70 (13.4%) 
 
 
3.3 ± 1.7 
408 (76.1%) 
128 (23.9%) 
Potential confounder Boys Girls Overall 
Psychological symptoms score 9.1 ± 6.0 8.0 ± 5.0 8.5 ± 5.6 
Smokers 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
Alcohol user 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
Physical activity 
Team sport (Yes) 
Team sport (No) 
Individual sport (Yes) 
Individual sport (No) 
 
326 (96.5%) 
9 (2.6%) 
2 (0.6%) 
1 (0.3%) 
- 
 
162 (47.9%) 
105 (31.1%) 
40 (11.8%) 
15 (4.4%) 
16 (4.7%) 
 
171 (78.1%) 
48 (21.9%) 
163 (75.1%) 
54 (24.9%) 
 
377 (99.5%) 
2 (0.5%) 
- 
- 
- 
 
240 (63.3%) 
108 (28.5%)  
17 (4.5%) 
6 (1.6%) 
8 (2.1%) 
 
147 (58.8%) 
103 (41.2%) 
193 (75.1%) 
64 (24.9%) 
 
703 (98.1%) 
11 (1.5%) 
2 (0.3%) 
1 (0.1%) 
- 
 
402 (56.1%) 
213 (29.7%) 
57 (7.9%) 
21 (2.9%) 
24 (3.4%) 
 
318 (67.8%) 
171 (32.2%) 
356 (75.1%) 
118 (24.9%) 
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5.4.3 Baseline characteristics of children without musculoskeletal pain  
Baseline descriptive analyses of children without musculoskeletal pain are outlined in Table 5.8. 
Figures on sleep problems show that approximately 22% of children reported sleep problems, 
with similar proportions between boys and girls. There were more girls (56%) than boys (44%) 
without musculoskeletal pain. Approximately 21% of girls were in a mid/advanced pubertal stage 
(mid pubertal, late pubertal or post-pubertal stage) compared to only 3% of boys. The average 
number of hours of screen time per day in children was 3.5, with similar values between boys and 
girls (3.5 h/day vs 3.4 h/day), and approximately 81% of children (85% of boys vs. 78% of girls) had 
an average of screen time of > 2 h/day. The average psychological symptoms score was 8.3 ± 5.4 
and it was higher in boys compared to girls (8.8 ± 5.5 vs. 7.8 ± 5.3). Approximately 99% of children 
reported that they had never smoked before, and only 2 children smoked 1 or more times. 
Approximately 28% of children (34% boys and 23% of girls) had already had more than just one 
sip of alcohol, even if most of them for only 1 or 2 times. Outside school hours, 58% of children 
engaged in team sports, with more boys (69%) than girls (48%), while around 71% of children 
engaged regularly in individual sports, with no gender differences.  
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Table 5.8 Baseline characteristics of children without musculoskeletal pain 
Sleep problems Boys Girls Overall 
Yes 45 (21.7%) 57 (21.8%) 102 (21.8%) 
No 162 (78.3%) 204 (78.2%) 366 (78.2%) 
Potential effect modifier Boys Girls Overall 
Gender (N %) 
Puberty 
Pubertal score 
Pubertal stages 
Pre-Early puberty 
Mid-Advanced puberty 
 
Screen time 
Screen time (mean) 
Screen time >2 hours 
Screen time ≤2 hours 
208 (44.1%) 
 
1.3 ± 0.4 
 
156 (96.9%) 
5 (3.1%) 
 
 
3.5 ± 1.9 
141 (84.9%) 
25 (15.1%) 
264 (55.9%) 
 
1.4 ± 0.4 
 
149 (79.3%) 
39 (20.7%) 
 
 
3.4 ± 1.8 
153 (77.7%) 
44 (22.3%) 
472 
 
1.4 ± 0.4 
 
305 (87.4%) 
44 (12.6%) 
 
 
3.5 ± 1.9 
294 (80.9%) 
69 (19.1%) 
Potential confounder Boys Girls Overall 
Psychological symptoms score 8.8 ± 5.5 7.8 ± 5.3 8.3 ± 5.4 
Smokers 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
Alcohol user 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
Physical activity 
Team sport (Yes) 
Team sport (No) 
Individual sport (Yes) 
Individual sport (No) 
 
207 (99.5%) 
1 (0.5%) 
- 
- 
- 
 
137 (66.2%) 
45 (21.7%) 
16 (7.7%) 
3 (1.5%) 
6 (2.9%) 
 
99 (68.8%) 
45 (31.2%) 
104 (70.3%) 
44 (29.7%) 
 
262 (99.6%) 
1 (0.4%) 
- 
- 
- 
 
202 (76.5%) 
51 (19.3%)  
9 (3.4%) 
1 (0.4%) 
1 (0.4%) 
 
79 (48.2%) 
85 (51.8%) 
120 (71.0%) 
49 (28.9%) 
 
469 (98.6%) 
2 (0.4%) 
- 
- 
- 
 
339 (71.9%) 
96 (20.4%) 
25 (5.3%) 
4 (0.9%) 
7 (1.5%) 
 
178 (57.8%) 
130 (42.2%) 
224 (70.7%) 
93 (29.3%) 
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5.4.4 Baseline characteristics of children with chronic musculoskeletal pain  
Table 5.9 outlines the baseline characteristics of children with chronic musculoskeletal pain. 
Figures on sleep problems show that approximately 49% of children reported sleep problems, 
with a slightly higher proportion in girls (50%) compared to boys (48%). There were more girls 
(53%) than boys (47%) with chronic musculoskeletal pain at baseline. Approximately 24% of girls 
were in a mid/advanced pubertal stage (mid pubertal, late pubertal or post-pubertal stage) 
compared to only 3% of boys. The average number of hours of screen time per day in children 
was 3.4 ± 1.7, with no gender differences in values, and approximately 80% of children (85% of 
boys vs. 75% of girls) had an average of screen time of > 2 h/day. The average psychological 
symptoms score was 9.5 ± 5.9 and it was higher in boys compared to girls (10.2 ± 6.4 vs. 8.9 ± 5.4). 
Approximately 97% of children reported that they had never smoked before, and only 5 children 
smoked 1 or more times. Approximately 47% of children (61% of boys and 35% of girls) had 
already had more than just one sip of alcohol, even if most of them for only 1 or 2 times. Outside 
school hours, 68% of children engaged in team sports, with more boys (69%) than girls (66%), 
while around 78% of children engaged regularly in individual sports, with no gender differences. 
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Table 5.9 Baseline sleep problems of children with chronic musculoskeletal pain 
Sleep problems Boys Girls Overall 
Yes 39 (47.6%) 48 (50.0%) 87 (48.9%) 
No 43 (52.4%) 48 (50.0%) 91 (51.1%) 
Potential effect modifier Boys Girls Overall 
Gender (N %) 
Puberty 
Pubertal score 
Pubertal stages 
Pre-Early puberty 
Mid-Advanced puberty 
 
Screen time 
Screen time (mean) 
Screen time >2 hours 
Screen time ≤2 hours 
84 (46.7%) 
 
1.3 ± 0.3 
 
58 (96.7%) 
2 (3.3%) 
 
 
3.4 ± 1.5 
52 (85.3%) 
9 (14.7%) 
96 (53.3%) 
 
1.5 ± 0.5 
 
53 (75.7%) 
17 (24.3%) 
 
 
3.4 ± 2.0 
54 (75.0%) 
18 (25.0%) 
180 
 
1.4 ± 0.4 
 
111 (85.4%) 
19 (14.6%) 
 
 
3.4 ± 1.8 
106 (79.7%) 
27 (20.3%) 
Potential confounder Boys Girls Overall 
Psychological symptoms score 10.2 ± 6.4 8.9 ± 5.4 9.5 ± 5.9 
Smokers 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
Alcohol user 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
Physical activity 
Team sport (Yes) 
Team sport (No) 
Individual sport (Yes) 
Individual sport (No) 
 
79 (94.0%) 
4 (4.8%) 
- 
1 (1.2%) 
- 
 
33 (39.3%) 
35 (41.7%) 
10 (11.9%) 
2 (2.4%) 
4 (4.8%) 
 
38 (69.1%) 
17 (30.9%) 
44 (78.6%) 
12 (21.4%) 
 
96 (100%) 
- 
- 
- 
- 
 
62 (64.6%) 
24 (25.0%)  
6 (6.2%) 
2 (2.1%) 
2 (2.1%) 
 
41 (66.1%) 
21 (33.9%) 
48 (77.4%) 
14 (22.6%) 
 
175 (97.2%) 
4 (2.2%) 
- 
1 (0.6%) 
- 
 
95 (52.8%) 
59 (32.8%) 
16 (8.9%) 
4 (2.2%) 
6 (3.3%) 
 
79 (67.5%) 
38 (32.5%) 
92 (77.9%) 
26 (22.1%) 
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5.4.5 Baseline characteristics of children without chronic musculoskeletal pain  
Table 5.10 outlines the baseline characteristics of children without chronic musculoskeletal pain. 
Figures on sleep problems show that approximately 33% of children reported sleep problems, 
with similar proportions between boys and girls. There were more girls (54%) than boys (46%) 
without chronic musculoskeletal pain. Approximately 21% of girls were in a mid/advanced 
pubertal stage (mid pubertal, late pubertal or post-pubertal stage) compared to only 3% of boys. 
The average number of hours of screen time per day in children was 3.3 ± 1.7, with similar values 
between boys and girls (3.4 h/day vs 3.3 h/day), and approximately 78% of children (81% of boys 
vs. 75% of girls) had an average of screen time of > 2 h/day. The average psychological symptoms 
score was 8.2 ± 5.4 and it was higher in boys compared to girls (8.8 ± 5.7 vs. 7.7 ± 5.1). 
Approximately 99% of children reported that they had never smoked before, and only 11 children 
smoked 1 or more times. Approximately 36% of children (42% boys and 31% of girls) had already 
had more than just one sip of alcohol, even if most of them for only 1 or 2 times. Outside school 
hours, 63% of children engaged in team sports, with more boys (75%) than girls (53%), while 
around 72% of children engaged regularly in individual sports, with no gender differences.   
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Table 5.10 Baseline sleep problems of children without chronic musculoskeletal pain 
Sleep problems Boys Girls Overall 
Yes 145 (31.6%) 182 (33.5%) 327 (32.6%) 
No 314 (68.4%) 361 (66.5%) 675 (67.4%) 
Potential effect modifier Boys Girls Overall 
Gender (N %) 
Puberty 
Pubertal score 
Pubertal stages 
Pre-Early puberty 
Mid-Advanced puberty 
 
Screen time 
Screen time (mean) 
Screen time >2 hours 
Screen time ≤2 hours 
462 (45.8%) 
 
1.3 ± 0.3 
 
337 (96.8%) 
11 (3.2%) 
 
 
3.4 ± 1.8 
286 (80.8%) 
68 (19.2%) 
547 (54.2%) 
 
1.4 ± 0.4 
 
311 (78.7%) 
84 (21.2%) 
 
 
3.3 ± 1.7 
310 (75.2%) 
102 (24.8%) 
1,009 
 
1.4 ± 0.4 
 
648 (87.2%) 
95 (12.8%) 
 
 
3.3 ± 1.7 
596 (77.8%) 
170 (22.2%) 
Potential confounder Boys Girls Overall 
Psychological symptoms score 8.8 ± 5.7 7.7 ± 5.1 8.2 ± 5.4 
Smokers 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
Alcohol user 
Never 
1 or 2 times 
3 to 5 times 
6 to 9 times 
10 or more times 
Physical activity 
Team sport (Yes) 
Team sport (No) 
Individual sport (Yes) 
Individual sport (No) 
 
454 (98.3%) 
6 (1.3%) 
2 (0.4%) 
- 
- 
 
265 (57.6%) 
115 (25.0%) 
46 (10.0%) 
16 (3.5%) 
18 (3.9%) 
 
232 (75.3%) 
76 (24.7%) 
223 (72.2%) 
86 (27.8%) 
 
543 (99.5%) 
3 (0.5%) 
- 
- 
- 
 
380 (69.4%) 
135 (24.7%)  
20 (3.7%) 
5 (0.9%) 
7 (1.3%) 
 
185 (52.6%) 
167 (47.4%) 
265 (72.8%) 
99 (27.2%) 
 
997 (98.9%) 
9 (0.9%) 
2 (0.2%) 
- 
- 
 
645 (64.0%) 
250 (24.8%) 
66 (6.6%) 
21 (2.1%) 
25 (2.5%) 
 
417 (63.2%) 
243 (36.8%) 
488 (72.5%) 
185 (27.5%) 
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5.5 Discussion 
5.5.1 Descriptive analysis 
5.5.1.1 Prevalence of musculoskeletal pain in the CATS cohort 
Baseline descriptive analysis showed that approximately 60% (718/1190) of children reported 
having had musculoskeletal pain that lasted one day or more in the last month. In comparison to 
a range of literature carried out on children of a similar age, with reported prevalence figures 
between 27% - 39% (Jones, Watson, et al., 2003; Mikkelsson, Salminen, & Kautiainen, 1997; 
Szpalski, Gunzburg, Balague, Nordin, & Melot, 2002), the baseline prevalence of musculoskeletal 
pain is higher in this cohort. Although this may raise questions about the generalizability of the 
results of this study (Hennekens & Buring, 1987), it should be considered that a direct comparison 
between figures of this cohort with those of other cohorts is limited due to variability in the 
assessment of pain and differences in musculoskeletal pain sites. For example, other studies (as 
outlined above) assessed only the presence of low back pain, or the timeline on presence of 
musculoskeletal pain was different (e.g. at least once a month), such differences would lead to a 
lower reported prevalence. Furthermore differences might be explained by different methods of 
data collection (pain questionnaire together with pain manikin provided by means of an iPad in 
CATS) compared to earlier studies (paper questionnaire based), however such differences are 
likely to be small as electronic data collection has been shown to be comparable to paper versions 
(von Baeyer, Lin, Seidman, Tsao, & Zeltzer, 2011).  
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5.5.1.2 Sleep problems 
Several studies report figures about prevalence of sleep problems in children. Figures range 
between 0.5% and 9.3% for having “often” sleep problems, nightmares and being too tired, in a 
study of Finnish adolescents 15-16 years old (Auvinen et al., 2010), and between 14% and 42% for 
daytime-tiredness, difficulty in falling asleep and waking up during the night in Finnish children 
10-12 years old (Mikkelsson et al., 2008). In a sample of 15 years old English children, 15.2% of 
children considered themselves “poor sleepers” and 43.5% reported waking up during the night 
one or more times (Harrison et al., 2014), and a review of studies on sleep problems (ranging from 
difficulties in falling asleep and night waking to obstructive sleep apnea) reports a range of 25-
40% for children and adolescents (Owens & Witmans, 2004). The figure from children within the 
CATS cohort (35% of children with sleep problems), does appear within the range of figures 
provided in previous studies suggesting that CATS provides a representative sample. 
 
5.5.1.3 Differences between children with and without musculoskeletal pain or chronic 
musculoskeletal pain at baseline 
Comparison between children with and without musculoskeletal pain or chronic musculoskeletal 
pain showed that the proportion of children with sleep problems was higher among those with 
musculoskeletal pain (44%) or chronic musculoskeletal pain (49%) compared to those without 
musculoskeletal pain (22%) or without chronic musculoskeletal pain (33%). These figures are 
consistent with the potential bi-directional relationship between musculoskeletal pain and sleep 
problems reported in the literature (Finan, Goodin, & Smith, 2013), where the initial presence of 
musculoskeletal pain may affect sleep leading to an increase of sleep problems. In addition, in 
accordance with the proposed reciprocal relationship between psychological symptoms and pain 
(Dersh, Polatin, & Gatchel, 2002; Keefe, Rumble, Scipio, Giordano, & Perri, 2004; Linton & Shaw, 
2011), the average psychological symptoms score was higher among those with musculoskeletal 
pain (8.5 ± 5.6) or chronic musculoskeletal pain (9.5 ± 5.9) compared to those without 
musculoskeletal pain (8.3 ± 5.4) or without chronic musculoskeletal pain (8.2 ± 5.4). Similarly, the 
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proportion of those playing team sports and individuals sport was higher among those with 
musculoskeletal pain (68% participated in team sports, 75% in individual sports) or chronic 
musculoskeletal pain (68% team sports, 78% individual sports) compared to those without 
musculoskeletal pain (58% team sports, 71% individual sports) or without chronic musculoskeletal 
pain (63% team sports, 72% individual sports). It may be hypothesised that higher levels of 
physical activity lead to an increase in musculoskeletal pain of traumatic origin, as suggested by 
previous studies (El-Metwally, Salminen, Auvinen, MacFarlane, & Mikkelsson, 2007; Kamada et 
al., 2016). 
 
 
5.5.2 Analysis of missing data due to loss to follow-up 
The difference in baseline characteristics between children who completed follow-up and those 
lost at follow-up were described to assess the potential risk for selection bias due to attrition 
(Section 5.3.3). Results showed that children lost at follow-up had a higher psychological 
symptoms score, were more likely to be girls, reported higher levels of screen time, were in a 
more advanced pubertal status, and were less likely to perform individual and team sports than 
completers. However, the difference in these variables was small (up to a 10% difference for most 
variables). In addition, the proportion of children loss to follow-up was also small (7% of those 
without musculoskeletal pain and 6% of those without chronic musculoskeletal pain at baseline). 
Therefore, it is unlikely that loss to follow-up resulted in a substantive selection bias effect. 
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Chapter Six. The association of sleep problems with 
musculoskeletal pain onset in children: results of the Childhood 
to Adolescence Transition Study (CATS) cohort 
This chapter’s focus is on the analysis performed on the group of children without 
musculoskeletal pain and chronic musculoskeletal pain at baseline. The results of the logistic 
regression analysis of the association between sleep problems and the onset of both 
musculoskeletal pain and chronic musculoskeletal pain will be outlined, together with a discussion 
of the results. The following section details the process for imputation of missing data before the 
results of the logistic regression analysis are described. For a full description of the processes to 
account for missing data please see chapter 4, Section 4.5.5. 
 
6.1 MCAR test and multiple imputation 
The process of selection of children for analysis, which led to 441 children without 
musculoskeletal pain at baseline who reported data on musculoskeletal pain at follow-up (944 
children for chronic musculoskeletal pain), was outlined in Section 5.3.1, along with a description 
of the baseline missing data (Section 5.3.2). A Little’s test of MCAR was performed to test whether 
data were missing completely at random (MCAR); the test was not significant either among 
children without musculoskeletal pain at baseline (p = 0.14) and children without chronic 
musculoskeletal pain at baseline (p = 0.18), showing that data were MCAR. Following this, 
multiple imputation was performed to replace missing data, in order to increase statistical power 
and provide more accurate estimates of variability compared to complete-case analysis. A chained 
equation multiple imputation method was applied to impute missing baseline characteristics (the 
outcome musculoskeletal pain at follow-up was not imputed) taking account of all variables to be 
included in the analysis within the dataset. Once imputed the logistic regression analysis was 
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carried out (Section 6.2). A sensitivity analysis was performed with the complete-case dataset and 
comparisons of the main findings between the imputed and the complete-case dataset are 
described in appendix V.  
 
6.2 Associations between sleep problems and musculoskeletal pain onset in children 
6.2.1 Sleep problems at baseline and incidence of musculoskeletal pain in children at follow-
up 
The 1-year incidence of musculoskeletal pain at follow-up was 42.6% (188/441 children present at 
follow-up). The two sleep categories: sleep problems (often, almost always) and no sleep 
problems (never, almost never, sometimes) were examined in relation to the proportion of 
musculoskeletal pain at follow-up. The proportion of children reporting musculoskeletal pain was 
higher in those with sleep problems (48/96, 50.0%) compared to those with no sleep problems 
(140/345, 40.6%) (Table 6.1).  
 
 
  
Table 6.1 Sleep problems at baseline and musculoskeletal pain presence 
at follow-up among children musculoskeletal pain-free at baseline 
 Musculoskeletal pain at follow-up  
Sleep problems Yes No Total 
Yes 48 (50.0%) 
140 (40.6%) 
48 (50.0%) 
205 (59.4%) 
96 
No 345 
Total 188 253 441 
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6.2.2 Association between baseline sleep problems and musculoskeletal pain onset at follow-
up (logistic regression analysis) 
Logistic regression analysis was performed to investigate the association between sleep problems 
at baseline and the onset of musculoskeletal pain at follow-up. Two stages of analysis were 
performed, first unadjusted and then with adjustment for psychological symptoms, individual 
sports and team sports at baseline. Results are shown in Table 6.2. The unadjusted result shows a 
non-significant trend of increased odds for the onset of musculoskeletal pain in children with 
sleep problems (OR = 1.47; 95% CI 0.93, 2.31). This effect is attenuated after adjustment for 
psychological symptoms, individual sports and team sports but still shows an increased odds of 
musculoskeletal pain with sleep problems (Adj. OR = 1.35; 95% CI 0.84, 2.16). 
 
 
 
   
Table 6.2 Logistic regression of the association between sleep problems 
at baseline and musculoskeletal pain onset at follow-up 
Unadjusted analysis 
Overall (N = 441) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 1.47 0.93, 2.31 
Adjusted analysis* 
Overall (N = 441) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 1.35 0.84, 2.16 
*Analysis adjusted for psychological symptoms (total score), individual sports and team sports 
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6.2.2.1 Effect modification by gender 
Effect modification was assessed by performing stratified analysis by gender and an interaction 
test (gender # sleep problems). Results are shown in Table 6.3. Stratified analysis showed that 
male children with sleep problems were statistically significantly at higher odds for the onset of 
musculoskeletal pain (Adj. OR = 2.79; 95% CI 1.39, 5.59) compared to males without sleep 
problems. Conversely, a non-significant effect was found for females, though the direction of 
effect shows a reduction of odds (Adj. OR = 0.58; 95% CI 0.28, 1.18). The interaction test (gender # 
sleep problems) was significant (Adj. OR = 3.88; 95% CI 1.48, 10.16) indicating the presence of a 
statistically significant interaction. 
 
 
  
Table 6.3 Logistic regression of the association between sleep problems at 
baseline and musculoskeletal pain onset at follow-up stratified by gender 
Unadjusted analysis 
Females  (N = 245) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 0.87 0.46, 1.63 
Males (N = 196) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 2.76 1.38, 5.52 
Adjusted analysis* 
Females  (N = 245) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 0.58 0.28, 1.18 
Males (N = 196) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 2.79 1.39, 5.59 
Interaction term* 
Musculoskeletal pain at follow-up  Odds ratio 95% CI 
Gender # Sleep problems 3.88 1.48, 10.16 
*Analysis adjusted for psychological symptoms (total score), individual sports and team sports 
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6.2.2.2 Effect modification by pubertal stage 
Effect modification was assessed by performing stratified analysis by pubertal stages and an 
interaction test (puberty # sleep problems). Analysis stratified by pubertal stages showed that 
children with sleep problems, both in an early pubertal stage (Adj. OR = 1.38; 95% CI 0.83, 2.30) 
and in an advanced pubertal stage (Adj. OR = 1.31; 95% CI 0.25, 6.90) were not statistically 
significantly at increased odds for the onset of musculoskeletal pain (Table 6.4), with estimates of 
risk similar to that of the overall effect (Adj. OR = 1.35; 95% CI 0.84, 2.16, see Section 6.2.2). The 
interaction test (puberty # sleep problems) was not significant (Adj. OR = 1.15; 95% CI 0.22, 5.94). 
 
 
 
  
Table 6.4 Logistic regression of the association between sleep problems at 
baseline and musculoskeletal pain onset at follow-up stratified by 
pubertal stage 
Unadjusted analysis 
Early pubertal stage (N = 377) ● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 1.45 0.89, 2.37 
Advanced pubertal stage (N = 50) ● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 1.69 0.38, 7.63 
Adjusted analysis* 
Early pubertal stage (N = 377) ● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 1.38 0.83, 2.30 
Advanced pubertal stage (N = 50) ●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 1.31 0.25, 6.90 
Interaction term* 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Puberty # Sleep problems 1.15 0.22, 5.94 
*Analysis adjusted for psychological symptoms (total score), individual sports and team sports 
● Sample size vary between 377 and 391 
●● Sample size vary between 50 and 64 
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6.2.2.3 Effect modification by screen time 
Effect modification was assessed by performing stratified analysis by levels of screen time and an 
interaction test (screen time # sleep problems). Analysis stratified by levels of screen time showed 
trends of association in different directions. Children with low levels of screen time showed a non-
significant trend of lessening of odds (Adj. OR = 0.79; 95% CI 0.21, 2.95). Conversely, those with 
high levels of screen time were at non-significant higher odds for the onset of musculoskeletal 
pain (Adj. OR = 1.47; 95% CI 0.88, 2.48) (Table 6.5), and the estimate was similar to that of the 
overall analysis (Adj. OR = 1.35; 95% CI 0.84, 2.16). The interaction test (screen time # sleep 
problems) was not significant (Adj. OR = 1.83; 95% CI 0.47, 7.07). 
 
 
   
Table 6.5 Logistic regression of the association between sleep problems at 
baseline and musculoskeletal pain onset at follow-up stratified by screen 
time 
Unadjusted analysis 
Low screen time (≤2 hours/day) (N = 79) ● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 0.85 0.25, 2.90 
High screen time (>2 hours/day) (N = 345) ●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 1.62 0.98, 2.68 
Adjusted analysis* 
Low screen time (≤2 hours/day) (N = 79) ● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 0.79 0.21, 2.95 
High screen time (>2 hours/day) (N = 345) ●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 1.47 0.88, 2.48 
Interaction term* 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Screen time # Sleep problems 1.83 0.47, 7.07 
*Analysis adjusted for psychological symptoms (total score), individual sports and team sports 
● Sample size vary between 79 and 96 
●● Sample size vary between 345 and 362 
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6.2.3 Sleep problems at baseline and incidence of chronic musculoskeletal pain in children at 
follow-up 
The relationship between the presence of sleep problems at baseline and the onset of chronic 
musculoskeletal pain in children at follow-up was tested. The sample used to carry out this 
analysis included those children without chronic musculoskeletal pain at baseline and who 
completed questionnaires at follow-up (N= 944). Ninety-nine children among these 944 
developed chronic musculoskeletal pain, therefore the 1-year incidence is estimated at 10.5% 
(99/944). The two sleep categories: sleep problems (often, almost always) and no sleep problems 
(never, almost never, sometimes) were examined in relation to the proportion of chronic 
musculoskeletal pain at follow-up. The proportion of chronic musculoskeletal pain was 
approximately double in children with sleep problems (16.9%) compared to those with no sleep 
problems at baseline (7.4%) (Table 6.6).  
 
 
 
 
 
 
  
Table 6.6 Sleep problems at baseline and chronic musculoskeletal pain 
at follow-up among children without chronic musculoskeletal pain at 
baseline 
 Chronic musculoskeletal pain at follow-up  
Sleep problems Yes No Total 
Yes 52 (16.9%) 
47 (7.4%) 
255 (83.1%) 
590 (92.6%) 
307 
No 637 
Total 99 845 944 
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6.2.4 Association between baseline sleep problems and chronic musculoskeletal pain onset at 
follow-up (logistic regression analysis) 
Logistic regression analysis was performed to test the association between sleep problems at 
baseline and the onset of chronic musculoskeletal pain at follow-up. Two stages of analysis were 
performed, first unadjusted and then with adjustment for psychological symptoms, individual 
sports, team sports and musculoskeletal pain at baseline. Results are shown in Table 6.7. Children 
with sleep problems were statistically significantly at higher odds for the onset of chronic 
musculoskeletal pain (Adj. OR = 2.22; 95% CI 1.43, 3.44). 
 
  
Table 6.7 Logistic regression of the association between sleep problems at 
baseline and chronic musculoskeletal pain onset at follow-up 
Unadjusted analysis 
Overall (N = 944) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 2.56 1.68, 3.90 
Adjusted analysis* 
Overall (N = 944) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 2.22 1.43, 3.44 
*Analysis adjusted for psychological symptoms (total score), individual sports, team sports and 
baseline musculoskeletal pain 
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6.2.4.1 Effect modification by gender 
Stratified analysis by gender and a test for interaction (gender # sleep problems) were carried out 
on the above model. Results are shown in Table 6.8. Stratification shows a very similar effect in 
both males (Adj. OR = 2.15; 95% CI 1.15, 4.01) and females (Adj. OR = 2.36; 95% CI 1.26, 4.43), 
with estimates similar to that of the overall analysis (Adj. OR = 2.22; 95% CI 1.43, 3.44, see Section 
6.2.4). The interaction test was not significant (Adj. OR = 0.85; 95% CI 0.36, 1.97). 
 
 
   
Table 6.8 Logistic regression of the association between sleep problems 
at baseline and chronic musculoskeletal pain onset at follow-up stratified 
by gender 
Unadjusted analysis 
Females  (N = 510) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 2.75 1.51, 4.99 
Males (N = 434) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 2.40 1.32, 4.36 
Adjusted analysis* 
Females (N = 510) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 2.36 1.26, 4.43 
Males (N = 434) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 2.15 1.15, 4.01 
Interaction term* 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Gender # Sleep problems 0.85 0.36, 1.97 
*Analysis adjusted for psychological symptoms (total score), individual sports, team sports and 
baseline musculoskeletal pain 
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6.2.4.2 Effect modification by pubertal stage 
Stratified analysis by pubertal stages and a test for interaction (puberty # sleep problems) were 
performed. Results are shown in Table 6.9. Stratification shows that the association is stronger in 
the subgroup with an advanced pubertal stage (Adj. OR = 4.15; 95% CI 0.85, 20.20), although the 
estimates for this subgroups shows large uncertainty (wide Confidence Intervals) and the effect is 
not significant. Children in an early pubertal stage (Adj. OR = 2.08; 95% CI 1.29, 3.34) showed an 
estimate of odds similar to that of the overall analysis (Adj. OR = 2.22; 95% CI 1.43, 3.44). The 
interaction test was not significant (Adj. OR = 2.02; 95% CI 0.38, 10.55). 
 
  
  
Table 6.9 Logistic regression of the association between sleep problems 
at baseline and chronic musculoskeletal pain onset at follow-up stratified 
by pubertal stage 
Unadjusted analysis 
Early pubertal stage (N = 808)● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 2.39 1.52, 3.75 
Advanced pubertal stage (N = 112)●● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 4.80 1.02, 22.65 
Adjusted analysis* 
Early pubertal stage (N = 808)● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems* 2.08 1.29, 3.34 
Advanced pubertal stage (N = 112)●● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems* 4.15 0.85, 20.20 
Interaction term* 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Puberty # Sleep problems 2.02 0.38, 10.55 
*Analysis adjusted for psychological symptoms (total score), individual sports, team sports and 
baseline musculoskeletal pain 
●Sample size vary between 808 and 832   
●●Sample size vary between 112 and 136 
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6.2.4.3 Effect modification by screen time 
Stratified analysis by levels of screen time and a test for interaction (screen time # sleep 
problems) were performed. Results are shown in Table 6.10. Stratified analysis showed that 
children with high levels of screen time were statistically significantly at increased odds for the 
onset of chronic musculoskeletal pain (Adj. OR = 2.22; 95% CI 1.33, 3.70), but not those with low 
levels of screen time (Adj. OR = 2.11; 95% CI 0.73, 6.06), and both strata showed an estimate of 
odds similar to that of the overall analysis (Adj. OR = 2.22; 95% CI 1.43, 3.44). The interaction test 
was not significant (Adj. OR = 1.20; 95% CI 0.38, 3.80). 
Table 6.10 Logistic regression of the association between sleep problems 
at baseline and chronic musculoskeletal pain onset at follow-up stratified 
by screen time 
Unadjusted analysis 
Low screen time (≤2 hours/day) (N = 198)● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 2.15 0.79, 5.84 
High screen time (>2 hours/day) (N = 720)●● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 2.68 1.64, 4.37 
Adjusted analysis* 
Low screen time (≤2 hours/day) (N = 198)● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 2.11 0.73, 6.06 
High screen time (>2 hours/day) (N = 720)●● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 2.22 1.33, 3.70 
Interaction term* 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Screen time # Sleep problems 1.20 0.38, 3.80 
*Analysis adjusted for Psychological symptoms (total score), individual sports, team sports and 
baseline musculoskeletal pain 
●Sample size vary between 198 and 224   
●●Sample size vary between 720 and 746 
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6.3 Discussion  
6.3.1 Interpretation of the findings and comparison with previous literature 
6.3.1.1 Association between the presence of sleep problems at baseline and the onset of 
musculoskeletal pain or chronic musculoskeletal pain at follow-up in children 
Overall the results show that the 1-year incidence for musculoskeletal pain onset was 42.6% 
which is similar to the 38% incidence for musculoskeletal pain reported in a relevant review of 
musculoskeletal pain in children (McBeth & Jones, 2007). Also, in a study that used the same pain 
questionnaire as used in this study, the 1-year incidence for low back pain onset was 18.6%, and 
given the wider range of body sites used in the CATS study (e.g. whole body) it would be expected 
that incidence would be higher. The incidence of chronic musculoskeletal pain onset (10.5%) was 
broadly in line with that reported for chronic widespread pain (7.7%) in a previously published 
review (McBeth & Jones, 2007).  
Within the logistic regression analysis, the association between sleep problems and the onset of 
musculoskeletal pain was non-significant overall, however the direction of association showed a 
trend for increased odds (Adj. OR = 1.35; 95% CI 0.84, 2.16) (See Table 6.2), the findings on the 
association for chronic musculoskeletal pain onset was significant indicating an over twofold 
increase in odds for children reporting sleep problems compared to those without (Adj. OR = 2.22; 
95% CI 1.43, 3.44) (See Table 6.7). The findings of this current study are in agreement with the 
results of the systematic review (Chapter 2, Section 2.4.3), which showed inconsistent evidence of 
association between sleep problems and the onset of musculoskeletal pain, though most studies 
considered in the review do report trends of non-significant increased odds for the associations as 
reported here. In addition, only one of the studies identified within the review investigated the 
association for the onset of chronic musculoskeletal pain, and reported that children with sleep 
problems were at significantly increased odds for chronic musculoskeletal pain (Harrison et al., 
2014). This is in accordance with the results of this current study. The general direction of effects 
is also in line with studies conducted in adults, where individuals with sleep problems were 
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generally at a higher odds for incident musculoskeletal pain and chronic musculoskeletal pain 
(Finan, Goodin, & Smith, 2013; Gupta et al., 2007; McBeth et al., 2014; Mork & Nilsen, 2012; 
Nitter, Pripp, & Forseth, 2012; Taylor et al., 2014). 
 
6.3.1.2 Potential explanations of the association between sleep problems and musculoskeletal 
pain onset 
Results of this current study showed that children with sleep problems were at increased odds 
(albeit non-significant) for the onset of musculoskeletal pain, and at significant increased odds for 
the onset of chronic musculoskeletal pain (Section 6.3.1.1). Given that explanations of association 
are likely to be multifactorial, a biopsychosocial approach will be taken to explain and 
contextualise these results (a brief introduction to the biopsychosocial model can be found in 
Section 1.5.1.8). Biological factors observed in children with sleep disturbances include increased 
production of cytokine and inflammatory mediators (Auvinen et al., 2010; Finan et al., 2013), 
increased muscle tension (which may lead to pain in itself and to potential postural change and 
subsequent pain onset) (Auvinen et al., 2010; Bonvanie et al., 2016). Other authors have indicated 
specific disturbances of sleep architecture that may associate with pain, such as having a shorter 
duration of slow-wave-phase or a phasic alpha electroencephalogram sleep pattern within the 
slow-wave-sleep phase suggesting a cyclic process (Kelly, Blake, Power, O’keeffe, & Fullen, 2011; 
Moldofsky, 2001). Alternatively, sleep problems may affect the neurophysiology of children 
(possibly through a modification of the opiodergic or serotoninergic neurotransmission systems), 
which may result in reductions of pain thresholds (Bonvanie et al., 2016; Finan et al., 2013; 
Harrison et al., 2014). The association between sleep quality and pain may also be partially 
explained by genetic factors (e.g. susceptibility genes for both conditions), although little is known 
on specific genes potentially associated with both sleep and pain, and effects are most likely to be 
gene on gene, and gene on environment interactions (Zhang et al., 2012). There may also be 
psychological factors that explain the association between sleep and pain. For example, sleep 
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problems have been found to be more frequent in children with attention deficit hyperactivity 
disorder (ADHD) (Chervin, Dillon, Bassetti, Ganoczy, & Pituch, 1997; O’Brien et al., 2003), and are 
linked to negative affect (e.g. mood and emotions) and rumination (Finan et al., 2013), which may 
place children at increased odds for musculoskeletal pain. Also, sleep problems may be a marker 
for the development of depression (sleep problems being one of the key symptoms of 
depression), with evidence that both sleep and depression are linked to pain (Bonvanie et al., 
2016; Campbell, Tang, et al., 2013). However, inspection of the data show that the odds for the 
onset of musculoskeletal pain were similar after adjustment for psychological factors (as 
measured by the SDQ) in this current study, therefore the proposed psychological hypothesis is 
less plausible. Alternatively, there may be influence from social factors that may give explanation 
to the association between sleep problems and musculoskeletal pain. For example child abuse 
and problems within the school or the family environment have been linked to sleep problems 
(because sleep is a state of loss of awareness of the external environment, and children need to 
feel safe to fall asleep (Dahl & Lewin, 2002; Noll, Trickett, Susman & Putnam, 2006), and these 
wider social factors are also associated with musculoskeletal pain (Brattberg, 1994; Kroner-
Herwig, Gassmann, van Gessel, & Vath, 2011; Malleson, Connell, Bennett, & Eccleston, 2001; Noll 
et al., 2006; Smaldone, Honig, & Byrne, 2007). Similarly, another explanation may involve parental 
health status, as evidence shows that poor parental health (and risky health behaviour) is 
associated both with sleep problems and musculoskeletal pain in children (Brattberg, 1994; 
Smaldone et al., 2007). Overall the proposed explanations suggest potential complex interactions 
(a probable combination effect) for the reported association, and further work to assess these 
influences is required. The above factors may also play a significant role in explaining the findings 
for chronic musculoskeletal pain. However, the effect for chronic musculoskeletal pain was much 
stronger (significant finding of over double the odds). This additional effect may be explained by a 
bi-directional relationship between sleep and musculoskeletal pain. Here sleep problems can at 
first affect the onset of musculoskeletal pain, but then the presence of musculoskeletal pain 
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disrupts sleep and the cycle continues. This effect may have resulted in the exacerbation of the 
biological, psychological and social factors proposed above, making children more vulnerable to 
the development of chronic musculoskeletal pain. This is supported by the potential bi-directional 
relationship between sleep and musculoskeletal pain reported in recent reviews (Finan et al., 
2013; McBeth, Wilkie, Bedson, Chew-Graham, & Lacey, 2015). In conclusion, the explanation of 
the association between sleep problems and musculoskeletal pain is probably complex and likely 
to be explained by several factors, therefore further research to unravel the proposed 
mechanisms is needed. 
 
6.3.1.3 Effect modification by gender 
The test for interaction between sleep and gender showed a statistically significant result. Results 
of analysis stratified by gender showed estimates of association that were different compared to 
the overall estimate for both strata. In male children with sleep problems at baseline the odds for 
the onset of musculoskeletal pain one year later were 179% higher compared to male children 
without sleep problems. Opposite, in female children the presence of sleep problems at baseline 
had the direction of a protective effect (42% decreased odds) on the onset of musculoskeletal 
pain one year later, though this estimate was not statistically significant. Overall these results 
suggest that the relationship between sleep problems and the onset of musculoskeletal pain may 
be modified by gender. There may be several explanations for these findings. Evidence shows that 
boys, before the period of adolescence, may be at increased likelihood of sleep problems 
compared to girls (Archbold, Pituch, Panahi, & Chervin, 2002; Blunden & Galland, 2014), and 
consequently are at increased odds of onset of musculoskeletal pain. However, girls may be at an 
increased odds in older adolescence (Bonvanie et al., 2016), which is consistent with the findings 
from the review (Chapter 2). In the review, two studies explored the relationship between sleep 
problems and the onset of musculoskeletal pain by gender and reported an evidence of 
association for neck pain onset, albeit only in girls (Auvinen et al., 2010; Ståhl et al., 2008). 
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However, both these studies included individuals at an older age (than this current study), the 
effect was only found in neck pain and the study designs (e.g. length of follow-up) and assessment 
of both sleep problems and musculoskeletal pain differed to this current study. In addition, 
findings of this current study are supported by figures on sleep problems within the data. Whilst 
the prevalence of sleep problems in children without musculoskeletal pain at baseline was similar 
in both genders (22%), further exploratory description shows that among those with sleep 
problems, 53% of girls reported having trouble sleeping “often” and 47% “almost always”, while 
33% of boys with sleep problems reported having trouble sleeping “often”, with a much higher 
percentage at 67% reporting “almost always” indicating more frequent sleep problems in boys 
(and potentially an indication of greater severity) compared to girls, which may partly explain the 
reported modification effect. Another explanation involves psychological and behavioural factors, 
which may influence the sleep pattern of children. For example, a significant association between 
anxiety and increased need for sleep has been reported in male young adults, but not in females 
(Lindberg et al., 1997). Also, symptoms of inattention and hyperactivity in children may explain 
the findings. Attention-deficit/hyperactivity disorder (ADHD) is more common in boys compared 
to girls and has been associated to sleep problems (Chervin et al., 1997; O’Brien et al., 2003). 
However, as mentioned within the discussion of the overall effects, the potential effect of 
psychological symptoms was controlled for in the adjusted analysis. Regarding the onset of 
chronic musculoskeletal pain, results of the interaction test and of analysis stratified by gender 
(Section 6.2.4.1) showed no evidence of a modification effect, suggesting that the presence of 
sleep problems would pose a similar increase in odds for both genders. To my knowledge, no one 
study on the relationship between sleep and the onset of chronic musculoskeletal pain stratified 
by gender has been conducted in children, therefore comparison with the findings of this current 
study is not possible. Studies conducted in adults show inconsistent results for an effect 
modification of gender on the association between sleep and chronic musculoskeletal pain, but it 
has been proposed that gender differences on this association may begin in older 
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adolescence/emerging adulthood (Bonvanie et al., 2016; Mork et al., 2014; Zhang et al., 2012). 
Therefore, it may be possible that in children with sleep problems a modification effect by gender 
does not occur when pain is already present, that the proposed reciprocal relationship between 
sleep and pain may not be modified by gender or any such modification leads to an overall 
balance of the effects reported (Section 6.3.1.2). This is supported by further inspection of the 
data, for example children with non-chronic musculoskeletal pain at baseline reported similar 
frequency of sleep problems (48% of girls and 49% of boys reported having trouble sleeping 
“often”, 52% of girls and 51% of boys “almost always”) and this is quite different to those 
frequencies reported for the onset of musculoskeletal pain. 
 
6.3.1.4 Effect modification by puberty 
The test for interaction between sleep and puberty was not statistically significant, and results of 
the analysis for the onset of musculoskeletal pain stratified by pubertal stage were similar to that 
of the overall estimate for both strata. Overall this suggests no effect modification by pubertal 
stage. These results are in contrast with the hypothesis that the odds for the onset of 
musculoskeletal pain in children with sleep problems would change depending on pubertal status 
with an increase in onset aligned to a more advanced pubertal status (Section 3.3.2.2). In 
addition, this finding does not fully support the results of previous studies (where children were 
older compared to children of this sample, 11-16 years old) that have showed increased odds for 
musculoskeletal pain in those with a more advanced pubertal status (Janssens et al., 2011; Kløven, 
Hoftun, Romundstad, & Rygg, 2017; Sperotto, Brachi, Vittadello, & Zulian, 2015; Wedderkopp, 
Andersen, Froberg, & Leboeuf-Yde, 2005). The lack of effect modification by puberty in this 
current study is most likely explained by the young age of children in the sample (9 years old) 
leading to a lack of range of pubertal stages. Inspection of the pubertal status variable showed a 
right skew, with only a small minority of the cohort reporting an advanced pubertal stage (only 
13% of children were in mid/advanced puberty; 3% of boys and 21% of girls). Therefore only a 
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small number of participants would have undergone the hypothesised effects of hormones on 
sleep, and the resultant change in sleep schedule (i.e. delays in bedtime, altered waking patterns) 
that occur during puberty (and thus potentially increase risk of musculoskeletal pain) as reported 
in the literature (Carskadon & Tarokh, 2014; Carskadon, 2011; Hagenauer & Lee, 2013). 
Conversely, a stronger yet non-significant effect for children in an advanced pubertal stage was 
found in the analysis for the onset of chronic musculoskeletal pain with a doubling of the effect 
for those in the more advanced pubertal stage. However, for both the analysis of musculoskeletal 
pain onset and chronic musculoskeletal pain onset, the certainty of the results was partly 
compromised by low sample numbers within the advanced pubertal stage groups. The wide 95% 
Confidence Intervals indicate a lack of precision of the estimate attributable to the small number 
of individuals present in the strata (only 50 and 112 children were present in the mid/advanced 
pubertal group in the stratified analysis for the onset of musculoskeletal pain and chronic 
musculoskeletal pain, respectively), and a larger sample size may have increased precision 
(Kamangar, 2012). Overall the results of this current study suggest a lack of evidence for effect 
modification by puberty on the association between sleep problems and the onset of 
musculoskeletal pain or chronic musculoskeletal pain in this sample of 9 years old Australian 
children, although this analysis was hampered by the limited range of pubertal status. Therefore, 
further investigation of the potential effect modification of puberty is warranted, perhaps best set 
within a cohort where a full range of pubertal status is present, for example a prospective cohort 
of children aged from 9 to 16. 
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6.3.1.5 Effect modification by screen time 
Results of the analysis showed no significant interaction effect for the modification effect of 
screen time. When stratified by screen time, results showed a non-significant decrease in odds for 
the onset of musculoskeletal pain in children with low levels of screen time. Conversely, children 
with high levels of screen time were at non-significant increased odds, which was similar to the 
estimate found in the overall analysis prior to stratification. As with the analysis on puberty above 
(Section 6.3.1.4), the precision of estimates for screen time is affected by low numbers, the 95% 
Confidence Intervals in children with low levels of screen time widely overlap those found in 
children with high levels of screen time, thus lessening confidence on the conclusions that can be 
drawn. For the onset of chronic musculoskeletal pain results of the logistic regression analysis 
stratified by screen time were similar to that of the overall analysis for both strata, and the result 
of the interaction test was not statistically significant. This suggests no effect modification by 
screen time for the onset of chronic musculoskeletal pain. Overall these results do not support 
the hypothesis that high levels of screen time would lead to a stronger association of sleep 
problems with the risk of future musculoskeletal pain in children. The proposed biological 
mechanisms here would be a disruption on the production of melatonin, which is necessary for 
falling asleep (Aguilar et al., 2015; Hale & Guan, 2015; Higuchi et al., 2005), and which may have 
analgesic effects through the interaction with receptors placed in the central nervous systems and 
in the dorsal horn of the spinal cord (e.g. opioidergic, benzodiazepinergic, muscarinic, nicotinic, 
serotonergic, and α1 and α2-adrenergic receptors) (Chen, Zhang, & Huang, 2016; Srinivasan et al., 
2012). It was suggested that the decrease in melatonin production may consequently increase the 
odds for musculoskeletal pain (Section 3.3.2.3). However, it is worthy of note that there appears 
to be a “protective” modification effect of low screen time use on the relationship between sleep 
problems and musculoskeletal pain onset, although the estimate was imprecise as reported 
above. The protective effect found might be explained by external factors that relate to the social 
characteristics of the children who report low screen time use (Section 6.3.1.2), such as parental 
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monitoring of the children’s screen time. Parents who have a discordant relationship or that 
spend excessive time at work, may allow their children to spend more time with electronic 
devices, and evidence shows that these children are more likely to have ADHD and behavioural 
issues (Froiland & Davison, 2016). Conversely, in families where parents have a greater 
monitoring on children’s screen time habits, children show lower levels of both screen time and 
aggressive behaviour, and improved sleep (Gentile, Reimer, Nathanson, Walsh, & Eisenmann, 
2014). However, the above suggested explanations for the protective effect are speculative and 
the results were compromised by small numbers and low precision, therefore more information is 
required about these potential mechanisms. There are also other potential reasons why this study 
did not find the hypothesised relationship of increased screen time modifying the relationship 
between sleep and musculoskeletal pain outcomes. One particular aspect is the amount of screen 
time use as defined in this current study. According to a recent systematic review that reports a 
consistent significant association between increased screen time use and poor sleep outcomes 
(reduced sleep duration and increased sleep problems), the mean estimate of screen time for 
children is 7 hours/day (Hale & Guan, 2015). Conversely, the mean screen time in this sample was 
much lower (3.3 hours a day, only 5% of children has screen time levels ≥7 hours/day). Therefore, 
it may be that levels of exposure to screen time were too low to show a significant effect, as 
confirmed by the data of this current study (proportions of children with sleep problems were 
similar across strata of screen time). In addition, evidence suggests that the effects of screen time, 
melatonin, and sleep problems are more pronounced in those already experiencing puberty 
(Hagenauer & Lee, 2013), however as outlined in the above section on puberty, this current study 
had restricted numbers within an advanced pubertal stage and therefore would be less likely to 
find an effect based on these components (i.e. screen time within those with advanced pubertal 
development). Another possible reason for the lack of effect is the definition of screen time use. 
The cut-off level for a high level of screen time was set following established guidelines (American 
Academy of Pediatrics, 2013), see Section 5.2.3.2. However, screen time use is a dynamic and 
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changing phenomena, with evidence of ever increasing use and therefore guidelines are often 
breached and moved (Bucksch et al., 2016; Hale & Guan, 2015). It may be the case that the cut-off 
chosen in this study was not representative of the actual amount of use, and the use of different 
cut-off levels for screen time (i.e. <2 hours, 2-4 hours, 4-6 hours, > 6 hours) might have produced 
different results. The actual measure used to assess screen time also presents some limitations, as 
information about key aspects of screen time was not collected in this current study. For example, 
the effect of screen time on sleep may vary depending on the time of the day when screen time 
exposure occurs (day-time vs. bedtime) (Hale & Guan, 2015). Information on media content was 
not present (e.g. playing violent videogames might lead to emotional problems (Mundy et al., 
2017), and consequently this may affect the sleep of children and also increase odds for 
musculoskeletal pain onset). Also, missing from the measure and assessment of screen time was 
information on screen time exposure due to smartphone use, the characteristics of screen (e.g. 
size, closeness to face, volume of device) and the use of multiple electronic devices at the same 
time which may affect sleep (Hale & Guan, 2015). Finally, screen time use was parent-reported. 
Evidence showed that this could have led to underestimation of screen time, potentially because 
parents may not be fully engaged and aware of their children’s screen time activities (Thorn, 
Delellis, Chandler, & Boyd, 2013). 
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6.3.2 Strengths and weaknesses 
Strengths of this study include the use of a prospective cohort design, which provides incidence 
estimates, and allows greater confidence in the understanding of the temporal sequence between 
exposure and outcome (Delgado-Rodríguez & Llorca, 2004). Another is the exploration of 
potential effect modifiers, which were chosen based on evidence gathered from the systematic 
review, and enabled the examination of sub-groups of the population in whom the association 
between sleep problems and musculoskeletal pain may vary in strength. This approach offers to 
address the current inconsistencies in the evidence of an effect between sleep problems and 
musculoskeletal pain and has the potential to identify groups of individuals at high risk where 
interventions may be more relevant and impactful. To my knowledge this is the first study that 
explores the modifying effect of pubertal stage and screen time on the association between sleep 
problems and musculoskeletal pain, and adds further to the current knowledge of effect 
modification by gender. However, limitations are also present in this study. First, a limitation 
concerns the measurement and assessment of variables used within the analysis (general points 
of measurement and assessment are discussed in chapter 11). Information was not available 
about the severity, frequency and impact of musculoskeletal pain (e.g. pain interference or 
disability), which could have provided a better understanding of the experience of pain (Kamper, 
Henschke et al., 2016) and a greater scope to investigate the association with sleep problems. 
Furthermore, as research on the consequences and impact of pain in children has shown (see 
introduction, Section 1.3.3), those suffering from musculoskeletal pain or chronic musculoskeletal 
pain may be less likely to attend school, thus selection bias may be hypothesized (Kløven, Hoftun, 
Romundstad, & Rygg, 2017). However, looking at the data, if a selection bias was present in this 
cohort, it would be more likely to be in the opposite direction, as a high percentage of children 
reported baseline musculoskeletal pain (Section 5.5.1.1). Also, as with the assessment of pain, 
there are important components in the conceptualisation of sleep problems (i.e. sleep latency, 
sleep duration, sleep efficiency, use of sleep medications, sleep disruption, daytime dysfunction 
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due to sleep, excessive daytime sleepiness and practices of sleep hygiene, objective measures 
such as polysomnography and actigraphy) (Erwin & Bashore, 2017), that the current measure 
could not capture. Methods available for objective measures of sleep patterns such as 
polysomnography and actigraphy (which allows an accurate estimate of sleep quantity) are not 
generally suitable for use in epidemiological studies (Meltzer et al., 2013). In addition, in this 
study a binary sleep variable was created in order to identify children with sleep problems within 
the population, based on a categorization used in a previous study (Section 5.2.2.1). However, 
there are restrictions in the use of binary variables as they group persons from the extremes and 
mid points together, therefore exploratory analysis was carried out using the categorical variable 
with 5 frequencies of sleep problems in the analysis to examine potential differences (e.g. 
nonlinear relationship). Results (outlined in appendix VI) showed that increasing frequency of 
sleep problems were associated with increasing odds for the onset of musculoskeletal pain and 
chronic musculoskeletal pain (this effect was more pronounced here e.g. dose effect), and these 
findings are consistent with the proposed bi-directional relationship between sleep and pain 
(Section 6.3.1.2). Within stratified analysis carried out with the categorical variable the effects 
were overall in the same direction of those reported in Section 6.2, although limitations arose 
with the low cell count within some subgroups (children in mid/advanced puberty and with low 
levels of screen time) that did not allow to estimate the odds for the onset of musculoskeletal 
pain and chronic musculoskeletal pain (Appendix VI). There are also limitations with the 
conceptualisation and definition of the effect modifiers of puberty and screen time. Whilst the 
gold standard for the assessment of puberty is the physical examination, this method may have 
been perceived as too invasive by children, and was not feasible in the CATS design due to 
restrictions in terms of costs and time (Bond et al., 2006; Coleman & Coleman, 2002). The parent-
reported pubertal development scale (PDS) has been shown to have a good agreement with 
physical examination of pubertal status of girls (.76), but lower agreement for boys (.54) aged 8-
10 years old (Miller, Tucker, Pasch, & Eccles, 1988). This might have led to some misclassification 
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overall, and more so potentially in boys. For the measure of screen time, as reported in Section 
6.3.1.5, a limitation is that no information is known about smartphone use, content of media, 
characteristics of the screen, use of multiple electronic devices and time of the day of screen time 
exposure. Such additional information would have led to the development of a better defined 
high screen user phenotype. There are also limitations with the confounder variable of physical 
activity, the questions used did not provide information about the intensity, duration and 
frequency of physical activity that can be gathered by means of validated self-reported 
questionnaires, therefore it was not possible to classify children adequately according to levels of 
physical activity (Sylvia, 2015). Another key issue is statistical power, the number of children at 
risk of developing musculoskeletal pain at baseline may not have been sufficiently large to 
estimate the association with sufficient precision (more so within the interaction and stratified 
analysis). There were only 472 (40%) children without musculoskeletal pain at baseline, and the 
resulting power to detect the effect size found (OR=1.35) was only 35.0%. A retrospective power 
analysis shows that the minimum sample size to detect this effect (OR = 1.35) with a power of 
more than 80% in a cohort where 35% of children have sleep problems (as found in this cohort) 
would need to be at least 1300 children (with a much larger sample size required to detect 
statistically significant effect modification). Finally, 6-7% of children were lost to follow-up. These 
children had higher psychological symptoms score, had higher levels of screen time, were in a 
more advanced pubertal status, and less likely to perform individual sports and team sports than 
completers (Section 5.5.2). If these characteristics were associated with increased odds for the 
onset of musculoskeletal pain or chronic musculoskeletal pain, then the results of this current 
study would be an underestimation of the magnitude of the association. However, given the low 
proportion of those lost to follow-up, this effect is unlikely to have significantly impacted on the 
reported results. 
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6.3.3 Implications 
The results of this current study may be important from a clinical point of view. Indeed, although 
children with sleep problems at baseline were overall not significantly at higher odds of the onset 
of musculoskeletal pain one year later, they were twice as likely to report chronic musculoskeletal 
pain, that is to say musculoskeletal pain of a longer duration. This clinically would mean that 
having a low sleep quality, and possibly pain episodes in childhood may be a risk factor for the 
development of more burdensome chronic musculoskeletal pain conditions. Potential strategies 
for the prevention of chronic musculoskeletal conditions are outlined in the discussion chapter 
(Section 11.5.3.1). 
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6.3.4 Key messages 
 The association between sleep problems and the onset of musculoskeletal pain was non-
significant, however the direction of association showed a trend for increased odds, in 
accordance with the overall results of the systematic review conducted in this study.  
 Children with high levels of sleep problems at baseline were at significantly increased 
odds of the onset of chronic musculoskeletal pain, and this is in line with previous studies 
conducted in adults.  
 In male children a stronger association between sleep problems and the onset of 
musculoskeletal pain was found compared to girls. Effect modification by gender was not 
observed for the onset of chronic musculoskeletal pain. 
 Effect modification of the association between sleep problems and the onset of 
musculoskeletal pain or chronic musculoskeletal pain by levels of screen time or pubertal 
stages was not observed.
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Chapter seven. The association of psychological symptoms with 
musculoskeletal pain onset in adolescents: description of the 
Avon Longitudinal Study of Parents and Children (ALSPAC) cohort 
In this chapter, a description of the ALPSAC cohort and the measures included within the cohort 
are outlined, followed by a description of the missing data, the non-response analysis for missing 
data, and the descriptive findings. Finally, the descriptive findings of the cohort will be discussed. 
Please note that the actual assessment of psychological symptoms within this analysis specifically 
measures the constructs of internalizing symptoms and externalizing symptoms (see Section 7.2.2 
below), and these terms will be used throughout the remainder of this chapter. 
 
7.1 Background of cohort 
7.1.1 Design and recruitment 
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a birth-cohort that was set-up to 
investigate the contribution of both genetic and environmental factors on the health of both 
parents and children. All pregnant women resident in Avon (Southwest England) who were 
expected to give birth between April 1, 1991 and December 31, 1992 were invited to take part 
(Boyd et al., 2013; Fraser et al., 2013; Golding, Pembrey, & Jones, 2001). The recruitment was 
opportunistic and the strategy of enrolment included the approach of pregnant women through 
posters displayed in public spaces, advertisements in the local media (TV, radio and press), 
information sent to the mother by the hospital, and an approach by ALSPAC staff when the 
mother attended an ultrasound examination appointment (Boyd et al., 2013; Golding et al., 2001). 
It was explained to potential participants that enrolment was not compulsory, and that 
participants could drop out from the study at any point, also potential participants were given 
assurances about the confidentiality of data produced from participation (Golding et al., 2001). 
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Information on parents and their children were collected from pregnancy to the onward years 
after childbirth (Fraser et al., 2013; Golding et al., 2001).  
 
7.1.2 Description of baseline participants and non-participants 
Figure 7.1 shows the description of participants and non-participants to the study. The 
recruitment process included more than one stage. During the first stage 14,541 pregnancies 
were recruited, and that generated 14,062 live born children, 13,988 of whom were alive at 1 year 
of age. Further 452 and 254 children were enrolled in phase two (seven years after birth) and 
phase three (eight years after birth), respectively. As a result there were 15,247 eligible 
pregnancies enrolled in ALSPAC overall, this generated 14,701 alive children at 1 year of age (Boyd 
et al., 2013). In the following section, the study population included in this current study is 
described.  
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Figure 7.1. Flowchart of recruitment of participants to the ALSPAC study 
 
 
  
No 
20, 248 eligible pregnancies 
Known recruitment contact 
 
Eligible but unknown 
recruitment status n = 3514 
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Not enrolled in ALSPAC n = 5,707 
 
            
 
 
 
 
 
        
        
 
 
Invited to “focus@7” assessment visit 
 
            
 
 
 
 
 
        
        
 
 
Attended “focus@7” 
 
            
 
 
 
        
        
 
 
Enrolled in ALSPAC n = 452 
 
            
 
 
 
 
 
        
        
 
 
Opportunistic invitation 
 
            
 
 
 
 
 
        
        
 
 
Provided any data 
 
            
 
 
 
 
 
        
        
 
 
Enrolled in ALSPAC n = 254 
 
            
 
 
 
 
 
        
        
 
Not enrolled in ALSPAC 
n = 5,707 
 
            
 
 
 
 
 
        
        
15, 247 eligible pregnancies enrolled in ALSPAC 
Yes No 
Yes 
Opted out via expression of 
interest card 
Opted out  
Yes 
No 
Yes 
No 
Yes No 
Recruitment Phase 2 
at age 7 years 
Recruitment Phase 3 
from age 8 years 
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7.1.3 Population eligible for this current study 
In this current study, only data from the time points when adolescents were 13 years old and 
when they were 17 years old were used. I will hereafter refer to these two time points as baseline 
and follow up, respectively. Regarding the participation rate, at baseline the questionnaire with 
questions relative to psychological symptoms (i.e. internalizing and externalizing symptoms) was 
completed for 7,159 adolescents (35.4% of the initial eligible sample). The questionnaire that 
included the question relative to baseline pain was completed by 7,136 (35.2%) adolescents. 
Some variables (i.e. screen time, cigarette use, marijuana use and drug use) were collected 1 year 
after baseline. At follow-up (at age 17), 3,999 (19.8%) adolescents completed the questionnaire 
that included the question relative to musculoskeletal pain. For a description of the adolescents 
who represent the study population of this current study please refer to Figure 7.2. In the 
following section, the variables included in the study are described.  
 
Figure 7.2. Flowchart describing the number of adolescents included in this current study 
 
 
  
15,247 eligible pregnancies enrolled in ALSPAC 
20, 248 eligible pregnancies 
7,136 completed questionnaire at baseline 
3,999 completed questionnaire at follow-up 
Information about screen time, smoking, marijuana use 
and drug use collected 1 year after baseline 
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7.2 Study measures 
The variables included within the analysis for this thesis are described below. Strengths and 
limitations of the measures will be discussed within Section 8.5.3. 
7.2.1 Musculoskeletal pain 
7.2.1.1 Baseline Pain 
Pain presence at baseline was assessed through the question “do you often have aches and pains 
in your arms or legs?”. Children were considered as having pain at baseline if the answer was 
“yes, arm(s)”, “yes leg(s)”, “yes both” and not having pain if the answer was “no, not often”.  
 
7.2.1.2 Musculoskeletal pain at follow-up 
The question “have you had any aches or pains that have lasted for a day or longer in the past 
month?” was used to assess the presence of musculoskeletal pain at follow-up. In the case where 
the response at follow-up was “yes”, the children were asked a further question on duration; 
“When did the pain start?”. Possible responses were “less than three months ago” and “more 
than three months ago”, the latter was chosen to indicate chronic pain status. These questions 
and categories have been used previously in studies on musculoskeletal pain carried out within 
the ALSPAC cohort (Harrison et al., 2014; Tobias et al., 2013). The follow-up question relative to 
pain status was also supported by a manikin (pictorial description of body areas that includes two 
diagrams, one for the front and one for the back of the body) as well as the sentence “Please 
shade in the diagrams to show where exactly you felt the pain(s)” (appendix VII). This pain 
manikin was used to assess a total of 26 different pain sites (e.g. back pain, neck pain, shoulder 
pain, etc.). This measure consists of a drawing of a blank body manikin where the subject has to 
indicate the extent and distribution of the pain, and these types of recording of location of bodily 
pain have been shown to be valid and reliable within population cohorts (Hamill et al., 2014; 
Lacey et al., 2005; Margolis et al., 1988). The body sites included in the manikin (excluding that 
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relative to the head), together with the answers to the questions relative to pain status and pain 
duration, were used to create outcome variables that represented the presence of 
musculoskeletal pain or chronic musculoskeletal pain at follow-up (i.e. adolescents who reported 
pain or chronic pain that related only to the head were excluded). The musculoskeletal pain 
measure was entered in the analysis as a binary variable with values of 1 and 0 according to the 
presence or absence of self-reported musculoskeletal pain, respectively. The measure of chronic 
musculoskeletal pain was also entered in the analysis as a binary variable with values of 1 and 0 
according to the self-reported start of musculoskeletal pain “more than three months ago” or 
“less than three months ago” respectively. 
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7.2.2 Predictor  
7.2.2.1 Internalizing/externalizing symptoms 
Internalizing and externalizing symptoms were assessed through information given by the parents 
at baseline through the Strengths and Difficulties Questionnaire (SDQ). The SDQ is a 25-item 
questionnaire for use in children and adolescents with five subscales: emotional problems, peer 
problems, conduct problems, hyperactivity and prosocial behaviour (Goodman, 1997). Each 
subscale includes 5 questions that are rated on a 3-point scale (“Not true” = 0, “Somewhat true” = 
1, “Certainly true” = 2). Therefore each subscale produced a score that ranges from 0 to 10. This 
scale has been used in previous studies carried out within the ALSPAC cohort (Edwards et al., 
2014; Huisman et al., 2010). The specific questions for each single psychological subscale are 
shown in appendix IV. Two domains were created (i.e. internalizing and externalizing symptoms) 
by combining the “emotional symptoms” and “peer item” subscales for internalizing symptoms, 
and the subscales “conduct problems” and “hyperactivity” for externalizing symptoms. This 
approach of combining subscales into broader “internalizing” and “externalizing” constructs has 
been indicated in previous research using the SDQ, and this approach has been shown to be 
suitable for use in epidemiological studies with acceptable or good validity demonstrated 
specifically in adolescent populations (Goodman et al., 2010; Vella, Cliff, Magee, & Okely, 2015; 
Vella, Swann, Allen, Schweickle, & Magee, 2017). The range for the internalizing symptoms scale 
was 0-20, as was the range for externalizing symptoms scale. Binary variables were created, by 
using the 90th percentile cut-off as indicated in previous research (Goodman, 1997, 2001). These 
cut-off values obtained for the 90th percentile of each subscale matched the recommended values 
for abnormal levels of psychological symptoms, which can be used to identify adolescents with 
symptoms of clinical relevance (Goodman, 1997, 2001). Hereafter in this thesis, those adolescents 
with an internalizing and externalizing score >90th percentile will be referred to as having 
internalizing and externalizing symptoms, respectively. 
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7.2.3 Effect modifiers 
7.2.3.1 Gender 
Gender was entered in the analysis as a binary variable with values of 1 or 0 according to the 
gender, male or female respectively. 
 
7.2.3.2 Screen time  
Screen time was measured through self-reported information gathered with the questionnaire 
“Boys'/Girls' Experiences, Thoughts and Behaviour” at 14 years of age. Average daily computer 
use was calculated for week days and weekend days combined, and the same was done for TV 
watching. By using these 2 measures, the average daily screen time was calculated. In order to 
account for the distribution of data in terms of stratification, screen time was entered in the 
analysis as a categorical variable, with three categories representing low (20% lower use, 
approximately < 2 hours of screen time/ day), medium (60% middle use, approximately 2-4 hours 
of screen time/ day) and high (higher 20% use, > 4 hours of screen time/ day) levels of screen 
time, respectively. Screen time was entered in the analysis as a categorical variable with values of 
0, 1 or 2 according to the level of screen time use (low levels of screen time, medium levels of 
screen time or high levels of screen time respectively). 
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7.2.3.3 Puberty  
Pubertal stages were measured using five-point rating scales (Tanner’s Sexual Maturation Scale, 
(Coleman & Coleman, 2002), and categorized in Tanner stages (from 1 to 5) according to the 
parental-responses to the questionnaire “growing and changing 5” at baseline, which included 
two drawings for each gender for the assessment of pubertal stages. These two drawings 
represented two scales for each gender (breast development and pubic hair development for 
girls; genital development and pubic hair development for boys), and parents indicated the stage 
(1 to 5) of development their child had reached in each scale. The highest between the two 
ratings was used to indicate pubertal stage (i.e. the highest between the breast development 
scale and pubic hair development scale for girls, between genital development scale or pubic hair 
development scale for boys), as used previously (Johnson et al., 2009). Adolescents with a Tanner 
stage score <3 were grouped in the pre-early puberty group, those with a Tanner stage score of 3 
and 4 were grouped in the mid/advanced puberty group and those with a Tanner stage score of 5 
were grouped in the post pubertal group according to categorization used previously (Bond et al., 
2006). Puberty was entered in the analysis as a categorical variable with values of 0, 1 or 2 
according to the pubertal stage (pre-early puberty, mid/advanced puberty or post puberty 
respectively). 
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7.2.4 Confounders 
7.2.4.1 Physical activity  
Parent-reported information on physical activity was gathered through the question “In the past 
month, what was the average number of times that your son/daughter participated in vigorous 
physical activity (such as running, football, swimming, athletics)?” from the questionnaire 
“growing and changing 5” delivered at baseline (age 13). The response options were: “none/ less 
than once a week/ 1-3 times a week/ 4-6 times a week/ daily”. Physical activity was entered in the 
analysis as a binary variable with values of 1 or 0 based on the response of frequency of physical 
activity (>3 times a week and ≤3 times a week, respectively) as carried out in a previous study 
(Ståhl et al., 2008). 
 
7.2.4.2 Smoking 
Smoking was assessed through the question “Have you ever smoked a cigarette (including roll-
ups)?” taken from the questionnaire “Life of a Teenager” at age 14. Smoking was entered in the 
analysis as a binary variable with values of 1 or 0 based on the response “Yes” or “No” to the 
question relative to cigarette smoking, respectively. 
 
 
7.2.4.3 Marijuana use  
Marijuana use was assessed through the question “Have you ever tried cannabis (also called 
marijuana, hash, dope, pot, blow, skunk, puff, grass, draw, ganja, spliff, joints, smoke, weed)?” 
taken from the questionnaire “Life of a Teenager” at age 14. Marijuana use was entered in the 
analysis as a binary variable with values of 1 or 0 based on the response “Yes” or “No” to the 
question relative to marijuana use, respectively. 
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7.2.4.4 Drug use 
Drug use was assessed through two questions. The first question was: “Have you ever tried 
inhaling or sniffing any of the following:” 
 Aerosols 
 Gas (butane and lighter refills) 
 Glue 
 Solvents (including petrol and paint thinners) 
 Poppers (also called amyl nitrates, liquid gold, rush) 
 
The second question “Have you ever tried, taken or used any of the following:”  
 Amphetamines (also called speed, uppers, whizz, sulphate, billy, crystal meth) 
 Ecstasy (also called 'E', pills) 
 LSD (also called acid, tabs, trips, dots) 
 Magic mushrooms (also called shrooms) 
 Spanglers (also called spangs) 
 Cocaine (also called Charlie, 'C') 
 Crack (also called rock, stone) 
 Heroin (also called brown, smack, gear, junk, 'H') 
 
The questions were taken from the questionnaire “Life of a Teenager” at age 14. Drug use was 
entered in the analysis as a binary variable with values of 1 if the response was “Yes” to any of the 
drugs listed above, or 0 otherwise.   
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7.3 Selection of adolescents for analysis and missing data 
The following sections outline a description of the process of selection of adolescents used in the 
analysis (Section 7.3.1) and description of missing data present in the study. Investigation of 
missing data that originated from item non-response to the questionnaire is outlined in Section 
7.3.2. Investigation of missing data that originated from loss to follow-up is outlined in Section 
7.3.3. 
 
7.3.1 Selection of adolescents for analysis 
At baseline (when children in the cohort were of age 13) 7,136 adolescents participated. The self-
report question for pain presence at baseline was completed by 6,971 children (98%), of whom 
3,427 (49%) reported pain in the arms or legs and 3,544 (51%) no pain in the arms or legs. Among 
the 3,544 children who reported no pain in the arms or legs at baseline, 1,604 (45%) reported 
information on the presence of musculoskeletal pain or chronic musculoskeletal pain at follow-up, 
and this forms the cohort for the analysis in this thesis. A description of the process of selection of 
individuals used in the analysis from baseline onward is provided in Figure 7.3. 
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Figure 7.3. Flowchart describing the selection of the adolescents for the analysis of 
musculoskeletal pain onset 
 
  
1,604 adolescents pain-free at baseline 
with data on musculoskeletal pain at 
follow-up 
15,247 eligible pregnancies enrolled in ALSPAC 
7,136 completed questionnaire at baseline 
6,971 completed pain question at baseline 
Number of complete 
observations present for each 
variable: 
 Smoking (75%) 
 Marijuana use (75%) 
 Drug use (75%) 
 Physical activity (76%) 
 Puberty (72%) 
 Screen time (78%) 
3,544 adolescents pain-free at baseline 3,427 adolescents with pain at 
baseline 
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7.3.2 Missing data for baseline variables 
The association between internalizing or externalizing symptoms at baseline and the onset of 
musculoskeletal pain at follow-up was assessed in the group of adolescents who were without 
pain at baseline and reported information on the presence of musculoskeletal pain at follow-up 
(N= 1,604; Figure 7.3). Missing data was found for some baseline variables because of non-
completion of the questionnaire or because individual items had been missed. Therefore, all 
variables included in the analysis were inspected for missingness, and the proportion of complete 
data and missing data for each variable at baseline was estimated. Results are shown in Table 7.1.  
 
  Table 7.1 Percentage of Complete data Vs. Missing data at baseline 
among  adolescents without pain at baseline and with data on 
musculoskeletal pain at follow-up 
 Complete data, n (%) Missing data, n (%) 
Predictors   
Internalizing symptoms 1,467 (91.5%) 137 (8.5%) 
Externalizing symptoms 1,468 (91.5%) 136 (8.5%) 
Effect Modifiers   
Gender 1,604 (100%) 
1,260 (78.6%) 
1,403 (87.5%) 
- 
344 (21.4%) 
201 (12.5%) 
Puberty 
Screen time 
Confounders   
Smoking 1,378 (85.9%) 
1,383 (86.2%) 
1,388 (86.5%) 
1,304 (81.3%) 
226 (14.1%) 
221 (13.8%) 
216 (13.5%) 
300 (18.7%) 
Marijuana Use 
Drug use  
Physical activity 
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7.3.3 Missing data due to loss to follow-up  
The total number of adolescents available at follow-up for the analysis of musculoskeletal pain 
onset is 1,604, indicating 1,940 adolescents (54.7%) were lost to follow-up (See Figure 7.3). The 
difference in baseline characteristics between those adolescents still present at follow-up 
(completers) and adolescents lost at follow-up was assessed (Table 7.2). The proportion of 
adolescents with internalizing (9.0% vs. 7.6%) and externalizing (8.5% vs. 6.0) symptoms was 
higher in the group of adolescents lost to follow-up compared to those who completed at follow-
up. The proportion of males was also higher in the group of adolescents lost to follow-up 
compared to those who completed at follow-up (51.3% vs 41.2%, respectively). Adolescents who 
completed at follow-up were in a more advanced pubertal stage compared to adolescents lost to 
follow-up (19.5% vs. 17.4% in the post-pubertal stage, respectively). It was found that adolescents 
who completed at follow-up had lower levels of screen time (18.6% vs. 20.6% high screen 
category), lower levels of smoking experience (19.1% vs. 22.5%), lower marijuana use (6.1% vs. 
7.1%), lower drugs ever (11.2% vs. 11.7%) and lower levels of physical activity (42.5% vs. 43.1%).  
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Table 7.2 Baseline values of completers vs. loss to follow-up  
Total Completers Lost to follow-up 
 1,604 (45.3%) 1,940 (54.7%) 
Psychological symptoms Completers Lost to follow-up 
Internalizing (>90th percentile) 
Internalizing (<90th percentile) 
112 (7.6%) 
1,355 (92.4%) 
148 (9.0%) 
1,489 (91.0%) 
 
Externalizing (>90th percentile) 
Externalizing (<90th percentile) 
87 (6.0%) 
1,381 (94.0%) 
139 (8.5%) 
1,498 (91.5%) 
 
Potential effect modifier Completers Lost to follow-up 
Gender (N %) 
Boys 
Girls 
 
 
661 (41.2%) 
942 (58.8%) 
 
995 (51.3%) 
945 (48.7%) 
 
Puberty 
Pre-Early puberty 
Mid-Advanced puberty 
Post puberty 
 
Screen time 
Low Screen time 
Medium Screen time 
High Screen time 
 
125 (9.9%) 
889 (70.6%) 
246 (19.5%) 
 
 
259 (18.5%) 
883 (62.9%) 
261 (18.6%) 
 
158 (12.3%) 
905 (70.3%) 
225 (17.4%) 
 
 
205 (15.2%) 
863 (64.2%) 
277 (20.6%) 
 
Potential confounder Completers Lost to follow-up 
Smoking (No) 
Smoking (Yes) 
 
Marijuana use (No) 
Marijuana use (Yes) 
 
Drug use (No) 
Drug use (Yes) 
 
Physical activity >3 times a week 
Physical activity ≤3 times a week 
1,115 (80.9%) 
263 (19.1%) 
 
1,299 (93.9%) 
84 (6.1%) 
 
1,233 (88.8%) 
115 (11.2%) 
 
554 (42.5%) 
750 (57.5%) 
989 (77.5%) 
288 (22.5%) 
 
1,190 (92.9%) 
91 (7.1%) 
 
1,137 (88.3%) 
150 (11.7%) 
 
601 (43.1%) 
793 (56.9%) 
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7.4 Results of descriptive analysis 
Descriptive analyses of the Avon Longitudinal Study of Parents and Children (ALSPAC) dataset at 
baseline were performed to explore generalisability of the sample. The results of these analyses 
are shown in the following sections. 
 
7.4.1 Baseline characteristics of the total sample 
The baseline characteristics of the total sample are outlined in Table 7.3. In total 49% of the 
cohort reported the presence of pain in their arms and legs, with a higher proportion reported by 
girls (50.4%) compared to boys (47.7%). Girls and boys had similar mean internalizing scores (girls 
2.7 ± 2.7, boys 2.6 ± 2.8), while boys had higher mean externalizing scores compared to girls (boys 
4.6 ± 3.3, girls 3.7 ±2.9). These differences are shown again when applying the 90th percentile cut-
off value, with 689 children with internalizing symptoms, with similar proportions between boys 
and girls (9.7% vs. 9.8%, respectively), and 702 children with externalizing symptoms, here more 
boys than girls have externalizing symptoms (12.7% vs 7.2%, respectively). More boys than girls 
were present in the sample (51.4% vs 48.6%, respectively). More adolescents were in the 
mid/advanced pubertal status (69.4%) compared to the proportion of those in pre-early puberty 
(11.4%) and post pubertal status (19.2%), and girls were overall in a more advanced pubertal 
status compared to boys (25.9% vs. 11.0% were in the post pubertal stage, respectively). Boys 
more often reported high levels of screen time compared to girls (20.4% vs. 18.6%, respectively). 
Approximately 26% of adolescents reported having ever tried smoking, with more girls (31.3%) 
than boys (18.9%), while 8.6% reported having ever tried marijuana, with similar proportions 
between genders. Approximately 15% of adolescents tried any type of drugs ever, with more girls 
(17.7%) than boys (12.5%). Finally, approximately 45% of adolescents performed physical activity 
more than 3 times a week, with more boys (53.9%) than girls (37.6%). 
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Table 7.3 Baseline characteristics of the sample 
Pain in arms and legs Boys Girls Overall 
Yes 1,510 (47.7%) 1,914 (50.4%) 3,427 (49.2%) 
No 1,656 (52.3%) 1,887 (49.6%) 3,544 (50.8%) 
Psychological characteristics Boys Girls Overall 
Internalizing score 2.6 (± 2.8) 2.7 (± 2.7) 2.6 (± 2.8) 
Externalizing score 4.6 (± 3.3) 3.7 (± 2.9) 4.2(± 3.2) 
Psychological symptoms >90th percentile Boys Girls Overall 
Internalizing 343 (9.7%) 346 (9.8%) 689 (9.8%) 
Externalizing   446 (12.7%) 256 (7.2%) 702 (9.9%) 
Effect modifier Boys Girls Overall 
Gender 7,635 (51.4%) 7,219 (48.6%) 14,854 
Pubertal stage    
Pre-Early puberty 
Mid-Advanced puberty 
Post puberty 
389 (15.8%) 
1,801 (73.2%) 
272 (11.0%) 
240 (7.8%) 
2,025 (66.3%) 
791 (25.9%) 
629 (11.4%) 
3,830 (69.4%) 
1,063 (19.2%) 
Screen time     
Low 
Medium 
High 
474 (17.3%) 
1,708 (62.3%) 
560 (20.4%) 
629 (18.4%) 
2,157 (63.0%) 
635 (18.6%) 
1,103 (17.9%) 
3,865 (62.7%) 
1,195 (19.4%) 
Potential confounder Boys Girls Overall 
Cigarettes smoking (ever) 
Yes 
No 
 
Marijuana smoking (ever) 
Yes 
No 
 
Drug use (ever) 
Yes 
No 
 
Physical activity 
>3 times a week 
≤3 times a week 
 
489 (18.9%) 
2,095 (81.1%) 
 
 
216 (8.3%) 
2,373 (91.7%) 
 
 
328 (12.5%) 
2,287 (87.5%) 
 
 
1,490 (53.9%) 
1,276 (46.1%) 
 
1,038 (31.3%) 
2,282 (68.7%) 
 
 
294 (8.8%) 
3,040 (91.2%) 
 
 
592 (17.7%) 
2,755 (82.3%) 
 
 
1,175 (37.6%) 
1,953 (62.4%) 
 
1,527 (25.9%) 
4,377 (74.1%) 
 
 
510 (8.6%) 
5,413 (91.4%) 
 
 
920 (15.4%) 
5,042 (84.6%) 
 
 
2,665 (45.2%) 
3,229 (54.8%) 
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7.4.2 Baseline characteristics of adolescents with pain at baseline 
The baseline characteristics of adolescents with pain at baseline, are outlined in Table 7.4. The 
average internalizing score was slightly higher in girls than boys (boys 2.6 ± 2.9, girls 2.9 ± 2.8), 
while boys had higher average externalizing score compared to girls (boys 4.7 ± 3.2, girls 3.9 ±3.1). 
The use of the 90th percentile cut-off value led to 306 adolescents with internalizing symptoms, 
with similar proportions between boys (10.4%) and girls (10.8%). Overall 282 children had 
externalizing symptoms, with more boys than girls having externalizing symptoms (11.7% vs 8.1%, 
respectively). More girls than boys had pain at baseline (55.9% vs 44.1%, respectively). More 
adolescents were in the mid/advanced pubertal status (70.1%) compared to the proportion of 
those in pre-early puberty (10.7%) and post pubertal status (19.2%), and girls were overall in a 
more advanced pubertal status compared to boys (25.7% vs. 10.7% were in the post pubertal 
stage, respectively). Proportions of screen time levels were similar between boys and girls (18.7% 
vs. 18.6% had high levels of screen time, respectively). Approximately 28% of adolescents 
reported having ever tried smoking, with more girls (34.5%) than boys (19.9%) in proportion, 
while 9.6% reported having ever tried marijuana, with similar proportions between genders (9.2% 
in boys, 9.9% in girls). Approximately 18% of adolescents ever tried any type of drugs, with more 
girls (21.2%) than boys (14.4%). Finally, just below 48% of adolescents performed physical activity 
more than 3 times a week, with more boys (57.2%) than girls (40.8%). 
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Table 7.4 Baseline sample characteristics in children with pain at baseline 
Psychological characteristics Boys Girls Overall 
Internalizing score 2.6 (± 2.9) 2.9 (± 2.8) 2.7 (± 2.8) 
Externalizing score 4.7 (± 3.2) 3.9 (± 3.1) 4.2 (± 3.2) 
Psychological symptoms >90th percentile Boys Girls Overall 
Internalizing 140 (10.4%) 166 (10.8%) 306 (10.6%) 
Externalizing  157 (11.7%) 125 (8.1%) 282 (9.8%) 
Effect modifier Boys Girls Overall 
Gender 1,511 (44.1%) 1,916 (55.9%) 3,427 
Pubertal stage Boys Girls Overall 
Pre-Early puberty 
Mid-Advanced puberty 
Post puberty 
154 (14.9%) 
770 (74.4%) 
110 (10.7%) 
102 (7.5%) 
909 (66.8%) 
349 (25.7%) 
256 (10.7%) 
1,679 (70.1%) 
459 (19.2%) 
Screen time     
Low 
Medium 
High 
198 (17.9%) 
704 (63.4%) 
207 (18.7%) 
274 (18.6%) 
923 (62.7%) 
274 (18.6%) 
472 (18.3%) 
1,627 (63.1%) 
481 (18.6%) 
Potential confounder Boys Girls Overall 
Cigarettes smoking (ever) 
Yes 
No 
 
Marijuana smoking (ever) 
Yes 
No 
 
Drug use (ever) 
Yes 
No 
 
Physical activity 
>3 times a week 
≤3 times a week 
 
208 (19.9%) 
842 (80.1%) 
 
 
97 (9.2%) 
954 (90.8%) 
 
 
153 (14.4%) 
912 (85.6%) 
 
 
654 (57.2%) 
488 (42.8%) 
 
496 (34.5%) 
942 (65.5%) 
 
 
142 (9.9%) 
1,302 (90.1%) 
 
 
308 (21.2%) 
1,143 (78.8%) 
 
 
568 (40.8%) 
825 (59.2%) 
 
704 (28.3%) 
1,784 (71.7%) 
 
 
239 (9.6%) 
2,256 (90.4%) 
 
 
461 (18.3%) 
2,055 (81.7%) 
 
 
1,222 (48.2%) 
1,313 (51.8%) 
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7.4.3 Baseline characteristics of adolescents without pain at baseline 
The baseline characteristics of adolescents without pain at baseline, which is the sample in which 
the main research question was analysed, are outlined in Table 7.5. The average internalizing 
score was similar for boys and girls (boys 2.4 ± 2.7, girls 2.5 ± 2.7), while boys had higher average 
externalizing score compared to girls (boys 4.2 ± 3.2, girls 3.3 ±2.7). The use of the 90th percentile 
cut-off value led to 260 adolescents with internalizing symptoms, with more boys (8.8%) than girls 
(8.0%) in the group. Overall 226 children had externalizing symptoms, with more boys than girls 
having externalizing symptoms (9.6% vs 5.1%, respectively). More girls than boys without pain at 
baseline were present (53.3% vs 46.7%, respectively). More adolescents were in the 
mid/advanced pubertal status (70.4%) compared to the proportion of those in pre-early puberty 
(11.1%) and post pubertal status (18.5%), and girls were overall in a more advanced pubertal 
status compared to boys (24.5% vs. 10.8% were in the post pubertal stage, respectively). Boys 
more often reported high levels of screen time compared to girls (20.8% vs. 18.6%, respectively). 
Approximately 21% of adolescents reported having ever tried smoking, with more girls (24.8%) 
than boys (15.8%) in proportion, while 6.6% reported having ever tried marijuana, with similar 
proportions between genders (6.2% in boys, 6.8% in girls). Approximately 11% of adolescents ever 
tried any type of drugs, with more girls (12.6%) than boys (9.9%). Finally, just below 43% of 
adolescents performed physical activity more than 3 times a week, with more boys (51.0%) than 
girls (35.9%). 
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Table 7.5 Baseline sample characteristics in children without pain at baseline 
Psychological characteristics Boys Girls Overall 
Internalizing score 2.4 (± 2.7) 2.5 (± 2.7) 2.5 (± 2.7) 
Externalizing score 4.2 (± 3.2) 3.3 (± 2.7) 3.8 (± 3.0) 
Psychological symptoms >90th percentile Boys Girls Overall 
Internalizing 131 (8.8%) 129 (8.0%) 260 (8.4%) 
Externalizing  144 (9.6%) 82 (5.1%) 226 (7.3%) 
Effect modifier Boys Girls Overall 
Gender 1,656 (46.7%) 1,888 (53.3%) 3,544 
Pubertal stage Boys Girls Overall 
Pre-Early puberty 
Mid-Advanced puberty 
Post puberty 
172 (15.3%) 
831 (73.9%) 
122 (10.8%) 
111 (7.8%) 
962 (67.7%) 
349 (24.5%) 
283 (11.1%) 
1,794 (70.4%) 
471 (18.5%) 
Screen time     
Low 
Medium 
High 
202 (16.3%) 
779 (62.9%) 
258 (20.8%) 
262 (17.4%) 
966 (64.0%) 
280 (18.6%) 
464 (16.9%) 
1,746 (63.5%) 
538 (19.6%) 
Potential confounder Boys Girls Overall 
Cigarettes smoking (ever) 
Yes 
No 
 
Marijuana smoking (ever) 
Yes 
No 
 
Drug use (ever) 
Yes 
No 
 
Physical activity 
>3 times a week 
≤3 times a week 
 
187 (15.8%) 
997 (84.2%) 
 
 
74 (6.2%) 
1,113 (93.8%) 
 
 
118 (9.9%) 
1,077 (90.1%) 
 
 
634 (51.0%) 
610 (49.0%) 
 
364 (24.8%) 
1,107 (75.2%) 
 
 
101 (6.8%) 
1,376 (93.2%) 
 
 
187 (12.6%) 
1,293 (87.4%) 
 
 
521 (35.9%) 
932 (64.1%) 
 
551 (20.8%) 
2,104 (79.2%) 
 
 
175 (6.6%) 
2,489 (93.4%) 
 
 
305 (11.4%) 
2,370 (88.6%) 
 
 
1,155 (42.8%) 
1,543 (57.2%) 
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7.5 Discussion 
7.5.1 Descriptive analysis 
7.5.1.1 Baseline pain 
Baseline descriptive analysis showed that approximately 49% (3,427/6,971) of children reported 
having had pain in their arm(s) or leg(s). Figures on musculoskeletal pain provided by cohort 
studies conducted in adolescents of similar age to that of this study showed prevalence rates 
ranging from 30% to 70% (Auvinen et al., 2010; Gill et al., 2014; Mikkonen et al., 2013; Paananen 
et al., 2010; Sjolie & Ljunggren, 2001). Prevalence figures reported in a recent systematic review 
were between 15-21 % for knee and ankle foot pain and 33-63% for shoulder pain, although 
estimates for “often/usually” pain in the upper extremity and lower extremity were lower (9.4-
11.7% and 28.9-31.9%, respectively) (Fuglkjær, Dissing, & Hestbæk, 2017). Although direct 
comparison with other cohorts is limited because of differences in the nature of the pain 
questions (i.e. body sites assessed and time-frame considered), the figures for baseline pain 
within this current are overall in line with those reported previously in the literature.  
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7.5.1.2 Predictor: psychological symptoms  
In this cohort, the mean internalizing score was 2.6 (2.7 in girls; 2.6 in boys), while the mean 
externalizing score was 4.2 (3.7 in girls; 4.6 in boys). These values are in agreement with parent-
reported normative data provided for Danish schoolchildren aged 10-12; the internalizing score is 
2.7 in girls and 2.6 in boys, and the externalizing score is 2.6 in girls and 3.4 in boys 
(http://www.sdqinfo.com/norms/SDQ_Danish_means_and_SD_10_12_year_olds.pdf), with 
further evidence of comparability from a range of other countries (Japanese schoolchildren aged 
13-15, http://www.sdqinfo.com/norms/JapaneseMeans.pdf, Australian children aged 11-13 
http://www.sdqinfo.com/norms/AusNorm2.pdf, and American children 11-14 years old 
http://www.sdqinfo.com/norms/USNorm1.pdf). Taken together, the evidence from other cohorts 
suggests that the internalizing and externalizing scores found in this cohort are in line with 
normative data for this age group (adolescents) reported in the literature. 
 
7.5.1.3 Differences between children with and without pain at baseline 
Comparison between children with and without pain at baseline showed that those with pain at 
baseline had higher internalizing and externalizing scores (2.7 ± 2.8 and 4.2 ± 3.2, respectively) 
compared to those without pain at baseline (2.5 ± 2.7 and 3.8 ± 3.0, respectively). This is 
consistent with the reciprocal relationship between psychological symptoms and pain reported in 
the literature (Dersh et al., 2002; Keefe et al., 2004; Linton & Shaw, 2011). In addition, 
proportions of adolescents who ever tried smoking, marijuana or any type of drugs was higher 
among those with pain (28.3%, 9.6% and 18.3%, respectively) compared to those without pain at 
baseline (20.8%, 6.6%, and 11.4%, respectively). This is in accordance with the reported 
association between musculoskeletal pain and smoking or substance use (Brattberg, 1994; 
Feldman et al., 1999, 2001; Gill, Davis, Smith, & Straker, 2014; Mikkonen et al., 2008). Finally, the 
proportion of adolescents with high levels of physical activity was higher among those with pain 
214 
 
at baseline (48.2%) compared to those without pain at baseline (42.8%), in accordance with the 
potential increase in musculoskeletal pain of traumatic origin among adolescents with higher 
levels of physical activity (El-Metwally et al., 2007; Kamada et al., 2016). 
 
7.5.2 Analysis of loss to follow-up 
The results of the responder analysis showed that adolescents lost to follow-up had in proportion 
more internalizing and externalizing symptoms, high levels of screen time, included more males, 
had higher smoking levels, and were less advanced in terms of pubertal stage compared to those 
who completed at follow-up. Therefore if any of these factors were associated with the onset of 
musculoskeletal pain, then the actual observed incidence of musculoskeletal pain may be lower, 
compared to the expected incidence in the target population. This may potentially lead to an 
underestimation of the association found. 
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Chapter eight. The association of psychological symptoms with 
musculoskeletal pain onset in adolescents: results of the Avon 
Longitudinal Study of Parents and Children (ALSPAC) cohort 
 
This chapter reports the results of the analysis of thesis objective number 2 (i.e. the association 
between psychological symptoms and the onset of musculoskeletal pain in adolescents free of 
pain at baseline). The results of the logistic regression analysis of the association between 
psychological symptoms (internalizing and externalizing symptoms in this analysis) and the onset 
of both musculoskeletal pain and chronic musculoskeletal pain are presented (Section 8.2 - 8.5), 
together with a discussion of the results (Section 8.7). The following section details the process for 
imputation of missing data before the results of the logistic regression tests are described. 
 
8.1 MCAR test and multiple imputation 
The process of selection of adolescents for analysis (i.e. from the initial cohort to the group of 
adolescents entered in the analysis) was outlined in Section 7.3.1, followed by a description of the 
baseline missing data (Section 7.3.2). A Little’s MCAR test was performed to test whether data 
were missing completely at random (MCAR). Results showed the test as significant indication (p < 
0.001) that data were not missing completely at random. The main (primary) analysis 
investigating the association between the presence of internalizing and externalizing symptoms 
and the onset of musculoskeletal pain was performed based on all adolescents with outcome data 
on pain presence at follow-up. Whilst the data were not MCAR simulation studies have shown 
that multiple imputation can reduce the risk of bias and increase the precision of estimates , and 
therefore multiple imputation of missing data on exposure, potential effect modifiers and 
confounding variables was performed under the missing at random assumption. A chained 
equation multiple imputation method was applied taking account of all variables to be entered in 
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the analysis. Once data was imputed, the logistic regression analysis was carried out (Section 8.2  - 
8.5). A sensitivity analysis was performed with the complete-case dataset to assess the robustness 
of results of the main analysis, which are described in Section 8.6.  
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8.2 Association between baseline internalizing symptoms and musculoskeletal pain 
onset in adolescents  
8.2.1 Internalizing at baseline and onset of musculoskeletal pain in adolescents at follow-up 
The 4-year incidence of musculoskeletal pain at follow-up was 35.8% (575/1604 children present 
at follow-up). The two internalizing symptoms categories: yes (internalizing score > 90th 
percentile) and no (internalizing score < 90th percentile) were examined in relation to the 
proportion of musculoskeletal pain at follow-up. The proportion of adolescents reporting 
musculoskeletal pain was higher in those with internalizing symptoms (41.9%) compared to those 
without internalizing symptoms (35.3%) (Table 8.1).  
 
 
 
  
Table 8.1 Internalizing symptoms at baseline and musculoskeletal pain 
presence at follow-up among adolescents pain-free at baseline 
 Musculoskeletal pain at follow-up  
Internalizing 
symptoms 
Yes No  Total 
Yes 52 (41.9%) 
523 (35.3%) 
72 (58.1%) 
957 (64.7%) 
124 
No 1,480 
Total 575 1,029 1,604 
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8.2.2 Results of logistic regression of the association between baseline internalizing 
symptoms and musculoskeletal pain onset at follow-up 
Logistic regression analysis was performed to investigate the association between internalizing 
symptoms at baseline and the onset of musculoskeletal pain at follow-up. Two stages of analysis 
were performed, first unadjusted and then with adjustment for smoking, marijuana use, drug use 
and physical activity (adjustment for sleep problems was not performed due to the high 
percentage of missing data, > 90%) (Table 8.2). The unadjusted result showed a non-significant 
increased odds for the onset of musculoskeletal pain in adolescents with internalizing symptoms 
(OR = 1.34; 95% CI 0.90, 1.99). This effect was stronger after adjustment for smoking, marijuana 
use, drug use and physical activity, but still non-significant (OR = 1.43; 95% CI 0.96, 2.12).  
 
 
 
   
Table 8.2 Logistic regression of the association between internalizing at 
baseline and musculoskeletal pain onset at follow-up 
Unadjusted analysis 
Overall (N = 1,604) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.34 0.90, 1.99 
Adjusted analysis* 
Overall (N = 1,604) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.43 0.96, 2.12 
*Analysis adjusted for Smoking, Marijuana use, Drug use and Physical activity 
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8.2.2.1 Effect modification by gender 
Effect modification was assessed by performing an interaction test and stratification analysis by 
gender. Results are shown in Table 8.3. The interaction test was not significant (Female gender # 
Internalizing Adj. OR = 1.07; 95% CI 0.48, 2.40), indicating no presence of statistically significant 
effect modification. Stratified analysis showed that estimates of odds were similar between 
genders (Females: Adj. OR = 1.48; 95% CI 0.86, 2.52; Males: Adj. OR = 1.41; 95% CI 0.77, 2.57) and 
similar to the overall estimate (Adj. OR = 1.43; 95% CI 0.96, 2.12).  
 
 
  
Table 8.3 Logistic regression of the association between internalizing at 
baseline and musculoskeletal pain onset at follow-up stratified by gender  
Unadjusted analysis 
Females (N = 942) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.38 0.81, 2.34 
Males (N = 662) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.31 0.72, 2.39 
Adjusted analysis* 
Females (N = 942) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.48 0.86, 2.52 
Males (N = 662) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.41 0.77, 2.57 
Interaction term* 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Female gender # Internalizing 1.07 0.48, 2.40 
*Analysis adjusted for Smoking, Marijuana use, Drug use and Physical activity 
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8.2.2.2 Effect modification by pubertal stage 
A test for interaction using “Early puberty” as the reference category (Early puberty # 
Internalizing, Mid/Advanced puberty # Internalizing, Post puberty # Internalizing) and stratified 
analysis by pubertal stages were performed. Results are shown in Table 8.4. The interaction test 
was not significant (Mid/advanced puberty # Internalizing Adj. OR = 0.76; 95% CI 0.20, 2.96; Post 
puberty # Internalizing Adj. OR = 0.50; 95% CI 0.11, 2.30), indicating no presence of statistically 
significant effect modification, although the direction of the result does suggest a lessening of 
association as pubertal stage advances. Stratified analysis showed a similar decreasing odds with 
increasing levels of pubertal development (Early pubertal stage: Adj. OR = 2.12; 95% CI 0.59, 7.64; 
Mid/advanced pubertal stage: Adj. OR = 1.51; 95% CI 0.92, 2.47; Post pubertal stage: Adj. OR = 
1.05; 95% CI 0.44, 2.49). 
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Table 8.4 Logistic regression of the association between internalizing at 
baseline and musculoskeletal pain onset at follow-up stratified by 
pubertal stage 
Unadjusted analysis 
Early pubertal stage (N = 153)● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.86 0.54, 6.41 
Mid/Advanced pubertal stage (N = 1,110)●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.43 0.87, 2.34 
Post pubertal stage (N = 297)●●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 0.94 0.40, 2.20 
Adjusted analysis* 
Early pubertal stage (N = 153)● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 2.12 0.59, 7.64 
Mid/Advanced pubertal stage (N = 1,110)●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.51 0.92, 2.47 
Post pubertal stage (N = 297) ●●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.05 0.44, 2.49 
Interaction term* 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Mid/Advanced puberty # Internalizing 0.76 0.20, 2.96 
Post puberty # Internalizing 0.50 0.11, 2.30 
*Analysis adjusted for Smoking, Marijuana use, Drug use and Physical activity 
● Sample size vary between 153 and 175 
●● Sample size vary between 1,110 and 1,151 
●●● Sample size vary between 297 and 326 
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8.2.2.3 Effect modification by screen time 
A test for interaction using “Low screen time” as the reference category (Low Screen time # 
Internalizing, Medium Screen time # Internalizing, High Screen time # Internalizing) and stratified 
analysis by screen time were performed. Results are shown in Table 8.5. The interaction test was 
not significant (Medium Screen time # Internalizing Adj. OR = 0.70; 95% CI 0.22, 2.21; High Screen 
time # Internalizing Adj. OR = 0.27; 95% CI 0.07, 1.11), indicating no presence of statistically 
significant effect modification, though a pattern of a reduction in association (odds) is seen with 
increasing screen time. Stratified analysis are in the direction of a decrease in odds with increasing 
levels of screen time, showing a non-significant increase in odds in adolescents with low levels of 
screen time (Adj. OR = 2.36; 95% CI 0.83, 6.74), a significant increase in odds in those with 
medium levels of screen time (Adj. OR = 1.67; 95% CI 1.01, 2.75) and a non-significant decrease in 
odds in those with high levels of screen time (Adj. OR = 0.66; 95% CI 0.25, 1.75).  
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Table 8.5 Logistic regression of the association between internalizing at 
baseline and musculoskeletal pain onset at follow-up stratified by 
screen time 
Unadjusted analysis 
Low screen time (N = 267)● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 2.31 0.82, 6.48 
Medium screen time (N = 990)●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.52 0.93, 2.49 
High screen time (N = 302)●●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 0.65 0.24, 1.73 
Adjusted analysis* 
Low screen time (N = 267)● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 2.36 0.83, 6.74 
Medium screen time (N = 990)●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.67 1.01, 2.75 
High screen time (N = 302)●●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 0.66 0.25, 1.75 
Interaction term* 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Medium Screen time # Internalizing 0.70 0.22, 2.21 
High Screen time # Internalizing 0.27 0.07, 1.11 
*Analysis adjusted for Smoking, Marijuana use, Drug use and Physical activity 
● Sample size vary between 267 and 288 
●● Sample size vary between 990 and 1,027 
●●● Sample size vary between 302 and 334 
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8.3 Association between baseline externalizing symptoms and musculoskeletal pain 
onset in adolescents  
8.3.1 Externalizing at baseline and onset of musculoskeletal pain in adolescents at follow-up 
The two externalizing symptoms categories: yes (externalizing symptoms > 90th percentile) and no 
(externalizing symptoms < 90th percentile) were examined in relation to the proportion of 
musculoskeletal pain at follow-up. The proportion of adolescents reporting musculoskeletal pain 
was higher in adolescents with externalizing symptoms (51.5%) compared to those without 
externalizing symptoms (34.8%) (Table 8.6). 
 
 
 
 
 
 
 
 
  
Table 8.6 Externalizing symptoms at baseline and musculoskeletal pain 
presence at follow-up among adolescents pain-free at baseline 
 Musculoskeletal pain at follow-up  
Externalizing 
symptoms 
Yes No Total 
Yes 51 (51.5%) 
524 (34.8%) 
48 (48.5%) 
981(65.2%) 
99 
No 1,505 
Total 575 1,029 1,604 
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8.3.2 Results of logistic regression of the association between baseline externalizing 
symptoms and musculoskeletal pain onset at follow-up 
Logistic regression analysis was performed in order to test the association between externalizing 
symptoms at baseline and the onset of musculoskeletal pain at follow-up. Two stages of analysis 
were performed, first unadjusted and then with adjustment for smoking, marijuana use, drug use 
and physical activity (Table 8.7). The unadjusted result shows significant increased odds for the 
onset of musculoskeletal pain in adolescents with externalizing symptoms (OR = 1.99; 95% CI 
1.29, 3.09). This effect is unchanged after adjustment for smoking, marijuana use, drug use and 
physical activity (OR = 1.99; 95% CI 1.28, 3.10).  
 
 
 
 
  
Table 8.7 Logistic regression of the association between externalizing at 
baseline and musculoskeletal pain onset at follow-up 
Unadjusted analysis 
Overall (N = 1,604) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 1.99 1.29, 3.09 
Adjusted analysis* 
Overall (N = 1,604) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 1.99 1.28, 3.10 
*Analysis adjusted for Smoking, Marijuana use, Drug use and Physical activity 
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8.3.2.1 Effect modification by gender 
Effect modification was assessed by performing an interaction test and stratification analysis by 
gender. Results are shown in Table 8.8. The interaction test was not significant (Female gender # 
Externalizing Adj. OR = 1.09; 95% CI 0.43, 2.75), indicating no presence of statistically significant 
effect modification. Stratified analysis showed significant associations with estimates of odds that 
were similar between genders (Females: Adj. OR = 2.20; 95% CI 1.10, 4.40; Males: Adj. OR = 2.03; 
95% CI 1.11, 3.70), and similar to the overall estimate (Adj. OR = 1.99; 95% CI 1.28, 3.10). 
 
 
 
 
 
  
Table 8.8 Logistic regression of the association between externalizing at 
baseline and musculoskeletal pain onset at follow-up stratified by gender 
Unadjusted analysis 
Females (N = 942) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 2.22 1.12, 4.37 
Males (N = 662) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 1.96 1.09, 3.53 
Adjusted analysis* 
Females (N = 942) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 2.20 1.10, 4.40 
Males (N = 662) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 2.03 1.11, 3.70 
Interaction term* 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Female gender # Externalizing 1.09 0.43, 2.75 
*Analysis adjusted for Smoking, Marijuana use, Drug use and Physical activity 
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8.3.2.2 Effect modification by pubertal stage 
An interaction test using “Early puberty” as the reference category (Early puberty # Externalizing, 
Mid/Advanced puberty # Externalizing, Post puberty # Externalizing) and stratified analysis by 
pubertal stages were performed. Results are shown in Table 8.9. The interaction test was not 
significant (Mid/Advanced puberty # Externalizing Adj. OR = 4.89; 95% CI 0.60, 40.16; Post puberty 
# Externalizing Adj. OR = 3.49; 95% CI 0.36, 33.71), indicating no presence of statistically 
significant effect modification. Stratified analysis showed that those in the early pubertal stage 
were at non-significant decreased odds of a musculoskeletal pain outcome, those in the 
mid/advanced pubertal stage were at statistically significant increased odds and those at the post 
pubertal stage were at non-significant increased odds (Early pubertal stage: Adj. OR = 0.57; 95% CI 
0.07, 4.68; Mid/advanced pubertal stage: Adj. OR = 2.49; 95% CI 1.43, 4.34; Post pubertal stage: 
Adj. OR = 1.81; 95% CI 0.66, 4.93).  
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Table 8.9 Logistic regression of the association between externalizing at 
baseline and musculoskeletal pain onset at follow-up stratified by 
pubertal stage 
Unadjusted analysis 
Early pubertal stage (N = 153)● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 0.54 0.08, 3.78 
Mid/Advanced pubertal stage (N = 1,110)●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 2.50 1.44, 4.36 
Post pubertal stage (N = 297)●●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 1.74 0.66, 4.57 
Adjusted analysis* 
Early pubertal stage (N = 153)● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 0.57 0.07, 4.68 
Mid/Advanced pubertal stage (N = 1,110)●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 2.49 1.43, 4.34 
Post pubertal stage (N = 297)●●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 1.81 0.66, 4.93 
Interaction term* 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Mid/Advanced puberty # Externalizing 4.89 0.60, 40.16 
Post puberty # Externalizing 3.49 0.36, 33.71 
*Analysis adjusted for Smoking, Marijuana use, Drug use and Physical activity 
● Sample size vary between 153 and 175 
●● Sample size vary between 1,110 and 1,151 
●●● Sample size vary between 297 and 326 
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8.3.2.3 Effect modification by screen time 
A test for interaction using “Low screen time” as the reference category (Low Screen time # 
Externalizing, Medium Screen time # Externalizing, High Screen time # Externalizing) and stratified 
analysis by screen time were performed. Results are shown in Table 8.10. The interaction test 
showed no statistical effect (Medium Screen time # Externalizing Adj. OR = 0.91; 95% CI 0.22, 
3.86; High Screen time # Externalizing Adj. OR = 0.54; 95% CI 0.11, 2.69), indicating no statistically 
significant effect modification. Stratified analysis showed a non-significant increase in odds in 
adolescents with low levels of screen time, a significant increase in odds for those with medium 
levels of screen time, and a non-significant increase in odds in those with high levels of screen 
time. Although stratified analysis showed an increase in odds for all strata, overall the direction of 
effect showed a decreasing trend of effect size of estimates with increasing levels of screen time 
(Low screen time: Adj. OR = 2.46; 95% CI 0.66, 9.21; Medium screen time: Adj. OR = 2.22; 95% CI 
1.24, 3.99; High screen time: Adj. OR = 1.36; 95% CI 0.49, 3.77).  
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Table 8.10 Logistic regression of the association between externalizing at 
baseline and musculoskeletal pain onset at follow-up stratified by screen 
time 
Unadjusted analysis 
Low screen time (N = 267)● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 2.42 0.66, 8.88 
Medium screen time (N = 990)●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 2.26 1.27, 4.02 
High screen time (N = 302)●●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 1.34 0.49, 3.64 
Adjusted analysis* 
Low screen time (N = 267)● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 2.46 0.66, 9.21 
Medium screen time (N = 990)●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 2.22 1.24, 3.99 
High screen time (N = 302)●●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 1.36 0.49, 3.77 
Interaction term* 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Medium Screen time # Externalizing 0.91 0.22, 3.86 
High Screen time # Externalizing 0.54 0.11, 2.69 
*Analysis adjusted for Smoking, Marijuana use, Drug use and Physical activity 
● Sample size vary between 267 and 288   
●● Sample size vary between 990 and 1,027 
●●● Sample size vary between 302 and 334 
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8.4 Association between baseline internalizing symptoms and chronic 
musculoskeletal pain onset in adolescents 
8.4.1 Internalizing at baseline and onset of chronic musculoskeletal pain in adolescents at 
follow-up 
The 4-year incidence of chronic musculoskeletal pain at follow-up was 17.0% (273/1604 children 
present at follow-up). The two internalizing symptoms categories: yes (internalizing score > 90th 
percentile) and no (internalizing score < 90th percentile) were examined in relation to the 
proportion of chronic musculoskeletal pain at follow-up. The proportion of children reporting 
chronic musculoskeletal pain was higher in those with internalizing symptoms compared to those 
without internalizing symptoms (20.5% vs. 16.7%) (Table 8.11). 
 
  
Table 8.11 Internalizing symptoms at baseline and chronic 
musculoskeletal pain presence at follow-up among adolescents 
musculoskeletal pain-free at baseline 
 Chronic musculoskeletal pain at follow-up  
Internalizing 
symptoms 
Yes No Total 
Yes 25 (20.5%) 
248 (16.7%) 
97 (79.5%) 
1,234 (83.3%) 
122 
No 1,482 
Total 273 1,331 1,604 
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8.4.2 Results of logistic regression of the association between baseline internalizing 
symptoms and chronic musculoskeletal pain onset at follow-up 
Logistic regression analysis was performed to test the association between internalizing 
symptoms at baseline and the onset of chronic musculoskeletal pain at follow-up. Two stages of 
analysis were performed, first unadjusted, and then with adjustment for smoking, marijuana use, 
drug use and physical activity (Table 8.12). The results show an increase in odds for the onset of 
chronic musculoskeletal pain in children with internalizing symptoms, although this effect is not 
significant (OR = 1.24; 95% CI 0.75, 2.05). Similarly after adjustment (smoking, marijuana use, drug 
use and physical activity) the increase of effect is stronger but again non-significant (OR = 1.28; 
95% CI 0.77, 2.11). Due to the low number of adolescents with internalizing symptoms who report 
chronic musculoskeletal pain at follow-up (n = 25, Table 8.11), interaction analysis and stratified 
analysis to assess potential effect modification were not performed (given the low statistical 
power for interaction analysis, and low cell count for stratification). 
 
 
    
Table 8.12 Logistic regression of the association between internalizing at 
baseline and chronic musculoskeletal pain onset at follow-up 
Unadjusted analysis 
Overall (N = 1,598) 
Chronic MSK pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.24 0.75, 2.05 
Adjusted analysis* 
Overall (N = 1,598) 
Chronic MSK pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.28 0.77, 2.11 
*Analysis adjusted for Smoking, Marijuana use, Drug use and Physical activity 
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8.5 Association between baseline externalizing symptoms and chronic 
musculoskeletal pain onset in adolescents 
8.5.1 Externalizing at baseline and onset of chronic musculoskeletal pain in adolescents at 
follow-up 
The two externalizing symptoms categories: yes (externalizing symptoms > 90th percentile) and no 
(externalizing symptoms < 90th percentile) were examined in relation to the proportion of 
musculoskeletal pain at follow-up. The proportion of children reporting chronic musculoskeletal 
pain was higher in adolescents with externalizing symptoms compared to those without 
externalizing symptoms (25.3% vs. 16.5%, respectively) (Table 8.13). 
 
 
   
Table 8.13 Externalizing symptoms at baseline and chronic 
musculoskeletal pain presence at follow-up among adolescents 
musculoskeletal pain-free at baseline 
 Chronic musculoskeletal pain at follow-up  
Externalizing 
symptoms 
Yes No Total 
Yes 25 (25.3%) 
248 (16.5%) 
74 (74.7%) 
1,257 (83.5%) 
99 
No 1,505 
Total 273 1,331 1,604 
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8.5.2 Results of logistic regression of the association between baseline externalizing 
symptoms and musculoskeletal pain onset at follow-up 
Logistic regression analysis was performed in order to test the association between externalizing 
symptoms at baseline and the onset of chronic musculoskeletal pain at follow-up. Two stages of 
analysis were performed, first unadjusted and then with adjustment for smoking, marijuana use, 
drug use and physical activity (Table 8.14). The unadjusted result showed significant increased 
odds for the onset of chronic musculoskeletal pain in children with externalizing symptoms (OR = 
1.69; 95% CI 1.01, 2.83). However this effect is non-significant after adjustment for smoking, 
marijuana use, drug use and physical activity (OR = 1.68; 95% CI 0.96, 2.73). As with the findings 
on internalizing, due to the low number of adolescents with externalizing symptoms who 
reported chronic musculoskeletal pain at follow-up (n = 25, Table 8.13), no further analysis to 
investigate effect modification (interaction/ stratification) was performed. 
 
 
     
Table 8.14 Logistic regression of the association between externalizing at 
baseline and chronic musculoskeletal pain onset at follow-up 
Unadjusted analysis 
Overall (N = 1,598) 
Chronic MSK pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 1.69 1.01, 2.83 
Adjusted analysis* 
Overall (N = 1,598) 
Chronic MSK pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 1.68 0.96, 2.73 
*Analysis adjusted for Smoking, Marijuana use, Drug use and Physical activity 
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8.6 Sensitivity analysis: complete-case analysis 
The results presented in Section 8.2 - 8.5 refer to the logistic regression analysis performed with 
the multiple imputed dataset. As described in Section 8.1, data was shown to be missing not 
completely at random. Sensitivity analysis was carried out to assess the robustness of this primary 
analysis and explore if different results would be obtained when using participants with complete 
data only. The sensitivity analysis showed that adolescents with complete data were at lower 
odds for the onset of musculoskeletal pain (Internalizing symptoms analysis; complete data OR = 
1.17, missing data OR = 2.33; Externalizing symptoms analysis; complete data OR =1.58, missing 
data OR = 4.00) and chronic musculoskeletal pain (Internalizing symptoms analysis; complete data 
OR = 0.96, missing data OR = 2.38; Externalizing symptoms analysis; complete data OR = 1.33, 
missing data OR = 2.55). The lower odds found within the complete case dataset may be 
explained by selective loss to follow-up. For a full description of the results obtained with the 
complete-case analysis please refer to appendix VIII.  
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8.7 Discussion 
This section will start with a comparison of the results in the context of the wider literature to give 
interpretation of the findings of this current study (Section 8.7.1), which will be followed by the 
strengths and weaknesses (Section 8.7.2) and finally key messages (Section 8.7.3). 
 
8.7.1 Interpretation of the findings and comparison with previous literature  
8.7.1.1 Association between the presence of internalizing and externalizing symptoms at 
baseline and the onset of musculoskeletal pain at follow-up  
Overall the results show that the 4-year incidence rate for musculoskeletal pain onset was 35.8%, 
which generally fits within the approximations from other relevant cohort studies (Feldman et al., 
2002b; Jones, Watson, et al., 2003; Mikkonen et al., 2013; Paananen et al., 2010), although direct 
comparisons cannot be made due to differing age groups, time scales for follow-up, and measures 
and assessments of pain. These results indicate that a significant proportion of the adolescent 
population will report musculoskeletal pain onset. However, it should be noted that the baseline 
measure used to identify pain (i.e. to exclude those with pain presence at baseline) may have 
missed adolescents with musculoskeletal pain presence (i.e. this study excluded those who 
reported arm and leg pain only, and this may have missed proportions who may have had other 
bodily regional pain, such as back pain, neck pain, shoulder pain). However, literature shows many 
adolescents will report multisite pain (Mikkelsson et al., 1997; Rathleff, Roos, Olesen, & 
Rasmussen, 2013), and extremity pain (especially leg and lower limb pain) is common (Michaleff, 
Campbell, Protheroe, Rajani, & Dunn, 2017), nonetheless this limitation may have resulted in an 
overestimation of incidence. Results of the logistic regression analysis show a non-significant 
increasing odds effect for the association between internalizing symptoms and musculoskeletal 
pain onset (Table 8.2) and a significant higher odds for musculoskeletal pain onset observed in 
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adolescents with high levels of externalizing symptoms (Table 8.7). Several studies, identified in 
the systematic review within this thesis, have investigated the effect of internalizing and 
externalizing symptoms on musculoskeletal pain, and a range of significant and mixed findings 
was reported (Gill, Davis, Smith, & Straker, 2014; Jussila et al., 2014; Kroner-Herwig, Gassmann, 
van Gessel, & Vath, 2011; Paananen et al., 2010). Differences between the studies identified in 
the review and the results found in this current study may be explained by differences in how the 
exposure and outcome variables were measured and entered in the analysis. A comparison of 
findings with two studies identified within the systematic review that used the same tool (SDQ) to 
evaluate psychological symptoms may be attempted, although these studies investigated the 
separate effect for each subscale of the SDQ rather than the internalizing and externalizing 
constructs used here (Jones, Silman, et al., 2003; Jones, Watson, et al., 2003). These studies 
report a significant effect for the onset of back pain and widespread pain for medium and higher 
levels of conduct problems, but not for any of the other scales (hyperactivity, emotional 
symptoms and peer problems), where only non-significant trends for increased odds were found. 
This is partly consistent with our findings that externalizing symptoms (in which conduct problems 
form part of the externalising construct) are significantly predictive of the onset of 
musculoskeletal pain whereas those subscales that make up the internalizing construct 
(emotional symptoms, peer problems) were not, and only demonstrated a non-significant trend. 
This does suggest that externalizing appears a more robust marker of onset of musculoskeletal 
pain. On examination of the other literature there are some other important differences, for 
example different cut-off points were used to denote internalizing and externalizing symptoms in 
this study which makes comparisons difficult. Within previous studies the SDQ score was divided 
in three bands according to tertiles (low, medium and high) of psychological symptoms, and the 
“low” category was used as a reference. Conversely, in this current study the 90th percentile was 
used as a cut-off value, chosen to identify those with a clinical level of symptoms, and chosen 
based on the trends of the review which indicated increasing effects in those with greater 
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symptom severity. In addition, considering population norm scores (as outlined in chapter 7, 
Section 7.5.1.2) the internalizing score of this current study was generally in line with the norm 
values, however externalizing scores were slightly higher than norms, which given the evidence of 
a linear relationship, may have increased the likelihood of the expected effect for this construct 
(Section 7.5.1.2).   
 
8.7.1.2 Association between the presence of internalizing and externalizing symptoms at 
baseline and the onset of chronic musculoskeletal pain at follow-up 
The 4-year incidence rate of chronic musculoskeletal pain onset was 17.0% in this cohort. This 
figure is generally higher than the incidence for chronic regional pain (4.7%) and chronic 
widespread pain (7.7%) reported in previous cohorts (Harrison et al., 2014; McBeth & Jones, 
2007), though this would be expected as this current study used less restrictive criteria to define 
chronic pain (all musculoskeletal pain inclusive of single site and multisite). The incident figures 
from this current study are within the range of incidence estimate for chronic musculoskeletal 
pain (11-26%) reported in studies carried out in adults (Mork et al., 2014; Nakamura, Nishiwaki, 
Ushida, & Toyama, 2014), however as highlighted for musculoskeletal pain onset above, the 
baseline exclusion of those with pain only included pain in the arms and legs and therefore the 
reported incidence estimate may be imprecise. As with the finding on musculoskeletal pain onset, 
there is a non-significant increase in odds with the presence of internalizing, and a significant 
increase in odds with externalizing for chronic musculoskeletal pain onset (Section 8.4.2, Table 
8.12, Section 8.5.2, Table 8.14). The findings on internalizing are broadly in line with findings 
reported in a review that show that internalizing constructs, such as depression, are most likely 
not a predictor of the onset of chronic musculoskeletal pain (Dersh et al., 2002). As outlined there 
is a greater strength of effect for externalizing for both musculoskeletal and chronic 
musculoskeletal pain onset suggesting that externalizing symptoms have a more consistent role. 
However the relationship with externalizing to chronic musculoskeletal pain onset is perhaps 
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more complex (e.g. the effect was non-significant after adjustment) and may indicate that once a 
musculoskeletal pain episode occurs, other factors (e.g. exacerbation of substance use, or a 
change in the levels of physical activity), or the coping response to the initial pain episode may 
contribute to the development of chronic musculoskeletal pain. Potential explanations for the 
findings are proposed in the following section. 
 
8.7.1.3 Potential explanation for the associations found 
The overall aim of this thesis was not necessarily to investigate the mechanisms leading from 
internalizing or externalizing symptoms to musculoskeletal pain onset but merely to investigate 
the linkage and examine potential effect modification. However, in line with the biopsychosocial 
model of pain, in this section potential biopsychosocial explanations are briefly described. As 
introduced in chapter 1 (Section 1.3.1), the HPA axis may become dysfunctional in response to 
prolonged periods of stress. Theoretically, in response to a stressful situation, the HPA axis initially 
becomes hyperactive, with consequential higher production of cortisol (Generaal et al., 2014; 
Gupta & Silman, 2004; Hannibal & Bishop, 2014; McBeth et al., 2007). Following this hyperactive 
period, the HPA axis may reach an exhaustive status and become hypoactive with an increased 
sensitivity to stressful life-events and a decreased production of cortisol. This status may increase 
the vulnerability to musculoskeletal pain, as supported by evidence of association between 
hypocortisolism and musculoskeletal pain (Generaal et al., 2014; Hannibal & Bishop, 2014; Kaplow 
et al., 2013; McBeth et al., 2007). In addition, evidence shows that the HPA functioning may be 
modulated by psychological and behavioural factors such as rumination and attention, by early 
life adversities (e.g. experiences of physical, emotional, and sexual abuse), and by the experience 
of family problems and family discord (Frodl & O’Keane, 2013; Keiley, Howe, Dodge, Bates, & 
Pettit, 2001). The effect of these factors may result in either an hyperactive or hypoactive HPA 
status increasing the likelihood of a link to musculoskeletal pain (Alink et al., 2008; Frodl & 
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O’Keane, 2013; Kaplow et al., 2013; Lopez-Duran, Kovacs, & George, 2009; van voorhees & 
Scarpa, 2004). Another factor involved in the HPA axis activity is serotonin (serotonin levels are 
low in the dysfunctional HAP axis), which is a neurotransmitter also involved in the pain process 
(serotonin is a suppressor of substance P, a nociceptive neurotransmitter, and low levels of 
serotonin are associated with pain) (Gupta & Silman, 2004; Hannibal & Bishop, 2014; McBeth et 
al., 2007). The HPA response to stressors may work differently between individuals with 
externalizing and internalizing symptoms and give some explanation to the differences in effect 
reported. Two meta-analyses show associations between depression (which is part of the 
internalizing construct) in children and adolescents and HPA dysregulation (Lopez-Duran et al., 
2009) and changes in cortisol (linked to both internalizing and externalizing) (Alink et al., 2008; 
Lopez-Duran et al., 2009) making the hypothesis of a link between psychological affect, biological 
changes, and increased vulnerability to musculoskeletal onset plausible, although less of an effect 
was noted for internalizing in this study which encompasses depression.  
Whilst a biological explanation has been outlined above and some synthesis attempted between 
biological factors and the psychological constructs of internalizing and externalizing symptoms, 
there are broader psychological, behavioural, and social factors to consider that may also help to 
explain the reported results. For example, problems within the family environment may make 
adolescents more susceptible to psychological symptoms and the onset of musculoskeletal pain 
(Brattberg, 1994; Kroner-Herwig et al., 2011). Familial problems may originate as a result of low 
socioeconomic status, which may act as a stressor in the family environment and foster the 
development of psychological symptoms in adolescents (Alink et al., 2008; Ramchandani & 
Psychogiou, 2009). Other familial stressors associated with the development of internalizing and 
externalizing symptoms in adolescents are the presence of parental mental health and 
behavioural problems (e.g. depression, anxiety, substance use), with mechanisms of transmission 
to the offspring that may be genetic, environmental, or involve a gene–environment interaction 
(Ramchandani & Psychogiou, 2009). In addition, there is evidence of association between chronic 
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pain conditions in the parents and increased internalizing and externalizing symptoms in 
adolescents, which may be partly due to the anger and frustration resulting from the burden of 
taking care of the parents’ health problems as well as behavioural influences such as children and 
adolescents vicariously learning how to cope (or not) with pain (Higgins et al., 2015). Evidence 
from the literature suggest that psychological and behavioural factors are also involved in the 
reciprocal relationship between psychological symptoms and pain that may lead to chronic 
musculoskeletal pain. In the bi-directional relationship between psychological symptoms and 
pain, baseline internalizing and externalizing symptoms may initially lead to pain, which in turn 
may act as a stressor and lead to problems in emotion regulation (e.g. anger, aggressive 
behaviour, nervousness, impulsivity, anxiety) increasing the influence of internalizing and 
externalizing factors (Vaalamo, Pulkkinen, Kinnunen, Kaprio, & Rose, 2002). In addition this 
stressful emotional response may result in the activation of the sympathetic nervous system, 
which may increase muscle tension and reduce pain tolerance (potentially because of increased 
catastrophizing thoughts about pain) (Keefe et al., 2004; Vaalamo et al., 2002). This bi-directional 
relationship may also be influenced by other pre-existing, semi-dormant factors such as pain 
catastrophizing, pain-related anxiety and fear of pain (often constructs related to core emotional 
affect such as internalizing and externalizing), which may act in a diathesis stress-model (Dersh et 
al., 2002; Linton & Shaw, 2011). For example, in adolescents who already suffer from anxiety and 
hold pain-catastrophizing or fear-avoidance beliefs about pain, the initial acute pain may start a 
fear-avoidance behaviour (e.g. avoiding movements or limiting activities which are believed to 
increase pain) that may lead to chronicity (Dersh et al., 2002; Linton & Shaw, 2011). In conclusion, 
the evidence presented above shows that biological (i.e. dysfunctional HPA axis), psychological, 
behavioural and social factors (i.e. problems in the family environment, pain catastrophizing, pain-
related anxiety, fear of pain), or a combination of all these factors, are plausible explanations for 
the relationship between internalizing and externalizing symptoms and the onset of 
musculoskeletal pain or chronic musculoskeletal pain as reported within this thesis. More work is 
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now needed to understand the developmental aspects of these constructs and this is further 
discussed in chapter 11. 
 
8.7.1.4 Effect modification by gender 
The results of the interaction tests, together with results of the stratified analysis, suggest that 
gender is not an effect modifier of the association between musculoskeletal pain and both 
internalizing symptoms and externalizing symptoms. These results do not support the 
hypothesized difference in effect by gender proposed in Section 3.4.2.1, which was based on the 
known gender imbalance on the prevalence of internalizing and externalizing symptoms, with 
higher risk of internalizing symptoms in girls and of externalizing symptoms in boys (Maughan et 
al., 2004; Merikangas et al., 2009). This gender imbalance was found only for externalizing 
symptoms but not for internalizing symptoms in this cohort (see Section 7.4.2, Table 7.5). 
Considering the literature within the systematic review, the findings of this study are mostly 
supported, with two studies reporting no gender differences (Jussila et al., 2014; Paananen et al., 
2010), which is in accordance with the results, and one study reporting a statistically significant 
association for the onset of multiple pain only in girls with internalizing symptoms and only in 
boys with externalizing symptoms (Kroner-Herwig et al., 2011). As suggested by the authors, the 
presence of pain at baseline may have affected the psychological vulnerability of children, 
potentially in a different manner between boys and girls (i.e. increasing externalizing symptoms in 
boys and internalizing symptoms in girls) (Kroner-Herwig et al., 2011; Vaalamo et al., 2002). This 
may consequently have resulted in the difference of association between genders found in that 
study (Kroner-Herwig et al., 2011). In conclusion, the results of this current study together with 
findings from the systematic review suggest that in adolescents an effect modification by gender 
of the association between internalizing and externalizing symptoms and the onset of 
musculoskeletal pain is unlikely. 
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8.7.1.5 Effect modification by puberty 
Results of analysis for the onset of musculoskeletal pain in adolescents with internalizing 
symptoms stratified by levels of pubertal development showed a directional effect between 
strata, with decreasing odds for the onset of musculoskeletal pain with increasing levels of 
pubertal development (Early puberty Adj. OR = 2.12; 95% CI 0.59, 7.64; Mid/advanced puberty 
Adj. OR = 1.51; 95% CI 0.92, 2.47; Post puberty Adj. OR = 1.05; 95% CI 0.44, 2.49), although the 
interaction tests were not statistically significant. Conversely, results of the association between 
externalising symptoms and musculoskeletal pain showed a directional difference of effect 
between strata, whilst the statistical interaction tests were non-significant. Findings show a 
general protective effect (Adj. OR = 0.57; 95% CI 0.07, 4.68) for those in the early pubertal stage, 
whilst both mid/advanced pubertal status (Adj. OR = 2.49; 95% CI 1.43, 4.34) and post puberty 
(Adj. OR = 1.81; 95% CI 0.66, 4.93) show an increase in odds (Table 8.9). According to the potential 
modification effect hypothesized in Section 3.4.2.2, a difference in odds for the onset of 
musculoskeletal pain across strata of pubertal development was expected. The findings show the 
direction of effect was towards increased odds for the onset of musculoskeletal pain in those who 
are at an earlier or later pubertal stages compared to their peers as predicted. This effect is 
possibly due to the effect on psychological health of adolescents which result from hormonal 
interactions, social changes (e.g. the feeling of being different from peers of the same age), and 
brain maturation experienced during puberty (Graber, 2013; Kaltiala-Heino et al., 2003; Mendle, 
2014). The levels of psychological symptoms in adolescents in this cohort are in line with these 
pubertal stage differences reported in the literature (Graber, 2013), such as those who develop 
earlier or later compared to their peers have higher levels of internalizing (Early puberty 8.6%; 
Mid/advanced puberty 7.0%; Post puberty 9.7%) and externalizing symptoms (Early puberty 6.9%; 
Mid/advanced puberty 5.7%; Post puberty 7.2%). However, the results of the stratified analysis do 
not fully support the potential modification effect hypothesized, as there is a “dose” effect 
present for internalizing (lessening odds as pubertal stage advances), and the findings on 
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externalizing, whilst showing differences in early and late stage, show a general increasing effect 
as pubertal stage advances. Potential explanations for these findings will now be discussed. One 
of the key elements missing from the data collection is information on the actual change and rate 
of development of puberty from the time at baseline (where assessed) to the time of follow up 
(not assessed). Taking a current “snap shot” of status does not indicate pubertal tempo (i.e. the 
pace of development through puberty), which varies from individual to individual (e.g. 
adolescents can develop at a different pace regardless of what stage they are at time of 
assessment) and this “rate” can affect psychological status (Mendle, 2014). This may help to 
explain the nonlinear effect in adolescents with externalizing and internalizing symptoms 
(reduced odds reported for those within the post puberty groups compared to mid/advanced in 
both datasets). It may be possible that a dampening effect of puberty on the association between 
externalizing symptoms and musculoskeletal pain occurred among adolescents who were in the 
post pubertal stage at baseline (i.e. the full effects of puberty were already experienced by this 
group as indicated by their status). However there is a clear difference between internalising and 
externalising within the early puberty groups (internalizing = increased effect, externalizing = 
decreased or protective effect). A potential explanation may be the nature of these constructs in 
relation to this stage of puberty. Perhaps internalising features lead to greater rumination and 
perhaps hypersensitivity to pain, research shows a consistent relationship with the characteristics 
of internalizing and pain (De Heer et al., 2014), whereas the construct of externalizing is more 
associated with “external” problematic behaviours such as alcohol abuse, drug abuse and 
antisocial behaviour (Colder et al., 2013) which is more linked to later pubertal stages (Evensen, 
Lyngstad, Melkevik, & Mykletun, 2016). However, any interpretation or conclusion drawn from 
these results is speculative and more research is required, and it must be noted that both these 
findings are non-significant and the confidence intervals are wide and further research is required 
to establish these effects. 
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Another potential factor which was not accounted for in the analysis is sleep problems and the 
interaction this may have with pubertal stage. As outlined in the findings of chapter 6 there is an 
effect present between sleep and pain (more so for chronic musculoskeletal pain onset), and 
although no modification effect was shown for puberty, there was not the range of pubertal 
status within the CATS cohort to investigate this fully. Certainly sleep problems are associated 
with psychological problems (Coulombe, Reid, Boyle, & Racine, 2011; Pieters et al., 2014), they 
may be predictive of the onset of musculoskeletal pain (Section 2.4.3.1 and Section 6.2), and are 
observed among those in a more advanced pubertal stage, due to the change in sleep patterns 
that occurs during puberty (Carskadon & Tarokh, 2014; Dahl & Lewin, 2002).  
In conclusion, the findings of this study show some support to the hypotheses, with an expected 
difference in the association based on different levels of pubertal status. However explanations of 
this effect are most likely complex and it may be a combination of factors (pubertal status and 
tempo, linkage with sleep problems, external events and situations that influence expression of 
psychological symptoms) that explain the direction of the results reported for the modification 
effect of pubertal status on the relationship between internalizing and externalizing and 
musculoskeletal pain onset. Therefore further research which enables the tracking of variations in 
psychological symptoms and pubertal development during the follow-up is needed to inform 
more clearly the findings of this current study.  
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8.7.1.6 Effect modification by screen time 
Results of analysis for the association between internalizing and externalizing symptoms and the 
onset of musculoskeletal pain stratified by levels of screen time do not support the hypothesis 
that an increase in odds will be found in those with higher levels of screen time use (Section 
3.4.2.3). For both internalizing and externalizing symptoms, a directional effect between strata 
was found, with a decreasing trend of odds for the onset of musculoskeletal pain with increasing 
levels of screen time, although interaction tests were not significant. A variety of reasons have 
been considered to explain these findings. The decreasing trend found in this study may suggest 
that increasing levels of screen time has a lessening effect on the association between 
internalizing and externalizing symptoms and the onset of musculoskeletal pain. One plausible 
explanation may be that high levels of screen time may lessen the risk for physical trauma (and so 
less musculoskeletal pain) due to a decrease in physical activity (the proportion of adolescents 
with high levels of physical activity was 56%, 43% and 31% in those with low, medium and high 
screen time, respectively) and research shows higher physical activity and lower screen time use 
are associated with less severe mental health and psychological problems (Kremer et al., 2014). 
However, physical activity was adjusted for within the analysis, and the change from unadjusted 
and adjusted was not that marked, therefore this is unlikely to fully explain the findings. 
Alternatively, screen time may be a marker or indicator of other factors that may explain this 
relationship. For example research shows that deprivation is linked to low levels of access to 
electronic media (Danielsson, 2016), perhaps those with low screen time use are more susceptible 
to pain onset due to factors associated with deprivation such as increased disruption and 
problems within the family; research shows childhood abuse and other problems in the family 
environment are linked both to psychological problems and to the onset of musculoskeletal pain 
(Alink et al., 2008; Brattberg, 1994; Kroner-Herwig et al., 2011; Malleson et al., 2001; 
Ramchandani & Psychogiou, 2009; van voorhees & Scarpa, 2004). Low screen time users may also 
have less exposure to social support from online sources (social media groups), and such online 
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support has been shown to have beneficial effects on wellbeing (Oh, Ozkaya, & Larose, 2014). 
However, the explanations above to explain these weak trend effects are speculative and further 
research is required to understand these trends effects for screen time. In conclusion, findings 
from this study show an unexpected decreasing trend of odds for the onset of musculoskeletal 
pain in adolescents with internalizing and externalizing symptoms as screen time increases. Some 
explanations have been explored that may indicate more complex interactions involving other 
factors, however further research that includes other potential variables and confounders is 
required to explain these findings. 
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8.7.2 Strengths and weaknesses 
This study includes several strengths. A key strength of this study is the use of a prospective 
cohort design. Such designs allow the estimation of the incidence rate, and gives greater 
confidence of the temporal sequence between exposure and outcome (Delgado-Rodríguez & 
Llorca, 2004). As with the CATS study also, another strength is that potential effect modifiers were 
explored based on a priori defined hypotheses (Section 3.4.2). This enabled a finer level of 
analysis of the role of internalizing and externalizing symptoms and pain onset within potentially 
important sub-groups (i.e. identification of groups of higher risk). To my knowledge this is the first 
study that provides information on the effect of pubertal stage and screen time on the association 
between internalizing and externalizing symptoms and musculoskeletal pain, and adds further to 
the current knowledge of the effect of gender. In addition, another strength is that internalizing 
and externalizing symptoms were assessed by means of the SDQ, which is a valid and suitable 
measure to assess behavioural and emotional disorders for children within this cohorts’ age group 
(A. Goodman, Lamping, & Ploubidis, 2010; R. Goodman, 1997). The 90th percentile cut-off, which 
corresponded to the “abnormal” levels of internalizing and externalizing symptoms, was used to 
identify adolescents with symptoms of clinical relevance (Goodman, 1997, 2001). Advantages of 
this approach are that in low-risk samples (such as this general population sample) this cut-off is 
used to reduce the occurrence of false-positive cases and therefore reduces potential 
misclassification. This study also presents several limitations. First, a major drawback to this study 
is the assessment of pain. The questions used for the assessment of musculoskeletal pain differed 
between baseline and follow-up (Section 7.2.1). The baseline question (assessment of limb pain 
presence) may have led to an underestimation of adolescents with musculoskeletal pain at 
baseline. Consequently, this may have led to an overestimation of the association (i.e. adolescents 
who had musculoskeletal pain may have been considered as without pain at baseline and 
consequently part of the effect observed would be attributable to a recurrence or persistence of 
musculoskeletal pain rather than onset). Furthermore, with both baseline and follow up 
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assessments there was no information about the severity or impact of pain (e.g. pain interference 
or disability). Information on these factors would have enabled a greater understanding of the 
effects that psychological symptoms have on musculoskeletal pain. Second, there may also be 
limitations with regard to the assessment of effect modifiers. In this cohort puberty was assessed 
by means of a questionnaire that included the Tanner’s Sexual Maturation scale, which was 
completed by the parents. Although an advantage is that parental-report is more reliable than 
children self-report for pubertal status assessed using this measure (Lum et al., 2015), the gold 
standard for the assessment of puberty is physical examination, which would have provided 
greater accuracy (Owen Blackmore, Berenbaum & Liben, 2008). In addition, it was not possible to 
assess how pubertal status changed during the follow-up period. Changes in pubertal status may 
have affected the psychological status of children and as a result the likelihood of experiencing 
musculoskeletal pain at follow-up and the potential issues about this are discussed in the sections 
above. The measure used for screen time use assessed the time spent using computers and 
watching TV, but did not provide any information on the content of screen time use (which may 
have an impact of the predictors and outcome), and on the use of multiple electronic devices at 
the same time (e.g. computer use while watching the TV). This may have provided a more 
accurate estimate of screen time (Hale & Guan, 2015), which may potentially have changed the 
percentages of adolescents within groups of exposure to screen time and perhaps changed some 
of the estimates found in the analysis stratified by levels of screen time. Third, some 
considerations are needed on the statistical power for the analysis. Post-hoc calculations showed 
that the resulting power to detect a statistically significant effect for the relationship between 
internalizing symptoms and musculoskeletal pain with an effect size of 1.43 was only 28%. The 
minimum sample size to detect this effect with a power of more than 80% in a cohort where 8.4% 
of adolescents without musculoskeletal pain have internalizing symptoms (as found in this cohort) 
would be at least 6000 children, with a much larger sample size required to detect effect 
modification (Kamangar, 2012), especially when using a high threshold for defining internalising / 
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externalising symptoms. In the effect modification analysis, the size of the strata was small. As a 
result of this, the 95% CIs of the estimates were wide, thus providing less confidence on the 
accuracy of the estimates found. Therefore, no conclusive statements can be made regarding the 
hypothesised associations tested, and in particular for the effect modification by screen time or 
pubertal stage (although some tentative explanations have been provided). The results of effect 
modification analysis of this current study are therefore informative, and future research to 
further test these hypotheses is needed. Finally, a limitation may concern the generalizability of 
the results. Only 7,136 (35.2%) adolescents among the initial 20,248 pregnancies eligible in the 
study completed the question relative to baseline pain (Section 7.1.2). This represented the 
baseline group for the analysis. If these adolescents were different from the source population 
(e.g. they have different levels of psychological symptoms compared to adolescents who did not 
participate), this would limit the generalizability of the findings, as the associations found may 
differ among those who did not participate to the study (Hennekens & Buring, 1987). In addition 
this study suffered from more than 50% of adolescents who were lost to follow-up. Examination 
of characteristics between those who were lost to follow up and those who remained in the study 
showed those lost to follow-up were significantly more likely to be males, smokers, to have 
increased internalizing and externalizing symptoms and high levels of screen time compared to 
completers. This may have affected the estimate of the incidence, and may have biased the 
estimates of association (i.e. towards an underestimation of effect), if those lost to follow-up 
were at increased odds for the onset of musculoskeletal pain and chronic musculoskeletal pain 
compared to those who completed to follow-up (Section 7.5.2). This is supported by the reported 
characteristics of the participants across waves of ALSPAC, which showed that those lost to 
follow-up were from families of a lower socioeconomic status (Boyd et al., 2013) which may act as 
a general marker for a group with increased levels of internalizing and externalizing symptoms 
(Alink et al., 2008; Ramchandani & Psychogiou, 2009). 
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8.7.3 Key messages 
 No association for the onset of musculoskeletal pain and chronic musculoskeletal pain 
was found in adolescents with internalizing symptoms, although the direction of both the 
associations indicate a non-significant trend for increased odds. 
 Adolescents with externalizing symptoms were at statistically significant increased odds 
for the onset of musculoskeletal pain and for the onset of chronic musculoskeletal pain, 
but this latter association was attenuated after adjustment for confounding variables. 
 No gender effect modification was found in the relationship between internalizing or 
externalizing symptoms and musculoskeletal pain outcomes. 
 Trends of decreasing odds for the onset of musculoskeletal pain in adolescents with 
internalizing symptoms were observed across increasing pubertal stages and levels of 
screen time. This suggests areas where further research is needed. 
 A protective effect for the onset of musculoskeletal pain in adolescents in an early 
pubertal stage and increased odds in those in mid/advanced or post puberty was 
observed in adolescents with externalizing symptoms. 
 A trend of decreasing odds for the onset of musculoskeletal pain across increasing levels 
of screen time were observed in adolescents with externalizing symptoms. This suggests 
areas where further research is needed. 
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Chapter nine. The association of sleep and psychological 
symptoms with musculoskeletal pain onset in children and 
adolescents in primary care: description of the Consultations in 
Primary Care Archive (CiPCA) cohort 
 
This chapter will describe the Consultations in Primary Care Archive (CiPCA) cohort and the 
variables included (Section 9.1), followed by the descriptive findings (Section 9.2), and discussion 
of these descriptive findings (Section 9.3).  
 
9.1 Background  
The Consultations in Primary Care Archive (CiPCA) is a database that consists of medical 
consultation data (e.g. consultations, prescriptions, referrals) recorded since 1998 from a sample 
of general practices (up to 13) in North Staffordshire, UK (Jordan et al., 2007; Jordan et al., 2010; 
Porcheret et al., 2004). Comparisons have been made between CiPCA and national datasets 
(Royal College of General Practitioners Weekly Returns Service, General Practice Research 
Database [now CPRD], Fourth Morbidity Statistics from General Practice), and results show similar 
consultation prevalence rates of musculoskeletal conditions, providing evidence for 
generalisability of this regional healthcare database to the wider UK consulting population (Jordan 
et al., 2007), as well as evidence of European comparability (Skåne Health Care Register in 
Sweden) (Jordan et al., 2014). To maintain data quality, an annual cycle of training in morbidity 
coding, assessment and feedback is undertaken by participating CiPCA general practices and 
auditing is regularly performed by a dedicated Informatics team at Keele University (Jordan et al., 
2010; Porcheret et al., 2004). CiPCA has ethical approval and data is pseudo anonymised (i.e. 
patient identifiable information is removed and only a patient ID number is used) (Jordan et al., 
2010; Porcheret et al., 2004). The use of consultation data assures good representativeness of 
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healthcare attendance in the general population, as more than 98% of the population in the UK 
are registered with a general practice (Herrett et al., 2015; Jordan et al., 2010). In the following 
sections a description is given of the design of the study that was nested within CiPCA (Section 
9.1.1) and variable development (Section 9.1.2 - 9.1.5).  
 
9.1.1 Design and cohort definition 
In this current study medical record consultation data for 11 general practices available from year 
2005 to 2012 were used. This timescale was chosen based on the optimum recording quality and 
completeness of data (before 2005 the quality of recording was lower, after 2012 the dataset was 
not fully complete at time of data request) in order to maximise the largest possible sample to 
address the research questions.  
Two studies were carried out within this part of the CiPCA dataset. Each study used a matched 
cohort design (individuals with exposure at baseline vs. matched individuals without exposure). 
Each matched cohort dataset was created by selecting the individuals with a consultation for the 
exposure variable (sleep problems, described in Section 9.1.4.1, and psychological 
diagnosis/problems, Section 9.1.4.2) between calendar years 2005 and 2010. Data were used 
from children and adolescents who were aged between 6 and 19 years old at baseline (i.e. date of 
first consultation for the exposure), and any adolescents who became older than 19 years old 
during the follow-up (i.e. 2 years after the first consultation for the exposure) were censored from 
the study. Only individuals who were continually registered at each practice for the duration of 
the study (i.e. between calendar years 2005 and 2010) were included to ensure capturing active 
consultations. To achieve this, consultation records were checked at 6 monthly intervals 
(July/Dec) throughout the study period. In the preparation of datasets, individuals with a recorded 
consultation for sleep problems (actual N = 107) and psychological diagnosis/problems (actual N = 
507) were identified and considered “exposed”. These individuals were assigned an “index date” 
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(i.e. date of first consultation for the exposure). Each “exposed” individual identified with a 
consultation for the exposure variable was matched to five controls (“unexposed individuals”). 
Individuals were matched on age (± 2 years), gender and practice, following previous 
methodology for survival analysis (Green, Muller, Mallen, & Hider, 2015; Hancock et al., 2014; 
Jordan & Croft, 2010; Muller, Hider, Belcher, Helliwell, & Mallen, 2014). Age, gender and practice 
were considered as potential confounders and used as matching variables, in order to reduce risk 
of confounding and make the “exposed” and “unexposed” groups similar by evenly distributing 
potential confounders within both groups (Hennekens & Buring, 1987). Matched individuals were 
assigned an “index date” that was equivalent to the date of first consultation for the exposure 
variable. “Exposed” individuals and selected “unexposed” controls were followed-up for a period 
of 2-years after the “index date” (date of consultation for the exposure variable).  
In addition, in order to maximise the probability that the outcome of a musculoskeletal 
consultation from 2005 onwards was an incident consultation, data was inspected to remove the 
“exposed” and matched “unexposed” individuals who had a previous musculoskeletal 
consultation within the time period of 2 years before the “index date” of consultation for the 
exposure variable. The matched “unexposed” individuals were also censored if they had a 
consultation for the exposure variable in the period after the index date and prior to a 
consultation for a musculoskeletal condition or the end of the follow-up period. A summary of the 
inclusion and exclusion criteria for the “exposed” and “unexposed” individuals is outlined in Table 
9.1. As a result of matching two groups were within each dataset at baseline: 
 Group 1: Individuals without a recorded consultation for a musculoskeletal condition who 
had a recorded consultation for the exposure variable (sleep problem or psychological 
diagnosis/problem). 
 Group 2: Individuals without a recorded consultation for a musculoskeletal condition and 
no recorded consultation of the exposure variable. 
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This process resulted in the creation of two matched cohort datasets. One dataset was used to 
investigate the relationship between sleep problems and the onset of musculoskeletal conditions, 
and included 638 individuals (107 “exposed” individuals matched to 531 “unexposed” individuals). 
The other dataset was used to investigate the relationship between psychological 
diagnosis/problems and the onset of musculoskeletal conditions, and included 3,042 individuals 
(507 “exposed” individuals matched to 2,535 “unexposed” individuals). A statistician from the 
centre (Y.C.) assisted in the preparation of the datasets. A description of the identification and 
definition of the study variables and of the baseline characteristics of the resulting datasets is 
outlined in section 9.1.2 - 9.1.5 and 9.2.  
 
 
Table 9.1 Criteria for inclusion and exclusion in the “Exposed” and 
“Unexposed” groups 
Inclusion criteria Exclusion criteria 
“Exposed group” 
Consultation for the exposure variable 
between calendar years 2005 (start January) 
and 2010 (end December) 
Previous musculoskeletal consultation within 
the time period of 2 years before the “index 
date” of consultation for the exposure 
variable 
“Unexposed” group 
Five individuals matched to each of the 
“exposed” individuals on age (± 2 years), 
gender and practice 
Previous musculoskeletal consultation within 
the time period of 2 years before the matched 
“index date” 
 Consultation for the exposure variable after 
the matched “index date” and prior to a 
consultation for a musculoskeletal condition 
or the end of the 2-year follow-up period 
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9.1.2 Identification of variables 
In order to address objective 3 (Section 3.5), it was necessary to identify appropriate recorded 
consultations for sleep problems, psychological symptoms, musculoskeletal pain, and potential 
confounders. These were identified by means of Read Codes (a full list of Read Codes for each 
variable is provided in appendix IX). The “Read Code” system is used within the UK to record on 
practice computers all consultations and patient encounters in primary care. With this system 
categories of symptoms and diagnoses are recorded by means of four-digit alpha-numeric codes 
that include the numbers from 0 to 9 and both capital and lower case letters from A to Z, with the 
exception of “O” and “l” for which errors can occur (Benson, 2012). The Read codes chapters A-Q 
follow the International Classification of Disease (ICD-10) criteria (Benson, 2012). Upon entering 
the medical term related to the condition, a list of Read Codes potentially relevant to the 
symptom/diagnosis is returned to the general practitioner, who selects and records the most 
appropriate Read Code for the diagnosis or symptom identified (Benson, 2012). For example if the 
patient had a consultation for depressive symptoms, after entering the term “depression” a list of 
relevant Read Codes (e.g. E11z2: Masked depression; E135: Agitated depression, E2003: Anxiety 
with depression) will be returned to the general practitioner, who will choose the most 
appropriate for the patient. A number of stages were applied to refine the list of potential Read 
codes used in this study. Stage 1: A review of previous relevant studies (e.g. focus on either 
musculoskeletal, sleep, psychological consultations) using Read-coded electronic health records 
was carried out to retrieve previously used code lists (Campbell et al., 2016; Carr et al., 2017; 
Culliford et al., 2015; Fairhurst et al., 2016; Fairhurst, Watt, Martin, Bland, & Brackenbury, 2014; 
Hayward, Jordan, & Croft, 2010, 2012; Hire, Ashcroft, Springate, & Steinke, 2015; John et al., 
2015, 2016; Kontopantelis, Reeves, Valderas, Campbell, & Doran, 2013; Marston, Nazareth, 
Petersen, Walters, & Osborn, 2014; Michaleff et al., 2017; Monk, Muller, Mallen, & Hider, 2013; 
Olivier et al., 2010; Reeves et al., 2014; Wallander, Johansson, Ruigómez, García Rodríguez, & 
Jones, 2007; Windfuhr et al., 2016; Wood, Muller, & Peat, 2011). Further Read codes were added 
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from additional Read code lists that have been used previously within the Research Institute of 
Primary Care and Health Sciences. Stage 2: Further checks were carried out on all Read codes with 
an academic GP (E.R.) experienced in the application of Read codes during consultations. The GP 
checked the code lists for relevance, use and appropriateness (i.e. whether the Read code was 
relevant and appropriate for the condition that was to be identified, and if it was currently in use 
in general practices). Stage 3: All Read codes were then checked for compatibility with the CiPCA 
operating system (5 byte EMIS system) as many drawn from the wider literature used alternative 
systems (all proposed Read codes were found to be compatible within this current system). In the 
following sections, a description of the development and definition of variables, as used within 
the analysis, is outlined (Section 9.1.3 - 9.1.5). 
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9.1.3 Outcome variables 
9.1.3.1 Musculoskeletal conditions  
Survival analysis, which is the analysis method used within the CiPCA datasets, is a statistical 
technique that takes into account the time before the occurrence of an event and therefore is 
suitable where data over time are collected, as compared to a static data collection period such as 
baseline and follow up (for further details of this method see chapter 4, Section 4.5.2.2). In terms 
of the development of the variable, a recorded consultation for a musculoskeletal condition was 
used as the outcome. One-thousand six-hundred eleven Read codes were identified as relevant. 
All the individuals (aged 6-19 years) with a consultation for musculoskeletal conditions (e.g Read 
codes for diagnosis and symptoms for all body areas) in calendar years 2005-2012 were identified 
(for a list of the Read Codes pertaining to musculoskeletal conditions please see appendix IX), and 
the following definitions and criteria to factor time were used: 
 If individuals had a recorded consultation for a musculoskeletal condition, the time 
passed between the index date of consultation for the exposure variable and the date of 
consultation for a musculoskeletal condition was calculated.  
 If individuals did not have a recorded consultation for a musculoskeletal condition, the 
value for the variable was set as 731 days (corresponding to the 2-years of follow-up 
period). 
 Data was censored if the date of consultation for a musculoskeletal condition exceeded 
the follow-up period or if matched “unexposed” individuals had a consultation for the 
exposure variable before the end of the follow-up period or before the consultation for a 
musculoskeletal condition. 
 
  
259 
 
9.1.3.2 Persistent musculoskeletal conditions 
In order to capture individuals who appear to have chronic problems with musculoskeletal pain 
(i.e. in a similar vein to the chronic groups outlined in the previous cohort studies; CATS, ALSPAC) 
a variable was created using information on repeated musculoskeletal consultations to identify 
“persistent musculoskeletal pain”. Whilst actual “chronicity” could not be truly established within 
the consultation data it was decided to create a definition based on frequency and temporal 
proximity of relevant musculoskeletal consultations. These persistent consulters were individuals 
with another consultation or consultations for a musculoskeletal condition within a 3-month 
period after the first consultation and before the end of follow-up. This definition was based on 
the finding of a study carried out in a primary care setting where individuals were asked to report 
when they experienced their last pain-free month. Results from that study showed that among 
those who reported new onset of pain within the last 3 months, only 24% had a pain-free month 
in the last 3 months (Dunn, de Vet, Hooper, Ong, & Croft, 2006). This suggests that individuals 
who consult for a musculoskeletal condition may experience a persistent condition. 
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9.1.4 Exposure variables 
9.1.4.1 Sleep problems 
A recorded consultation for sleep problems or tiredness was used as the exposure variable to test 
the association between sleep problems and the onset of musculoskeletal conditions. In total 88 
Read codes were identified as relevant. These included Read codes for sleep problems and for 
daytime tiredness (e.g. persistent insomnia, nightmares, tired all the time, excessive sleep; for a 
list of the Read Codes pertaining to sleep problems or tiredness please see appendix IX). All the 
individuals (aged 6-19 years) with a consultation for sleep problems or tiredness in calendar years 
2005-2010 were identified and considered as “exposed”. After checking that exposed individuals 
did not previously consult for a musculoskeletal condition, they were included in a “Sleep 
problems group” and from hereafter in the text they will be referred as “individuals with sleep 
problems”. In addition, this variable was entered as a confounder in the analysis for the 
association between psychological diagnosis/problems and the onset of musculoskeletal 
conditions. When used as a confounder, the recorded consultation for sleep problems or 
tiredness had to have occurred in a 2-year period prior to the exposure (i.e. recorded consultation 
for psychological diagnosis/problems).  
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9.1.4.2 Psychological diagnosis/problems 
A recorded consultation for psychological diagnosis/problems was used as the exposure variable 
to test the association between psychological diagnosis/problems and the onset of 
musculoskeletal conditions. All the individuals (aged 6-19 years) with a consultation for a 
psychological diagnosis/problems in calendar years 2005-2010 were identified and considered as 
“exposed”. A variety of different psychological diagnosis/problems was considered (for a total of 
1020 Read codes identified), including anxiety, depression, severe mental illness, 
schizophrenia/psychosis, stress, neurosis, suicide/self-harm, attention deficit hyperactivity 
disorder (ADHD), conduct problems, hyperactivity, nervousness, anorexia, bulimia, grief and 
bereavement (please see appendix IX). Exposed individuals with psychological diagnosis/problems 
who did not previously consult for a musculoskeletal condition were included in the 
“psychological diagnosis/problems” group and from hereafter in the text they will be referred as 
“individuals with psychological diagnosis/problems”. In addition, this variable was also used as a 
confounder in the analysis for the association between sleep problems and the onset of 
musculoskeletal conditions. When used as a confounder, the recorded consultation for 
psychological diagnosis/problems had to have occurred in a 2-year period prior to the exposure (a 
consultation for sleep problems or tiredness).   
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9.1.5 Confounders 
9.1.5.1 Year of index date 
The year of index date of the exposure was assessed and analysis adjusted for to check for 
potential age-period cohort effects, and take into account the effect of the period of study on the 
exposure (Bhopal, 2002). For example the exposure variable (i.e. sleep problems or psychological 
diagnosis/problems) may be affected by external factors that may have occurred at a different 
frequency during specific calendar years (e.g. increased exposure to screen time in recent years 
may have affected the sleep patterns and psychological health of individuals). A continuous 
variable was created for the year of index date and entered in the analysis. 
 
9.1.5.2 Age at index date 
The age of the individuals at the index date of the exposure was assessed and entered as a 
confounder in the analysis based on the knowledge that musculoskeletal pain may be associated 
with increasing age in children and adolescents (Henschke et al., 2015; King et al., 2011; McBeth & 
Jones, 2007) and such patterns have been shown in consultation data previously (Jordan et al., 
2010). 
 
9.1.5.3 Gender 
The gender of the individuals was entered as a confounder in the analysis based on the 
knowledge that females consult more than males and may be at higher risk for musculoskeletal 
pain (Campbell & Roland, 1996; Henschke et al., 2015; King et al., 2011). 
 
9.1.5.4 Practice 
The analysis was adjusted for practice to check for potential effects of the practice (Campbell & 
Roland, 1996). For example, the decision of consulting for a health problem may be influenced by 
the location of the general practice (e.g. different consultation patterns between rural areas and 
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urban areas or because of physical distance from the practice), the decision of the doctor to 
initiate a consultation (e.g. follow-up for a health problem) or the presence of other type of care 
(e.g. patients may prefer to visit the emergency department) (Campbell & Roland, 1996). A 
categorical variable was created with all practices and entered in the analysis. 
 
9.1.5.5 Number of consultations 
The number of consultations was assessed by counting the number of recorded consultations of 
any kind in a period of 2 years prior to the index date of consultation for the exposure. Number of 
consultations was entered as a confounder to take into account the effect of frequent primary 
care attendance for other health issues, which may potentially increase the likelihood of receiving 
a consultation for the exposure or outcome variable (Paananen et al., 2011). A continuous 
variable was created for the number of consultations and entered in the analysis. 
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9.2 Baseline data descriptive analyses 
The matching process outlined in Section 9.1.1 resulted in the creation of two matched cohort 
datasets. These datasets were used to investigate the association between sleep problems and 
consultations for musculoskeletal conditions and between psychological diagnosis/problems and 
consultations for musculoskeletal conditions. Descriptive analyses of the baseline variables for 
both datasets were carried out. The results of these analyses are shown in the following sections 
(Section 9.2.1 and 9.2.2, respectively).  
 
9.2.1 Matched cohort - Sleep problems  
9.2.1.1 Sleep problems 
Baseline descriptive analyses of sleep problems are outlined in Table 9.2. Overall the dataset 
included 638 children, with 347 girls (54%) and 291 boys (46%). Figures on sleep problems show 
that 107 children (49 boys and 58 girls) had a recorded consultation for sleep problems in the 
study period (“exposed” group). Each one of these children was matched with 5 controls without 
a medical recorded consultation for sleep problem (“unexposed group”), resulting in 531 controls 
overall (242 boys and 289 girls). 
 
 
 
  
Table 9.2 Baseline sleep problems  
Sleep problems Boys Girls Overall 
Exposed (individuals with sleep problems) 49 (45.8%) 58 (54.2%) 107  
Unexposed (individuals without sleep problems) 242 (45.6%) 289 (54.4%) 531  
Overall 291 (45.6%) 347 (54.4%) 638  
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9.2.1.2 Musculoskeletal conditions  
Figures regarding recorded consultations for musculoskeletal conditions showed that among the 
638 individuals included in the dataset, 123 (19%) reported a recorded consultation for a 
musculoskeletal condition within the 2-years follow-up period (Table 9.3). The proportion of 
individuals with a recorded consultation for a musculoskeletal condition was higher in girls 
compared to boys (21.3% vs. 16.8%), respectively (Table 9.3). In addition, 32 children (5%) were 
persistent consulters for musculoskeletal conditions (Table 9.4). The proportion of persistent 
consulters was higher in girls compared to boys (6.3% vs. 3.4%, respectively) (Table 9.4). 
 
 
 
 
  
Table 9.3 Recorded consultations for musculoskeletal conditions  
Musculoskeletal conditions Girls Boys Overall 
No 273 (78.7%) 242 (83.2%) 515 (80.7%) 
Yes 74 (21.3%) 49 (16.8%) 123 (19.3%) 
Overall 347  291  638  
Table 9.4 Persistent consulters for musculoskeletal conditions 
Musculoskeletal conditions Girls Boys Overall 
No 325 (93.7%) 281 (96.6%) 606 (94.9%) 
Yes 22 (6.3%) 10 (3.4%) 32 (5.1%) 
Overall 347 291 638  
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9.2.1.3 Confounders  
Table 9.5 outlines the baseline characteristics (potential confounding variables) of individuals with 
or without a recorded consultation, overall and stratified by exposed and non-exposed 
individuals. 
Table 9.5 Baseline characteristics of potential confounders 
Potential confounder Exposed Unexposed Overall 
Psychological symptoms 
No psychological symptoms 
Year of index date 
2005 
2006 
2007 
2008 
2009 
2010 
Age at index date 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
Mean (± SD) 
Practice 
B 
C 
D 
E 
G 
H 
I 
L 
M 
N 
P 
Number of consultations 
1 ≤ 
2-3 
4-5 
6-9 
≥10 
Mean (± SD) 
8 (7.5%) 
99 (92.5%) 
 
25 (23.4%) 
27 (25.2%) 
17 (15.9%) 
12 (11.2%) 
19 (17.8%) 
7 (6.5%) 
 
4 (3.7%) 
13 (12.2%) 
7 (6.5%) 
4 (3.7%) 
9 (8.4%) 
5 (4.7%) 
7 (6.5%) 
2 (1.9%) 
8 (7.5%) 
3 (2.8%) 
8 (7.5%) 
17 (15.9%) 
14 (13.1%) 
6 (5.6%) 
13.1 (± 4.3) 
 
2 (1.9%) 
6 (5.6%) 
6 (5.6%) 
17 (15.9%) 
5 (4.7%) 
9 (8.4%) 
17 (15.9%) 
11 (10.3%) 
10 (9.4%) 
9 (8.4%) 
15 (14.0%) 
 
15 (14.0%) 
23 (21.5%) 
17 (15.9%) 
21 (19.6%) 
31 (29.0%) 
7.2 (± 6.4) 
19 (3.6%) 
512 (96.4%) 
 
125 (23.5%) 
135 (24.2%) 
85 (16.0%) 
59 (11.1%) 
92 (17.3%) 
35 (6.6%) 
 
27 (5.1%) 
54 (10.2%) 
36 (6.8%) 
27 (5.1%) 
39 (7.3%) 
24 (4.5%) 
30 (5.7%) 
22 (4.1%) 
29 (5.5%) 
31 (5.8%) 
39 (7.3%) 
74 (13.9%) 
55 (10.4%) 
44 (8.3 %) 
13.1 (± 4.3) 
 
10 (1.9%) 
30 (5.7%) 
30 (5.7%) 
85 (16.0%) 
25 (4.7%) 
45 (8.5%) 
85 (16.0%) 
55 (10.4%) 
50 (9.4%) 
42 (7.9%) 
74 (13.9%) 
 
166 (31.3%) 
99 (18.6%) 
93 (17.5%) 
81 (15.3%) 
92 (17.3%) 
5.2 (± 5.8) 
27 (4.2%) 
611 (95.8%) 
 
150 (23.5%) 
162 (25.4%) 
102 (16.0%) 
71 (11.1%) 
111 (17.4%) 
42 (6.6%) 
 
31 (4.9%) 
67 (10.5%) 
43 (6.7%) 
31 (4.9%) 
48 (7.5%) 
29 (4.6%) 
37 (5.8%) 
24 (3.8%) 
37 (5.8%) 
34 (5.3%) 
47 (7.4%) 
91 (14.3%) 
69 (10.8%) 
50 (7.8%) 
13.1 (± 4.3) 
 
12 (1.9%) 
36 (5.6%) 
36 (5.6%) 
102 (16.0%) 
30 (4.7%) 
54 (8.5%) 
102 (16.0%) 
66 (10.3%) 
60 (9.4%) 
51 (8.0%) 
89 (13.9%) 
 
181 (28.4%) 
122 (19.1%) 
110 (17.2%) 
102 (16.0%) 
123 (19.3%) 
5.5 (± 5.9) 
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9.2.2 Matched cohort - Psychological diagnosis/problems 
9.2.2.1 Psychological diagnosis/problems 
Baseline descriptive analyses of psychological diagnosis/problems are outlined in Table 9.6. 
Overall the dataset included 3,042 children, with 1,566 girls (51%) and 1,476 boys (49%). Figures 
regarding psychological diagnosis/problems show that 507 children (246 boys and 261 girls) had a 
recorded consultation for a psychological diagnosis/problems in the study period (“exposed 
group”). Each one of these children was matched with 5 controls without a recorded consultation 
for psychological diagnosis/problems (“unexposed group”), resulting in 2,535 controls overall 
(1,230 boys and 1,305 girls). 
 
 
 
  
Table 9.6 Baseline Psychological diagnosis/problems   
Psychological  diagnosis/problems Boys Girls Overall 
Exposed (individuals with psy. diagnosis/problems) 246 (48.5%) 261 (51.5%) 507  
Unexposed (individuals without psy. diagnosis/problems) 1,230 (48.5%) 1,305 (51.5%) 2,535  
Overall 1,476 (48.5%) 1,566 (51.5%) 3,042  
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9.2.2.2 Musculoskeletal conditions  
Figures regarding recorded consultations for musculoskeletal conditions showed that among the 
3,042 individuals included in the dataset, 574 (19%) reported a recorded consultation for a 
musculoskeletal condition within the 2-years follow-up period (Table 9.7). Proportions of 
recorded consultations for musculoskeletal conditions were similar between girls and boys (Table 
9.7). In addition, 124 children (4%) were persistent consulters for musculoskeletal conditions 
(Table 9.8). Proportions of persistent consulters for musculoskeletal conditions were similar 
between girls and boys (Table 9.8). 
 
 
 
 
 
 
  
Table 9.7 Recorded consultations for musculoskeletal conditions 
Musculoskeletal conditions Girls Boys Overall 
No 1,261 (80.5%) 1,207 (81.8%) 2,468 (81.1%) 
Yes 305 (19.5%) 269 (18.2%) 574 (18.9%) 
Overall 1,566 1,476 3,042  
Table 9.8 Persistent consulters for musculoskeletal conditions 
Musculoskeletal conditions Girls Boys Overall 
No 1,506 (96.2%) 1,412 (95.7%) 2,918 (95.9%) 
Yes 60 (3.8%) 64 (4.3%) 124 (4.1%) 
Overall 1,566 1,476 3,042 
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9.2.2.3 Confounders 
Table 9.9 outlines the baseline characteristics (potential confounding variables) of individuals with 
or without a recorded consultation, overall and stratified by exposed and non-exposed 
individuals. 
Table 9.9 Baseline characteristics of potential confounders 
Potential confounder Exposed Unexposed Overall 
Sleep problems 
No sleep problems 
Year of index date 
2005 
2006 
2007 
2008 
2009 
2010 
Age at index date 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
Mean (± SD) 
Practice 
B 
C 
D 
E 
G 
H 
I 
L 
M 
N 
P 
Number of consultations 
1 ≤ 
2 
3-4 
4-8 
≥9 
Mean (± SD) 
26 (5.1%) 
481 (94.9%) 
 
169 (33.3%) 
112 (22.1%) 
66 (13.0%) 
42 (8.3%) 
70 (13.8%) 
48 (9.5%) 
 
16 (3.2%) 
19 (3.8%) 
26 (5.1%) 
35 (6.9%) 
33 (6.5%) 
21 (4.1%) 
36 (7.1%) 
36 (7.1%) 
39 (7.7%) 
42 (8.3%) 
48 (9.5%) 
51 (10.1%) 
69 (13.6%) 
36 (7.1%) 
13.7 (± 3.8) 
 
49 (9.7%) 
57 (11.2%) 
27 (5.3%) 
37 (7.3%) 
23 (4.5%) 
48 (9.5%) 
72 (14.2%) 
61 (12.0%) 
44 (8.7%) 
30 (5.9%) 
59 (11.6%) 
 
88 (17.4%) 
54 (10.7%) 
88 (17.4%) 
106 (20.9%) 
171 (33.7%) 
7.7 (± 8.5) 
9 (0.4%) 
2,535 (99.6%) 
 
845 (33.3%) 
560 (22.1%) 
330 (13.0%) 
210 (8.3%) 
350 (13.8%) 
240 (9.5%) 
 
107 (4.2%) 
99 (3.9%) 
144 (5.7%) 
144 (5.7%) 
156 (6.2%) 
138 (5.4%) 
161 (6.4%) 
179 (7.1%) 
187 (7.4%) 
228 (8.9%) 
255 (10.1%) 
242 (9.5%) 
225 (8.9%) 
270 (10.7 %) 
13.7 (± 4.0) 
 
245 (9.7%) 
285 (11.2%) 
135 (5.3%) 
185 (7.3%) 
115 (4.5%) 
240 (9.5%) 
360 (14.2%) 
305 (12.0%) 
220 (8.7%) 
150 (5.9%) 
295 (11.6%) 
 
851 (33.6%) 
353 (13.9%) 
453 (17.9%) 
509 (20.1%) 
369 (14.6%) 
4.4 (± 5.3) 
35 (1.1%) 
3,007 (98.9%) 
 
1,014 (33.3%) 
672 (22.1%) 
396 (13.0%) 
252 (8.3%) 
420 (13.8%) 
288 (9.5%) 
 
123 (4.0%) 
118 (3.9%) 
170 (5.6%) 
179 (5.8%) 
189 (6.2%) 
159 (5.2%) 
197 (6.5%) 
215 (7.0%) 
226 (7.4%) 
270 (8.9%) 
303 (9.9%) 
293 (9.6%) 
294 (9.7%) 
306 (10.1%) 
13.7 (± 4.0) 
 
294 (9.7%) 
342 (11.2%) 
162 (5.3%) 
222 (7.3%) 
138 (4.5%) 
288 (9.5%) 
432 (14.2%) 
366 (12.0%) 
264 (8.7%) 
180 (5.9%) 
354 (11.6%) 
 
939 (30.9%) 
407 (13.4%) 
541 (17.8%) 
615 (20.2%) 
540 (17.8%) 
4.9 (± 6.1) 
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9.3 Discussion 
9.3.1 Descriptive analysis 
In Section 9.2 figures regarding the exposures, the outcome and potential confounders were 
provided. Whilst there is a lack of information within the literature specifically on primary care 
consultations in children and adolescents, this discussion will attempt to contextualise the 
findings and make comparison with figures reported in the literature.  
 
9.3.1.1 Musculoskeletal pain 
Despite the knowledge that musculoskeletal pain is common in children and adolescents, and 
numerous general population studies have been carried out, little is known on the prevalence of 
consultations for musculoskeletal conditions among children and adolescents in primary care. Six 
studies that were carried out in primary care settings, or that used medical health records 
reported annual consultation prevalence figures ranging from 2%-10% in Australian, Dutch, 
Spanish and English children and adolescents (De Inocencio, 1998; De Inocencio, 2004; Henschke 
et al., 2014; Jordan et al., 2010; Michaleff et al., 2017; van Suijlekom-Smit et al., 1997). Two of 
these studies were carried out within the same dataset (CiPCA) as used in this current study 
(Jordan et al., 2010; Michaleff et al., 2017). A direct comparison between the two studies 
conducted in CiPCA and this current study is complex because of differences in study period 
considered (from calendar year 2005 to 2012 in this current study, calendar years 2006 and 2010 
in the other studies) and study design used (cross-sectional in those studies, prospective 
matched-cohort in the current study which did not allow to calculate the prevalence). In addition, 
when defining the dataset for this current study consultations for a musculoskeletal condition 
that occurred prior to the exposure or after the 2 years follow-up period were censored, which 
may have resulted in an underestimation of the prevalence of musculoskeletal conditions. 
However, overall the annual prevalence figures provided by the two other studies conducted in 
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CiPCA (5-10%) (Jordan et al., 2010; Michaleff et al., 2017) are comparable to those of studies 
carried out in other countries, suggesting that findings from the CiPCA cohort are generalizable. 
 
9.3.1.2 Sleep problems 
As with musculoskeletal conditions, the estimation of the prevalence of sleep problems within 
this current study was not possible given the method used to define the cohort at risk of the 
outcome (musculoskeletal conditions). Despite the knowledge that 107 children had a 
consultation for sleep problems between 2005 and 2010, it was not possible to calculate the total 
number of children at risk within this cohort due to the exclusion of children who became older 
than 19 years old during the study period. In addition, children with a consultation for a 
musculoskeletal condition prior to the consultation for sleep problems were excluded. However, 
data on the prevalence of sleep problems in paediatric primary care were reported in a recent 
systematic review, with different figures provided depending on the collection method used and 
the age-range considered (Honaker & Meltzer, 2016). An 11-12% prevalence of sleep problems 
within primary care settings, assessed with sleep questionnaires, was reported by parents in 
studies of children aged between 2 and 14 years old. The reported prevalence of a recorded sleep 
diagnosis as assessed with the International Classification of Diseases 9th Edition (ICD-9) criteria 
was further lower, 3.7% (Honaker & Meltzer, 2016; Meltzer et al., 2010). This suggests that sleep 
problems are commonly under-recognized in paediatric primary care, potentially because of an 
underestimation of the problem by parents of children and adolescents, or due to the lack of 
willingness of general practitioners to assess sleep problems if they feel not confident to manage 
the problem (Meltzer et al., 2014; Meltzer et al., 2010). 
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9.3.1.3 Psychological diagnosis/problems 
As with musculoskeletal conditions and sleep problems, the estimation of the prevalence of 
psychological diagnosis/problems was not possible, given the definition of a cohort at risk of 
musculoskeletal consultations. In line with the iceberg theory of disease (Bhopal, 2002), it has 
been suggested that individuals consult solely if the level of psychological symptoms is severe and 
only approximately 10% of those with a psychological symptoms consult in primary care (Kramer 
& Garralda, 2000). Data on the prevalence of psychological symptoms have been reported in 
some studies. Figures from the “Mental health of children and young people in Great Britain, 
2004” showed that approximately 10% of children aged 5-16 met the ICD-10 (International 
Classification of Diseases, tenth revision) criteria for a mental health problem (emotional disorder, 
conduct disorder, hyperkinetic disorder or any other type of psychological disorder) (Green, 
McGinnity, Meltzer, Ford, & Goodman, 2005). Studies in UK primary care settings that reported 
on the prevalence of prescriptions for psychological problems in children and adolescents were 
carried out. A 3.6-9.2 annual prevalence per 1000 persons (0.36-0.92%) of pharmacologically 
treated attention deficit hyperactivity disorder (McCarthy et al., 2012), a 63 per 100.000 person 
years at risk (0.063%) rate of prescription of any antipsychotic (Marston, Nazareth, Petersen, 
Walters, & Osborn, 2014) and 1.8% prevalence of prescription of psychotropic drugs (Schneider-
Lindner, 2011) were reported. Whilst a direct comparison with figures of this current study is 
complex due to differences in study designs and to the use of a single outcome variable including 
a whole range of psychological symptoms in this current study (see Section 9.1.4.2), these figures 
show that the prevalence of children and adolescents that meet diagnostic criteria for 
psychological diagnosis/problems is approximately 10%, with much lower figures for prescription 
of drugs for psychological problems. 
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9.4 Summary 
This chapter has presented the Consultations in Primary Care Archive (CiPCA) cohort, a 
description of the variables included within the cohort, the descriptive findings of the cohort, and 
a discussion of these descriptive findings. The following chapter will describe the results of 
analysis of the association of sleep and psychological symptoms with musculoskeletal pain onset 
in children and adolescents in primary care. 
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Chapter ten. The association of sleep and psychological symptoms 
with musculoskeletal pain onset in children and adolescents in 
primary care: results of the Consultations in Primary Care Archive 
(CiPCA) cohort 
 
In this chapter the results of the survival analysis of the association between the presence of sleep 
problems (Section 10.1), psychological diagnosis/problems (Section 10.2) and musculoskeletal 
conditions, together with a discussion of the results (Section 10.3) and final key messages (Section 
10.4) will be presented. 
 
10.1 Sleep problems and onset of musculoskeletal conditions  
10.1.1 Musculoskeletal pain frequency 
The dataset used to investigate the association between sleep problems and musculoskeletal 
conditions included 638 individuals, 123 (19%) of which reported a medical recorded consultation 
for a musculoskeletal condition within the 2-years follow-up period (Table 10.1). The proportion 
of individuals with a consultation for a musculoskeletal condition was higher among individuals 
with sleep problems compared to those without sleep problems (28.1% vs. 17.5%, respectively) 
(Table 10.1). In addition, 32 (5%) individuals were persistent consulters for musculoskeletal 
conditions (Table 10.2). The proportion of persistent consulters for musculoskeletal conditions 
was similar between individuals with sleep problems and those without sleep problems (5.6% vs. 
4.9%, respectively) (Table 10.2). 
 
Table 10.1 Sleep problems and onset of musculoskeletal conditions 
Consultation for musculoskeletal conditions No Yes Overall 
Controls without sleep problems 438 (82.5%) 93 (17.5%) 531  
Individuals with sleep problems 77 (71.9%) 30 (28.1%) 107  
Overall 515 (80.7%) 123 (19.3%) 638  
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Table 10.2 Sleep problems and persistent musculoskeletal conditions 
Persistent musculoskeletal conditions No Yes Overall 
Controls without sleep problems 505 (95.1%) 26 (4.9%) 531  
Individuals with sleep problems 101 (94.4%) 6 (5.6%) 107  
Overall 606 (95.0%) 32 (5.0%) 638  
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10.1.2 Survival analysis of the association between consultations for sleep problems and 
consultations for musculoskeletal conditions  
 
10.1.2.1 Proportional hazard assumption test  
Data were tested to check the proportional hazard assumption by means of the Schoenfeld 
residuals test for the unadjusted and adjusted datasets and results indicated that data met the 
proportional hazard assumption. A Kaplan-Meier graph was used to describe the difference in 
survival curves in relation to the onset of a musculoskeletal condition between individuals with 
sleep problems compared to those without sleep problems (Section 10.1.2.2). The association 
between sleep problems and musculoskeletal conditions was investigated by means of Cox 
regression analysis (Section 10.1.2.3). Analysis were repeated to estimate the hazard for 
persistent musculoskeletal conditions (Section 10.1.3). Results are shown in the following 
sections. 
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10.1.2.2 Kaplan-Meier graph of the association between consultations for sleep problems and 
consultations for musculoskeletal conditions 
Survival curves within the Kaplan-Meier graph (Figure 10.1) showed that individuals with sleep 
problems were at higher hazard to consult for a musculoskeletal condition during the follow-up 
period compared to those without sleep problems. 
 
Figure 10.1 Association between consultation for sleep problems and musculoskeletal 
conditions 
 
 
Further explanation of the figures shown in the graph: At 1-year follow-up, 45/531 (8.5%) 
individuals without sleep problems and 18/107 (16.8%) consulters with sleep problems consulted 
for a musculoskeletal condition or were censored from the study, respectively. At 2-year follow-
up, 96/531 (18.1%) individuals without sleep problems and 30/107 (28.0%) consulters with sleep 
problems consulted for a musculoskeletal condition or were censored from the study, 
respectively.   
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10.1.2.3 Cox regression analysis of the association between consultation for sleep problems and 
consultations for musculoskeletal conditions  
Cox regression analysis was performed to estimate the hazard ratio for musculoskeletal 
conditions in consulters with sleep problems compared to those without sleep problems. Results 
for both unadjusted and adjusted models are shown in Table 10.3. Results of unadjusted analysis 
show a statistically significant 72% increased hazard of consultation for a musculoskeletal 
condition in those with sleep problems compared to those without (model 1). This estimate was 
unchanged after adjustment for psychological diagnosis/problems, index year, gender, age at 
index date and practice (model 2), but was attenuated to a 49% non-significant increased hazard 
after further adjustment for number of consultations (model 3). 
 
 
   
Table 10.3 Cox regression of the association between consultations for  
sleep problems at baseline and  consultations for musculoskeletal 
conditions at follow-up 
Unadjusted analysis (Model 1) (N = 638) 
Musculoskeletal conditions at follow-up Hazard ratio 95% CI 
Sleep problems 1.72 1.14, 2.60 
Adjusted analysis* (Model 2) (N = 638) 
Musculoskeletal conditions at follow-up Hazard ratio 95% CI 
Sleep problems 1.72 1.13, 2.60 
Adjusted analysis** (Model 3) (N = 638) 
Musculoskeletal conditions at follow-up Hazard ratio 95% CI 
Sleep problems 1.49 0.98, 2.27 
*Analysis adjusted for Psychological diagnosis/problems, Index year, Gender, Age at index date 
and Practice 
** Analysis adjusted for the above confounders and additionally by number of consultations 
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10.1.3 Survival analysis of the association between consultations for sleep problems and 
consultations for persistent musculoskeletal conditions  
 
10.1.3.1 Proportional hazard assumption test 
Data were tested to check the proportional hazard assumption by means of the Schoenfeld 
residuals test and it was found that data met the proportional hazard assumption. However, the 
Schoenfeld residuals test for the variable “gender” was significant (p < 0.05), therefore the 
variable “gender” was entered as a time-varying confounder (i.e. an interaction term between the 
confounder and a function of time t, which can take into account the variation of the effect of the 
confounder over time), following previous methodology (Bellera et al., 2010). 
  
280 
 
10.1.3.2 Kaplan-Meier graph of the association between consultations for sleep problems and 
consultations for persistent musculoskeletal conditions 
The Kaplan-Meier graph (Figure 10.2) showed very little difference between survival curves for 
persistent musculoskeletal conditions between individuals consulting for sleep problems and 
those without sleep problems, suggesting a similar hazard for persistent musculoskeletal 
conditions between groups. 
Figure 10.2 Association between consultations for sleep problems and persistent 
musculoskeletal conditions 
  
 
Further explanation of the figures shown in the graph: At 1-year follow-up, 17/531 (3.2%) 
individuals without sleep problems and 2/107 (1.9%) consulters with sleep problems consulted for 
persistent musculoskeletal conditions or were censored from the study, respectively. At 2-year 
follow-up, 30/531 (5.6%) individuals without sleep problems and 6/107 (5.6%) consulters with 
sleep problems consulted for persistent musculoskeletal conditions or were censored from the 
study, respectively.   
No 
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10.1.3.3 Cox regression analysis of the association between consultations for sleep problems and 
consultations for persistent musculoskeletal conditions 
Cox regression analysis was performed to estimate the hazard ratio for consulting with persistent 
musculoskeletal conditions in consulters with sleep problems compared to those without sleep 
problems. Results for both unadjusted and adjusted models are shown in Table 10.4. Results of 
unadjusted analysis show that children and adolescents with a recorded consultation for sleep 
problems were at non-significant 14% increased hazard for persistent musculoskeletal conditions. 
The association was similar (6% non-significant increased hazard) after adjustment for 
psychological diagnosis/problems, index year, gender, age at index date and practice, but was 
changed to a 13% non-significant decreased hazard after further adjustment for numbers of 
consultations. 
 
 
   
Table 10.4 Cox regression of the association between consultations for  
sleep problems at baseline and consultations for persistent 
musculoskeletal conditions at follow-up 
Unadjusted analysis (Model 1) (N = 638) 
Persistent MSK conditions at follow-up Hazard ratio 95% CI 
Sleep problems 1.14 0.47, 2.76 
Adjusted analysis* (Model 2) (N = 638) 
Persistent MSK conditions at follow-up Hazard ratio 95% CI 
Sleep problems 1.06 0.43, 2.59 
Adjusted analysis** (Model 3) (N = 638) 
Persistent MSK conditions at follow-up Hazard ratio 95% CI 
Sleep problems 0.87 0.36, 2.14 
*Analysis adjusted for Psychological diagnosis/problems, Index year, Gender, Age at index date 
and Practice 
**Analysis adjusted for the above confounders and additionally by number of consultations 
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10.2 Psychological diagnosis/problems and onset of musculoskeletal conditions 
10.2.1 Musculoskeletal pain frequency 
The dataset used to investigate the association between psychological diagnosis/problems and 
musculoskeletal conditions included 3,042 individuals, 19% of which reported a consultation for a 
musculoskeletal condition within the 2-years follow-up period (Table 10.5). The proportion of 
individuals with a consultation for a musculoskeletal condition was higher in individuals with 
psychological diagnosis/problems compared to those without psychological diagnosis/problems 
(26.0% vs. 17.4%, respectively) (Table 10.5). In addition, 124 individuals (4%) were persistent 
consulters for musculoskeletal conditions (Table 10.6). The proportion of individuals with 
persistent musculoskeletal conditions was higher in individuals with psychological 
diagnosis/problems compared to those without psychological diagnosis/problems (5.7% vs. 3.8%, 
respectively) (Table 10.6). 
 
 
 
  
Table 10.5 Psychological diagnosis/problems and onset of musculoskeletal conditions 
Consultation for musculoskeletal conditions No Yes Overall 
Controls without psychological diagnosis/problems 2,093 (82.6%) 442 (17.4%) 2,535  
Individuals with psychological diagnosis/problems 375 (74.0%) 132 (26.0%) 507  
Overall 2,468 (81.1%) 574 (18.9%) 3,042  
Table 10.6 Psychological diagnosis/problems and persistent musculoskeletal 
conditions 
Persistent musculoskeletal conditions No Yes Overall 
Controls without psychological diagnosis/problems 2,440 (96.2%) 95 (3.8%) 2,535  
Individuals with psychological diagnosis/problems 478 (94.3%) 29 (5.7%) 507  
Overall 2,918 (95.9%) 124 (4.1%) 3,042  
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10.2.2 Survival analysis of the association between consultations for psychological 
diagnosis/problems and consultations for musculoskeletal conditions  
10.2.2.1 Proportional hazard assumption test 
Data were tested to check the proportional hazard assumption by means of the Schoenfeld 
residuals test for the unadjusted and adjusted datasets and results indicated that data met the 
proportional hazard assumption for the unadjusted dataset but not for the adjusted dataset, 
where the test was significant. Therefore, the variable for which the test was significant (i.e. index 
year, p = 0.002) was entered in the analysis as a time-varying confounder following the 
methodology indicated in Section 10.1.3.1 (Bellera et al., 2010). 
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10.2.2.2 Kaplan-Meier graph of the association between consultations for psychological 
diagnosis/problems and consultations for musculoskeletal conditions 
Survival curves within the Kaplan-Meier graph (Figure 10.3) showed that individuals with a 
consultation for psychological diagnosis/problems were at higher hazard for a consultation for 
musculoskeletal conditions during the follow-up period compared to those without psychological 
diagnosis/problems. 
Figure 10.3 Association between consultations for psychological diagnosis/problems and 
musculoskeletal conditions 
  
Further explanation of the figures shown in the graph: At 1-year follow-up, 228/2535 (9.0%) 
individuals without psychological diagnosis/problems and 80/507 (15.8%) consulters with 
psychological diagnosis/problems consulted for a musculoskeletal condition or were censored 
from the study, respectively. At 2-year follow-up, 470/2535 (18.5%) individuals without 
psychological diagnosis/problems and 132/507 (26.0%) consulters with psychological 
diagnosis/problems consulted for a musculoskeletal condition or were censored from the study, 
respectively.   
No 
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10.2.2.3 Cox regression analysis of the association between consultations for psychological 
diagnosis/problems and consultations for musculoskeletal conditions 
Cox regression analysis was performed to estimate the hazard ratio for a consultation for 
musculoskeletal conditions in consulters with psychological diagnosis/problems compared to 
those without psychological diagnosis/problems. Results for both unadjusted and adjusted 
models are shown in Table 10.7. Results of unadjusted analysis show that children and 
adolescents with a recorded consultation for psychological diagnosis/problems were at 
statistically significant 59% increased hazard of consultation for a musculoskeletal condition. This 
estimate was unchanged after adjustment for sleep problems, index year, gender, age at index 
date and practice, and it was attenuated to a 39% statistically significant increased hazard after 
further adjustment for numbers of consultations. 
 
 
 
  
Table 10.7 Cox regression of the association between consultations for  
psychological  diagnosis/problems at baseline and consultations for  
musculoskeletal conditions at follow-up 
Unadjusted analysis (Model 1) (N = 3,042) 
Musculoskeletal conditions at follow-up Hazard ratio 95% CI 
Psychological diagnosis/problems 1.59 1.31, 1.93 
Adjusted analysis* (Model 2) (N = 3,042) 
Musculoskeletal conditions at follow-up Hazard ratio 95% CI 
Psychological diagnosis/problems 1.59 1.31, 1.94 
Adjusted analysis** (Model 3) (N = 3,042) 
Musculoskeletal conditions at follow-up Hazard ratio 95% CI 
Psychological diagnosis/problems 1.39 1.14, 1.70 
*Analysis adjusted for Sleep problems, Index year, Gender, Age at index date and Practice 
** Analysis adjusted for the above confounders and additionally by number of consultations 
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10.2.3 Survival analysis of the association between consultations for psychological 
diagnosis/problems and consultations for persistent musculoskeletal conditions 
10.2.3.1 Proportional hazard assumption test 
Data were tested to check the proportional hazard assumption by means of the Schoenfeld 
residuals test for the unadjusted and adjusted datasets and results indicated that data met the 
proportional hazard assumption. However, the Schoenfeld residuals test for the variable “index 
year” was significant, therefore this confounder was entered in the analysis as a time-varying 
confounder.  
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10.2.3.2 Kaplan-Meier graph of the association between consultations for psychological 
diagnosis/problems and consultations for persistent musculoskeletal conditions 
Survival curves within the Kaplan-Meier graph (Figure 10.4) showed that consulters with 
psychological diagnosis/problems were at higher hazard for persistent musculoskeletal conditions 
compared to those without psychological diagnosis/problems, although the difference was small. 
Figure 10.4 Association between consultations for psychological diagnosis/problems and 
persistent musculoskeletal conditions 
 
Further explanation of the figures shown in the graph: At 1-year follow-up, 64/2535 (2.5%) 
individuals without psychological diagnosis/problems and 20/507 (3.9%) consulters with 
psychological diagnosis/problems consulted for persistent musculoskeletal conditions or were 
censored from the study, respectively. At 2-year follow-up, 144/2535 (5.7%) individuals without 
psychological diagnosis/problems and 29/507 (5.7%) consulters with psychological 
diagnosis/problems consulted for persistent musculoskeletal conditions or were censored from 
the study, respectively.  
No 
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10.2.3.3 Cox regression analysis of the association between consultations for psychological 
diagnosis/problems and consultations for persistent musculoskeletal conditions 
Cox regression analysis was performed to estimate the hazard ratio for consultations for 
persistent musculoskeletal conditions in consulters with psychological diagnosis/problems 
compared to those without psychological diagnosis/problems. Results for both unadjusted and 
adjusted models are shown in Table 10.8. Results of unadjusted analysis show that children and 
adolescents with a recorded consultation for psychological diagnosis/problems were at 
statistically significant 54% increased hazard for consultations for persistent musculoskeletal 
conditions. This estimate increased to a 64% significant increased hazard after adjustment for 
sleep problems, index year, gender, age at index date and practice, but was attenuated to a 34% 
non-significant increased hazard after further adjustment for numbers of consultations. 
 
 
 
  
Table 10.8 Cox regression of the association between consultations for 
psychological diagnosis/ problems at baseline and  consultations for 
persistent musculoskeletal conditions at follow-up 
Unadjusted analysis (Model 1) (N = 3,042) 
Persistent MSK conditions at follow-up Hazard ratio 95% CI 
Psychological diagnosis/problems 1.54 1.02, 2.33 
Adjusted analysis* (Model 2) (N = 3,042) 
Persistent MSK conditions at follow-up Hazard ratio 95% CI 
Psychological diagnosis/problems 1.64 1.08, 2.48 
Adjusted analysis** (Model 3) (N = 3,042) 
Persistent MSK conditions at follow-up Hazard ratio 95% CI 
Psychological diagnosis/problems 1.34 0.88, 2.04 
*Analysis adjusted for Sleep problems, Index year, Gender, Age at index date and Practice 
** Analysis adjusted for the above confounders and additionally by number of consultations 
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10.3 Discussion 
10.3.1 Interpretation of findings and comparison with previous literature 
10.3.1.1 Sleep problems and onset of musculoskeletal conditions 
The results of this study using primary care medical record data showed that 28% of 
children/adolescents with recorded sleep problems consulted in primary care with 
musculoskeletal pain within a 2-year follow-up period compared to 17.5% of those without 
recorded sleep problems. This result translated to a significant 72% increased hazard for a 
musculoskeletal consultation in individuals with sleep problems compared to those without sleep 
problems. This effect size was attenuated to a non-significant 49% increased hazard (95% CI 0.98; 
2.27) after controlling for the number of consultations in the two years prior to the index (sleep) 
consultation (Section 10.1.2.3). Whilst the systematic review (chapter 2) showed no published 
studies that are directly comparable (i.e. using primary care records), attempts will be made to 
contextualise these results with the cohort findings within this thesis (chapter 6) and the wider 
literature. Whilst results from the wider literature are broadly inconsistent, they do support the 
general direction of effect as found in this study (i.e. increase in risk or odds for the presence of 
sleep problems). The effect found in CiPCA is also in accordance with the increased odds for the 
onset of chronic musculoskeletal pain in children and adolescents with sleep problems in the CATS 
dataset (Chapter 6), and in studies conducted both in children and adults (Gupta et al., 2007; 
Harrison et al., 2014; Mork et al., 2014). Although it is not easy to directly compare the strength of 
associations found in the CiPCA and CATS cohorts, slightly stronger and more precise estimates 
were found for the effect of sleep on pain onset in the CiPCA cohort. One potential explanation 
for this may be differences in severity of the condition between the cohorts. Research shows that 
the decision to refer to primary care (as is the case with the CiPCA cohort) occurs when the 
severity (or perceived severity), frequency, duration or limitations associated with the symptoms 
(i.e. both sleep problems and musculoskeletal pain in this current study) are more advanced 
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leading to an active decision to seek healthcare (Campbell & Roland, 1996; Paananen et al., 2011; 
Perquin et al., 2000). Therefore the reason for the more precise or stronger effects found in 
consultation data might have been driven by an elevated level of severity of the outcome (e.g. 
persistent, recurring, or more severe pain). This hypothesis is further supported by the clinical 
iceberg of disease theory, which suggests that there is a proportion of not recognized cases, 
whose severity may be milder (i.e. individuals with pre-clinical levels in this study), who do not 
present in primary care (Bhopal, 2002; Campbell & Roland, 1996; Last, 1963; Last & Adelaide, 
2013). Such “pre-clinical” individuals, however, would respond to questions about their pain 
within a general population survey, but by the rationale of a linear association (as assumed in 
these studies), the effects overall would be weaker. The attenuation of effect size after 
adjustment for the number of consultations requires explanation. This reduction in effect may be 
explained by frequent primary care attendance, perhaps for other comorbidities (Paananen et al., 
2011). In this scenario, frequent consulters would be more likely to have a consultation for both 
the exposure and outcome as a result of their frequent visits to general practice, compared to 
individuals who seldom consult (e.g. more opportunities to discuss health related problems with 
their doctor). 
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10.3.1.2 Sleep problems and persistent musculoskeletal conditions 
The results of this study showed that the proportion of individuals who consulted with persistent 
musculoskeletal conditions within a 2-year follow-up period was similar between individuals with 
and without a primary care record for sleep problems (5.6% vs. 4.9%, respectively). This result 
translated to a small non-significant 14% increased hazard of persistent musculoskeletal 
conditions, which decreased to a 13% reduction in hazard after adjustment for number of 
consultations. Some considerations upon these results are needed. These results do not support 
the hypothesis posed in the previous section (10.3.1.1) that individuals consulting with new onset 
musculoskeletal conditions have more severe problems, where it would be expected that the 
effect would be stronger for those with persistent pain, as was demonstrated within the CATS 
cohort. A few issues need to be considered here. Firstly, only 32 individuals overall were classified 
as consulting with persistent musculoskeletal conditions, and therefore statistical power for this 
analysis was low, resulting in imprecise estimates. Secondly, and perhaps more importantly, is the 
way in which persistent pain was defined within this cohort. The criterion used was the presence 
of second or more repeat consultations for a musculoskeletal condition within a 3-month period 
after the first consultation for a musculoskeletal condition (see Section 9.1.3.2). Inspection of the 
consultation dates for musculoskeletal conditions showed that approximately half (17/32) of the 
repeat musculoskeletal conditions were within 10 days from the first consultation for 
musculoskeletal conditions. It may be possible, due to close time proximity between consultations 
that individuals were consulting for the same episode of pain, which may be fairly short, and not 
persistent or severe (perhaps a follow up appointment to check on recovery). It may be 
speculated that different criteria to define persistent musculoskeletal conditions could be used to 
capture those with genuine chronic pain (for a fuller explanation see Section 10.3.2), and such a 
change in definition may result in a change of the estimate (potentially in the direction of a 
stronger effect). In addition, the decrease in hazard after adjustment for number of consultations 
suggests that consultations for persistent musculoskeletal conditions was linked to primary care 
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attendance due to other comorbidities (Paananen et al., 2011) and may also represent partial 
over adjustment (i.e. a variable created based on consultation frequency adjusted for prior 
consultation frequency).  
 
10.3.1.3 Psychological diagnosis/problems and musculoskeletal conditions 
The results of this study using primary care records showed that 26.0% of individuals presenting 
with psychological diagnosis/problems subsequently consulted with musculoskeletal conditions 
within a 2-year follow-up period, compared to 17.4% of those without a record of psychological 
diagnosis/problems. This translates to a significant 59% increased hazard for musculoskeletal 
conditions (39% after all potential confounders were controlled for) in individuals with 
psychological diagnosis/problems compared to those without psychological diagnosis/problems. 
These findings are in line with the results for the onset of musculoskeletal pain in children with 
psychological problems found in the systematic review outlined in this thesis (Section 2.4.2.1) and 
the direction of effects found in the ALSPAC analysis reported in chapter 8, and also with the 
general findings of effect reported in adult populations (McBeth & Jones, 2007; Pinheiro et al., 
2015; Taylor et al., 2014). Given the potentially higher severity, frequency and duration of 
musculoskeletal conditions in individuals who present to primary care (as outlined in the above 
Section 10.3.1.1), these results may support the hypothesized reciprocal relationship between 
psychological problems and musculoskeletal pain described in Section 8.7.1.3 of this thesis. In this 
scenario, latent psychological problems may set the stage for the onset of musculoskeletal 
conditions which initially do not require medical attention. Subsequently, musculoskeletal pain 
may in turn worsen the psychological status of the individual or exacerbate pre-clinical or 
dormant psychological problems, as suggested by the diathesis stress model (Dersh, 2002). Here 
the hypothesis is that individuals with elevated levels of stress (latent psychological problems)  
who then experience an adverse event (e.g. musculoskeletal condition) would develop greater 
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levels of stress, leading to difficulties in psychological coping, subsequently increasing and 
exacerbating both the stress (psychological problems) and experience of pain. This may result in a 
more severe or frequent musculoskeletal condition, or lead to chronicity, for which the individual 
may consequently seek care. In addition, factors related to the family environment may also 
partly account for the observed increased hazard for consulting healthcare for musculoskeletal 
conditions. Familial patterns of access to health care have been observed, with parents being the 
driving factor of a child or adolescents consultation. For example there is a relationship between 
parental catastrophizing about their child’s pain and the child’s own psychological reactions to 
pain and behaviour (Caes, Vervoort, Eccleston, Vandenhende, & Goubert, 2011), it may be that 
children of such parental influences may refer to primary care more frequently or present with 
more severe symptom (Campbell & Roland, 1996; Cardol et al., 2005, 2006, 2007). Members of 
the same family also share both genetic and environmental factors that may be associated with 
musculoskeletal pain, and an increased probability of having pain has been observed if another 
member of the family reports pain in both a general population setting and also within 
consultation populations (Campbell, Shraim, Jordan, & Dunn, 2016; Campbell, Jordan, Smith, 
Scotland, & Dunn, 2017; Shraim et al., 2013). Finally, as with the relationship between sleep 
problems and the onset of musculoskeletal conditions (Section 10.3.1.1), results of the analysis 
suggest that the reduction in hazard observed after adjustment for number of consultations may 
be explained by a behaviour of frequent primary care attendance for other comorbidities 
(Paananen et al., 2011) as well as potential over adjustment. 
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10.3.1.4 Psychological diagnosis/problems and persistent musculoskeletal conditions 
Just below 6.0% of individuals with a primary care record of psychological diagnosis/problems 
consulted with persistent musculoskeletal conditions within a 2-year follow-up period, compared 
to 3.8% of those without recorded psychological diagnosis/problems. This translates to a 
significant 54% increased hazard of persistent musculoskeletal conditions in individuals with 
psychological diagnosis/problems, which was attenuated to a 34% non-significant increased 
hazard after that analysis was controlled for the number of consultations. As proposed in Section 
10.3.1.3, factors such as maladaptive coping may explain these results. If musculoskeletal 
conditions persist after the first consultation, individuals with psychological diagnosis/problems 
may struggle to cope with the condition, leading to a subsequent new consultation for the 
problem. In addition, a further exacerbation of psychological problems (e.g. pain catastrophizing, 
pain-related anxiety, fear-avoidance behaviour) may have occurred in individuals who already 
have psychological problems, which may explain the non-significant higher hazard of developing 
persistent conditions found. However, as proposed in Section 10.3.1.2, the definition of persistent 
musculoskeletal conditions within this cohort should be considered when interpreting these 
effects. Inspection of the consultation dates showed that 43% (54/124) of persistent 
musculoskeletal conditions were within 10 days from the first consultation for musculoskeletal 
conditions, thus suggesting that the second consultation may refer to the same, potentially short 
episode. Therefore the use of alternative definitions of persistent pain may have been more 
suitable (e.g. to increase the number of consultations and to impose a longer period where those 
consultations take place), and could have produced different estimates of effect. In addition, as 
mentioned in previous sections above, the attenuation of effect after adjustment for number of 
consultations may suggest that the estimate of hazard for persistent musculoskeletal conditions 
may be partly attributable to the effect of frequent primary care attendance (Paananen et al., 
2011) and may represent over adjustment.   
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10.3.2 Strengths and limitations of this study 
There are a number of strengths with this study. First, analysis was performed using routinely 
collected data from a high quality primary care dataset. This brings the advantage that the entire 
temporal frame of data can be used compared to studies where data are collected solely at fixed 
points in time, and consequently allows the identification of the episodes of pain that would be 
missed if they occurred between the fixed time-points. Second, individuals were matched by age, 
gender and practice in order to reduce the risk of confounding, as these variables may be 
associated with increased healthcare seeking and musculoskeletal pain (Campbell & Roland, 1996; 
Henschke et al., 2015; Kamper et al., 2016; King et al., 2011; McBeth & Jones, 2007). Third, 
registration status was checked to avoid the loss of information in individuals who moved to other 
practices. Fourth, CiPCA includes a large sample, which is representative of the national general 
population: 98% of the population is registered with a GP in the UK and the prevalence of 
musculoskeletal consultations in CiPCA is similar to those of other national and international 
datasets (Herrett et al., 2015; Jordan et al., 2007, 2010, 2014). Fifth, this dataset reflects actual 
“real” consultation events, therefore there is no selection bias or reporting bias, and this confers 
an advantage over the answers given within self-report measures. 
This current study also includes several limitations. First, some limitations pertain to the use of 
Read codes which are the codes that record the reason for consultations. For example a limitation 
is the inability to assess the severity, duration and impact of pain as well as the cause of the 
condition with Read codes (Michaleff et al., 2017; Muller, 2014). In addition, information on 
variables relative to lifestyle (e.g. smoking, physical activity, substance use) are generally less well 
recorded (Glasgow, Kaplan, Ockene, Fisher, & Emmons, 2012). As consultations for these variables 
were not present in this current study, it was not possible to adjust within the analysis, and so 
unmeasured confounders may be present. Also, as outlined previously, many individuals may 
have pre-clinical status for both exposure and outcome that will not be recorded (which may have 
included individuals in the matched controls) (Glasgow et al., 2012; Jordan et al., 2010; Muller, 
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2014). This is supported by the iceberg theory of disease, for which pre-clinical symptoms would 
go unrecognized or wrongly diagnosed, this influence is supported by the finding that 
psychological symptoms, sleep problems and musculoskeletal pain in children and adolescents are 
under-recognized in primary care settings (Bhopal, 2002; Cornish, John, Boyd, Tilling, & Macleod, 
2016; Last, 1963; Last & Adelaide, 2013; Meltzer et al., 2010; Paananen et al., 2011). In addition, 
there are issues which may affect data quality. These include inadequate or incorrect coding of 
symptoms or diagnosis and missed codes in individuals who consulted for multiple health 
problems, as only the most prominent condition may be recorded (Jordan & Croft, 2008; Muller, 
2014). Other issues include the possibility of errors when entering data because of semantic 
similarity of the Read code with the intended term (Benson, 2012), and that general practitioners 
may be limited to use certain codes which are not fully appropriate for the identified condition, 
such information may be better described in free text that the general practitioner can enter 
along with the Read code (Jordan, Porcheret, & Croft, 2004). As free-text information was not 
used in this study (as it was beyond the scope and timescale for the analysis), this may potentially 
have led to a loss of cases or important information about included consulters (e.g. additional 
comorbidities, outcome or exposure symptoms not coded, causes or reasons for consultation, 
lifestyle indicators) (Cornish, John, Boyd, Tilling, & Macleod, 2016; Muller, 2014). In addition, 
some overlap between the Read codes for sleep problems and psychological diagnosis/problems 
is present, due to the potential coexistence of certain symptoms (i.e. sleep problems as a core 
feature of a depression diagnosis). To overcome these influences analyses were adjusted for 
psychological diagnosis/problems and for sleep problems.  
Second, a number of factors aside from the condition itself may influence the decision to refer to 
primary care. This includes the family patterns of illness behaviour, the parental economic status 
and job, family size, the perceived benefits of seeking care, the faith in the effectiveness of the 
general practitioner, the knowledge about the illness, the information seeking behaviour and the 
accessibility of care (Campbell & Roland, 1996; Cardol et al., 2006, 2007), all of which are not 
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generally measurable using electronic health records. The decision to refer to primary care may 
also be influenced by the parent’s perceived severity of symptoms (Kamper, Dissing, & Hestbaek, 
2016). However, although parents may overlook aches and pains of minor importance, good 
concordance between parent and child report has been shown for musculoskeletal pain of a 
greater severity (Kamper, Dissing, et al., 2016).  
Third, the method to define a proxy for “chronic pain” or more precisely persistent pain contained 
some issues. The criteria (more than one consultation for musculoskeletal conditions within a 3-
month period) was based on the finding of a study where individuals where asked when they had 
their last pain-free month. Results from that study showed that only 24% of those with new onset 
of pain within the last 3 months had a pain-free month in the last 3 months (Dunn, de Vet, et al., 
2006). In this current study an average of 26% and 22% of those with a consultation for 
musculoskeletal conditions reported persistent musculoskeletal conditions, which is similar to 
estimates reported in previous studies carried out in children consulting for musculoskeletal pain 
(Michaleff et al., 2017). Despite this fits with the literature in terms of the definition chosen, most 
consultations for persistent musculoskeletal conditions were within 10 days from the first 
consultation, and it was not possible to assess if the identified persistent musculoskeletal 
conditions were representative of a chronic condition or not, for example this may have been a 
follow up appointment arranged by the general practitioner to check on progress rather than a re-
consultation due to persistent pain. These issue underline the complexity in the definition of 
chronic musculoskeletal conditions in general, and more so within electronic health record 
research. It may also be the case that those with genuine chronic pain may not have consulted 
more than once in this period and would not have been identified as having persistent pain. 
Previous research on long-lasting conditions such as pain have shown that the date of 
consultation does not reflect the actual date of onset or the duration of the problem (Jordan et 
al., 2007; Michaleff et al., 2017).  
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Fourth, the observed attenuation of estimates after adjustment for number of consultations may 
be potentially attributable to the effect of over-adjustment, which occurs when the variable for 
which the analysis is adjusted for is in the pathway between the exposure and the outcome and 
tend to bias the results towards the null (Schisterman, Coleb, & Platt, 2009).  
Fifth, the analysis was adjusted for practice in order to take into account potential practice 
effects, which include differences in consultation patterns between different areas and may be 
linked to the socio-economic status. For example increased consultation rates are associated with 
lower social class (Campbell & Roland, 1996), and children of families from a lower socio-
economic status may be more exposed to problems in the family environment, which may 
increase the risk for musculoskeletal pain (Alink et al., 2008; Brattberg, 1994; Kroner-Herwig et al., 
2011; Ramchandani & Psychogiou, 2009). However, each practice may have families from a range 
of different socio-economic statuses although they live in the same area. Therefore, a more 
detailed measure such as the familial deprivation status would have allowed a finer adjustment of 
the potential socio-economic influences that may have been present within the analysis, 
unfortunately measures on deprivation were not available. 
Sixth, statistical power is a potential issue. The matched-cohort dataset used to investigate the 
relationship between sleep problems and musculoskeletal conditions included 638 individuals and 
only 123 events (medical recorded consultation for a musculoskeletal condition). Calculations 
showed that approximately 900 individuals would be needed to have 80% of power based on the 
reported effect size, indicating that the analysis was potentially underpowered to detect an 
association with statistical significance. Conversely, statistical power was not an issue for the 
matched-cohort dataset used to investigate the relationship between psychological symptoms 
and musculoskeletal conditions which included 3,042 and 574 events (medical recorded 
consultation for a musculoskeletal condition), as calculations showed a 99% power given the 
effect size found with this sample size. Finally, whilst these findings are of interest they are 
situated within the primary care system in the United Kingdom, and therefore may not be 
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generalizable to other healthcare systems where different models of care are practiced, for 
example where GPs are not the sole gatekeeper of primary care provision (Kringos et al., 2013). 
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10.4 Key messages 
 Children and adolescents who present to primary care for sleep problems are at higher 
hazard for a subsequent consultation for musculoskeletal conditions. 
 Children and adolescents who present to primary care with psychological symptoms are 
at higher hazard for a subsequent consultation for musculoskeletal conditions. 
 Children and adolescents who present to primary care with sleep problems do not seem 
to be at higher hazard for consulting with persistent musculoskeletal conditions, while 
those with psychological symptoms seem to be at small non-significant increased hazard. 
However, the definition of persistent musculoskeletal conditions used may have 
influenced the estimate of hazard found. 
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Chapter eleven. Discussion 
 
11.1 Thesis summary 
The overall aim of this thesis was to identify potential risk factors for the onset of musculoskeletal 
pain in children and adolescents from the current literature, and to generate hypotheses and test 
those hypotheses using existing cohort data. A systematic review of the current literature was 
performed, and 37 studies reporting on risk factors for the onset of musculoskeletal pain were 
identified. From an evidence synthesis two potential risk factors for the onset of musculoskeletal 
pain were identified, namely the presence of sleep problems and of psychological symptoms. This 
led to the development of the three objectives addressed within this thesis.  
1. To investigate whether sleep problems are a risk factor for the onset of musculoskeletal 
pain in children.  
2. To investigate whether psychological symptoms are risk factors for the onset of 
musculoskeletal pain in adolescents.  
3. To investigate whether consultations for sleep problems and psychological symptoms are 
associated with consultations for musculoskeletal pain in children and adolescents within 
a primary care setting. 
 
In addition to the identification of risk factors from the review, a number of potential effect 
modifiers of the associations studied in the thesis were also identified, namely; gender, pubertal 
status, and screen time use. Each risk factor and effect modifiers were tested within separate 
general population cohort datasets, sleep problems within CATS, psychological symptoms within 
ALSPAC, and then both risk factors were tested within a primary care consultation population 
(CiPCA). A detailed description of the analyses and results undertaken in these datasets was 
presented in Chapters 5-10. In this chapter, a summary of the key points and findings will be 
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discussed, along with discussion of the strengths and limitations applicable to all datasets, as well 
as a discussion of the potential implications for future research and clinical practice. 
 
11.2 Comparison between datasets 
Whilst comparisons between findings from these different datasets presents difficulties, because 
of differences in the characteristics of the cohort, differences in the measurement of variables, 
different time points used, and differences in the analysis approach (logistic regression, survival 
analysis), some inferences may be attempted, and these are now outlined in the following 
paragraphs. 
 
11.2.1 Sleep problems and musculoskeletal pain 
The association between sleep problems and the onset of musculoskeletal pain was explored in a 
general population dataset (CATS) and a primary care dataset (CiPCA). Results of the analysis 
performed within the CATS dataset showed that children with sleep problems had an increased 
odds of reporting musculoskeletal pain onset (35% increase), albeit non-significant, and a 
significant increased odds (122%) for the onset of chronic musculoskeletal pain. The direction of 
these effects was supported within the primary care dataset, with a 72% significant higher hazard 
ratio (attenuated to a 49% non-significant higher hazard after adjustment for number of 
consultations) and a 11% non-significant higher hazard for persistent musculoskeletal conditions 
(13% non-significant lower hazard after adjustment for number of consultations). Whilst there is 
general consensus between datasets on the direction of effect (i.e. increased odds/risk), there is a 
difference in the strength of effect, stronger for musculoskeletal pain onset in the consultation 
population, and a difference for chronic/persistent musculoskeletal pain onset, with a stronger 
effect found in the cohort but weaker within the consultation population. One possible 
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explanation for the stronger effect for musculoskeletal pain onset in the consultation population 
may be the severity of pain of the child or adolescents who consult. As discussed in Section 
10.3.1.1, it is suggested that children who refer to primary care for musculoskeletal pain, do so 
when the condition is more severe, frequent or of longer duration (Campbell & Roland, 1996; 
Paananen et al., 2011; Perquin et al., 2000). Therefore, the phenotype of those who are 
consulting (within the primary care dataset) may actually be more reflective of those with chronic 
pain within the CATS cohort, in the sense that they may have had their pain for a longer time 
before consulting, and given the evidence on the reasons for consultation (Campbell & Roland, 
1996) they may have a greater severity of pain (unfortunately a measure of severity was not 
within either dataset and so could not be tested). This therefore may explain the general stronger 
effect for the onset of musculoskeletal pain between the two datasets. Another potential reason 
for this difference, specifically for the chronic findings, as discussed fully in chapter 10 (Section 
10.3.1.2), is the definition of persistent pain used in CiPCA, with a high number of participants 
having a subsequent consultation only a short while after their index consultation, potentially 
indicating a short episode rather than long-term pain problem. Furthermore, such close proximity 
of consultations may also be routine follow up appointments and the patient may have (largely) 
recovered. Taking a wider perspective on the results of these specific datasets, there is some 
agreement with the results of the systematic review presented in this thesis, as the association 
between sleep problems and the onset of musculoskeletal pain was inconsistent (however the 
general direction was toward increased risk in the review findings), and the only study that 
investigated the onset of chronic musculoskeletal pain reported significantly higher odds in 
children with sleep problems (Harrison et al., 2014). The hypothesis that the association between 
sleep problems and the onset of chronic musculoskeletal pain is more evident (compared to the 
onset of any incident musculoskeletal pain) is also supported by studies conducted in adult 
populations, which report consistent associations between sleep problems and the onset of 
chronic musculoskeletal pain conditions (Gupta et al., 2007; McBeth et al., 2014; Mork et al., 
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2014; Nitter et al., 2012). All this evidence may therefore suggest that sleep problems are a risk 
factor for the development of more severe or chronic musculoskeletal pain conditions. It may 
therefore be possible that there is a reciprocal relationship between sleep and musculoskeletal 
pain, where a child experiences a musculoskeletal pain event, this then disrupts sleep patterns, 
which could then culminate in the development of more severe or chronic musculoskeletal 
conditions. This hypothesis is in agreement with the potential bi-directional relationship between 
sleep and musculoskeletal pain reported in recent reviews (Finan et al., 2013; McBeth et al., 
2015). Results of the effect modification analysis within the CATS dataset suggest a subgroup of 
children (i.e. boys) may be at higher risk for the onset of musculoskeletal pain. However, effect 
modification analysis did not show any statistically significant interaction for any of the other 
subgroups assessed (i.e. pubertal status, screen time). Overall, the results of the effect 
modification analysis should be considered exploratory and interpreted with care due to the 
limited sample size of subgroups in stratified analysis, which provided low power for testing the 
presence of an interaction effect (Bland, 2015). Further confirmatory studies with an adequate 
sample size are needed to test the potential effect modification of the variables assessed in this 
thesis. 
 
11.2.2 Psychological symptoms and musculoskeletal pain 
The relationship between psychological symptoms and the onset of musculoskeletal pain was 
explored in a general population dataset (ALPSAC) and a primary care dataset (CiPCA). Analysis 
performed within the ALSPAC dataset (where psychological symptoms were conceptualised and 
measured as internalizing and externalizing constructs, see chapter 7, Section 7.2.2.1) showed 
that children with internalizing symptoms were at 43% and 28% non-significant increased odds for 
the onset of musculoskeletal pain and chronic musculoskeletal pain, respectively. The results 
were stronger for externalizing symptoms with a 99% significant increased odds for the onset of 
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musculoskeletal pain, and a 68% non-significant increased odds for the onset of chronic 
musculoskeletal pain. Testing within the primary care consultation records (CiPCA) showed a 39% 
significant higher hazard for musculoskeletal pain consultation onset, and a 34% non-significant 
higher hazard for persistent musculoskeletal consultations. All of these results show a general 
increase in likelihood of a musculoskeletal event (pain or consultation) and this is in line with the 
findings from the systematic review, which reported both significant and inconsistent findings for 
internalizing and externalizing symptoms, overall in the direction of an increased likelihood of 
musculoskeletal pain with increasing levels of internalizing and externalizing. The results of the 
systematic review however did not provide clear consistent information on the individual 
contribution of internalizing versus externalizing factors to the onset of musculoskeletal pain. 
Whilst the general directions of results show an increase in likelihood of musculoskeletal pain 
onset, inspection of the constructs of internalizing and externalizing in the ALSPAC show that 
externalizing symptoms (e.g. conduct problems, behavioural problems) are more likely to be 
associated with musculoskeletal pain, whereas internalizing symptoms are not. The findings from 
primary care consultations, using a broad definition of psychological problems, show an increase 
in hazard, slightly more so (and significantly) for musculoskeletal consultation onset compared to 
persistent consultation. However, comparability between analysis for the onset of chronic 
musculoskeletal pain in ALSPAC and persistent musculoskeletal conditions in CiPCA is limited due 
to differences in the methods used to measure persistent musculoskeletal conditions (as 
discussed for the findings on sleep problems in Section 11.2.1 above). Overall the results of this 
thesis suggest that psychological symptoms in children are predictive of the development of 
musculoskeletal pain, either of onset (as observed in ALSPAC) or of conditions that may be more 
acute or severe as presented in a primary care setting. Results of the effect modification analysis 
for both internalizing and externalizing symptoms within the ALSPAC dataset did not show any 
statistically significant interaction for any of the subgroups assessed (i.e. gender, pubertal status, 
screen time). However some interesting trends were found, for example, a trend of decreasing 
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odds for the onset of musculoskeletal pain with increasing levels of screen time, a trend of 
increased odds of developing musculoskeletal pain with increasing pubertal stages was observed 
in children with externalizing symptoms, the opposite direction was found in children with 
internalizing symptoms (i.e. decreased odds with increasing pubertal stages). However, as with 
the CATS dataset discussed in the previous section, the limited sample size of subgroups in the 
stratified analysis provided low power for testing the presence of effect modification, and a 
number of variables that may potentially have confounded the analysis were not available within 
this dataset. Based on the general finding that psychological symptoms are a risk factor for 
musculoskeletal pain outcomes in children and adolescents, and that there is some evidence of 
particular groups at increased or decreased risk, further confirmatory studies with adequate 
sample size and perhaps hypothesised statistical modelling (e.g. structural models) that can 
account for effect modification and confounders are needed to assess the potential effect 
modification of the variables tested in this thesis. 
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11.3 Strengths and Limitations 
This current thesis and studies within presents several strengths and limitations. Strengths and 
limitations specific to each dataset investigated were outlined in Chapter 6, 8 and 10 of this 
thesis. In the following paragraphs, a discussion of the general strengths and limitations are 
outlined. 
11.3.1 Strengths of this thesis 
 A comprehensive systematic review on risk factors for the onset of musculoskeletal pain 
was performed, which identified a larger number of studies and encompassed a broader 
range of body sites and risk factors as compared to previous reviews. A further focused 
review using the same methodology, specifically reporting on the association between 
sleep problems and musculoskeletal pain was performed, resulting in a peer reviewed 
publication (Andreucci, Campbell, & Dunn, 2017). Are Sleep Problems a Risk Factor for 
the Onset of Musculoskeletal Pain in Children and Adolescents? A Systematic Review. 
Sleep, 40(7)). 
 Analyses were performed in two general population datasets (CATS and ALSPAC) and 
replicated within a primary care consultation dataset (CiPCA). Therefore the reported 
results of this thesis are informative both for the general population and also for primary 
care, thus providing new knowledge regarding sleep problems and psychological 
symptoms as potential risk factors of musculoskeletal pain in children and adolescents 
that is of potential public health and clinical relevance. 
 Prospective designs were used for the analyses carried out within the three datasets. This 
design (apart from an experimental design) is the optimal to provide evidence of a 
temporal sequence between exposure and outcome. 
 Effect modification analysis was applied based on inconsistencies of results identified by 
the systematic review. A priori variables (gender, screen time, pubertal status) were 
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identified from the systematic review and conceptually measured within the datasets. 
This enabled a detailed inspection of factors that potentially could increase or decrease 
risk between exposure and outcome. 
 The large sample sizes of CiPCA and ALSPAC provided sufficient power to estimate the 
overall associations with sufficient precision, although this was not the case for the 
analysis of effect modification.  
 A comprehensive search of previous studies using medical record data and an 
assessment of validated Read code lists available at the Research Institute for Primary 
Care & Health Sciences, Keele University, was carried out to define Read codes lists. 
These lists were reviewed by an academic GP to assess relevance, use, and 
appropriateness to successfully capture risk factors and outcome in the CiPCA cohort.  
 A further benefit of the use of medical health records is that they are not prone to recall 
bias compared to the collection of data with self-report questionnaires. 
 
11.3.2 Limitations of this thesis 
 The study design presents some limitations for the CATS and ALSPAC analyses. Because 
both datasets included two time points (i.e. baseline and follow up) it was not possible to 
assess any potential changes of the variables measured at baseline during the follow-up 
period (e.g. were the risk factors transient or stable). This would have allowed a more 
detailed investigation of the temporal associations between the exposures (e.g. sleep 
problems and psychological symptoms from baseline to follow-up) and onset of (chronic) 
musculoskeletal pain (Mork et al., 2014). Also, it was not possible to capture all the 
musculoskeletal pain events that may have occurred between baseline and follow-up (i.e. 
the assessment of musculoskeletal pain at follow-up included only the events occurring 
within the last month, but may have missed events that occurred previously). Therefore it 
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is possible that estimates of incidence found are an underestimation in these datasets 
(Kamada et al., 2016).  
 The analysis of existing data is useful but not the best option for investigating new 
research objectives not included within the primary aims of the original design. A bespoke 
cohort would have allowed a better assessment of both exposures and outcomes, and 
consequently of the associations investigated in this thesis. For example, on outcomes in 
all datasets, information on pain aetiology would be useful (e.g trauma, injury, or non-
specified), also information on pain severity, frequency, and perceived impact (e.g. pain 
interference or disability). For the assessment of sleep problems in CATS and CiPCA, again 
potentially important information was not assessed such as physiological measurements, 
sleep length, sleep diaries, all of which may have led to greater clarity on the associations 
reported (Section 6.3.2 and Section 10.3.2 for discussions on these issues). Also better 
assessments in ALSPAC and CiPCA would have provided greater clarity on the association 
of psychological symptoms with musculoskeletal pain, for example measurement and 
assessment of psychological reactions to pain such as fear avoidance and catastrophizing 
may have proved insightful (see Section 8.7.2 and 10.3.2 for a discussion). These general 
limitations of using existing data also apply to the measurement of effect modifiers and 
potential confounders. 
 Measures used to define sleep problems (CATS dataset) and psychological symptoms 
(ALSPAC dataset, internalizing/externalizing symptoms) were dichotomised based on 
recognised cut points, in order here to identify children with symptoms of clinical 
relevance. Whilst this is a commonly used approach to data analysis (especially with 
conditions that are widely prevalent), the dichotomisation process necessarily leads to a 
loss of information (e.g. two children may have nearly similar values for a variable, but 
after dichotomization one might be just above and the other just below the cut-off limit 
used, therefore will be treated differently in the analysis) (MacCallum, Zhang, Preacher, & 
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Rucker, 2002). This approach may have resulted in misclassification bias and a loss of 
precision compared to using continuous variables with linear regression (Altman, 2006; 
Delgado-Rodriguez & Llorca, 2004). 
 In CATS and ALSPAC data were collected by means of questionnaires. Errors may occur in 
coding and entering the responses from the questionnaires into the datasets. In addition, 
when using self-report questionnaires, it is not possible to ask for clarification of items 
and prevent potential misunderstandings. Additionally questionnaires generally do not 
permit a clinical diagnosis of the pain problem (de Leeuw et al., 2003; Sperotto et al., 
2015) and certainly the questions used to assess pain in these cohorts was limited.  
 A limitation of using medical health records for research is that variables relative to 
lifestyle are generally less well recorded (Glasgow et al., 2012). As a consequence, it was 
not possible to adjust the analysis for certain confounders (i.e. smoking, drug use, physical 
activity) that may have proved informative to the reported results. Other issues for 
medical record approaches is the actual coding practice, there may have been potential 
misclassification of symptoms or diagnoses, the missing of relevant health conditions 
when individuals present with multiple problems and only one is coded, the possibility of 
errors when entering data, and the predilection of GPs for certain Read codes.  
 The levels of evidence for causality include several criteria (i.e. consistency of evidence, 
temporality, dose-response, theoretical plausibility, magnitude of effect), some of which 
were not met in the analysis performed within this thesis. This study did include a 
prospective design which allowed the inference of causality but limitations existed in 
terms of the time points used for the analysis as discussed previously. Also, the evidence 
was not consistent, for both sleep problems and psychological symptoms, both within the 
systematic review and within the studies reported in this thesis. In addition, the effect for 
some of the associations studied in this thesis (i.e. associations between sleep problems, 
internalizing symptoms and the onset of musculoskeletal pain) was non-significant and of 
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modest size. Whilst potential biopsychosocial explanations for the findings were proposed 
to give theoretical plausibility (for example see Section 6.3.1.2 and 8.7.1.3), there was no 
opportunity to test theoretical models with appropriate scientific rigour (e.g. 
experimental manipulation of the exposure), and to date no conclusive evidence for 
mechanisms of causality have been established. Despite these limitations, the general 
results do suggest that increased risk of musculoskeletal pain onset is associated with 
both sleep problems and psychological symptoms in children and adolescents, there is 
also evidence of some effect modification and more research is now warranted. 
 Whilst findings from the CiPCA dataset are informative they are somewhat restrictive and 
applicable to the primary care health system practiced in the United Kingdom and 
therefore may not be generalizable to different healthcare systems (Kringos et al., 2013). 
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11.4 Identification of incident musculoskeletal pain 
In the previous section the strength and limitations of this thesis were outlined. A further 
drawback of this thesis is described in this paragraph, and concerns the identification of incident 
musculoskeletal pain in children and adolescents. As outlined in Section 3.1, the aim of this thesis 
was to investigate risk factors for the onset (incidence) of musculoskeletal pain in children and 
adolescents identified from the general population or primary care consultation records. This was 
achieved by estimating both the incidence of musculoskeletal pain and the strength of association 
between exposure and outcome. The incidence of musculoskeletal pain (Section 1.4) is the 
proportion of new cases of musculoskeletal pain that occur over a certain period of time among 
all the individuals at risk (i.e. those without musculoskeletal pain at baseline). However, 60% of 
children within the CATS cohort and 49% within the ALSPAC cohort reported the presence of 
musculoskeletal pain at baseline (Section 5.5.1.1 and 7.5.1.1). Therefore, a limitation of this thesis 
is that it was not possible to identify “true” incident cases of musculoskeletal pain (i.e. first ever 
onset of musculoskeletal pain) for all children and adolescents within the CATS and ALSPAC 
cohorts. In addition, figures and proportions relative to the risk factors investigated (sleep 
problems and psychological symptoms) as well as the potential confounders were higher/stronger 
among those with musculoskeletal pain at baseline compared to those without musculoskeletal 
pain at baseline (Section 5.5.1.3 and 7.5.1.3). It may therefore be hypothesised that children with 
and without musculoskeletal pain at baseline within this thesis represent different populations. In 
this scenario, those without musculoskeletal pain at baseline might undergo an effect similar to 
the healthy worker effect observed in adults (Delgado-Rodriguez & Llorca, 2004), and would 
therefore be healthier and consequently less likely to develop musculoskeletal pain at follow-up. 
Although it may be postulated that the strength of association in a cohort where it might be 
possible to identify the first ever onset of musculoskeletal pain in children would be different 
compared to the figures reported in this thesis (which may be an underestimation if children were 
"healthier"), it is not possible to estimate the actual difference within this thesis. Thus, future 
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studies tracking children from an earlier point in life (for example from the age of 6, which is the 
starting point for children to use the word “pain” and to form a conceptualisation of pain) with 
multiple time follow-up points are needed. This type of study would be more likely to identify the 
first ever onset of musculoskeletal pain and would allow finer investigations of any potential 
difference in the association between sleep problems, psychological symptoms and the onset of 
musculoskeletal pain between adolescents whose onset of musculoskeletal pain occurs earlier in 
life compared to those who experience musculoskeletal pain at a later stage.  
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11.5 Implications for research 
11.5.1 Interpretation of the findings and relevance to public health and primary care 
The results of the analyses carried out within this thesis show an increased likelihood for 
musculoskeletal pain (either onset or chronic) in children/adolescents with sleep problems or 
psychological symptoms both within general population and primary care settings (Section 11.2). 
However, the effect sizes reported in this current study were modest and varied depending on the 
outcome measured (i.e. onset of musculoskeletal pain vs. chronic/persistent musculoskeletal 
pain). Therefore, the key question is whether these results merit the initiation of prevention 
strategies (to prevent onset) or interventions (to prevent chronicity). When considering planning 
a prevention strategy or an intervention, epidemiological measures such as attributable risk, 
absolute risk reduction and numbers needed to treat or to prevent should be considered (Bhopal, 
2002). The attributable risk (AR) represents the number of outcome events that would not have 
occurred if a particular risk factor had not been present. Therefore this measure is informative of 
the excess in risk produced by the risk factor compared to the baseline risk (Bhopal, 2002). This 
measure can be calculated by dividing the difference in the incidence between the exposed and 
non-exposed group over the incidence in the exposed group as in the following formula (Ie = 
Incidence in the exposed group; Iu = Incidence in the non-exposed group): 
AR = (Ie – Iu) / Ie 
The absolute risk reduction (ARR) is the difference in rates of event between the two groups and 
can be calculated by subtracting the incidence in the non-exposed group from the incidence in the 
exposed group, as in the following formula: 
ARR = Ie – Iu 
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The numbers needed to treat (NNT) or to prevent (NNP) is a measure that indicates the number 
of people who need to be treated for one patient to benefit, and it is calculated as the inverse of 
the ARR: 
NNT (or NNP): 1 / ARR 
These measures have been calculated for objective number 1 (Investigation of sleep problems as 
a risk factor for the onset of musculoskeletal pain in children) and 2 (Investigation of internalizing 
and externalizing symptoms as risk factors for the onset of musculoskeletal pain in adolescents) 
using the unadjusted (crude) risks reported in CATS and ALSPAC. Results are shown in Table 11.1. 
 Table 11.1 Attributable risk, absolute risk reduction and number needed 
to prevent for the objectives investigated in this thesis 
Objective Exposure 
prevalence 
Ie Iu AR ARR NNP 
Sleep problems –
MSK pain  
21.8% 50.0% 40.6% 18.8% 9.4% 11 
Sleep problems - 
Chronic MSK pain 
32.6% 16.9% 7.4% 56.2% 9.5% 11 
Internalizing – 
MSK pain 
8.4% 41.9% 35.3% 15.8% 6,6% 15 
Externalizing –  
MSK pain 
7.3% 51.5% 34.8% 32.4% 16.7% 6 
Internalizing - 
Chronic MSK pain 
8.4% 20.5% 16.7% 18.5% 3.8% 26 
Externalizing - 
Chronic MSK pain 
7.3% 25.3% 16.5% 34.8% 8.8% 11 
N.b.: Figures do not take account of adjustment for potential confounders (measured or 
unmeasured) 
 
As can be seen from the above table there is variation in all the estimates provided, with some 
estimates of a higher significance than others, for example sleep problems are 56.2% of the risk 
for the development of chronic musculoskeletal pain in CATS, whilst only 15.8% is attributable to 
internalizing symptoms in ALSPAC. These differences depend on many factors including the risk 
ratio and prevalence, and so comparisons across the board as in table 11.1 are problematic, and 
beyond the scope of this thesis. However one useful metric is the NNP (NNT) where it is suggested 
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that a threshold of single numbers (i.e. < 10 patients) has plausible clinical relevance (Citrome, 
2008). Here it can be seen that an intervention targeting externalizing symptoms may be the most 
suitable, as 1 every 6 individuals treated would benefit from the treatment, targeting sleep 
problems (both onset and chronic) and externalizing for chronic musculoskeletal pain onset might 
be useful at 11 patients, however for other targets, an intervention may be less practical. Whilst 
the focus on targeting sleep problems and externalizing symptoms appears plausible, the 
assumptions at the basis of the interpretation should be clarified. Assumptions underlying the 
attributable risk for example are that: (i) the risk factor has to be a causal factor and the 
mechanisms of causality have to be understood; (ii) estimates of incidence have to apply to other 
populations (generalisability); (iii) the study is valid and accurate; (iv) there is no confounding by 
any other factor; and (v) and the proposed intervention would successfully reduce all of the 
excess risk associated with the risk factor (Bhopal, 2002). These criteria mirror some of the 
general limitations of the studies outlined in the above section (11.3.2) and although some 
mechanisms to explain the associations found have been proposed (see chapters 6 and 8, Section 
6.3.1.2 and 8.7.1.3), the mechanisms most probably involve multiple factors that will vary from 
individual to individual, and to date conclusive evidence regarding the pathways of causality from 
sleep problems and psychological symptoms to the onset of musculoskeletal pain or chronic 
musculoskeletal pain have not been fully established. Based on these issues, and given the 
modest effect size of the associations found in this current study, it is recommended that more 
research is carried out to understand potential mechanisms of causality for these risk factors and 
to identify further the groups of children and adolescents who may be at increased risk via effect 
modification (some of which have been tentatively identified in this thesis). If causal mechanisms 
were more concretely identified (e.g. through better measures, repeated measures over time, 
experimental designs, more sophisticated modelling that allows a more in-depth analysis of causal 
pathway), this would lay the foundation for the design and evaluation of interventions to reduce 
sleep problems and psychological symptoms in order to avert the onset of musculoskeletal pain. 
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Considering the problem in a wider perspective, the prevention of the onset of musculoskeletal 
conditions may result in beneficial long-term effects for affected individuals and in terms of an 
overall reduction in costs for the healthcare system. (e.g. the net ingredient cost of drugs for 
musculoskeletal and joint conditions in England has been estimated as £224 million in 2015) 
(Baker, 2016). Based on the findings of this thesis and the evaluation of the results some potential 
approaches for future research investigating musculoskeletal pain in children and adolescents are 
outlined in the following section. 
 
11.5.2 Alternative approaches to investigating musculoskeletal pain in children and 
recommendations for future research 
The investigation of risk factors for the onset of musculoskeletal pain in children and adolescents 
in this thesis generated ideas regarding alternative approaches that may be used to investigate 
these risk factors further. These proposed approaches are described below. 
 
11.5.2.1 The use of multiple data time points and innovative methods to collect data 
Studies that collect data at multiple time points are at an advantage. For example, recent research 
on trajectories in individuals with musculoskeletal pain has identified different groups of people 
based on their experience of pain over time (Dunn et al., 2011; Dunn, Jordan, et al., 2006; Dunn, 
Campbell, et al., 2013). Pairing these groups up with potential risk factors can identify what 
factors are important in the prediction of these trajectories groups (e.g. those with persistent pain 
over time). There are now also newer methods, such as Latent Class Growth Modelling, where 
dual or even more variables can be combined within longitudinal trajectory analysis (Xie, Mchugo, 
He, & Drake, 2010). Here, for example, repeated data on sleep problems or on psychological 
symptoms can be combined with data on musculoskeletal pain through time to give clearer 
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indications of the proposed bi-directional longitudinal relationships (i.e. when these factors have 
the greatest influence), again identifying individuals at the highest risk. Furthermore, innovative 
strategies that are appealing to young people could be used to collect data, for example, it may 
be useful to develop an app for smartphones/iPads that tracks the association between exposure 
to risk factors and musculoskeletal pain by collecting data at regular time points. Questions may 
be asked daily or weekly, and a reminder system (to parents or child/young person) can be 
installed to ensure greater participation, something that is more difficult using paper 
questionnaires (Dissing et al., 2017; Fuglkjaer, Hartvigsen et al., 2017; Kamper, Dissing et al., 2016; 
Leboeuf-Yde, Jensen, & Axén, 2012). This allows the collection of trajectory data with a high 
response rate and minimal recall bias (Leboeuf-Yde et al., 2012). It may also be possible to deliver 
interventions aimed at managing musculoskeletal pain and preventing the transition to chronicity 
through the smartphone. A recent systematic review reported the presence of 61 apps for the 
management of low back pain, and whilst they are generally of low quality at present, this growth 
in the use of technology indicates the potential for e-health interventions in the future (Machado 
et al., 2017). In addition, data collected through smartphones/iPads may be linked to primary care 
data, in order to investigate whether conditions reported with electronic devices are associated 
with consultation for the conditions in primary care or assess additional questions not recorded 
within a primary care consultation (severity, impact, reactions to pain). 
 
11.5.2.2 Additional measures to collect in future studies 
Potential mechanisms to explain the pathway from sleep problems or psychological symptoms to 
musculoskeletal pain onset have been outlined previously within this thesis (Section 6.3.1.2 and 
8.7.1.3, respectively). Therefore, if there was the possibility to set up a cohort study to investigate 
these presumed causal pathways, it would be important to collect additional data to gain a better 
understanding of the mechanisms potentially underlying associations between sleep and/or 
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psychological problems and onset of musculoskeletal pain. As stated previously musculoskeletal 
pain requires a better assessment. Information about the severity, frequency and impact of 
musculoskeletal pain (e.g. pain interference or disability) should be collected as this may provide a 
better understanding of the experience of pain (Section 11.3). As anticipated in Section 6.3.2, a 
validated tool for sleep problems (e.g. Sleep Disorders Inventory for Students, the Sleep 
Disturbance Scale for Children) would allow the assessment of the several components of sleep 
(Spruyt & Gozal, 2011). In addition, given the potential daily variation in pain (Tang, Goodchild, 
Sanborn, Howard, & Salkovskis, 2012), both sleep and pain diaries may be used to perform 
longitudinal studies in children and adolescents. Furthermore, the investigation of physiological/ 
biological pathways between sleep and musculoskeletal pain may add to the evidence for 
potential mechanisms of causality, and would require additional measurements. For example, 
levels of cytokines and inflammatory mediators may be measured in children with and without 
sleep problems, followed by repeated measurements of pain, including severity and impact. This 
may elucidate if these factors are involved in the pathway from sleep to musculoskeletal pain. In 
addition, the influence of social factors such as parental health status and problems within the 
family environment on the association between sleep problems and musculoskeletal pain in 
children may be elucidated, for example within a mediation analysis model in which parental 
health status and problems within the family environment precede sleep problems, and 
subsequent onset of musculoskeletal pain is investigated. Results from this type of analysis 
(where pathways and development through time are analysed) may potentially suggest targets 
for interventions.  
Regarding psychological symptoms, the role of the mechanism of response to stress may be 
assessed. Saliva samples may be collected in children to measure the levels of cortisol and ACTH, 
using methodology described in previous studies (Kaplow et al., 2013; van voorhees & Scarpa, 
2004). The association between the variation in levels of ACTH and cortisol and the development 
of musculoskeletal pain, including severity, may be subsequently assessed to elucidate the role of 
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HPA axis functioning and in the association between stress and musculoskeletal pain in children 
(Generaal et al., 2014). Another factor for which a better measure may be needed is puberty. The 
measurement of pubertal status at more frequent time-points may allow the assessment of 
pubertal tempo (i.e. the rate of change in pubertal development) among children who are 
experiencing puberty, and to assess the influence of such differences on the psychological 
development of children. Similarly to what was proposed above for sleep problems, measures to 
explore the effect of social factors that were not present within the datasets used in this thesis 
may be collected. For example, the contribution of relationship with the parents and problems in 
the family environment on the association between psychological symptoms and musculoskeletal 
pain may be assessed in a mediation model and potentially suggest future areas of intervention 
for the prevention of musculoskeletal pain (Section 11.5.3.1). Finally, measures regarding pain-
catastrophizing (e.g. Pain Catastrophizing Scale) and fear-avoidance behaviour (e.g. Fear of Pain 
Questionnaire Child and Parent Proxy Report) may be included in future studies that investigate 
the association between sleep problems, psychological symptoms and musculoskeletal pain 
(Asmundson, Noel, Petter, & Parkerson, 2012). This would allow estimating the influence of these 
factors in the transition from the onset of musculoskeletal pain to chronicity. 
 
11.5.2.3 Replication of the analysis within other databases and datasets 
It is important that findings are replicated to inform on generalisability. The analysis carried out 
within this thesis using ALSPAC and CiPCA datasets were performed in populations of 
predominantly white ethnicity (no information of ethnicity is present within CATS). Analysis 
performed within this thesis may be replicated in other databases that include a different range 
of children of differing ethnicities, as evidence suggests differences in the experience and 
expression of pain (Section 1.5.3.2). Age is also an important factor, with many biological and 
psychological changes taking placed in a relatively short period of time (e.g. puberty) therefore 
replication is required in datasets of differing age, or a cohort is set up to recruit children of 
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different ages to assess this important factor. In addition, analysis may be replicated in other 
primary care databases within the UK (i.e. Clinical Practice Research Datalink, CPRD) as CiPCA is 
situated in general practices within a more deprived area than the national UK average (Jordan et 
al., 2010), and replication should take place in other countries where health care systems differ. 
 
11.5.3 Interventions aimed at preventing the onset of musculoskeletal pain 
As reported in Section 11.5.1, to date there is no established evidence regarding the causal 
mechanisms leading from sleep problems and psychological symptoms to musculoskeletal pain. 
However, if future research can provide evidence on the potential pathways proposed within this 
thesis or otherwise, interventions may be planned. Interventions aimed at preventing the onset or 
the transition to chronicity of a condition in a population require a change in the population mean 
of an exposure as a whole (Bhopal, 2002). Therefore, interventions aimed at decreasing the 
percentage of children with sleep problems or psychological symptoms may be effective in 
reducing the impact of musculoskeletal pain in the population. 
 
11.5.3.1 Interventions targeting sleep problems and psychological symptoms 
Several strategies directed to sleep problems or psychological symptoms may help to prevent the 
onset of musculoskeletal pain or the transition to chronicity. An effective strategy may be to 
perform routine screening in primary care settings for the detection of children and adolescents 
with sleep problems (for example by using a Pediatric Sleep Toolkit) and with psychological 
problems for early recognition of symptoms (Kramer & Garralda, 2000; Meltzer et al., 2014). This 
may be especially beneficial for children who present to primary care with musculoskeletal 
problems as they could benefit from education on sleep hygiene or on how to cope with pain to 
prevent the transition to chronicity and worsening of musculoskeletal problems (Incledon, 
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O’Connor, Giallo, Chalkiadis, & Palermo, 2016; Vriend & Corkum, 2011). However, to date there is 
a dearth of knowledge among general practitioners about paediatric sleep problems (Honaker & 
Meltzer, 2016; Vriend & Corkum, 2011). Therefore, increasing the awareness of general 
practitioners and the children’ parents of the importance of paediatric sleep problems (which are 
currently under-recognized) and of the potential consequences for the musculoskeletal health of 
children and adolescents may be needed (Honaker & Meltzer, 2016; Meltzer et al., 2010; Vriend & 
Corkum, 2011). Potential interventions for sleep problems include pharmacological treatments, 
although this should not be the first choice of treatment due to the potential side effects and the 
limited long-term benefits (Honaker & Meltzer, 2016; Meltzer et al., 2014; Vriend & Corkum, 
2011). In addition, other potentially effective interventions for sleep problems or psychological 
symptoms may be delivered in primary care settings. These interventions may have a beneficial 
impact on both sleep problems and psychological problems, as they are reciprocally related 
(Campbell, Tang, et al., 2013; Coulombe et al., 2011; Pieters et al., 2014), and may further reduce 
the risk for musculoskeletal conditions. Potential interventions include parental management 
training aimed at improving the children’s psychological health and behaviour as well as 
interventions that are targeted directly towards children and adolescents, such as cognitive-
behavioural-approaches (CBT) (Kramer & Garralda, 2000; Sukhodolsky, Smith, McCauley, Ibrahim, 
& Piasecka, 2016). These approaches may be directed at the resolution of sleep problems, or at 
improving the children’ coping abilities and management of pain, and at reducing or avoiding 
potential adverse psychological responses to pain such as pain catastrophizing, negative thoughts 
about pain, pain-related anxiety and fear of pain. Potential cognitive-behavioural- approaches 
include anger control training, problem-solving skills training, psychological desensitization for 
lessening the fear of pain, psychoeducation, distraction (e.g. spending time with friends and 
family), deep breathing and muscle relaxation, or acceptance and commitment therapy and sleep 
restriction (Agoston & Sieberg, 2016; Asmundson et al., 2012; Sukhodolsky et al., 2016; Vriend & 
Corkum, 2011). Such treatments may also be remotely delivered, for example via Internet, 
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although more studies are needed to confirm their effectiveness (Agoston & Sieberg, 2016; Fisher, 
Law, Palermo, & Eccleston, 2015). Other types of interventions may be directed at the lifestyle of 
adolescents, for example interventions aimed at promoting physical activity in adolescents have 
been shown to be effective in decreasing the levels of internalizing and externalizing symptoms 
(Spruit, Assink, van Vugt, van der Put, & Stams, 2016).  
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11.6 Key messages 
 The systematic review performed within this thesis showed that sleep problems and 
psychological symptoms may be associated with musculoskeletal pain in children and 
adolescents. 
 Analysis within CATS and CiPCA datasets showed that sleep problems are a risk factor for the 
development of more severe or chronic musculoskeletal pain conditions in children, rather 
than for the onset of musculoskeletal pain. 
 Analysis within ALSPAC and CiPCA datasets showed that adolescents with psychological 
symptoms were at significantly increased likelihood of musculoskeletal pain onset, chronic 
musculoskeletal pain or consultation for musculoskeletal conditions. 
 Effect sizes found in this study were modest and varied depending on the outcome measured. 
Further analysis is required using a uniform set of optimum measures to establish greater 
consistency in a representative sample. 
 Effect modification was examined and some interesting findings were reported, however this 
particular analysis suffered from a lack of statistical power and further investigation is 
required. 
 Future research should build on the findings of this thesis and test further potential pathways 
from sleep problems and psychological symptoms to musculoskeletal pain (e.g. Latent Growth 
Modelling approaches that utilise frequent assessment stages) to identify mechanisms and 
groups at high risk, from which intervention studies may potentially be planned to prevent 
the impact of musculoskeletal pain in later life. 
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Reflections 
 
During my PhD I developed a range of skills that will be helpful in my future career as a 
researcher. Firstly, I learnt how to conduct a systematic review of the literature to summarize 
existing evidence on the risk factors for the onset of musculoskeletal pain in children and 
adolescents. Therefore, I learnt how to develop a search strategy and to critically appraise the 
articles during the process of selection of the studies for inclusion and exclusion within the 
review. Secondly, I developed research hypotheses and planned the analysis to be tested in 
suitable databases, which I identified in order to carry out the research. All this process also led 
me to the understanding of the administration processes, which are part of the research work. 
Thirdly, I learnt a range of statistical techniques and methods (e.g. logistic regression analysis, 
survival analysis, multiple imputation for missing data) when performing the analysis during my 
research. Fourthly, I improved my writing skills that resulted in the production of this PhD thesis 
and of articles that have been submitted for publication. I also experienced the disappointment 
resulting from my articles initially being rejected, although I learnt that perseverance always pays 
off in the research field. During my PhD I also found myself in situations where new unexpected 
problems arose, and I learnt to quickly find a solution for them. I overall feel that during my PhD I 
have grown both as a person and as a student, and have learnt a range of skills (both technical 
and soft skills) that will be helpful in my future career as a researcher.   
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Appendix II Full search strategy used for the systematic review 
 
Search strategy used in AMED 
 Searches Results 
1 exp adolescent/ 3190 
2 exp child/ 14169 
3 child$.ti,ab. 15468 
4 youth.ti,ab. 683 
5 schools/ 633 
6 pediatrics/ 409 
7 pediatric$.ti,ab. 1911 
8 paediatric$.ti,ab. 739 
9 young$.ti,ab. 6700 
10 boy$.ti,ab. 1214 
11 girl$.ti,ab. 1038 
12 puberty/ 30 
13 pubert$.ti,ab. 108 
14 pubescent$.ti,ab. 19 
15 prepubert$.ti,ab. 62 
16 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
or 9 or 10 or 11 or 12 or 13 or 14 
or 15 
26487 
17 incidence.ti,ab. 3181 
18 prevalence.ti,ab. 3533 
19 epidemiology/ 3081 
20 epidemiolog$.ti,ab. 1559 
21 risk factors/ 1194 
22 (risk adj3 factor$).ti,ab. 3206 
23 (Risk adj3 assessment).ti,ab. 403 
24 (Risk adj3 score).ti,ab. 67 
25 (Risk adj3 reduction).ti,ab. 213 
26 (Risk adj3 increase).ti,ab. 334 
27 (Risk adj3 evaluation).ti,ab. 68 
28 prevention/ 11211 
29 cohort studies/ 646 
30 (cohort adj3 stud$).ti,ab. 2012 
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31 prospective studies/ 774 
32 follow up studies/ 1182 
33 17 or 18 or 19 or 20 or 21 or 22 
or 23 or 24 or 25 or 26 or 27 or 
28 or 29 or 30 or 31 or 32 
25032 
34 pain/ 10426 
35 exp back/ 625 
36 neck/ 623 
37 shoulder/ 1171 
38 exp spine/ 4898 
39 low back pain/ 3934 
40 (chronic adj3 pain).ti,ab. 4035 
41 musculoskeletal pain/ 68 
42 (spinal adj3 pain).ti,ab. 491 
43 (widespread adj3 pain).ti,ab. 229 
44 (multisite adj3 pain).ti,ab. 3 
45 (regional adj3 pain).ti,ab. 218 
46 (juvenile adj3 fibromyalgia).ti,ab. 15 
47 35 or 36 or 37 or 38 6987 
48 34 and 47 656 
49 34 or 39 or 40 or 41 or 42 or 43 
or 44 or 45 or 46 or 48 
15961 
50 16 and 33 and 49 313 
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Search strategy used in EMBASE 
 Searches Results 
1 adolescent/ 1239535 
2 adolescen$.ti,ab. 226385 
3 child/ 1310917 
4 child$.ti,ab. 1255687 
5 youth$.ti,ab. 50219 
6 exp school/ 234676 
7 school$.ti,ab. 240668 
8 pediatrics/ 59820 
9 pediatric$.ti,ab. 266869 
10 paediatric$.ti,ab. 65690 
11 young$.ti,ab. 580850 
12 boy/ 18807 
13 boy$.ti,ab. 146319 
14 girl/ 19151 
15 girl$.ti,ab. 139888 
16 exp puberty/ 32211 
17 pubert$.ti,ab. 36310 
18 pubescent$.ti,ab. 775 
19 prepubert$.ti,ab. 13399 
20 juvenile/ 21829 
21 juvenile$.ti,ab. 71151 
22 teenage$.ti,ab. 20081 
23 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
or 9 or 10 or 11 or 12 or 13 or 14 
or 15 or 16 or 17 or 18 or 19 or 
20 or 21 or 22 
3350694 
24 incidence/ 216388 
25 inciden$.ti,ab. 789799 
26 risk factor/ 637208 
27 (risk adj3 factor$).ti,ab. 499560 
28 (Risk adj3 score).ti,ab. 16366 
29 (cohort adj3 stud$).ti,ab. 145670 
30 prospective study/ 266132 
31 (prospective adj3 stud$).ti,ab. 301587 
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32 follow up/ 851350 
33 (Follow up adj3 stud$).ti,ab. 66342 
34 onset.ti,ab. 452094 
35 predictor variable/ 15145 
36 predict$.ti,ab. 1211270 
37 24 or 25 or 26 or 27 or 28 or 29 
or 30 or 31 or 32 or 33 or 34 or 
35 or 36 
3820559 
38 pain/ 214428 
39 back/ 8236 
40 knee/ 44899 
41 exp neck/ 39941 
42 hand/ 24738 
43 shoulder/ 22849 
44 hip/ 35075 
45 foot/ 18239 
46 elbow/ 13905 
47 arm/ 62886 
48 forearm/ 18333 
49 wrist/ 18233 
50 leg/ 61490 
51 ankle/ 20722 
52 spine/ 31407 
53 39 or 40 or 41 or 42 or 43 or 44 
or 45 or 46 or 47 or 48 or 49 or 
50 or 51 or 52 
349814 
54 38 and 53 22402 
55 (back adj3 pain).ti,ab. 43352 
56 (knee adj3 pain).ti,ab. 7979 
57 (neck adj3 pain).ti,ab. 9722 
58 (hand adj3 pain).ti,ab. 1437 
59 (shoulder adj3 pain).ti,ab. 6709 
60 (hip adj3 pain).ti,ab. 4378 
61 (foot adj3 pain).ti,ab. 1719 
62 (elbow adj3 pain).ti,ab. 793 
63 (arm adj3 pain).ti,ab. 1893 
64 (forearm adj3 pain).ti,ab. 362 
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65 (wrist adj3 pain).ti,ab. 1511 
66 (leg adj3 pain).ti,ab. 5371 
67 (ankle adj3 pain).ti,ab. 1314 
68 (spinal adj3 pain).ti,ab. 4546 
69 backache/ 35058 
70 backache.ti,ab. 2403 
71 low back pain/ 37028 
72 (low back adj3 pain).ti,ab. 23432 
73 chronic pain/ 35474 
74 (chronic adj3 pain).ti,ab. 54095 
75 musculoskeletal pain/ 5377 
76 (musculoskeletal adj3 pain).ti,ab. 5348 
77 (widespread adj3 pain).ti,ab. 2070 
78 (multisite adj3 pain).ti,ab. 46 
79 (regional adj3 pain).ti,ab. 4406 
80 (juvenile adj3 fibromyalgia).ti,ab. 107 
81 55 or 56 or 57 or 58 or 59 or 60 
or 61 or 62 or 63 or 64 or 65 or 
66 or 67 or 68 or 69 or 70 or 71 
or 72 or 73 or 74 or 75 or 76 or 
77 or 78 or 79 or 80 
172807 
82 38 or 54 or 81 353428 
83 23 and 37 and 82 19972 
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Search strategy used in HMIC 
 Searches Results 
1 adolescen$.ti,ab. 3772 
2 exp children/ 18871 
3 child$.ti,ab. 29219 
4 youth$.ti,ab. 2005 
5 exp schools/ 1211 
6 school$.ti,ab. 8174 
7 pediatric$.ti,ab. 256 
8 exp paediatrics/ 584 
9 paediatric$.ti,ab. 2342 
10 exp young people/ 10095 
11 young$.ti,ab. 12284 
12 boys/ 231 
13 boy$.ti,ab. 1146 
14 girls/ 345 
15 girl$.ti,ab. 1255 
16 exp puberty/ 25 
17 pubert$.ti,ab. 84 
18 prepubert$.ti,ab. 5 
19 juvenile$.ti,ab. 559 
20 teenage$.ti,ab. 1391 
21 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
or 9 or 10 or 11 or 12 or 13 or 14 
or 15 or 16 or 17 or 18 or 19 or 
20 
48472 
22 "incidence of disease"/ 810 
23 inciden$.ti,ab. 8164 
24 exp risk factors/ 4275 
25 (risk adj3 factor$).ti,ab. 5062 
26 (Risk adj3 score).ti,ab. 166 
27 cohort studies/ 966 
28 (cohort adj3 stud$).ti,ab. 3468 
29 prospective studies/ 189 
30 (prospective adj3 stud$).ti,ab. 2704 
31 follow up studies/ 191 
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32 (Follow up adj3 stud$).ti,ab. 828 
33 onset.ti,ab. 1338 
34 predict$.ti,ab. 7558 
35 22 or 23 or 24 or 25 or 26 or 27 
or 28 or 29 or 30 or 31 or 32 or 
33 or 34 
25224 
36 pain/ 386 
37 back pain/ 314 
38 knees/ 42 
39 neck/ 89 
40 exp hands/ 121 
41 shoulders/ 20 
42 exp hip joints/ 143 
43 exp feet/ 38 
44 elbows/ 3 
45 arms/ 11 
46 exp wrists/ 17 
47 legs/ 88 
48 ankles/ 7 
49 exp spinal column/ 34 
50 38 or 39 or 40 or 41 or 42 or 43 
or 44 or 45 or 46 or 47 or 48 or 
49 
570 
51 36 and 50 21 
52 (back adj3 pain).ti,ab. 463 
53 (knee adj3 pain).ti,ab. 23 
54 (neck adj3 pain).ti,ab. 37 
55 (hand adj3 pain).ti,ab. 7 
56 (shoulder adj3 pain).ti,ab. 27 
57 (hip adj3 pain).ti,ab. 11 
58 (foot adj3 pain).ti,ab. 1 
59 (elbow adj3 pain).ti,ab. 3 
60 (arm adj3 pain).ti,ab. 15 
61 (forearm adj3 pain).ti,ab. 1 
62 (wrist adj3 pain).ti,ab. 9 
63 (leg adj3 pain).ti,ab. 7 
64 (ankle adj3 pain).ti,ab. 2 
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65 (spinal adj3 pain).ti,ab. 8 
66 backache.ti,ab. 25 
67 low back pain/ 111 
68 (low back adj3 pain).ti,ab. 209 
69 (chronic adj3 pain).ti,ab. 284 
70 (musculoskeletal adj3 pain).ti,ab. 39 
71 (widespread adj3 pain).ti,ab. 7 
72 (regional adj3 pain).ti,ab. 10 
73 52 or 53 or 54 or 55 or 56 or 57 
or 58 or 59 or 60 or 61 or 62 or 
63 or 64 or 65 or 66 or 67 or 68 
or 69 or 70 or 71 or 72 
813 
74 36 or 37 or 51 or 73 1157 
75 21 and 35 and 74 34 
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Search strategy used in MEDLINE 
 Searches Results 
1 Incidence/ 185780 
2 risk factors/ 600969 
3 (risk adj3 factor$).ti,ab. 386758 
4 (Risk adj3 score).ti,ab. 10136 
5 exp Cohort Studies/ 1438154 
6 (cohort adj3 stud$).ti,ab. 116635 
7 Prospective Studies/ 390949 
8 (prospective adj3 stud$).ti,ab. 236660 
9 Follow-Up Studies/ 520109 
10 (Follow up adj3 stud$).ti,ab. 53020 
11 onset.ti,ab. 362174 
12 predict$.ti,ab. 1013981 
13 inciden$.ti,ab. 627575 
14 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
or 9 or 10 or 11 or 12 or 13 
3500457 
15 Adolescent/ 1679899 
16 adolescen$.ti,ab. 188599 
17 exp Child/ 1603455 
18 child$.ti,ab. 1046293 
19 youth.ti,ab. 38454 
20 Schools/ 22234 
21 school$.ti,ab. 204181 
22 Pediatrics/ 41935 
23 pediatric$.ti,ab. 193436 
24 paediatric$.ti,ab. 44437 
25 young$.ti,ab. 485527 
26 boy$.ti,ab. 117801 
27 girl$.ti,ab. 113007 
28 exp Puberty/ 15343 
29 pubescent$.ti,ab. 622 
30 pubert$.ti,ab. 29824 
31 prepubert$.ti,ab. 11758 
32 juvenile$.ti,ab. 61088 
33 teenage$.ti,ab. 16425 
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34 15 or 16 or 17 or 18 or 19 or 20 
or 21 or 22 or 23 or 24 or 25 or 
26 or 27 or 28 or 29 or 30 or 31 
or 32 or 33 
3302779 
35 Pain/ 113662 
36 exp Back/ 16684 
37 Knee/ 11608 
38 Neck/ 23732 
39 exp Hand/ 73891 
40 Shoulder/ 10238 
41 Hip/ 10162 
42 exp Foot/ 42413 
43 Elbow/ 5808 
44 Arm/ 27933 
45 Forearm/ 14971 
46 Wrist/ 7057 
47 Leg/ 57437 
48 Ankle/ 7438 
49 exp Spine/ 112786 
50 36 or 37 or 38 or 39 or 40 or 41 
or 42 or 43 or 44 or 45 or 46 or 
47 or 48 or 49 
368918 
51 35 and 50 9518 
52 (back adj3 pain).ti,ab. 32977 
53 (knee adj3 pain).ti,ab. 6042 
54 (neck adj3 pain).ti,ab. 7681 
55 (hand adj3 pain).ti,ab. 1029 
56 (shoulder adj3 pain).ti,ab. 5393 
57 (hip adj3 pain).ti,ab. 3341 
58 (foot adj3 pain).ti,ab. 1321 
59 (elbow adj3 pain).ti,ab. 664 
60 (arm adj3 pain).ti,ab. 1396 
61 (forearm adj3 pain).ti,ab. 323 
62 (wrist adj3 pain).ti,ab. 1310 
63 (leg adj3 pain).ti,ab. 3898 
64 (ankle adj3 pain).ti,ab. 1077 
65 (spinal adj3 pain).ti,ab. 3465 
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66 backache.ti,ab. 2056 
67 Low Back Pain/ 14927 
68 (low back adj3 pain).ti,ab. 18568 
69 Chronic Pain/ 4092 
70 (chronic adj3 pain).ti,ab. 39909 
71 Musculoskeletal Pain/ 986 
72 (musculoskeletal adj3 pain).ti,ab. 4020 
73 (widespread adj3 pain).ti,ab. 1421 
74 (multisite adj3 pain).ti,ab. 38 
75 (regional adj3 pain).ti,ab. 2727 
76 (juvenile adj3 fibromyalgia).ti,ab. 75 
77 52 or 53 or 54 or 55 or 56 or 57 
or 58 or 59 or 60 or 61 or 62 or 
63 or 64 or 65 or 66 or 67 or 68 
or 69 or 70 or 71 or 72 or 73 or 
74 or 75 or 76 
103895 
78 35 or 51 or 77 197923 
79 14 and 34 and 78 13927 
  
364 
 
Search strategy used in PsycINFO 
 Searches Results 
1 adolescen$.ti,ab. 165009 
2 child$.ti,ab. 490525 
3 youth$.ti,ab. 61494 
4 exp schools/ 49630 
5 school$.ti,ab. 262606 
6 pediatrics/ 15886 
7 pediatric$.ti,ab. 21023 
8 paediatric$.ti,ab. 3037 
9 young$.ti,ab. 177351 
10 boy$.ti,ab. 53174 
11 girl$.ti,ab. 50288 
12 exp puberty/ 1941 
13 pubert$.ti,ab. 5031 
14 pubescent$.ti,ab. 224 
15 prepubert$.ti,ab. 1210 
16 juvenile$.ti,ab. 17828 
17 teenage$.ti,ab. 10200 
18 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
or 9 or 10 or 11 or 12 or 13 or 14 
or 15 or 16 or 17 
872558 
19 incidence.ti,ab. 34722 
20 exp risk factors/ 49602 
21 (risk adj3 factor$).ti,ab. 58581 
22 (Risk adj3 score).ti,ab. 781 
23 (cohort adj3 stud$).ti,ab. 13700 
24 exp prospective studies/ 436 
25 (prospective adj3 stud$).ti,ab. 20976 
26 exp followup studies/ 12306 
27 (Follow up adj3 stud$).ti,ab. 11717 
28 onset.ti,ab. 68895 
29 predict$.ti,ab. 302833 
30 19 or 20 or 21 or 22 or 23 or 24 
or 25 or 26 or 27 or 28 or 29 
479711 
31 pain/ 18321 
32 back pain/ 2884 
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33 knee/ 707 
34 "neck (anatomy)"/ 864 
35 "hand (anatomy)"/ 2682 
36 "shoulder (anatomy)"/ 391 
37 hips/ 874 
38 "feet (anatomy)"/ 568 
39 "elbow (anatomy)"/ 201 
40 "arm (anatomy)"/ 1501 
41 wrist/ 406 
42 "leg (anatomy)"/ 862 
43 ankle/ 317 
44 exp spinal column/ 541 
45 33 or 34 or 35 or 36 or 37 or 38 
or 39 or 40 or 41 or 42 or 43 or 
44 
8915 
46 31 and 45 770 
47 (back adj3 pain).ti,ab. 4057 
48 (knee adj3 pain).ti,ab. 241 
49 (neck adj3 pain).ti,ab. 863 
50 (hand adj3 pain).ti,ab. 147 
51 (shoulder adj3 pain).ti,ab. 364 
52 (hip adj3 pain).ti,ab. 99 
53 (foot adj3 pain).ti,ab. 72 
54 (elbow adj3 pain).ti,ab. 20 
55 (arm adj3 pain).ti,ab. 145 
56 (forearm adj3 pain).ti,ab. 50 
57 (wrist adj3 pain).ti,ab. 36 
58 (leg adj3 pain).ti,ab. 210 
59 (ankle adj3 pain).ti,ab. 23 
60 (spinal adj3 pain).ti,ab. 583 
61 backache.ti,ab. 105 
62 (low back adj3 pain).ti,ab. 2451 
63 chronic pain/ 9741 
64 (chronic adj3 pain).ti,ab. 13231 
65 (musculoskeletal adj3 pain).ti,ab. 1054 
66 (widespread adj3 pain).ti,ab. 403 
67 (multisite adj3 pain).ti,ab. 13 
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68 (regional adj3 pain).ti,ab. 626 
69 (juvenile adj3 fibromyalgia).ti,ab. 24 
70 47 or 48 or 49 or 50 or 51 or 52 
or 53 or 54 or 55 or 56 or 57 or 
58 or 59 or 60 or 61 or 62 or 63 
or 64 or 65 or 66 or 67 or 68 or 
69 
19247 
71 31 or 32 or 46 or 70 33666 
72 18 and 30 and 71 923 
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Appendix III Pain manikin used in CATS 
The pain manikin used to describe the presence of pain in the body is shown below. 
 
The pain sites present in the manikin were grouped in 17 pain areas as follow: 
 Head pain: 17 and 26 
 Neck/throat pain: 27 
 Shoulder pain: 15, 16, 42 and 43 
 Elbow pain: 12, 14, 40 and 41 
 Hand pain: 9, 10, 36 and 37 
 Forearm pain: 11, 13, 38 and 39 
 Upper back pain: 24 and 25 
 Lower back pain: 22 and 23 
 Thoracic spine pain: 18 
 Lumbar spine pain: 19 
 Knee pain: 5, 6, 32 and 33 
 Foot pain: 0, 2, 28 and 29 
 Abdominal pain: 46, 47, 48 and 49 
 Chest pain: 44, 45 and 50 
 Buttock pain: 20 and 21 
 Thigh pain: 34 and 35 
 Shin/calf pain: 3, 4, 30 and 31  
368 
 
Appendix IV Strengths and Difficulties Questionnaire 
The Strengths and Difficulties Questionnaire includes the following items, which are listed below: 
 
Hyperactivity Scale: 
 Restless, overactive, cannot stay still for long 
 Constantly fidgeting or squirming 
 Easily distracted, concentration wanders 
 Thinks things out before acting 
 Sees tasks through to the end, good attention span 
Emotional Symptoms Scale: 
 Often complains of headaches, stomach-aches or sickness 
 Many worries, often seems worried 
 Often unhappy, down-hearted or tearful 
 Nervous or clingy in new situations, easily loses confidence 
 Many fears, easily scared 
Conduct Problems Scale: 
 Often has temper tantrums or hot tempers 
 Generally obedient, usually does what adults request 
 Often fights with other children or bullies them 
 Often lies or cheats 
 Steals from home, school or elsewhere 
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Peer Problems Scale: 
 Rather solitary, tends to play alone 
 Has at least one good friend 
 Generally liked by other children 
 Picked on or bullied by other children 
 Gets on better with adults than with other children 
Prosocial Scale: 
 Considerate of other people's feelings 
 Shares readily with other children (treats, toys, pencils etc) 
 Helpful if someone is hurt, upset or feeling ill 
 Kind to younger children 
 Often volunteers to help others (parents, teachers, other children) 
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Appendix V Association between baseline sleep problems and the onset of 
musculoskeletal pain between the imputed and the complete-case dataset 
Comparison of the odds for the onset of musculoskeletal pain in analysis performed with the 
multiple imputed dataset and the complete-case dataset 
The estimates for the onset of musculoskeletal pain obtained with the multiple imputed dataset 
and the complete-case dataset were compared. Results for the association between sleep 
problems and the onset of musculoskeletal pain (Table I) and the onset of chronic musculoskeletal 
pain (Table II) are shown. Results showed that the estimates of odds for the onset of 
musculoskeletal pain or chronic musculoskeletal pain reported in the adjusted analysis performed 
within the multiple imputed dataset were slightly lower than those reported with the complete-
case dataset. This may be explained by the fact that the inclusion of the group of children with 
missing data for the confounding variables has lowered the odds for the onset of musculoskeletal 
pain. This is consistent with the results of the sensitivity analysis performed to explore the 
difference in odds for the onset of musculoskeletal pain between the group of children with 
complete data and those with missing data for the confounding variables (Please see below 
section “Sensitivity analysis between the group of adolescents with complete data and those with 
missing data for the confounding variables”). 
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Table II Logistic regression of the association between 
sleep problems at baseline and musculoskeletal pain 
onset at follow-up 
Complete-case dataset 
Unadjusted (n=438) Odds ratio (95%CI) 
Sleep problems 1.48 (0.94, 2.34) 
Adjusted (n=279) Odds ratio (95%CI) 
Sleep problems 1.53 (0.87, 2.70) 
Multiple imputed dataset 
Imputed Unadjusted 
analysis (n=441) 
Odds ratio (95%CI) 
Sleep problems 1.47 (0.93, 2.31) 
Imputed Adjusted 
analysis (n=441) 
Odds ratio (95%CI) 
Sleep problems 1.35 (0.84, 2.16) 
Table II Logistic regression of the association between 
sleep problems at baseline and chronic musculoskeletal 
pain onset at follow-up 
Complete-case dataset 
Unadjusted (n=938) Odds ratio (95%CI) 
Sleep problems 2.56 (1.68, 3.90) 
Adjusted (n=609) Odds ratio (95%CI) 
Sleep problems 2.32 (1.37, 3.90) 
Multiple imputed dataset 
Imputed Unadjusted 
analysis (n=944) 
Odds ratio (95%CI) 
Sleep problems 2.56 (1.68, 3.90) 
Imputed Adjusted 
analysis (n=944) 
Odds ratio (95%CI) 
Sleep problems 2.22 (1.43, 3.44) 
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Sensitivity analysis between the group of adolescents with complete data and those with 
missing data for the confounding variables 
Sensitivity analysis were performed to explore the difference in odds for the onset of 
musculoskeletal pain between the group of children with complete data (N = 279) and those with 
missing data (N = 159) for the confounding variables. Results from the unadjusted logistic 
regression analysis showed that children with missing data for the confounding variables were at 
lower odds for the onset of musculoskeletal pain compared to those with complete data (Table 
III). Similarly, children with missing data (N = 329) for the confounding variables were at lower 
odds for the onset of chronic musculoskeletal pain compared to with complete data (N = 609) 
(Table IV). 
 
 
 
 
  
Table III Logistic regression of the association between sleep problems 
at baseline and musculoskeletal pain onset at follow-up 
Group with missing data (N = 159) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 1.06 0.46, 2.46 
Group with complete data (N = 279) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 1.67 0.96, 2.89 
Table IV Logistic regression of the association  between sleep problems 
at baseline and chronic musculoskeletal pain onset at follow-up 
Group with missing data (N = 329) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 1.68 1.02, 2.77 
Group with complete data (N = 609) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Sleep problems 2.08 1.47, 2.96 
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Appendix VI Sensitivity analysis with sleep problems as a categorical variable 
Analysis of the association between sleep problems and the onset of musculoskeletal pain and 
chronic musculoskeletal pain with sleep problems entered as a categorical variable with 5 
frequencies of sleep problems (never sleep problems as the reference group) were carried out. 
Results showed that increasing frequency of sleep problems were associated with overall 
increasing odds for the onset of musculoskeletal pain and chronic musculoskeletal pain. The effect 
was more pronounced and linear for the association between sleep problems and the onset of 
chronic musculoskeletal pain compared to analysis for the onset of musculoskeletal pain. The low 
cell count within some subgroups (children in advanced puberty, Table VII and Table XI, and with 
low levels of screen time, Table VIII) did not permit to estimate the odds for the onset of 
musculoskeletal pain and chronic musculoskeletal pain. Results are outlined below (Table V –
Table XII).  
 
 
 
Table V Logistic regression of the association between sleep problems at 
baseline and musculoskeletal pain onset at follow-up 
Unadjusted analysis 
Overall (N = 441) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 1.20 0.70, 2.06 
Sometimes 1.48 0.88, 2.47 
Often 2.13 1.03, 4.38 
Almost always 1.55 0.82, 2.95 
Adjusted analysis* 
Overall (N = 441) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 1.23 0.71, 2.13 
Sometimes 1.49 0.88, 2.52 
Often 1.99 0.95, 4.18 
Almost always 1.45 0.75, 2.79 
*Analysis adjusted for psychological symptoms (total score), individual sports and team sports 
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Table VI Logistic regression of the association between sleep problems at 
baseline and musculoskeletal pain onset at follow-up stratified by gender 
Unadjusted analysis 
Females  (N = 245) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 1.12 0.54, 2.32 
Sometimes 1.08 0.54, 2.13 
Often 1.44 0.57, 3.66 
Almost always 0.59 0.22, 1.55 
Males (N = 196) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 1.20 0.53, 2.74 
Sometimes 2.13 0.96, 4.73 
Often 3.48 1.09, 11.15 
Almost always 3.78 1.50, 9.52 
Adjusted analysis* 
Females  (N = 245) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 1.15 0.53. 2.46 
Sometimes 0.97 0.47, 1.99 
Often 0.90 0.32, 2.53 
Almost always 0.39 0.14, 1.12 
Males (N = 196) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 1.19 0.52, 2.74 
Sometimes 2.19 0.97, 4.96 
Often 3.52 1.08, 11.47 
Almost always 3.88 1.52, 9.91 
Interaction term* 
Musculoskeletal pain at follow-up  Odds ratio 95% CI 
Gender # Sleep problems 4.03 1.51, 10.78 
*Analysis adjusted for psychological symptoms (total score), individual sports and team sports 
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Table VII Logistic regression of the association between sleep problems at 
baseline and musculoskeletal pain onset at follow-up stratified by 
pubertal stage 
Unadjusted analysis 
Early pubertal stage (N = 377) ● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 1.13 0.62, 2.06 
Sometimes 1.60 0.90, 2.82 
Often 1.81 0.82, 3.99 
Almost always 1.75 0.87, 3.51 
Advanced pubertal stage (N = 50) ● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never / / 
Sometimes / / 
Often / / 
Almost always / / 
Adjusted analysis* 
Early pubertal stage (N = 377) ● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 1.15 0.63, 2.12 
Sometimes 1.62 0.91, 2.88 
Often 1.76 0.78, 3.95 
Almost always 1.70 0.83, 3.49 
Advanced pubertal stage (N = 50) ●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never / / 
Sometimes / / 
Often / / 
Almost always / / 
Interaction term* 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Puberty # Sleep problems 1.10 0.21, 5.79 
*Analysis adjusted for psychological symptoms (total score), individual sports and team sports 
● Sample size vary between 377 and 391 
●● Sample size vary between 50 and 64 
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Table VIII Logistic regression of the association between sleep problems at 
baseline and musculoskeletal pain onset at follow-up stratified by screen 
time 
Unadjusted analysis 
Low screen time (≤2 hours/day) (N = 79) ● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never / / 
Sometimes / / 
Often / / 
Almost always / / 
High screen time (>2 hours/day) (N = 345) ●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 1.26 0.67, 2.37 
Sometimes 1.74 0.96, 3.14 
Often 2.79 1.26, 6.21 
Almost always 1.68 0.82, 3.46 
Adjusted analysis* 
Low screen time (≤2 hours/day) (N = 79) ● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never / / 
Sometimes / / 
Often / / 
Almost always / / 
High screen time (>2 hours/day) (N = 345) ●● 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 1.25 0.66, 2.37 
Sometimes 1.73 0.94, 3.16 
Often 2.59 1.14, 5.88 
Almost always 1.52 0.72, 3.20 
Interaction term* 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Screen time # Sleep problems 1.74 0.45, 6.80 
*Analysis adjusted for psychological symptoms (total score), individual sports and team sports 
● Sample size vary between 79 and 96 
●● Sample size vary between 345 and 362 
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Table IX Logistic regression of the association between sleep problems at 
baseline and chronic musculoskeletal pain onset at follow-up 
Unadjusted analysis 
Overall (N = 944) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 0.91 0.42, 1.98 
Sometimes 1.39 0.68, 2.84 
Often 2.65 1.31, 5.35 
Almost always 2.96 1.51, 5.81 
Adjusted analysis* 
Overall (N = 944) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 0.90 0.41, 1.98 
Sometimes 1.41 0.69, 2.88 
Often 2.53 1.24, 5.13 
Almost always 2.89 1.45, 5.73 
*Analysis adjusted for psychological symptoms (total score), individual sports, team sports and 
baseline musculoskeletal pain 
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Table X Logistic regression of the association between sleep problems at 
baseline and chronic musculoskeletal pain onset at follow-up stratified 
by gender 
Unadjusted analysis 
Females  (N = 510) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 0.99 0.32, 3.07 
Sometimes 1.22 0.42, 3.54 
Often 2.96 1.07, 8.19 
Almost always 2.95 1.08, 8.06 
Males (N = 434) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 0.84 0.28, 2.53 
Sometimes 1.66 0.64, 4.33 
Often 2.43 0.90, 6.52 
Almost always 3.05 1.22, 7.62 
Adjusted analysis* 
Females (N = 510) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 0.93 0.30, 2.90 
Sometimes 1.15 0.39, 3.37 
Often 2.71 0.97, 7.61 
Almost always 2.92 1.05, 8.14 
Males (N = 434) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 0.88 0.29, 2.64 
Sometimes 1.69 0.65, 4.44 
Often 2.40 0.88, 6.50 
Almost always 2.96 1.17, 7.51 
Interaction term* 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Gender # Sleep problems 0.82 0.35, 1.93 
*Analysis adjusted for psychological symptoms (total score), individual sports, team sports and 
baseline musculoskeletal pain 
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Table XI Logistic regression of the association between sleep problems at 
baseline and chronic musculoskeletal pain onset at follow-up stratified 
by pubertal stage 
Unadjusted analysis 
Early pubertal stage (N = 808)● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 0.92 0.40, 2.12 
Sometimes 1.47 0.68, 3.15 
Often 2.56 1.19, 5.52 
Almost always 2.82 1.34, 5.89 
Advanced pubertal stage (N = 112)●● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never / / 
Sometimes / / 
Often / / 
Almost always / / 
Adjusted analysis* 
Early pubertal stage (N = 808)● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 0.92 0.40, 2.14 
Sometimes 1.48 0.69, 3.21 
Often 2.47 1.13, 5.38 
Almost always 2.75 1.29, 5.87 
Advanced pubertal stage (N = 112)●● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never / / 
Sometimes / / 
Often / / 
Almost always / / 
Interaction term* 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Puberty # Sleep problems 1.99 0.38, 10.50 
*Analysis adjusted for psychological symptoms (total score), individual sports, team sports and 
baseline musculoskeletal pain 
●Sample size vary between 808 and 832   
●●Sample size vary between 112 and 136 
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Table XII Logistic regression of the association between sleep problems at 
baseline and chronic musculoskeletal pain onset at follow-up stratified 
by screen time 
Unadjusted analysis 
Low screen time (≤2 hours/day) (N = 198)● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 0.95 0.20, 4.46 
Sometimes 0.83 0.15, 4.58 
Often 1.79 0.35, 9.20 
Almost always 2.19 0.49, 9.79 
High screen time (>2 hours/day) (N = 720)●● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 0.88 0.35, 2.23 
Sometimes 1.59 0.69, 3.64 
Often 2.95 1.30, 6.72 
Almost always 3.23 1.48, 7.04 
Adjusted analysis* 
Low screen time (≤2 hours/day) (N = 198)● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 0.89 0.19, 4.30 
Sometimes 0.82 0.15, 4.59 
Often 1.92 0.36, 10.07 
Almost always 2.15 0.47, 9.93 
High screen time (>2 hours/day) (N = 720)●● 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Almost never 0.85 0.33, 2.17 
Sometimes 1.60 0.69, 3.69 
Often 2.73 1.19, 6.29 
Almost always 2.98 1.34, 6.63 
Interaction term* 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Screen time # Sleep problems 1.19 0.37, 3.77 
*Analysis adjusted for Psychological symptoms (total score), individual sports, team sports and 
baseline musculoskeletal pain 
●Sample size vary between 198 and 224   
●●Sample size vary between 720 and 746 
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Appendix VII Pain manikin used in ALSPAC 
The pain manikin used to describe the presence of pain in the body, together with the questions 
used to assess the pain presence, is shown below. 
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The pain sites marked in the manikin were grouped in the following 26 pain areas: 
 Head pain 
 Neck/throat pain 
 Right shoulder pain  
 Right elbow pain 
 Right hand pain 
 Right lower arm pain 
 Left shoulder pain  
 Left elbow pain 
 Left hand pain 
 Left lower arm pain 
 Right knee pain 
 Right hip pain 
 Right foot/ankle pain  
 Right shin/calf pain 
 Left knee pain 
 Left hip pain 
 Left foot/ankle pain  
 Left shin/calf pain 
 Upper right back pain 
 Lower right back pain 
 Upper left back pain 
 Lower left back pain 
 Right buttock pain 
 Left buttock pain  
 Upper back/neck pain 
 Lower back pain 
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Appendix VIII Association between baseline internalizing and externalizing symptoms 
and the onset of musculoskeletal pain in those with missing data and those with 
complete data for the confounding variables 
Comparison of the odds for the onset of musculoskeletal pain in analysis performed with the 
multiple imputed dataset and the complete-case dataset 
The estimates for the onset of musculoskeletal pain obtained with the multiple imputed dataset 
and the complete-case dataset were compared. Results for the association between internalizing 
symptoms, externalizing symptoms and the onset of musculoskeletal pain (Table XIII and Table 
XIV) and the onset of chronic musculoskeletal pain (Table XV and Table XVI) are shown. Results 
showed that the estimates of odds for the onset of musculoskeletal pain or chronic 
musculoskeletal pain reported in the adjusted analysis performed within the multiple imputed 
dataset were consistently stronger in comparison to the complete-case. The pattern of 
adjustment showed a general reduction of effect in the complete case analysis, whereas there is a 
similar or increased effect within the multiple imputation dataset. This suggests the imputation of 
data leads to an increase in effect because the group with missing data includes individuals with a 
greater propensity to report musculoskeletal pain outcomes, as shown below in Section 
“Sensitivity analysis between the group of adolescents with complete data and those with missing 
data for the confounding variables”.  
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Table XIII Logistic regression of the association 
between internalizing symptoms at baseline and the 
onset of musculoskeletal pain at follow-up 
Complete-case dataset 
Unadjusted 
(n=1,467) 
Odds ratio (95%CI) 
Internalizing >90th 1.35 (0.91, 1.99) 
Adjusted (n=1,148) Odds ratio (95%CI) 
 
Internalizing >90th 1.23 (0.78, 1.93) 
Multiple-imputed dataset 
Imputed Unadjusted 
analysis (n=1,604) 
Odds ratio (95%CI) 
 
Internalizing >90th 1.34 (0.90, 1.99) 
Imputed Adjusted 
analysis (n=1,604) 
Odds ratio (95%CI) 
 
Internalizing >90th 1.43 (0.96, 2.12) 
Table XIV Logistic regression of the association 
between externalizing symptoms at baseline and the 
onset of musculoskeletal pain at follow-up 
Complete-case dataset 
Unadjusted 
(n=1,468) 
Odds ratio (95%CI) 
Externalizing >90th 2.04 (1.32, 3.16) 
Adjusted (n=1,149) Odds ratio (95%CI) 
 
Externalizing >90th 1.59 (0.95, 2.67) 
Multiple-imputed dataset 
Imputed Unadjusted 
analysis (n=1,604) 
Odds ratio (95%CI) 
 
Externalizing >90th 1.99 (1.29, 3.09) 
Imputed Adjusted 
analysis (n=1,604) 
Odds ratio (95%CI) 
 
Externalizing >90th 1.99 (1.28, 3.10) 
385 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table XV Logistic regression of the association 
between internalizing symptoms at baseline and the 
onset of chronic musculoskeletal pain at follow-up 
Complete-case dataset 
Unadjusted 
(n=1,461) 
Odds ratio (95%CI) 
Internalizing >90th 1.23 (0.75, 2.02) 
Adjusted (n=1,143) 
Odds ratio (95%CI) 
Internalizing >90th 0.96 (0.52, 1.78) 
Multiple-imputed dataset 
Imputed Unadjusted 
analysis (n=1,598) 
Odds ratio (95%CI) 
Internalizing >90th 1.24 (0.75, 2.05) 
Imputed Adjusted 
analysis (n=1,598) 
Odds ratio (95%CI) 
Internalizing >90th 1.28 (0.77, 2.11) 
Table XVI Logistic regression of the association 
between externalizing symptoms at baseline and the 
onset of chronic musculoskeletal pain at follow-up 
Complete-case dataset 
Unadjusted 
(n=1,462) 
Odds ratio (95%CI) 
Externalizing >90th 1.69 (1.01, 2.82) 
Adjusted (n=1,144) 
Odds ratio (95%CI) 
Externalizing >90th 1.29 (0.67, 2.49) 
Multiple-imputed dataset 
Imputed Unadjusted 
analysis (n=1,598) 
Odds ratio (95%CI) 
Externalizing >90th 1.69 (1.01, 2.83) 
Imputed Adjusted 
analysis (n=1,598) 
Odds ratio (95%CI) 
Externalizing >90th 1.68 (0.96, 2.73) 
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Sensitivity analysis between the group of adolescents with complete data and those with 
missing data for the confounding variables 
Sensitivity analysis were performed to explore the difference in odds for the onset of 
musculoskeletal pain between the group of adolescents with complete data (N = 1,149) and those 
with missing data (N = 319) for the confounding variables. Results showed that adolescents with 
missing data for the confounding variables were at higher odds for the onset of musculoskeletal 
pain compared to those with complete data (Table XVII and Table XVIII). Similarly, adolescents 
with missing data for the confounding variables were at higher odds for the onset of chronic 
musculoskeletal pain compared to those with complete data (Table XIX and Table XX). 
 
 
 
 
 
Table XVII Logistic regression of the association between internalizing 
symptoms at baseline and the onset of musculoskeletal pain at 
follow-up 
Group with missing data (N = 319) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 2.33 0.99, 5.50 
Group with complete data (N = 1,149) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 1.17 0.75, 1.82 
Table XVIII Logistic regression of the association between 
externalizing symptoms at baseline and the onset of musculoskeletal 
pain at follow-up 
Group with missing data (N = 319) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 4.00 1.67, 9.59 
Group with complete data (N = 1,149) 
Musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 1.58 0.94, 2.64 
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Table XIX Logistic regression of the association between internalizing 
symptoms at baseline and the onset of chronic musculoskeletal pain at 
follow-up 
Group with missing data (N = 318) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 2.38 0.96, 5.90 
Group with complete data (N = 1,144) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Internalizing symptoms 0.96 0.52, 1.76 
Table XX Logistic regression of the association between externalizing 
symptoms at baseline and the onset of chronic musculoskeletal pain at 
follow-up 
Group with missing data (N = 318) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 2.55 1.07, 6.07 
Group with complete data (N = 1,144) 
Chronic musculoskeletal pain at follow-up Odds ratio 95% CI 
Externalizing symptoms 1.33 0.70, 2.56 
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Appendix IX Read Codes for the variables used within CiPCA 
Musculoskeletal pain 
Musculoskeletal pain 
Read Code Description 
14V50 H/0: arthrodesis toe foot 
16 Baker's cyst knee 
16... Back sprain NOS back 
16... Baker's cyst knee 
16A Stiff neck symptom neck 
16A2 Stiff neck neck 
16A3 Torticollis - symptom neck 
16A3 Wry neck symptom neck 
16A3 Wry neck/torticollis neck 
16AZ Stiff neck symptom NOS neck 
16C Backache symptom back 
16C2 Backache back 
16C3 Backache with radiation back 
16C4 Back pain worse on sneezing back 
16C5 C/O - low back pain lower back 
16C6 Back pain without radiat NOS back 
16C6 Back pain without radiation NOS back 
16C7 C/O - upper back ache upper back 
16C8 Exacerbation of backache back 
16C9 Chronic low back pain lower back 
16CA Mechanical low back pain lower back 
16CZ Backache symptom NOS back 
16J0 Swollen calf lower leg 
16J1 Swollen toe foot 
16J2 Swollen thumb hand 
16J3 Swollen joint unspecified 
16J4 Swollen knee knee 
16J5 Facial swelling head 
16J6 Swollen hand hand 
16J7 Swollen foot foot 
16Z2 Growing pains unspecified 
182 Chest pain chest 
1822 Central chest pain chest 
1823 Precordial pain chest 
1824 Anterior chest wall pain chest 
1826 Parasternal pain chest 
1828 Atypical chest pain chest 
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182B Rib pain chest 
182B0 Costal margin chest pain chest 
182C Chest wall pain chest 
182Z Chest pain NOS chest 
1832 Ankle swelling ankle 
1832 Ankle swelling symptom ankle 
1833 Leg swelling lower limb 
1833 Leg swelling symptom lower limb 
1834 Finger swelling hand 
1834 Swollen finger hand 
19690 Abdominal wall pain abdomen 
1973 Left subcostal pain chest 
1974 Right subcostal pain chest 
1A53 C/O - loin pain pelvis 
1A53 C/O - lumbar pain lower back 
1A53 C/O - renal pain lower back 
1A53 Lumbar ache - renal lower back 
1A59 C/O pelvic pain pelvis 
1D12 C/O: stiffness unspecified 
1D130 C/O - pain in toes foot 
1D131 C/O - pain in big toe foot 
1D17 Morning stiffness - joint unspecified 
1D22 C/O - a chest wall symptom chest 
1D22 Symptom: chest wall chest 
1D24 Symptom: trunk posterior back 
1D26 C/O - upper limb symptom upper limb 
1D26 Symptom: upper limb upper limb 
1D27 Symptom: lower limb lower limb 
1D28 C/O - ankle symptom ankle 
1D28 C/O - foot symptom foot 
1D28 Symptom: ankle/foot ankle/foot 
1DCC Aching muscles unspecified 
1M0 Pain in upper limb upper limb 
1M00 Elbow pain elbow 
1M00 Pain in elbow elbow 
1M01 Pain in wrist wrist 
1M1 Pain in lower limb lower limb 
1M10 Knee pain knee 
1M11 Foot pain foot 
1M12 Anterior knee pain knee 
1M13 Ankle pain ankle 
ASDFGHI3 Hip Pain? hip 
ASDFGHI4 Hip Pain hip 
ASDFGJO2 Joint Symptoms unspecified 
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ASDFGJO3 Joint Pain unspecified 
ASDFGKN2 Knee Pain? knee 
ASDFGKN3 Knee Pain knee 
ASDFGKN4 Knee Pain Affects Sleep? knee 
ASDFGKN5 Knee Pain Affects Sleep knee 
ASDFGKN6 Knee Pain Does Not Affect Sleep knee 
ASDFGMU2 Muscle Symptoms unspecified 
ASDFGTE2 Tendon Symptoms unspecified 
DEGRADE_EVEN
T_1730_49 [DEGRADE Muscle Injury] unspecified 
DEGRADE_EVEN
T_2469_340 [DEGRADE Knee Pain] knee 
DEGRADE_EVEN
T_3154_40 [DEGRADE Knee Pain] knee 
EGTON1 Arthralgia unspecified 
EGTON107 Deformity of Feet foot 
EGTON110 Muscle Injury unspecified 
EGTON211 Sore Thumb hand 
EGTON224 Painful Shoulder shoulder 
EGTON264 Low Back Pain lower back 
EGTON267 Injury To Left Hand hand 
EGTON273 Left Loin Pain pelvis 
EGTON279 Painful Right Knee knee 
EGTON303 Groin Pain pelvis 
EGTON304 Painful Left Arm upper limb 
EGTON307 Myalgia unspecified 
EGTON309 Sore Neck neck 
EGTON312 Painful Elbow elbow 
EGTON436 Radiculopathy unspecified 
EGTON444 Gluteal Muscle Injury unspecified 
EGTON56 Calcaneal Spur foot 
EGTON57 Plantar Fasciitis foot 
EGTONBO1 Both Hips Unstable hip 
EGTONBO3 Both Hips Click hip 
EGTONHI2 Hip Unstable hip 
EGTONHI3 Hip Clicks hip 
EGTONHY1 Hyper-Extension Injury Of Finger hand 
EGTONLE3 Left Hip Unstable hip 
EGTONLE5 Left Hip Clicks hip 
EGTONRI3 Right Hip Unstable hip 
EGTONRI5 Right Hip Clicks hip 
EMISNQAN8 Ankle injury NOS ankle 
EMISNQFO5 Forced plantar flexion injury of ankle ankle 
EMISNQIN18 Inversion injury of ankle ankle 
EMISNQMU15 Musculoskeletal symptom unspecified 
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EMISNQMU2 Musculoskeletal pain present unspecified 
EMISNQMU4 Musculoskeletal pain moderate unspecified 
EMISNQMU5 Musculoskeletal pain severe unspecified 
EMISNQNE5 Nerve root pain present unspecified 
EMISNQSC20 Scoliosis of thoracic spine upper back 
EMISNQTE2 Tenderness of head of fibula lower leg 
EMISNQTH14 Thoracic back pain upper back 
EMISREQ|M2I5(
9) Hand joint pain -Req. hand 
HNG0157 (hn) Spinal Injury back 
HNG0160 (hn) Sports Injury unspecified 
HNG0162 (hn) Soft tissue injuries unspecified 
HNG0162 [RFC] Soft tissue injuries unspecified 
M4A8 Muscle Injury unspecified 
MAWBYHI1 Hip Pain hip 
MAWBYKN1 Knee Pain knee 
MAWBYMU1 Musculoskeletal Symptoms unspecified 
MHTBAGO1 Golfers Elbow-Epicondylitis elbow 
MUNNUKN1 Knee Pain knee 
N Musculoskelet/connectiv tissue unspecified 
N064 Transient arthropathy unspecified 
N0640 Transient arthr.-site unspecif unspecified 
N0641 Transient arthr.-shoulder shoulder 
N0642 Transient arthr.-upper arm upper arm 
N0643 Transient arthr.-forearm forearm 
N0644 Transient arthr.-hand hand 
N0645 Transient arthr.-pelvic/thigh pelvis/thigh 
N0646 Transient arthr.-lower leg lower leg 
N0647 Transient arthr.-ankle/foot ankle/foot 
N0648 Transient arthr.-other specif. unspecified 
N0649 Transient arthr.-multiple site unspecified 
N064A Transient arthropathy-shoulder shoulder 
N064B Transient arthrop-sternoclav j shoulder girdle 
N064C Transient arthr-acromioclav jt shoulder girdle 
N064D Transient arthropathy-elbow elbow 
N064E Transient arthropathy-dist RUJ forearm 
N064F Transient arthropathy-wrist wrist 
N064G Transient arthropathy-MCPJ hand 
N064H Transient arthrop-PIPJ-fing hand 
N064J Transient arthrop-DIPJ-fing hand 
N064K Irritable hip hip 
N064K Transient arthropathy-hip hip 
N064L Transient arthropathy-SIJ pelvis 
N064M Transient arthropathy-knee knee 
N064N Transient arthrop, tib-fib jnt lower leg 
392 
 
N064P Transient arthropathy-ankle ankle 
N064Q Transient arthrop-subtalar jnt foot 
N064R Transient arthrop-talonav jnt foot 
N064S Transient arthrop-oth tars jnt foot 
N064T Transient arthropathy-1st MTPJ foot 
N064U Transient arthrop-less MTPJ foot 
N064V Transient arthropathy-IPJ-toe foot 
N064z Transient arthropathy NOS unspecified 
N06z8 Arthropathy NOS-other specif. unspecified 
N06zz Arthropathy NOS unspecified 
N07 Internal derangement of knee knee 
N070 Medial meniscus derangement knee 
N0700 Medial menisc.derang.unspecif knee 
N0701 Old bucket handle tear-medial knee 
N0702 Medial menisc.ant.horn derang. knee 
N0703 Medial menisc.post.horn derang knee 
N0704 Parr beak tear-post/med menisc knee 
N0705 Periph detach-medial meniscus knee 
N0706 Radial tear of medial meniscus knee 
N0707 Horiz cleavage tear-med menisc knee 
N0708 Multiple tears of medial meniscus knee 
N0708 Multiple tears-medial meniscus knee 
N0709 Cyst of medial meniscus knee 
N070A Old tear of medial meniscus knee 
N070B Old tear post horn med menis knee 
N070z Medial meniscus derange.NOS knee 
N070z Medial meniscus derangement NOS knee 
N071 Lateral meniscus derangement knee 
N0710 Lateral menisc.derang.unspecif knee 
N0711 Old bucket handle tear-lat men knee 
N0712 Lateral menisc.ant.horn derang knee 
N0713 Lateral menisc.post.horn deran knee 
N0714 Lateral meniscus derangem.NOS knee 
N0715 Parr beak tear-post/lat menisc knee 
N0716 Periph detach-lateral meniscus knee 
N0717 Radial tear of lateral meniscus knee 
N0717 Radial tear-lateral meniscus knee 
N0718 Horiz cleavage tear-lat menisc knee 
N0719 Multiple tears-lat meniscus knee 
N071A Cyst of lateral meniscus knee 
N071B Discoid lateral meniscus knee 
N071C Old tear of lateral meniscus knee 
N072 Meniscus derangement NEC knee 
N072 Torn medial meniscus knee 
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N0720 Old torn meniscus of knee knee 
N0721 Degen lesion artic cart knee knee 
N0721 Degenerative lesion of articular cartilage of knee knee 
N0722 Cyst of semilunar cartilage knee 
N073 Loose body in knee knee 
N073 Rice bodies in knee knee 
N074 Chondromalacia patellae knee 
N07y Oth. internal knee derangement knee 
N07y0 Old lat.collat.lig.disruption knee 
N07y1 Old med.collat.lig.disruption knee 
N07y2 Old ant.cruciate lig.disrupt. knee 
N07y3 Old post.cruciate lig.disrupt. knee 
N07y4 Old capsular knee lig.disrupt. knee 
N07y5 Locked knee knee 
N07y6 Patellofemoral maltracking knee 
N07y7 Old part tear lat collat lig knee 
N07y8 Old compl tear lat collat lig knee 
N07y9 Old post/lat caps complex tear knee 
N07yA Old part tear med collat lig knee 
N07yB Old compl tear med collat lig knee 
N07yC Old med capsular complex tear knee 
N07yD Old part tear ant cruciate lig knee 
N07yE Old comp tear ant cruciate lig knee 
N07yF Old part tear post cruciat lig knee 
N07yG Old comp tear post cruciat lig knee 
N07yH Locking knee knee 
N07yy Other knee lig. old disruption knee 
N07yz Other intern.knee derang.NOS knee 
N07yz Other internal knee derangement NOS knee 
N07z Internal knee derangement NOS knee 
N08 Other derangement of joint unspecified 
N080 Articular cart.disor.excl.knee unspecified 
N0800 Artic.cart.dis.-site unspecif. unspecified 
N0801 Artic.cart.dis.-shoulder shoulder 
N0802 Artic.cart.dis.-upper arm upper arm 
N0803 Artic.cart.dis.-forearm forearm 
N0804 Artic.cart.dis.-hand hand 
N0805 Artic.cart.dis.-pelvic/thigh pelvis/thigh 
N0806 Artic.cart.dis.-ankle/foot ankle/foot 
N0807 Artic.cart.dis.-other specif. unspecified 
N0808 Artic.cart.dis.-multiple sites unspecified 
N0809 Hill-Sachs lesion shoulder 
N080B Artic cart disord oth j-should shoulder 
N080C Chondrolysis-femoral head hip 
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N080z Articular cartilage disord.NOS unspecified 
N081 Loose body in joint-excl.knee unspecified 
N0810 Loose body in joint unspecified 
N0810 Loose body in joint - unspec. unspecified 
N0811 Loose body joint-shoulder shoulder 
N0812 Loose body in joint upper arm upper arm 
N0813 Wrist joint loose body wrist 
N0814 Loose body joint-hand hand 
N0815 Loose body joint-pelvic/thigh pelvis/thigh 
N0816 Loose body in ankle joint ankle 
N0816 Loose body joint-ankle/foot ankle/foot 
N0817 Loose body in joint, joint OS unspecified 
N0818 Loose joint body-multip joints unspecified 
N0819 Loose body in shoulder joint shoulder 
N081A Loose body, oth joint-shoulder shoulder 
N081B Loose body in elbow joint elbow 
N081C Loose body in wrist joint wrist 
N081D Loose body in hip joint hip 
N081E Loose body, oth joint-pelvis pelvis 
N081F Loose body in ankle joint ankle 
N081G Loose body in foot joint foot 
N081z Loose joint body (ex.knee)NOS unspecified 
N082Z Non-trau subl acromiocl joint shoulder girdle 
N083a Carpal instability, V.I.S.I. hand 
N083b Carpal instab, ulnar transloc hand 
N083c Carpal instab, dorsal sublux hand 
N083C Recurrent sublux shoulder-ant shoulder 
N083d Carpal instability, other hand 
N083D Recurrent sublux shoulder-post shoulder 
N083f Recurrent sublux - CMC joint hand 
N083F Recurrent sublux shoulder-inf shoulder 
N083h Recurrent sublux - MCP joint hand 
N083h Recurrent subluxation of MCP joint hand 
N083H Recurrent sublux shoulder-ant shoulder 
N083k Recurrent sublux - IP joint hand 
N083K Recur sublux shoulder-multidir shoulder 
N083M Habitual sublux shoulder shoulder 
N083P Recurrent subluxation of elbow elbow 
N083q Recurrent sublux - patella knee 
N083R Recurr sublux, sup rad-uln jt forearm 
N083t Recurrent sublux - ankle ankle 
N083T Recurrent sublux-radial head elbow 
N083v Recurrent sublux-subtal joint foot 
N083V Recurr sublux, inf rad-uln jt forearm 
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N083w Recurrent sublux-oth foot jt foot 
N083x Recurrent subluxation hip hip 
N083X Carpal instability hand 
N083Y Recurrent subluxation of wrist wrist 
N083Z Carpal instability, D.I.S.I. hand 
N084 Contracture of joint unspecified 
N0840 Joint contracture-site unspec unspecified 
N0841 Joint contracture-shoulder shoulder 
N0842 Elbow joint contracture elbow 
N0842 Joint contracture-upper arm upper arm 
N0843 Wrist joint contracture wrist 
N0844 Joint contracture of the hand hand 
N0844 Joint contracture-hand hand 
N0845 Joint contracture-pelvic/thigh pelvis/thigh 
N0846 Knee joint contracture knee 
N0847 Joint contracture-ankle/foot ankle/foot 
N0848 Joint contracture-other specif unspecified 
N0849 Contracture of multiple joints unspecified 
N084a Flexion contracture-knee knee 
N084A Flexion contracture-shoulder shoulder 
N084b Equinus contracture of the ankle ankle 
N084b Equinus contracture-ankle ankle 
N084B Extension contracture-shoulder shoulder 
N084c Calcaneus contracture-ankle ankle 
N084C Abduction contracture-shoulder shoulder 
N084d Flexion contracture of MTPJ foot 
N084D Adduction contracture-shoulder shoulder 
N084e Extension contracture of MTPJ foot 
N084E Int rotat contracture-shoulder shoulder 
N084f Flexion contracture of toe IPJ foot 
N084F Ext rotat contracture-shoulder shoulder 
N084g Exten contracture of toe IPJ foot 
N084G Flexion contracture - elbow elbow 
N084H Extension contracture - elbow elbow 
N084J Pronation contracture - forearm forearm 
N084J Pronation contracture-forearm forearm 
N084K Supination contracture-forearm forearm 
N084L Flexion contracture - wrist wrist 
N084M Extension contracture- wrist wrist 
N084N Uln deviat contracture-wrist wrist 
N084P Rad deviat contracture-wrist wrist 
N084Q Flexion contracture of MCPJ hand 
N084R Extension contracture of MCPJ hand 
N084S Flexion contracture of PIP joint hand 
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N084S Flexion contracture of PIPJ hand 
N084T Flexion contracture of DIP joint hand 
N084T Flexion contracture of DIPJ hand 
N084U Flexion contracture of hip hip 
N084V Extension contracture of hip hip 
N084W Abduction contracture of hip hip 
N084X Adduction contracture of hip hip 
N084Y Int rotation contracture-hip hip 
N084z Contracture of joint NOS unspecified 
N084Z Ext rotation contracture-hip hip 
N086 Unsp.intrapelv.protr.acetabul. pelvis 
N0860 Protrusio acetabuli pelvis 
N0861 Protrus.acetabuli-pelvic/thigh pelvis/thigh 
N086z Protrusio acetabuli NOS pelvis 
N087 Fibrocartilage lesion of joint unspecified 
N0872 Glenoid labrum detachment shoulder 
N0873 Glenoid labrum tear shoulder 
N0874 Triangular fibrocartilage tear shoulder 
N0875 Triangular fibrocartil detach shoulder 
N0876 Acetabular labrum detachment hip 
N0877 Acetabular labrum tear hip 
N0878 Snapping shoulder shoulder 
N08y Instability of joint unspecified 
N08y Other joint derangement NEC unspecified 
N08y0 Oth.joint deran.NEC-site unsp. unspecified 
N08y1 Oth.joint deran.NEC-shoulder shoulder 
N08y2 Oth.joint deran.NEC-upper arm upper arm 
N08y3 Oth.joint deran.NEC-forearm forearm 
N08y4 Oth.joint deran.NEC-hand hand 
N08y5 Oth.joint deran.NEC-pelv/thigh pelvis/thigh 
N08y6 Oth.joint deran.NEC-lower leg lower leg 
N08y7 Oth.joint deran.NEC-ankle/foot ankle/foot 
N08y8 Oth.joint deran.NEC-other spec unspecified 
N08y9 Oth.joint deran.NEC-mult.sites unspecified 
N08yz Other joint derange.NEC NOS unspecified 
N08z Joint derangement NOS unspecified 
N08z0 Joint derange.NOS-site unspec. unspecified 
N08z1 Joint derange.NOS-shoulder shoulder 
N08z2 Joint derange.NOS-upper arm upper arm 
N08z3 Joint derange.NOS-forearm forearm 
N08z4 Joint derange.NOS-hand hand 
N08z5 Joint derange.NOS-pelvic/thigh pelvis/thigh 
N08z6 Joint derange.NOS-ankle/foot ankle/foot 
N08z7 Joint derange.NOS-other spec. unspecified 
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N08z8 Joint derange.NOS-multipl.site unspecified 
N08zz Joint derangement NOS unspecified 
N09 Other/unspecif.joint disorders unspecified 
N090 Effusion of joint unspecified 
N090 Swelling of joint - effusion unspecified 
N0900 Joint effusion-site unspecif. unspecified 
N0901 Joint effusion-shoulder region shoulder 
N0902 Joint effusion-upper arm upper arm 
N0903 Joint effusion of the forearm forearm 
N0903 Wrist joint effusion wrist 
N0904 Joint effusion of the hand hand 
N0904 Joint effusion-hand hand 
N0905 Joint effusion-pelvic/thigh pelvis/thigh 
N0906 Effusion - knee joint knee 
N0906 Joint effusion of the lower leg lower leg 
N0906 Joint effusion-lower leg lower leg 
N0906 Knee joint effusion knee 
N0907 Joint effusion-ankle/foot ankle/foot 
N0908 Joint effusion-other specif. unspecified 
N0909 Effusion of multiple joints unspecified 
N090A Effusion of shoulder shoulder 
N090B Effusion of sternoclav joint shoulder girdle 
N090B Effusion of sternoclavicular joint shoulder girdle 
N090C Effusion of acromioclav joint shoulder girdle 
N090D Effusion of elbow elbow 
N090E Effusion of distal RUJ forearm 
N090F Effusion of wrist wrist 
N090G Effusion of MCP joint hand 
N090H Effusion of PIP joint - finger hand 
N090H Effusion of PIP joint of finger hand 
N090J Effusion of DIP joint - finger hand 
N090K Effusion of hip hip 
N090L Effusion of sacro-iliac joint pelvis 
N090M Effusion of knee knee 
N090N Effusion, tibio-fibular joint lower leg 
N090P Effusion of ankle ankle 
N090Q Effusion of subtalar joint foot 
N090R Effusion of talonavicular joint foot 
N090R Effusion, talonavicular joint foot 
N090S Effusion of other tarsal joint foot 
N090T Effusion of 1st MTP joint foot 
N090U Effusion of lesser MTP joint foot 
N090V Effusion of IP joint of toe foot 
N090W Intermittent hydrarthrosis unspecified 
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N090X Chronic joint effusion unspecified 
N090Y Acute joint effusion unspecified 
N090z Effusion of joint NOS unspecified 
N094 Ache in joint unspecified 
N094 Pain in joint - arthralgia unspecified 
N0940 Arthralgia - site unspecified unspecified 
N0940 Arthralgia of unspecified site unspecified 
N0941 Arthralgia - shoulder shoulder 
N0941 Arthralgia of the shoulder region shoulder 
N0941 Painful Shoulder shoulder 
N0941 Shoulder joint pain shoulder 
N0942 Arthralgia - upper arm upper arm 
N0942 Arthralgia of the upper arm upper arm 
N0942 Elbow joint pain elbow 
N0943 Arthralgia - forearm forearm 
N0943 Arthralgia of the forearm forearm 
N0943 Wrist joint pain wrist 
N0944 Arthralgia - hand hand 
N0944 Arthralgia of the hand hand 
N0944 Hand joint pain hand 
N0945 Arthralgia - pelvic/thigh pelvis/thigh 
N0945 Arthralgia of the pelvic region and thigh pelvis/thigh 
N0945 Coxalgia hip 
N0945 Hip joint pain hip 
N0945 Irritable hip hip 
N0945 Pain in joint - coxalgia hip 
N0946 Arthralgia - lower leg lower leg 
N0946 Arthralgia of the lower leg lower leg 
N0946 Knee joint pain knee 
N0947 Ankle joint pain ankle 
N0947 Ankle/foot joint pain ankle/foot 
N0947 Arthralgia - ankle/foot ankle/foot 
N0947 Arthralgia of the ankle and foot ankle/foot 
N0948 Arthralgia - other specified unspecified 
N0948 Arthralgia of other specified site unspecified 
N0949 Arthralgia of multiple joints unspecified 
N0949 Multiple joint pain unspecified 
N094A Arthralgia of shoulder shoulder 
N094B Arthralgia - sternoclav joint shoulder girdle 
N094C Arthralgia - acromioclav joint shoulder girdle 
N094D Arthralgia of elbow elbow 
N094E Arthralgia of distal RUJ forearm 
N094F Arthralgia of wrist wrist 
N094F Wrist pain wrist 
399 
 
N094G Arthralgia of MCP joint hand 
N094H Arthralgia of PIP joint of finger hand 
N094H Arthralgia of PIPJ of finger hand 
N094J Arthralgia of DIP joint of finger hand 
N094J Arthralgia of DIPJ of finger hand 
N094K Arthralgia of hip hip 
N094K Coxalgia hip 
N094K Hip pain hip 
N094K Osteoarthritis unspecified 
N094L Arthralgia of sacro-iliac joint pelvis 
N094L Arthralgia of SIJ pelvis 
N094M Arthralgia of knee knee 
N094N Arthralgia of tib-fib joint lower leg 
N094P Arthralgia of ankle ankle 
N094Q Arthralgia of subtalar joint foot 
N094R Arthralgia of talonavic joint foot 
N094R Arthralgia of talonavicular joint foot 
N094S Arthralgia of oth tarsal joint foot 
N094S Arthralgia of other tarsal joint foot 
N094T Arthralgia of 1st MTP joint foot 
N094U Arthralgia of lesser MTP joint foot 
N094V Arthralgia of IP joint of toe foot 
N094W Anterior knee pain knee 
N094z Arthralgia NOS unspecified 
N094z Joint pain NOS unspecified 
N095 Joint stiffness NEC unspecified 
N0950 Stiff joint NEC-site unspecif. unspecified 
N0951 Shoulder joint stiffness shoulder 
N0951 Shoulder stiff shoulder 
N0951 Stiff joint NEC-shoulder shoulder 
N0952 Elbow stiff elbow 
N0952 Stiff joint NEC-upper arm upper arm 
N0953 Stiff joint NEC of the forearm forearm 
N0953 Wrist stiff wrist 
N0954 Hand joint stiff hand 
N0954 Hand joint stiffness hand 
N0954 Stiff joint NEC of the hand hand 
N0954 Stiff joint NEC-hand hand 
N0954 Stiff joint NEC, of the hand hand 
N0955 Stiff joint NEC-pelvic/thigh pelvis/thigh 
N0956 Knee stiff knee 
N0956 Stiff joint NEC-lower leg lower leg 
N0957 Stiff joint NEC-ankle/foot ankle/foot 
N0958 Stiff joint NEC-other specif. unspecified 
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N0959 Multiple joint stiffness unspecified 
N0959 Multiple stiff joints unspecified 
N095A Stiff shoulder NEC shoulder 
N095B Stiff sternoclavic joint NEC shoulder girdle 
N095C Stiff acromioclavicular joint NEC shoulder girdle 
N095D Stiff elbow NEC elbow 
N095E Stiff distal rad-uln joint NEC forearm 
N095F Stiff wrist NEC wrist 
N095G Stiff MCP joint NEC hand 
N095H Stiff PIP joint of finger NEC hand 
N095J Stiff DIP joint of finger NEC hand 
N095K Stiff hip NEC hip 
N095L Stiff sacro-iliac joint NEC pelvis 
N095M Stiff knee NEC knee 
N095N Stiff tibio-fibular joint NEC lower leg 
N095P Stiff ankle NEC ankle 
N095Q Stiff subtalar joint NEC foot 
N095R Stiff talonavicular joint NEC foot 
N095S Stiff other tarsal joint NEC foot 
N095T Stiff 1st MTP joint NEC foot 
N095U Stiff lesser MTP joint NEC foot 
N095V Stiff IP joint of toe NEC foot 
N095W Stiff finger hand 
N095z Joint stiffness NEC NOS unspecified 
N096 Joint crepitus unspecified 
N096 Musculoskeletal pain - joints unspecified 
N096 Other joint symptoms unspecified 
N0960 Other joint sympt.-site unspec unspecified 
N0960 Weakness of joint unspecified 
N0961 Other joint sympt.-shoulder shoulder 
N0961 Other joint symptoms of the shoulder region shoulder 
N0962 Other joint sympt.-upper arm upper arm 
N0963 Other joint sympt.-forearm forearm 
N0963 Other joint symptoms of the forearm forearm 
N0964 Other joint sympt.-hand hand 
N0964 Other joint symptoms of the hand hand 
N0965 Hip snapping hip 
N0965 Other joint sympt.-pelv./thigh pelvis/thigh 
N0966 Knee gives way knee 
N0966 Other joint sympt.-lower leg lower leg 
N0966 Unstable knee knee 
N0967 Other joint symptoms of the ankle and foot ankle/foot 
N0967 Unstable ankle ankle 
N0968 Other joint sympt.-other spec. unspecified 
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N0969 Other joint sympt.-multip.site unspecified 
N096A Other symptoms - shoulder shoulder 
N096B Other symptoms - sternoclav jt shoulder girdle 
N096C Other symptoms - acromioclav j shoulder girdle 
N096D Other symptoms - elbow elbow 
N096E Other symptoms - distal RUJ forearm 
N096F Other symptoms - wrist wrist 
N096G Other symptoms - MCPJ hand 
N096H Other symptoms - PIPJ finger hand 
N096H Other symptoms - PIPJ, finger hand 
N096J Other symptoms - DIPJ, finger hand 
N096K Other symptoms - hip hip 
N096L Other symptoms - SIJ pelvis 
N096M Other symptoms - knee knee 
N096N Other symptoms - tib-fib joint lower leg 
N096P Other symptoms - ankle ankle 
N096Q Other symptoms - subtal joint foot 
N096R Other symptoms - talonav joint foot 
N096S Other symptoms - oth tarsal jt foot 
N096T Other symptoms - 1st MTPJ foot 
N096T Other symptoms in 1st MTP joint foot 
N096U Other symptoms - lesser MTPJ foot 
N096V Other symptoms - IPJ of toe foot 
N096V Other symptoms in IP joint of toe foot 
N096z Other joint symptoms NOS unspecified 
N097 Difficulty in walking unspecified 
N0970 Walking difficulty due to unspecified site unspecified 
N0970 Walking difficulty-site unspec unspecified 
N0971 Walking diffic.-pelvic/thigh pelvis/thigh 
N0972 Walking difficulty-lower leg lower leg 
N0973 Walking difficulty-ankle/foot ankle/foot 
N0974 Walking difficulty-other spec. unspecified 
N0975 Walking difficulty-multip.site unspecified 
N097z Difficulty in walking NOS unspecified 
N098 Synovial osteochondromatosis unspecified 
N0980 Synov osteochondromat-shoulder shoulder 
N0981 Synov osteochondromat st-cla j shoulder girdle 
N0982 Synov osteochondromat ac-cla j shoulder girdle 
N0983 Synov osteochondromat-elbow elbow 
N0984 Synov osteochondromat-dist RUJ forearm 
N0985 Synov osteochondromat-wrist wrist 
N0986 Synov osteochondromat-MCPJ hand 
N0987 Synov osteochondromat PIPJ-fin hand 
N0988 Synov osteochondromat DIPJ-fin hand 
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N0989 Synov osteochondromat-hip hip 
N098A Synov osteochondromat-SIJ pelvis 
N098B Synov osteochondromat-knee knee 
N098C Synov osteochondromat-tibfib j lower leg 
N098D Synov osteochondromat-ankle ankle 
N098E Synov osteochondromat-subtal j foot 
N098F Synov osteochondromat-talnav j foot 
N098G Synov osteochondromat-oth ta j foot 
N098H Synov osteochondromat-1st MTPJ foot 
N098J Synov osteochondromat-les MTPJ foot 
N098K Synov osteochondromat-IPJ-toe foot 
N099 Clicking joint unspecified 
N0990 Clicking shoulder shoulder 
N0991 Clicking sternoclavic joint shoulder girdle 
N0991 Clicking sternoclavicular joint shoulder girdle 
N0992 Clicking acromioclavicular joint shoulder girdle 
N0993 Clicking elbow elbow 
N0994 Clicking distal rad-uln joint forearm 
N0995 Clicking wrist wrist 
N0996 Clicking MCP joint hand 
N0997 Clicking PIP joint of finger hand 
N0998 Clicking DIP joint of finger hand 
N0999 Clicking hip hip 
N099A Multiple clicking joints unspecified 
N099B Clicking sacro-iliac joint pelvis 
N099C Clicking knee knee 
N099D Clicking tibio-fibular joint lower leg 
N099E Clicking ankle ankle 
N099F Clicking subtalar joint foot 
N099G Clicking talonavicular joint foot 
N099H Clicking other tarsal joint foot 
N099J Clicking 1st MTP joint foot 
N099K Clicking lesser MTP joint foot 
N099L Clicking IP joint of toe foot 
N09A Patellofemoral disorder knee 
N09AX Disorder of patella unspecified knee 
N09AX Disorder of patella, unspec knee 
N09B Osteophyte unspecified 
N09y Other spec. joint disorders unspecified 
N09y0 Other joint dis.-site unspec. unspecified 
N09y1 Other joint dis.-shoulder shoulder 
N09y2 Other joint dis.-upper arm upper arm 
N09y3 Other joint dis.-forearm forearm 
N09y4 Other joint dis.-hand hand 
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N09y5 Other joint dis.-pelvic/thigh pelvis/thigh 
N09y6 Other joint dis.-lower leg lower leg 
N09y7 Other joint dis.-ankle/foot ankle/foot 
N09y8 Other joint dis.-other specif. unspecified 
N09y9 Other joint dis.-multiple site unspecified 
N09yz Other joint disorders NOS unspecified 
N09z Joint disorder NOS unspecified 
N09z Joint disorders NOS unspecified 
N09z0 Joint disord.NOS-site unspecif unspecified 
N09z1 Joint disord.NOS-shoulder shoulder 
N09z2 Joint disord.NOS-upper arm upper arm 
N09z3 Joint disord.NOS-forearm forearm 
N09z4 Joint disord.NOS-hand hand 
N09z5 Joint disord.NOS-pelvic/thigh pelvis/thigh 
N09z6 Joint disord.NOS-lower leg lower leg 
N09z7 Joint disord.NOS-ankle/foot ankle/foot 
N09z8 Joint disord.NOS-other specif. unspecified 
N09z9 Joint disord.NOS-multiple site unspecified 
N09zz Joint disorders NOS unspecified 
N0y Arthropathies OS unspecified 
N0z Arthropathies NOS unspecified 
N1 Vertebral column syndromes back 
N12 Acute back pain - disc back 
N12 Intervertebral disc disorders back 
N12 Slipped intervertebral disc back 
N120 Cervical disc displ.-no myelop neck 
N120 Cervical disc displacement neck 
N120 PID - prol cerv disc,no myelop neck 
N120 PID - prol cerv discno myelop neck 
N121 Thoracic disc displ.-no myelop upper back 
N122 Lumbar disc displacement lower back 
N122 Lumbar disc lesion - displaced lower back 
N122 PID - prolapsed lumbar disc lower back 
N123 Disc unsp.displ.-no myelopathy back 
N123 Intervertebral disc prol. NOS back 
N123 PID - prol i/v disc, no myelop back 
N123 Prolapsed intervertebral disc without myelopathy back 
N129 PID - prol i/v disc + myelop back 
N1290 Unspec.disc disorder+myelop. back 
N1291 Cervical disc disord.+myelop. neck 
N1292 Thoracic disc disord.+myelop. upper back 
N1293 Lumbar disc disord.+myelopathy lower back 
N129z Disc disorder+myelopathy NOS back 
N12B Disc prolapse with myelopathy back 
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N12B0 Cx disc prolapse + myelopathy neck 
N12B1 Th disc prolapse + myelopathy upper back 
N12B2 Lu disc prolapse + myelopathy lower back 
N12C Disc prolapse + radiculopathy back 
N12C Disc prolapse with radiculopathy back 
N12C0 Cx disc prolapse+radiculopathy neck 
N12C1 Th disc prolapse+radiculopathy upper back 
N12C2 Lu disc prolapse+radiculopathy lower back 
N12C3 Lu disc prol+caud eq compress lower back 
N12C4 Prol lumb interv disc sciatic lower back 
N12D Narrowing disc space back 
N12z Intervertebral disc lesion NOS back 
N12z Other/unspec.disc disorders back 
N12z0 Other disc disorders unspecif. back 
N12z1 Other cervical disc disorders neck 
N12z2 Other thoracic disc disorders upper back 
N12z3 Other lumbar disc disorders lower back 
N12z5 Annular tear of cervical disc neck 
N12z6 Resorption of cervical disc neck 
N12z9 Annular tear of thoracic disc upper back 
N12zA Resorption of thoracic disc upper back 
N12zD Annular tear of lumbar disc lower back 
N12zE Resorption of lumbar disc lower back 
N12zH Cerv disc disord + radiculopth neck 
N12zH Cervical disc disorder with radiculopathy neck 
N12zz Disc disorders NOS back 
N13 Cervical disorder NOS neck 
N13 Other cervical disorders neck 
N131 Cervicalgia neck 
N131 Cervicalgia - pain in neck neck 
N131 Pain in cervical spine neck 
N132 Cervicocranial syndrome head/neck 
N133 Cervicobrachial syndrome 
neck & upper 
limb 
N134 Brachial (cervical) neuritis upper limb 
N134 Brachial radiculitis upper limb 
N134 Cervical radiculitis upper limb 
N134 Cervical root pain upper limb 
N134 Ulnar neuritis upper limb 
N135 Torticollis unspecified neck 
N1350 Intermittent torticollis neck 
N1351 Rheumatic torticollis neck 
N135z Stiff neck NOS neck 
N135z Torticollis NOS neck 
N135z Wry neck neck 
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N138 Cervicalgia neck 
N13y Other cervical syndromes neck 
N13y0 Cervical syndrome NEC neck 
N13y2 Crick in neck neck 
N13y3 Cervical root syndrome neck 
N13yz Other cervical syndromes NOS neck 
N13z Cervical and neck disorders NOS neck 
N13z Cervical/neck disorder NOS neck 
N14 Back disorders - other back 
N14 Other/unspecif.back disorder back 
N141 Acute back pain - thoracic upper back 
N141 Pain in thoracic spine upper back 
N142 Acute back pain - lumbar lower back 
N142 Low back pain lower back 
N142 Lumbago lower back 
N142 Pain in lumbar spine lower back 
N1420 Lumbago with sciatica 
lower back & 
lower limb 
N143 Acute back pain + sciatica 
lower back & 
lower limb 
N143 Acute back pain with sciatica 
lower back & 
lower limb 
N143 Back pain - lower lower back 
N143 Low Back Pain lower back 
N143 Sciatica 
lower back & 
lower limb 
N144 Thoracic/lumbosacral neuritis back 
N1440 Thoracic nerve root pain upper back 
N1440 Thoracic neuritis unspecified upper back 
N1440 Thoracic neuritis, unspecified upper back 
N1441 Lumbosacral neuritis unspecif. lower back 
N144z Thoracic/lumbosac.neuritis NOS back 
N145 Acute back pain - unspecified back 
N145 Back pain unspecified back 
N145 Back pain, unspecified back 
N145 Backache NOS back 
N145 Backache unspecified back 
N145 Backache, unspecified back 
N146 Disorders of the sacrum pelvis 
N1463 Lumbosacral instability lower back 
N1463 Lumbosacral strain lower back 
N1464 Sacroiliac instability pelvis 
N1465 Sacral instability NOS pelvis 
N1466 Sacroiliac disorder pelvis 
N146z Disorders of the sacrum NOS pelvis 
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N146z Sacral disorder NOS pelvis 
N146z Sacroiliac strain pelvis 
N147 Disorders of the coccyx pelvis 
N1470 Unspecified disorder of coccy pelvis 
N1470 Unspecified disorder of coccyx pelvis 
N1470 Unspecified disorder of the coccyx pelvis 
N1471 Hypermobility of the coccyx pelvis 
N1472 Coccygodynia pelvis 
N1472 Pain in coccyx pelvis 
N147z Coccygeal disorder NOS pelvis 
N147z Coccyx disorder NOS pelvis 
N1487 Atlanto-occipital instability neck 
N1488 Atlanto-axial instability neck 
N1489 Cervical spine instability neck 
N148A Cervico-thoracic instability 
neck & upper 
back 
N148B Thoracic spine instability upper back 
N148C Lumbar spine instability lower back 
N149 Back stiffness back 
N14X Sacrococygeal disorders,NEC pelvis 
N14y Facet joint syndrome back 
N14y Other back symptoms back 
N14z Back disorder/symptom NOS back 
N14z Back disorders NOS back 
N14z Spinal disorder NOS back 
N1y Vertebral column disorders OS back 
N1y0 Rec atlantoax subl + myelopath neck 
N1z Vertebral column disorder NOS back 
N21 Peripheral enthesopathies unspecified 
N210 Bursitis - shoulder shoulder 
N211 Rotator cuff shoulder syndrome shoulder 
N211 Rotator cuff shoulder syndrome and allied disorders shoulder 
N211 Shoulder syndrome shoulder 
N2110 Rotator cuff syndrome unspecif shoulder girdle 
N2110 Rotator cuff syndrome unspecified shoulder girdle 
N2110 Supraspinatus syndrome shoulder girdle 
N2111 Calcifying tendinitis shoulder shoulder 
N2112 Bicipital tenosynovitis upper arm 
N2113 Supraspinatus tendinitis shoulder girdle 
N2114 Part thickn rotator cuff tear shoulder 
N2115 Full thickn rotator cuff tear shoulder 
N2115 Full thickness rotator cuff tear shoulder 
N2116 Subacromial bursitis shoulder 
N2117 Subdeltoid bursitis upper arm 
N2118 Bursitis of shoulder shoulder 
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N211z Painful arc syndrome shoulder 
N211z Rotator cuff syndrome NOS shoulder 
N211z Subacromial bursitis shoulder 
N212 Other shoulder affections NEC shoulder 
N2121 Scapulohumeral fibrositis shoulder girdle 
N2122 Subacromial impingement shoulder 
N2123 Coracoid impingement shoulder 
N2124 Impingement syndr of shoulder shoulder 
N2124 Impingement syndrome of shoul shoulder 
N2124 Impingement syndrome of shoulder shoulder 
N2125 Shoulder tendonitis shoulder 
N212z Other shoulder affect.NEC NOS shoulder 
N213 Enthesopathy of elbow region elbow 
N213 Enthesopathy of the elbow region elbow 
N2130 Elbow enthesopathy unspecified elbow 
N2131 Golfer's elbow elbow 
N2131 Golfers elbow elbow 
N2131 Medial epicondylitis - elbow elbow 
N2131 Medial epicondylitis of the elbow elbow 
N2132 Lateral epicondylitis - elbow elbow 
N2132 Lateral epicondylitis of the elbow elbow 
N2132 Tennis elbow elbow 
N2132 Tennis elbow - epicondylitis elbow 
N2133 Bursitis - elbow elbow 
N2133 Olecranon bursitis elbow 
N2134 Biceps tendinitis upper arm 
N2135 Triceps tendinitis upper arm 
N213z Elbow enthesopathy NOS elbow 
N214 Enthesopathy of wrist/carpus wrist/hand 
N2140 Bursitis of wrist wrist 
N2141 Bursitis of hand hand 
N214z Wrist/carpus enthesopathy NOS wrist/hand 
N215 Enthesopathy of hip region hip 
N2150 Hip enthesopathy, unspecified hip 
N2151 Bursitis - hip hip 
N2151 Bursitis of hip hip 
N2152 Gluteal tendinitis buttock 
N2153 Iliac crest spur pelvis 
N2154 Psoas tendinitis thigh 
N2155 Trochanteric tendinitis thigh 
N2156 Adductor tendinitis thigh 
N2157 Trochanteric bursitis thigh 
N2158 Snapping hip hip 
N2159 Iliotibial band syndrome knee 
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N215A Ischial bursitis pelvis 
N215z Hip enthesopathy NOS hip 
N216 Enthesopathy of knee knee 
N216 Enthesopathy of the knee knee 
N2160 Bursitis - knee knee 
N2160 Bursitis of knee NOS knee 
N2160 Bursitis of the knee NOS knee 
N2160 Popliteal bursitis knee 
N2160 Semi-membranosus bursitis unspecified 
N2161 Pes anserinus tendin./bursitis unspecified 
N2162 Tibial collateral lig.bursitis knee 
N2163 Fibular collat.lig.bursitis knee 
N2164 Patellar tendinitis knee 
N2165 Prepatellar bursitis knee 
N2166 Infrapatellar bursitis knee 
N2167 Subpatellar bursitis knee 
N2168 Biceps femoris tendinitis thigh 
N2169 Semimembranosus tendinitis unspecified 
N216z Knee enthesopathy NOS knee 
N216z Suprapatellar bursitis knee 
N217 Enthesopathy of ankle/tarsus ankle/foot 
N217 Tarsus enthesopathy ankle/foot 
N217 Tendinitis of ankle/tarsus ankle/foot 
N2170 Enthesopathy of ankle unspec. ankle 
N2171 Enthesopathy of tarsus unspec. foot 
N2172 Metatarsalgia NOS foot 
N2173 Achilles bursitis ankle 
N2173 Haglunds deformity foot 
N2174 Achilles tendinitis ankle 
N2175 Tibialis anterior tendinitis lower leg 
N2176 Tibialis posterior tendinitis lower leg 
N2177 Calcaneal spur foot 
N2178 Peroneal tendinitis lower leg 
N2179 Plantar fasciitis foot 
N217A Posterior calcaneal exostosis foot 
N217B Anterior ankle impingement ankle 
N217C Fibular impingement lower leg 
N217z Ankle/tarsus enthesopathy NOS ankle/foot 
N21y Other periph. enthesopathies unspecified 
N21y0 Anterior shin splints lower leg 
N21y1 Posterior shin splints lower leg 
N21z Enthesopathy NOS unspecified 
N21z0 Capsulitis NOS unspecified 
N21z2 Adductor tendonitis unspecified 
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N21z2 Bicepital tendonitis unspecified 
N21z2 Supraspinatus tendonitis shoulder 
N21z2 Tendinitis NOS unspecified 
N21z2 Tendonitis adductor unspecified 
N21z2 Tendonitis bicepital unspecified 
N21z2 Tendonitis NOS unspecified 
N21z3 Bone spur NOS unspecified 
N21z3 Exostosis of unspecified site unspecified 
N21z3 Osteophyte of unspecified site unspecified 
N21z4 Subungual exostosis hand & foot 
N21z5 Subungual exostosis great toe foot 
N21z5 Subungual exostosis of great toe foot 
N21z6 Subungual exostosis lesser toe foot 
N21z6 Subungual exostosis of lesser toe foot 
N21z7 Exostosis unspecified 
N21zz Peripheral enthesopathy NOS unspecified 
N22 Other synovium/tendon/bursa unspecified 
N220 Synovitis and tenosynovitis unspecified 
N220 Synovitis/tenosynovitis unspecified 
N2200 Synovitis or tenosynovitis NOS unspecified 
N2200 Synovitis/tenosynovitis NOS unspecified 
N2201 Synovit./tenosynovitis+dis EC unspecified 
N2202 Tendon sheath giant cell tumor unspecified 
N2204 De Quervain's disease wrist/hand 
N2204 De Quervains disease wrist/hand 
N2204 Radial styloid tenosynovitis wrist/hand 
N2204 Thumb trigger hand 
N2204 Trigger thumb - acquired hand 
N2205 Other hand/wrist tenosynovitis wrist/hand 
N2205 Other tenosynovitis of hand hand 
N2205 Other tenosynovitis of the hand hand 
N2205 Other tenosynovitis of the wrist wrist 
N2205 Other tenosynovitis of wrist wrist 
N2205 Synovitis/tenosyn.- hand hand 
N2205 Synovitis/tenosyn.- wrist wrist 
N2205 Tendonitis of thumb hand 
N2205 Tensynovitis of fingers wrist/hand 
N2206 Tenosynovitis of ankle ankle 
N2207 Tenosynovitis of foot foot 
N220A Flexor tenosynovitis of wrist wrist 
N220B Flexor tenosynovitis of finger hand 
N220C Flexor tenosynovitis of thumb hand 
N220D Extensor tenosynovitis of wrist wrist 
N220D Extensor tenosynovitis-wrist wrist 
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N220E Extensor tenosynovitis of finger hand 
N220E Extensor tenosynovitis-finger hand 
N220F Extensor tenosynovitis of thumb hand 
N220F Extensor tenosynovitis-thumb hand 
N220G Acquired trigger thumb hand 
N220H Achilles tenosynovitis ankle 
N220J Tibialis ant tenosynovitis lower leg 
N220J Tibialis anterior tenosynovitis lower leg 
N220K Tibialis post tenosynovitis lower leg 
N220K Tibialis posterior tenosynovitis lower leg 
N220L Exten hal longus tenosynovitis lower leg 
N220M Exten dig longus tenosynovitis foot 
N220N Peroneus longus tenosynovitis lower leg 
N220P Peroneus brevis tenosynovitis foot 
N220Q Transient synovitis unspecified 
N220R Chron crep synovit hand/wrist wrist/hand 
N220S Synovitis of hip hip 
N220T Synovitis NOS unspecified 
N220V Synovitis of knee knee 
N220z Other synovitis and tenosynovitis unspecified 
N220z Other synovitis/tenosynovitis unspecified 
N220z Shoulder synovitis shoulder 
N220z Synovitis of knee knee 
N221 Bunion foot 
N222 Specific bursitides unspecified 
N2220 Beat elbow elbow 
N2221 Beat hand hand 
N2222 Beat knee knee 
N2223 Miners' elbow elbow 
N2224 Miners' knee knee 
N2225 Housemaids knee knee 
N2225 Housemaids' knee knee 
N2226 Calcium deposit in bursa unspecified 
N222z Specific bursitides NOS unspecified 
N223 Bursitis NOS unspecified 
N223 Postcalcaneal bursitis unspecified 
N22y4 Synovial plica knee 
N22y4 Synovial plica of knee knee 
N22yN Achilles degeneration ankle 
N22yz Other synovial disorder NOS unspecified 
N22yz Other tendon disorder NOS unspecified 
N22z Synovial/tendon problem NOS unspecified 
N22z Synovium/tendon/bursa dis.NOS unspecified 
N23 Fascia disorders unspecified 
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N23 Ligament disorders unspecified 
N23 Muscle, ligament and fascia disorders unspecified 
N23 Muscle/ligament disorder NOS unspecified 
N23 Muscle/ligament/fascia disord. unspecified 
N232 Muscle wasting and disuse atrophy NEC unspecified 
N232 Muscle wasting/atrophy NEC unspecified 
N2322 Muscle wasting NEC unspecified 
N232z Muscle wasting/atrophy NEC NOS unspecified 
N232z Muscle wasting/disuse atrophy NEC NOS unspecified 
N233z Other specif.musc.disorder NOS unspecified 
N234 Laxity of ligament unspecified 
N235 Double-jointed (hypermobility) unspecified 
N235 Hypermobility syndrome unspecified 
N239 Myofascial pain syndrome unspecified 
N23y Other muscle/ligament/fascia unspecified 
N23y1 Calcification of ligament unspecified 
N23y4 Spasm of muscle unspecified 
N23y9 Calcific tendinitis unspecified 
N23yA Diastasis of muscle unspecified 
N23yD Muscle strain unspecified 
N23yE Spasm of back muscles back 
N23yz Other musc./lig./fasc.dis.NOS unspecified 
N23z Muscle/ligament disorder NOS unspecified 
N23z Muscle/ligament/fascia dis.NOS unspecified 
N24 Other soft tissue disorders unspecified 
N2401 Fibrositis unspecified unspecified 
N2402 Muscular rheumatism unspecified 
N2403 Rheumatic pain unspecified 
N2405 Fibrositis of neck neck 
N2406 Fibrositis arm upper limb 
N241 Myalgia and myositis unspecified unspecified 
N241 Myalgia/Myositis - Lower Leg lower leg 
N241 Myalgia/myositis - multiple unspecified 
N241 Myalgia/Myositis - Shoulder shoulder 
N241 Myalgia/Myositis - Upper Arm upper arm 
N241 Myalgia/Myositis -Pelvis/Thigh pelvis/thigh 
N241 Myalgia/myositis NOS unspecified 
N241 Myalgia/myositis unspecified unspecified 
N241-97 Myalgia/myositis - shoulder shoulder 
N2410 Intercostal myalgia chest 
N2410 Muscle pain unspecified 
N2410 Myalgia unspecified unspecified 
N2411 Myositis unspecified unspecified 
N241z Myalgia or myositis NOS unspecified 
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N241z Myalgia/myositis - NOS unspecified 
N241z Myalgia/myositis NOS unspecified 
N242 Neuralg./neurit./radicul.unsp. unspecified 
N242 Neuralgia/neuritis - fore arm forearm 
N242 Neuralgia/Neuritis - Hand hand 
N242 Neuralgia/Neuritis - Lower Leg lower leg 
N242 Neuralgia/neuritis NOS unspecified 
N242-92 Neuralgia/neuritis - lower leg lower leg 
N242-93 Neuralgia/Neurit.-Pelvis/Thigh pelvis/thigh 
N2420 Neuralgia unspecified unspecified 
N2421 Neuritis unspecified unspecified 
N2422 Radiculitis unspecified unspecified 
N2423 Neuropathic pain unspecified 
N242z Neuralg./neurit./radiculit.NOS unspecified 
N242z Neuralgia/neuritis - NOS unspecified 
N242z Policeman's disease unspecified 
N2431 Hypertrophy of knee fat pad knee 
N244 Fasciitis unspecified unspecified 
N245 Ankle pain ankle 
N245 Arm pain upper limb 
N245 Foot pain foot 
N245 Hand pain hand 
N245 Heel pain foot 
N245 Leg pain lower limb 
N245 Pain in buttock buttock 
N245 Pain in left arm upper limb 
N245 Pain in left leg lower limb 
N245 Pain In Left Leg lower limb 
N245 Pain in limb limb 
N245 Pain in limb - multiple limb 
N245 Pain In Limb NOS limb 
N245 Pain in right arm upper limb 
N245 Pain In Right Arm upper limb 
N245 Pain in right leg lower limb 
N245 Pain In Right Leg lower limb 
N245 Shoulder pain shoulder 
N245 Thigh pain thigh 
N245-94 Pain in limb NOS limb 
N2450 Finger pain hand 
N2450 Hand pain hand 
N2450 Thumb pain hand 
N2451 Foot pain foot 
N2451 Toe pain foot 
N2452 Aching leg syndrome lower limb 
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N2452 neuropathic pain unspecified 
N2452 Pain in leg lower limb 
N2453 Pain in arm upper limb 
N2454 Calf pain lower leg 
N2455 Axillary pain upper arm 
N2455 Pain In Right Leg lower limb 
N2456 Pain In Left Leg lower limb 
N2456 Tender heel pad foot 
N2457 Pain In Right Arm upper limb 
N2457 Shoulder pain shoulder 
N2459 Pain in buttock buttock 
N247 Other musculoskel.limb sympts. unspecified 
N2470 Swelling of calf lower leg 
N2470 Swelling of limb limb 
N2470 Swollen legs lower limb 
N2470 Swollen lower leg lower leg 
N2471 Leg cramps lower limb 
N2471 Night cramps unspecified 
N2472 Cramp unspecified 
N247z Hand cramps hand 
N247z Musculoskel.limb symptoms NOS limb 
N247z Musculoskeletal limb symptoms NOS limb 
N2480 Myofascial pain syndrome unspecified 
N24z Polyalgia unspecified 
N24z Soft tissue disorders NOS unspecified 
N3 Musculosk.inflam/deform.+other unspecified 
N30z8 Costochondritis NOS chest 
N32 Osteochondropathies unspecified 
N320 Vertebral epiphysitis back 
N3200 Juvenile spine osteochond.unsp back 
N3201 Scheuermann's disease back 
N3201 Scheuermanns disease back 
N3202 Calve's vertebral osteochondr. back 
N320z Juvenile spine osteochondr.NOS back 
N321 Pelvis juvenile osteochondrop. pelvis/hip 
N3210 Juv.osteochond.hip/pelvis unsp pelvis/hip 
N3211 Pseudocoxalgia pelvis/hip 
N3212 Ischiopubic synchondrosis pelvis 
N3213 Juvenile osteochond.-acetabul. pelvis 
N3214 Juven.osteochond.-iliac crest pelvis 
N3215 Symphysis pubis osteochond. pelvis 
N3216 Coxa plana unspecified 
N3217 Pseudocoxalgia pelvis/hip 
N321z Juv.osteochond.-hip/pelvis NOS pelvis/hip 
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N322 Non tr.slipped upper fem.epiph hip 
N3221 Non traum acute-on-chron SUFE hip 
N3222 Non traumatic chronic SUFE hip 
N323 Juvenile osteochondritis -hand hand 
N3230 Juven.osteochond.arm unspecif. upper limb 
N3231 Juven.osteochond.hand unspecif hand 
N3234 Humerus head juv. osteochondr. upper arm 
N3235 Metacarpal head juv. osteoch. hand 
N3237 Radial head juven. osteochond. forearm 
N323z Juven.osteochond.-arm/hand NOS upper limb 
N324 Juvenile osteochond.- leg/foot lower limb 
N324 Juvenile osteochondrosis - leg lower limb 
N3240 Juvenile osteochondr.-leg unsp lower limb 
N3243 Juv.osteoch.secondary.pat.ctre knee 
N3244 Osgood-Schlatter's dis.(tibia) lower leg 
N3244 Osgood-Schlatters dis - osteochondrosis of tibial lower leg 
N3244 Osgood-Schlatters dis.(tibia) lower leg 
N3244 Tibial tubercle juv. osteoch. lower leg 
N324z Juvenile osteochondr.-leg,NOS lower limb 
N325 Juvenile osteochondrosis-foot foot 
N3250 Juvenile osteochond.-foot unsp foot 
N325z Juvenile osteochond.-foot NOS foot 
N326 Other juven.osteochondroses unspecified 
N3260 Juvenile apophysitis NOS unspecified 
N3261 Juvenile epiphysitis NOS unspecified 
N3262 Juvenile osteochondritis NOS unspecified 
N3263 Juvenile osteochondrosis NOS unspecified 
N326z Juvenile osteochondroses NOS unspecified 
N327 Osteochond dissecans unspecified 
N327 Osteochondritis dissecans unspecified 
N3270 Osteochondritis dissec-patella knee 
N3271 Osteochondr diss-lat fem cond thigh 
N3272 Other osteochondr dissec-knee knee 
N3273 Osteochondr dissec-hum head upper arm 
N3274 Osteochondr dissec-capitellum unspecified 
N3275 Osteochondr dissec-radial head forearm 
N3276 Other osteochondr diss-elbow elbow 
N3277 Osteochondritis dissec-wrist wrist 
N3278 Osteochondr dissec-fem head thigh 
N3279 Osteochondritis dissec-talus foot 
N327y Osteochondr dissec-other site unspecified 
N328 Juv osteochondrosis of spine back 
N32y Slipped radial epiphysis unspecified 
N32yz Other spec.osteochondrop.NOS unspecified 
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N32z Osteochondropathy NOS unspecified 
N32z0 Apophysitis NOS unspecified 
N32z1 Epiphysitis NOS unspecified 
N32z2 Osteochondritis NOS unspecified 
N32z2 Osteochondritis of knee knee 
N32z3 Osteochondrosis NOS unspecified 
N32zz Osteochondropathy NOS unspecified 
N33 Other bone/cartilage disorders unspecified 
N3370 Disuse atrophy of bone unspecified 
N3372 Algodystrophy of hand hand 
N3373 Algodystrophy of knee knee 
N3374 Algodystrophy of foot foot 
N337z Algoneurodystrophy NOS unspecified 
N33A Bone pain unspecified 
N33A0 Bony pelvic pain pelvis 
N33A1 Clavicle pain shoulder girdle 
N33C Complex regionl pain syndrom I unspecified 
N33z Bone/cartilage disorder NOS unspecified 
N33z1 Epiphyseal arrest unspecified 
N33z2 Chondromalacia NOS unspecified 
N33z8 Complete epiphyseal arrest unspecified 
N33z9 Partial epiphyseal arrest unspecified 
N33zE Costochondritis chest 
N33zF Disorder of bone unspecified unspecified 
N33zF Disorder of bone, unspecified unspecified 
N33zG Disorder of cartilage, unspec unspecified 
N33zJ Chondritis unspecified 
N33zL Osteitis of symphysis pubis pelvis 
N33zz Bone or cartilage disorders NOS unspecified 
N33zz Bone/cartilage disorders NOS unspecified 
N33zz Costochondritis NOS chest 
N34 Fallen arches foot 
N34 Flat foot foot 
N34 Flat foot - pes planus foot 
N340 Pes planus - acquired foot 
N3400 Hypermobile flat foot foot 
N3401 Rigid flat foot foot 
N341 Talipes planus - acquired foot 
N34z Arches fallen foot 
N34z Flat foot NOS foot 
N35 Acquired deformities of toe foot 
N350 Hallux valgus - acquired foot 
N351 Hallux varus - acquired foot 
N352 Hallux rigidus - acquired foot 
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N353 Acq hammer deformity-great toe foot 
N353 Hallux malleus foot 
N354 Hammer toe - acquired foot 
N354 Other hammer toe - acquired foot 
N355 Claw toe - acquired foot 
N356 Clawing of great toe foot 
N357 Crossover toe foot 
N358 Mallet toe foot 
N359 Bunionette foot 
N35A Over-riding 5th toe foot 
N35y Other acquired toe deformity foot 
N3631 Coxa valga - acquired hip 
N3632 Coxa vara - acquired hip 
N3633 Acq internal femoral torsion hip 
N3634 Persistent femoral anteversion hip 
N3635 Acq external femoral torsion hip 
N363z Acquired hip deformity NOS hip 
N364 Acquired genu valgum/varum knee 
N3640 Acquired genu valgum knee 
N3640 Knock knee knee 
N3641 Acquired genu varum knee 
N3641 Bow legged lower limb 
N364z Acquired genu valgum/varum NOS knee 
N365 Genu recurvatum - acquired knee 
N366 Acquired knee deformity NOS knee 
N3660 Flexion deformity of knee knee 
N367 Acquired ankle/foot deformity ankle/foot 
N367 Other acquir.ankle/foot deform ankle/foot 
N3670 Acquir.ankle/foot deform.unsp. ankle/foot 
N3671 Acquired equinovarus-clubfoot ankle/foot 
N3672 Acquired equinus foot deform. ankle/foot 
N3672 Acquired equinus foot deformity foot 
N3673 Aquired cavus foot deformity foot 
N3674 Acquired claw foot foot 
N3675 Acquired cavovarus foot deform foot 
N3675 Acquired cavovarus foot deformity foot 
N3676 Other acquir.calcaneus deform. foot 
N3677 Acquired talipes NEC foot 
N3678 Acquired varus heel foot 
N3679 Acquired valgus heel foot 
N367A Plantar flexion-midtarsal jnt foot 
N367F Acq plantar-flexed forefoot foot 
N367G Acq plantar-flexed first ray foot 
N367H Acq plantar-flexed fifth ray foot 
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N367J Acquired dorsiflexed forefoot foot 
N367K Acquired dorsiflexed first ray foot 
N367L Acquired supinated forefoot foot 
N367M Acquired pronated forefoot foot 
N367N Acquired forefoot adductus foot 
N367P Acquired forefoot abductus foot 
N367Q Serpentine foot foot 
N367z Acquired ankle or foot deformity NOS ankle/foot 
N367z Acquired ankle/foot deform.NOS ankle/foot 
N368 Other knee deformity knee 
N3680 Acq internal tibial torsion lower leg 
N3681 Acq external tibial torsion lower leg 
N3681 Acquired external tibial torsion lower leg 
N3682 Chronic instability of knee knee 
N369 Flexion deformity unspecified 
N36y Other deformity of bone unspecified 
N36y Torsion tibia lower leg 
N36y0 Acquired unequal leg length lower limb 
N36y1 Acquired unequal arm length upper limb 
N37 Curvature of spine back 
N37 Curvature of spine - acquired back 
N370 Adolescent postural kyphosis back 
N371 Acquired kyphosis back 
N3710 Acquired postural kyphosis back 
N3711 Radiation kyphosis back 
N3712 Post-laminectomy kyphosis back 
N3713 Kyphosis due to oth treatment back 
N371z Acquired kyphosis NOS back 
N372 Acquired lordosis lower back 
N3720 Acquired postural lordosis lower back 
N3721 Post-laminectomy lordosis lower back 
N3722 Other post-surgical lordosis lower back 
N372z Acquired lordosis NOS lower back 
N373 Kyphoscoliosis and scoliosis back 
N373 Kyphoscoliosis/scoliosis back 
N373 Kyphoscoliosis/scoliosis-acqu. back 
N3730 Idiopathic scoliosis back 
N3731 Idiopathic kyphoscoliosis back 
N3732 Resolving infant.idiopath.scol back 
N3733 Progressive infant.idiop.scol. back 
N3734 Radiation scoliosis back 
N3735 Thoracogenic scoliosis upper back 
N3736 Postural scoliosis back 
N3737 Adolescent idiopath scoliosis back 
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N3737 Adolescent idiopathic scoliosis back 
N3738 Post-surgical scoliosis back 
N3739 Scoliosis due to oth treatment back 
N373z Kyphoscoliosis or scoliosis NOS back 
N373z Kyphoscoliosis/scoliosis NOS back 
N374 Spine curvature+other condits. back 
N3740 Curvature of spine unspecified back 
N3741 Kyphosis + other condition back 
N3742 Lordosis + other condition lower back 
N3743 Scoliosis + other condition back 
N3744 Kyphosis in skeletal dysplasia back 
N3745 Neuromuscular kyphosis back 
N3747 Lordosis in skeletal dysplasia lower back 
N3748 Lordosis in hip disease lower back 
N3749 Neuromuscular lordosis lower back 
N374A Scoliosis in skelet dysplasia back 
N374B Neuromuscular scoliosis back 
N374C Scoliosis in neurofibromatosis back 
N374D Scoliosis in conn tiss anomal back 
N374E Flatback syndrome back 
N374W Lordosis unspecified lower back 
N374W Lordosis, unspecified lower back 
N374X Other and unspecified kyphosis back 
N374X Other+unspecified kyphosis back 
N374z Spine curvature+other cond.NOS back 
N37y Other curvatures of spine back 
N37z Curvature of spine NOS back 
N37z0 Acquired hunchback back 
N37zz Curvature of spine NOS back 
N38 Other acquired deformity unspecified 
N383 Acquired chest and rib deformity chest 
N383 Acquired chest/rib deformity chest 
N3830 Acquired chest deformity unsp. chest 
N3831 Acquired rib deformity unsp. chest 
N3831 Acquired rib deformity, unspecified chest 
N3832 Acquired pectus carinatum chest 
N3833 Acquired pectus excavatum chest 
N383z Acquired chest/rib deform.NOS chest 
N385 Acquired deformity spine NOS back 
N386 Pelvic obliquity pelvis 
N38y Other acquired deformity unspecified 
N38yz Other acquired deformity NOS unspecified 
N38z Acquired deformity NOS unspecified 
N39 Nonallopathic lesions, NEC unspecified 
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N390 Nonallopathic lesion-head reg head 
N391 Nonallopathic lesion-cervical neck 
N392 Nonallopathic lesion-thoracic upper back 
N393 Nonallopathic lesion-lumbar lower back 
N394 Nonallopathic lesion-sacral pelvis 
N395 Nonallopathic lesion-pelvic pelvis 
N396 Nonallopathic lesion-legs lower limb 
N397 Nonallopathic lesion-arms upper limb 
N398 Nonallopathic lesion-rib cage chest 
N399 Nonallopathic lesion-abd.+oth. abdomen 
N39z Nonallopathic lesion NEC NOS unspecified 
N3y Musculoskeletal disorders OS unspecified 
N3y0 Biomec lesn,not elsewh clas unspecified 
N3y00 Segmental & somatic dysfunctn unspecified 
N3y01 Subluxatn complex (vertebral) back 
N3z Musculoskeletal problems NOS unspecified 
N3z Other musculoskeletal dis. NOS unspecified 
N3z Other musculoskeletal disorder NOS unspecified 
Ny Musculoskeletal diseases OS unspecified 
Ny2 Repetitive strain injury unspecified 
Nyu [X]Ad muscskl+con t dis cls tm unspecified 
Nyu35 [X]Other derangements/patella knee 
Nyu36 [X]Other disorders of patella knee 
Nyu37 [X]Other meniscus derangements knee 
Nyu38 [X]O spontn disrptn/lig(s)knee knee 
Nyu39 [X]Oth intrnl derangemnts/knee knee 
Nyu3A [X]Oth articulr cartilag disor unspecified 
Nyu3B [X]O spcf joint derangmnts,NEC unspecified 
Nyu3C [X]Other instability of joint unspecified 
Nyu3D [X]Other spcfd joint disorders unspecified 
Nyu3E [X]Disorder of patella, unspec knee 
Nyu5 [X]Deforming dorsopathies back 
Nyu50 [X]Other secondary kyphosis back 
Nyu51 [X]Other+unspecified kyphosis back 
Nyu52 [X]Other lordosis lower back 
Nyu53 [X]Other idiopathic scoliosis back 
Nyu54 [X]Other secondary scoliosis back 
Nyu55 [X]Other forms of scoliosis back 
Nyu57 [X]O recur atlantoaxl subluxtn neck 
Nyu58 [X]Oth recur vertebrl subluxtn back 
Nyu59 [X]Oth spcf deform dorsopaths back 
Nyu5A [X]Lordosis, unspecified lower back 
Nyu5B [X]Spin osteochondrosis, unsp back 
Nyu73 [X]Lumb+o intrvrt disc d+mylop back 
420 
 
Nyu74 [X]Lumb+o intvt disc d+radiclp back 
Nyu75 [X]O spc intervert disc displm back 
Nyu78 [X]Sacrococygeal disorders,NEC pelvis 
Nyu7A [X]Other dorsalgia back 
Nyu7B [X]Cervical disc disord, unsp neck 
Nyu8 [X]Disorders of muscles unspecified 
Nyu83 [X]Oth ruptr/muscl(nontraumtc) unspecified 
Nyu84 [X]Muscle wasting and atrophy NEC unspecified 
Nyu84 [X]Muscle wasting+trophy,NEC unspecified 
Nyu8B [X]Disorder of muscle unspecified unspecified 
Nyu8B [X]Disorder of muscle, unspec unspecified 
Nyu9 [X]Disorders/synovium+tendon unspecified 
Nyu91 [X]Oth synovitis+tenosynovitis unspecified 
Nyu92 [X]Spontans ruptr/oth tendons unspecified 
Nyu94 [X]O spcf diso/synovium+tendon unspecified 
Nyu95 [X]Synovitis+tenosyn/bact d CE unspecified 
Nyu96 [X]O diso/synovm+tendon/dis CE unspecified 
Nyu97 [X]Synovial hypertrophy, NEC unspecified 
NyuA [X]Other soft tissue disorders unspecified 
NyuA0 [X]Other bursitis of elbow elbow 
NyuA1 [X]Other bursitis of knee knee 
NyuA2 [X]Other bursitis of hip hip 
NyuA3 [X]O sft t d rl/use,overu+prss unspecified 
NyuA6 [X]Other bursitis NEC unspecified 
NyuA6 [X]Other bursitis,NEC unspecified 
NyuA7 [X]Other bursa disorder unspecified 
NyuA8 [X]Fasciitis,NEC unspecified 
NyuAA [X]Oth sft tis diso/oth dis CE unspecified 
NyuAC [X]O enthespath/lw limb,exc ft lower limb 
NyuAC [X]O enthespath/lw limbexc ft lower limb 
NyuAD [X]Other enthesopathy of foot foot 
NyuAE [X]Other enthesopathies,NEC unspecified 
NyuAF [X]Oth spcf soft tissu disords unspecified 
NyuAG [X]Uns sof tis d,use/overu/prs unspecified 
NyuAJ [X]Enthesopathy lowr limb,unsp lower limb 
NyuD [X]Chondropathies unspecified 
NyuD0 [X]O juv osteochndrsis/hp+pelv pelvis/hip 
NyuD1 [X]O juv osteochndrsis/up limb upper limb 
NyuD2 [X]O spf juvnl osteochondrosis unspecified 
NyuD3 [X]Oth spc osteochondropathies unspecified 
NyuD4 [X]Oth spcf disordrs/cartilage unspecified 
NyuDE [X]Disorder cartilage, unspec unspecified 
NyuE [X]Oth dis musculosk+connect unspecified 
NyuE0 [X]O spc acq defrm/muscskl sys unspecified 
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NyuE2 [X]O postproced muscskel disor unspecified 
NyuE3 [X]Other biomechanical lesions unspecified 
NyuE4 [X]Postproc muscsk disord,unsp unspecified 
NyX Postproc muscsk disord,unsp unspecified 
Nz Musculoskeletal and connective tissue diseases NOS unspecified 
Nz Musculoskeletal diseases NOS unspecified 
OX353C Sciatica Chronic /ox 
lower back & 
lower limb 
OX709MF Sore Feet /ox foot 
OX7259AP Intervertebral Disc Prolapsed /ox back 
OX7259AP Prolapsed Disc /ox back 
OX7280AD Pain Neck /ox neck 
OX7289A Back Pain With Sciatica /ox 
lower back & 
lower limb 
OX7289CB Chronic Backache /ox back 
OX7289CH back pain /ox back 
OX735AA Scoliosis Acquired /ox back 
OX738DB Deformity Foot /ox foot 
OX738VC In-Toeing /ox foot 
OX7873E Pain Knee /ox knee 
OX8479 Back Strain/Sprain /ox back 
OX848ML Pulled Muscle /ox unspecified 
OX8830L Laceration Finger /ox hand 
OX9963B Injury Wrist /ox wrist 
OX9965F Injury Finger /ox hand 
OX9967B Injury Foot /ox foot 
OX9967C Injury Knee /ox knee 
OXT741 Leg Problem /ox lower limb 
R00z2 [D]General aches and pains unspecified 
R00z2 [D]Pain generalized unspecified 
R01 [D]Musculoskeletal symptoms unspecified 
R01 [D]Nerv/musculoskeletal sympt. unspecified 
R01z [D]Nerv/musculoskel.symp.other unspecified 
R01z1 [D]Growing pains - limbs limb 
R01z2 [D]Musculoskeletal pain unspecified 
R01zz [D]Nerv/musculoskel.sympt.NOS unspecified 
R022K [D]Buttock swelling buttock 
R04 [D]Head and neck symptoms head/neck 
R0400 [D]Face ache head 
R0400 [D]Facial pain head 
R040z [D]Jaw pain head 
R040z [D]Pain in head NOS head 
R042 [D]Head swelling/mass/lump head 
R042 [D]Neck swelling/mass/lump neck 
R042 [D]Swell.masslump head/neck head/neck 
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R0420 [D]Swelling face head 
R0420 [D]Swelling in head or neck head/neck 
R04z [D]Head and neck other sympt. head/neck 
R04zz [D]Head and neck symptoms NOS head/neck 
R065 [D]Chest pain chest 
R0650 [D] Retrosternal chest pain chest 
R0650 [D]Chest pain unspecified chest 
R0652 [D]Anterior chest wall pain chest 
R0659 [D]Parasternal chest pain chest 
R065A [D]Musculoskeletal chest pain chest 
R065B [D]Non cardiac chest pain chest 
R065B [D]Non-cardiac chest pain chest 
R065C [D]Retrosternal chest pain chest 
R065D [D]Central chest pain chest 
R065z [D]Chest pain NOS chest 
R090B [D]Groin pain pelvis 
R090C [D]Loin pain pelvis 
R090G [D] Pelvic pain pelvis 
R090G [D] Perineal pain pelvis 
R090G [D]Pelvic and perineal pain pelvis 
R090J [D]Right upper quadrant pain trunk 
R090K [D]Left upper quadrant pain trunk 
R90C Left Loin Pain pelvis 
Ryu04 [X]Other chest pain chest 
Ryu3 [X]Sym/sign inv nv/muscskel sy unspecified 
Ryu70 [X]Other chronic pain unspecified 
S4 Subluxations unspecified 
S402 Closed subluxation jaw head 
S460 Acute meniscal tear medial knee 
S460 Bucket handle tear - current injury knee 
S460 Bucket handle tear-current inj knee 
S4600 Ac meniscal tear,med,ant horn knee 
S4600 Ac meniscal tearmedant horn knee 
S4601 Ac meniscal tear,med,post horn knee 
S4601 Ac meniscal tearmedpost horn knee 
S4602 Ac menscl tear,med,bckt hndle knee 
S4602 Ac menscl tearmedbckt hndle knee 
S4603 Ac meniscal tear,med,radial knee 
S4604 Ac mnscl tr,med,periph,dtchmt knee 
S4605 Ac mnscl tear,med,horiz clvge knee 
S461 Acute meniscal tear lateral knee 
S461 Acute meniscal tear, lateral knee 
S4610 Ac meniscal tear,lat,ant horn knee 
S4611 Ac meniscal tear,lat,post horn knee 
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S4611 Ac meniscal tearlatpost horn knee 
S4612 Ac menscl tear,lat,bckt hndle knee 
S4612 Ac menscl tearlatbckt hndle knee 
S4613 Ac meniscal tear,lat,radial knee 
S4613 Ac meniscal tearlatradial knee 
S4614 Ac mnscl tr,lat,periph,dtchmt knee 
S4615 Ac mnscl tear,lat,horiz clvge knee 
S462 Other acute meniscus tear knee 
S46B Tear/articulr cart/knee,currnt knee 
S46D Recurrent subluxation of patella knee 
S46D Recurrent subluxation, patella knee 
S498 Cls sublux cervical spine neck 
S4980 Cls sublux cervical spine,unsp neck 
S4981 Cls sublux atlanto-occiptl jt neck 
S4982 Cls sublux atlanto-axial jt neck 
S4983 Closed subluxation C2/C3 neck 
S4984 Closed subluxation C3/C4 neck 
S4985 Closed subluxation C4/C5 neck 
S4986 Closed subluxation C5/C6 neck 
S4987 Closed subluxation C6/C7 neck 
S4988 Closed subluxation C7/T1 neck 
S4989 Cl spn sublx+cerv crd lsn,unsp neck 
S498A Cl spn sublx+comp cerv crd lsn neck 
S498B Cl spn sublux+ant cerv crd lsn neck 
S498C Cl spn sublx+cntrl crv crd lsn neck 
S498D Cl spn sublux+post crv crd lsn neck 
S498x Cls sublux mlti cerv vertebrae neck 
S498z Cls sublux cerv vertebra NOS neck 
S49A Cls sublux thrcic+lumbar spine back 
S49A0 Closed subluxation lumbar spine lower back 
S49A0 Cls sublux lumbar spine lower back 
S49A1 Cls sublux thrcic spine upper back 
S49A2 Cl spn sublx+thrc crd lsn,unsp upper back 
S49A3 Cl spn sublx+comp thrc crd lsn upper back 
S49A4 Cl spn sublx+ant thrc crd lsn upper back 
S49A5 Cl spn sublx+cent thrc crd lsn upper back 
S49A6 Cl spn sublx+post thrc crd lsn upper back 
S49A7 Cl spn sublx+lmbr crd lsn,unsp lower back 
S49A8 Cl spn sublx+comp lmbr crd lsn lower back 
S49A9 Cl spn sublx+ant lmbar crd lsn lower back 
S49AA Cl spn sublx+cent lmbr crd lsn lower back 
S49AB Cl spn sublx+post lmbr crd lsn lower back 
S49AC Cl spn sublx+cauda equina lsn lower back 
S49Az Cls sublux thrc+lmbr spine NOS back 
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S49B2 Op spn sublx+thrc crd lsn,unsp upper back 
S49B3 Op spn sublx+comp thrc crd lsn upper back 
S49B4 Op spn sublx+ant thrc crd lsn upper back 
S49B5 Op spn sublx+cent thrc crd lsn upper back 
S49B6 Op spn sublx+post thrc crd lsn upper back 
S49B7 Op spn sublx+lmbr crd lsn,unsp lower back 
S49B8 Op spn sublx+comp lmbr crd lsn lower back 
S49B9 Op spn sublux+ant lmbr crd lsn lower back 
S49BA Op spn sublx+cent lmbr crd lsn lower back 
S49BB Op spn sublx+post lmbr crd lsn lower back 
S49BC Op spn sublx+cauda equina lsn lower back 
S49Bz Op sublx thrc+lmbr vertbra NOS back 
S49C Closed sublux other vertebra back 
S49C0 Closed sublux spine, unsp back 
S49C1 Closed subluxation of coccyx pelvis 
S49C2 Closed subluxation of sacrum pelvis 
S49Cz Closed subluxation spine NOS back 
S49Ez Oth closed subluxation NOS unspecified 
S5 Sprains and strains unspecified 
S5 Sprains and strains of joints and adjacent muscles unspecified 
S50 Sprain of shoulder and upper arm 
shoulder/upper 
arm 
S50 Sprain shoulder/upper arm 
shoulder/upper 
arm 
S50 Sprained shoulder shoulder 
S500 Sprain acromio-clav ligament shoulder 
S500 Sprain, acromio-clav ligament shoulder 
S500 Sprain, acromio-clavicular ligament shoulder 
S501 Sprain, coraco-clav ligament shoulder 
S502 Coracohumeral sprain shoulder 
S503 Sprain infraspinatus tendon shoulder 
S503 Sprain, infraspinatus tendon shoulder 
S504 Rotator cuff sprain shoulder 
S505 Sprain subscapularis tendon shoulder 
S505 Sprain, subscapularis tendon shoulder 
S506 Sprain supraspinatus tendon shoulder 
S506 Sprain, supraspinatus tendon shoulder 
S507 Sprain shoulder joint shoulder 
S507 Sprain, shoulder joint shoulder 
S5070 Sprain shoulder joint anterior shoulder 
S5070 Sprain,shoulder joint,anterior shoulder 
S5071 Sprain shoulder joint posterior shoulder 
S5071 Sprain,shoulder jnt,posterior shoulder 
S508 Sprain biceps tendon upper arm 
S508 Sprain, biceps tendon upper arm 
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S509 Sprain long head of biceps tendon upper arm 
S509 Sprain,long head biceps tendon upper arm 
S50A Sprain triceps tendon upper arm 
S50A Sprain, triceps tendon upper arm 
S50w Other shoulder sprain shoulder 
S50w Shoulder strain shoulder 
S50x Other upper arm sprain upper limb 
S50x Otherupperarmsprain upper arm 
S50X Spr/str oth/un part shl gir upper arm 
S50y Shoulder sprain NOS shoulder 
S50z Upper arm sprain NOS upper arm 
S51 Forearm sprain forearm 
S51 Sprain - fore arm forearm 
S51 Sprain elbow/forearm upper limb 
S51 Sprain of elbow and forearm upper limb 
S51 Sprained elbow elbow 
S510 Sprn,elbw jt,rdl clltrl lgmnt elbow 
S511 Sprn,elbw jt,uln clltrl lgmnt elbow 
S512 Radiohumeral sprain elbow 
S513 Ulnohumeral sprain elbow 
S51w Other elbow sprain elbow 
S51x Other forearm sprain forearm 
S51y Elbow sprain NOS elbow 
S51z Forearm sprain NOS forearm 
S52 Sprain - wrist wrist 
S52 Sprain of wrist and hand wrist/hand 
S52 Sprain wrist/hand wrist/hand 
S520 Sprain wrist ligament wrist 
S5200 Wrist sprain unspecified wrist 
S5201 Carpal joint sprain hand 
S5202 Sprn prox radcrp lgmnt non-sp forearm 
S5203 Distal radioulnar joint sprain forearm 
S5204 Sprain radial collateral ligament forearm 
S5204 Sprn radial collateral lgmnt forearm 
S5205 Sprn volar rad-carp lig non-sp wrist 
S5206 Sprn volar rad-carp lig sprfcl wrist 
S5207 Sprn radio-scapho-cptate lgmnt wrist 
S5208 Sprain radio-lunate ligament wrist 
S5209 Sprn radio-scapho-lunate lgmnt wrist 
S520A Sprn dorsal radio-carpal lgmnt wrist 
S520B Sprn ulnr carpal complx non-sp wrist 
S520C Sprain ulnar-carpal meniscus wrist 
S520D Sprn triangular fibrocartilage unspecified 
S520E Sprain ulno-lunate ligament wrist 
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S520F Sprain ulnar collateral ligament forearm 
S520F Sprn ulnar collateral lgmnt forearm 
S520G Sprn shrt intrnsc lgmnt non-sp unspecified 
S520H Sprain scapho-trapezium ligament hand 
S520H Sprn scapho-trapezium lgmnt hand 
S520J Sprn luno-triquetral lgmnt hand 
S520K Sprain scapho-lunate ligament hand 
S520L Sprn volar intrcrp/V lgmnt hand 
S520M Sprn dorsal intercarpal lgmnt hand 
S520z Wrist sprain NOS wrist 
S521 Hand sprain hand 
S521 Tendon injury - hand hand 
S5210 Finger sprain hand 
S5210 Hand sprain unspecified hand 
S5210 Thumb sprain hand 
S5211 Carpometacarpal sprain hand 
S5212 Metacarpophalangeal sprain hand 
S5213 Interphalangeal sprain hand 
S5213 Sprained finger/thumb hand 
S5214 Midcarpal joint sprain hand 
S521z Hand sprain NOS hand 
S521z Sprain - hand NOS hand 
S522 Sprain thumb hand 
S5220 Sprain thumb C.M.C.J hand 
S5221 Sprn thumb MCPJ non specific hand 
S5222 Sprn thmb MCPJ rdl collat lgmt hand 
S5223 Sprn thmb MCPJ uln collat lgmt hand 
S5224 Sprn thumb IPJ non specific hand 
S5225 Sprn thmb IPJ rdl collat lgmt hand 
S5226 Sprn thmb IPJ uln collat lgmnt hand 
S5227 Hyperextension injury of thumb hand 
S523 Sprain finger hand 
S5230 Sprain finger C.M.C.J. hand 
S5231 Sprn finger MCPJ non specific hand 
S5232 Sprn fngr MCPJ rdl collat lgmt hand 
S5233 Sprn fngr MCPJ uln collat lgmt hand 
S5234 Sprn finger PIPJ non specific hand 
S5235 Sprn fngr PIPJ rdl collat lgmt hand 
S5236 Sprn fngr PIPJ uln collat lgmt hand 
S5237 Sprn finger DIPJ non specific hand 
S5238 Sprn fngr DIPJ rdl collat lgmt hand 
S5239 Sprn fngr DIPJ uln collat lgmt hand 
S523F Hyperextension injury of finger hand 
S524 Sprain tendon wrist or hand wrist/hand 
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S5240 Sprain wrist extensors wrist 
S5241 Sprain wrist flexors wrist 
S525 Sprain tendon of thumb hand 
S5250 Sprn,flxr pollicis longus tndn hand 
S5251 Sprn,extnsr pollicis long tndn hand 
S5251 Sprnextnsr pollicis long tndn hand 
S526 Sprain tendon of finger hand 
S5260 Sprn,flxr digit superfic tndn hand 
S5261 Sprn,flxr digit profundus tndn hand 
S5262 Sprn,extnsr digitorum tendon hand 
S52z Wrist and hand sprain NOS wrist/hand 
S52z Wrist/hand sprain NOS wrist/hand 
S53 Groin sprain pelvis 
S53 Hamstring sprain thigh 
S53 Hip sprain hip 
S53 Sprain hip/thigh hip/thigh 
S53 Sprain of hip and thigh hip/thigh 
S53 Sprained hip hip 
S53 Sprained thigh - upper leg thigh 
S53 Thigh sprain thigh 
S530 Iliofemoral sprain thigh 
S531 Ischiocapsular sprain unspecified 
S532 Sprain hip joint hip 
S532 Sprain, hip joint hip 
S533 Sprain quadriceps tendon thigh 
S533 Sprain, quadriceps tendon thigh 
S534 Sprain patellar tendon knee 
S534 Sprain, patellar tendon knee 
S535 Sprain hamstring tendon thigh 
S535 Sprain, hamstring tendon thigh 
S53w Other hip sprain hip 
S53x Other thigh sprain thigh 
S53y Hip sprain NOS hip 
S53z Thigh sprain NOS thigh 
S54 Knee sprain knee 
S54 Leg sprain lower limb 
S54 Sprain - lower leg lower leg 
S54 Sprain knee/leg knee 
S54 Sprain of knee and leg knee 
S54 Sprained knee knee 
S540 Sprain - lateral knee ligament knee 
S540 Sprn/prt tr,knee,lat coll lgmt knee 
S540 Sprn/prt trkneelat coll lgmt knee 
S5400 Sprn,knee jt,lat collat lgmt knee 
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S5400 Sprnknee jtlat collat lgmt knee 
S5401 Part tear,knee,lat collat lgmt knee 
S541 Sprain - medial knee ligament knee 
S541 Sprain med.collateral lig.knee knee 
S5410 Sprn,knee jt,medial collat knee 
S5410 Sprnknee jtmedial collat knee 
S5411 Part tear,knee,mdl collat lgmt knee 
S5411 Part tearkneemdl collat lgmt knee 
S542 Sprain -cruciate knee ligament knee 
S542 Sprain cruciate ligament knee knee 
S5421 Part tr,knee,ant cruciate lgmt knee 
S5421 Part trkneeant cruciate lgmt knee 
S5422 Prt tr,knee,post cruciate lgmt knee 
S5422 Prt trkneepost cruciate lgmt knee 
S543 Sprain superior tibiofibular lower leg 
S544 Sprain plantaris tendon foot 
S544 Sprain, plantaris tendon foot 
S545 Tear of ligament of knee joint knee 
S54w Other specified knee sprain knee 
S54x Other specified leg sprain lower limb 
S54x1 Sprain gastrocnemius lower leg 
S54y Knee sprain NOS knee 
S54y Sprained knee NOS knee 
S54z Leg sprain NOS lower limb 
S55 Sprain ankle/foot ankle/foot 
S55 Sprain of ankle and foot ankle/foot 
S550 Ankle sprain ankle 
S550 Sprained ankle ankle 
S5500 Ankle sprain unspecified ankle 
S5500 Ankle sprain, unspecified ankle 
S5501 Deltoid ligament ankle sprain ankle 
S5501 Sprain ankle joint medial ankle 
S5501 Sprain, ankle joint, medial ankle 
S5502 Sprain ankle joint lateral ankle 
S5502 Sprain, ankle joint, lateral ankle 
S5503 Distal tibiofibular sprain ankle 
S5504 Sprain - Achilles tendon ankle 
S5504 Sprain, tendocalcaneus (Achilles tendon) ankle 
S5504 Sprntndocalcan(Achilles tndn) ankle 
S5505 Part tear,ankle,medial lgmt ankle 
S5505 Part tearanklemedial lgmt ankle 
S5506 Part tear,ankle,lat lgmt ankle 
S5506 Part tearanklelat lgmt ankle 
S550z Ankle sprain NOS ankle 
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S550z Sprain - ankle NOS ankle 
S551 Foot sprain foot 
S5510 Foot sprain unspecified foot 
S5510 Foot sprain, unspecified foot 
S5511 Sprain, tarso-metatarsal joint foot 
S5512 Sprn,metatarso-phalangeal jt foot 
S5513 Sprained toe foot 
S5513 Sprninter-phalangeal jttoe foot 
S5513 Toe sprain foot 
S5514 Sprain mid tarsal joint foot 
S5514 Sprain, mid tarsal joint foot 
S5515 Sprain, flexor tendon, foot foot 
S5516 Sprain extensor tendon foot foot 
S5516 Sprain, extensor tendon, foot foot 
S551z Foot sprain NOS foot 
S551z Sprain - foot NOS foot 
S55z Ankle and foot sprain NOS ankle/foot 
S55z Ankle/foot sprain NOS ankle/foot 
S56 Sprain pelvic ligament pelvis 
S560 Sprain, lumbosacral ligament lower back 
S561 Sacroiliac ligament sprain pelvis 
S5610 Sprn,ant sacro-iliac lgmt pelvis 
S5611 Sprn,post sacro-iliac lgmt pelvis 
S562 Sprain, sacrospinous ligament pelvis 
S563 Sprain, sacrotuberous ligament pelvis 
S564 Sprain, iliolumbar ligament lower back 
S56y Other spec sacroiliac sprains pelvis 
S56z Sacroiliac sprain NOS pelvis 
S57 Back sprain excl. lumbosacral back 
S57 Sprain of other parts of back back 
S57 Sprain other parts of back back 
S570 Neck sprain neck 
S570 Sprained neck neck 
S5700 Neck sprain unspecified neck 
S5700 Torticollis - traumatic neck 
S5700 Whiplash injury neck 
S5701 Cervical ant.longit.lig.sprain neck 
S5702 Atlanto-axial joint sprain neck 
S5703 Atlanto-occipital joint sprain neck 
S5704 Whiplash injury neck 
S570z Neck sprain NOS neck 
S571 Thoracic back sprain upper back 
S571 Thoracic sprain upper back 
S572 Lumbar back sprain lower back 
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S572 Lumbar sprain lower back 
S573 Sacrum sprain pelvis 
S5730 Sacral sprain unspecified pelvis 
S5730 Sacral sprain, unspecified pelvis 
S5731 Sacral/coccyx sprain lower back 
S5731 Sacrococcygeal sprain pelvis 
S573z Sacrum sprain NOS pelvis 
S574 Coccyx sprain pelvis 
S57X Spr/str ot/un pt lum sp/pel lower back 
S57z Back sprain NOS back 
S57z Sprain - back back 
S57z0 Pulled back muscle back 
S5Q6 Inj tendon rotator cuff should shoulder 
S5y Other sprains and strains unspecified 
S5y1 Jaw sprain head 
S5y1 Sprained jaw head 
S5y10 Jaw sprain unspecified head 
S5y10 Jaw sprain, unspecified head 
S5y11 Temporomandibular sprain head 
S5y1z Jaw sprain NOS head 
S5y3 Rib sprain chest 
S5y3 Sprained ribs chest 
S5y30 Rib sprain unspecified chest 
S5y31 Chondrocostal joint sprain chest 
S5y32 Costal cartilage sprain chest 
S5y3z Rib sprain NOS chest 
S5y4 Sternum sprain chest 
S5y40 Sternum sprain unspecified chest 
S5y41 Sternoclavicular sprain shoulder girdle 
S5y42 Chondrosternal sprain chest 
S5y43 Xiphoid cartilage sprain chest 
S5y4z Sternum sprain NOS chest 
S5y5 Pelvis sprain or complete tear pelvis 
S5y50 Sprain of pelvis unspecified pelvis 
S5y50 Sprain of pelvis, unspecified pelvis 
S5y51 Sprain symphysis pubis pelvis 
S5y51 Sprain, symphysis pubis pelvis 
S5y51 Sprained symphisis pubis trunk & pelvis 
S5y5z Sprain of pelvis NOS pelvis 
S5yX Spr/str oth/unsp parts thor chest 
S5yy Other spec sprains and strains unspecified 
S5yy Other specified sprains and strains unspecified 
S5yz Other sprains NOS unspecified 
S5yz Other sprains/strains NOS unspecified 
431 
 
S5yz1 Muscle injury / strain unspecified 
S5z Ligament sprain NOS unspecified 
S5z Muscle sprain NOS unspecified 
S5z Rectus muscle sprain unspecified 
S5z Sprains and strains NOS unspecified 
S5z Tendon injury - lower limb lower limb 
S5z Tendon sprain NOS unspecified 
S902 Tendon injury - upper limb upper limb 
SC07 Sprain - late effect unspecified 
SC08 Late effect-tendon injury unspecified 
SJ30 Cervical nerve root injury neck 
SJ30 Cervicalnerverootinjury neck 
SJ303 Cervical nerve root injury - C4 neck 
SJ304 Cervical nerve root injury - C5 neck 
SJ305 Cervical nerve root injury - C6 neck 
SJ306 Cervical nerve root injury - C7 neck 
SJ321 Lumbar nerve root injury - L2 lower back 
SJ34 Brachial plexus injury limb 
SJ34 Brachialplexusinjury limb 
SJ35 Lumbosacral plexus injury 
lower back & 
pelvis/lower 
limb 
SJ43 Latrl cutaneous branch T12 inj back 
SJ50 Axillary nerve injury upper arm 
SJ51 Median nerve injury upper limb 
SJ511 Cls injmed nrveplm sns brnch upper limb 
SJ52 Ulnar nerve injury forearm 
SJ52 Ulnarnerveinjury forearm 
SJ520 Closed injury ulnar nerve forearm 
SJ520 Closedinjuryulnarnerve limb 
SJ528 Inj/ulnar nerve/wrist+hand lev wrist/hand 
SJ53 Radial nerve injury wrist/hand 
SJ534 Inj/radial nerv/wrist+hand lev wrist/hand 
SJ56 Digital nerve injury hand 
SJ566 Injury of digital nerve of thumb hand 
SJ6 Leg peripheral nerve injury lower limb 
SJ60 Sciatic nerve injury lower limb 
SJ60 Sciaticnerveinjury lower limb 
SJ61 Femoral nerve injury thigh 
SJ62 Posterior tibial nerve injury thigh 
SJ63 Peroneal nerve injury lower limb 
SJ642 Cls inj lat cutan nerve thigh thigh 
SJ7z Injury to other nerve NOS unspecified 
SJ7z InjurytoothernerveNOS unspecified 
SJ9 Injur/nerv+spinl crd/thorx lev back 
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SJB Inj/nerves/should+upp arm levl 
shoulder/upper 
arm 
SJB0 Injury/ulnar nerve/upp arm lev upper arm 
SJB0 Injury/ulnarnerve/upparmlev upper arm 
SJz Peripheral nerve injury NOS unspecified 
SJz-98 Peripheral nerve injury NOS unspecified 
SK0y Compartmentsyndrome unspecified 
SK0y1 Compartment syndrome forearm forearm 
SK0y5 Compartment syndrome leg lower limb 
SK0y5 Compartmentsyndromeleg lower limb 
SK1 Other specified injury unspecified 
SK112 Other interscapular injuries shoulder 
SK113 Other buttock injuries buttock 
SK114 Other back injuries back 
SK114 Otherbackinjuries back 
SK115 Other abdominal wall injuries abdomen 
SK116 Other flank injuries trunk 
SK117 Other groin injuries pelvis 
SK117 Othergroininjuries pelvis 
SK122 Other shoulder injuries shoulder 
SK122 Othershoulderinjuries shoulder 
SK123 Other upper arm injuries upper arm 
SK12z Other should/upper arm inj.NOS 
shoulder/upper 
arm 
SK12z Othershould/upperarminj.NOS 
shoulder 
girdle/upper 
arm 
SK13 Injury arm NOS upper limb 
SK13 Other elbow/forearm/wrist inj. upper limb 
SK130 Other elbow injuries elbow 
SK130 Otherelbowinjuries elbow 
SK131 Injury arm upper limb 
SK131 Other forearm injuries forearm 
SK131 Otherforearminjuries forearm 
SK132 Other wrist injuries wrist 
SK132 Otherwristinjuries wrist 
SK133 Unspecified injury of wrist wrist 
SK133 Unspecifiedinjuryofwrist wrist 
SK13z Elbow/wrist/forearm inj.NOS upper limb 
SK14 Other hand injury (exc.finger) hand 
SK14 Other hand injury, excluding finger hand 
SK14 Otherhandinjury(exc.finger) hand 
SK14 Tendon injury to hand NOS hand 
SK140 Unspecified injury of hand hand 
SK140 Unspecifiedinjuryofhand hand 
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SK15 Other finger injuries hand 
SK15 Otherfingerinjuries hand 
SK150 Other finger injuries unsp. hand 
SK150 Other finger injuries unspecified hand 
SK150 Other finger injuries, unspecified hand 
SK150 Otherfingerinjuriesunsp. hand 
SK151 Other fingernail injuries hand 
SK151 Otherfingernailinjuries hand 
SK152 Other thumb injuries unsp. hand 
SK152 Other thumb injuries unspecified hand 
SK152 Other thumb injuries, unspecified hand 
SK152 Otherthumbinjuriesunsp. hand 
SK154 Finger injury hand 
SK15z Other finger injuries NOS hand 
SK15z OtherfingerinjuriesNOS hand 
SK16 Other hip and thigh injuries hip/thigh 
SK16 Other hip/thigh injuries hip/thigh 
SK160 Other hip injuries hip 
SK160 Otherhipinjuries hip 
SK161 Other thigh injuries thigh 
SK161 Otherthighinjuries thigh 
SK17 Injury toe foot 
SK17 Injurytoe foot 
SK17 Other knee/leg/ankle/foot inj. lower limb 
SK170 Other knee injury knee 
SK170 Otherkneeinjury knee 
SK171 Injury leg NOS lower limb 
SK171 Other leg injury lower limb 
SK171 Otherleginjury lower limb 
SK172 Other ankle injury ankle 
SK172 Otherankleinjury ankle 
SK173 Foot injury foot 
SK173 Other foot injury foot 
SK173 Otherfootinjury foot 
SK174 Calf injury lower leg 
SK174 Calfinjury lower leg 
SK175 Injury of lower leg lower leg 
SK175 Injuryoflowerleg lower limb 
SK17z Knee/leg/ankle/foot injury NOS lower limb 
SK1D0 Inj/adductor musc+tendon/thigh thigh 
SK1E Inj/musc+tendon/lower leg levl lower leg 
SK1F Injury of muscle and tendon at ankle and foot level ankle/foot 
SK1z Other injury NOS unspecified 
SK1z OtherinjuryNOS unspecified 
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SKz Injury NOS unspecified 
SKz InjuryNOS unspecified 
Syu18 [X]Spr/str jt/lg ot/un pt neck neck 
Syu3 [X]Injabd/low back/lum sp/pel lower back 
Syu31 [X]Sup inj ab/low back/peluns trunk & pelvis 
Syu36 [X]Spr/str ot/un pt lum sp/pel 
lower back & 
pelvis/lower 
limb 
Syu3K [X]Oth sp inj abd/low back/pel 
lower back & 
pelvis/lower 
limb 
Syu3L [X]Unsp inj abd/low back/pelv trunk & pelvis 
Syu4 [X]Inj to shoulder/upper arm 
shoulder/upper 
arm 
Syu46 [X]Spr/str oth/un part shl gir shoulder girdle 
Syu4E [X]Unspecif inj should/up arm 
shoulder/upper 
arm 
Syu5 [X]Inj to elbow & forearm forearm 
Syu5F [X]Oth spec inj elbow/forearm forearm 
Syu5G [X]Unspecif inj elbow/forearm forearm 
Syu6 [X]Injuries to the wrist and hand wrist/hand 
Syu66 [X]Spr/str ot/uns prt wris/hnd wrist/hand 
Syu6C [X]Inj int mus/tn ot finwt/hd wrist/hand 
Syu6M [X]Unsp injury wrist and hand wrist/hand 
Syu6M [X]Unspecified injury of wrist and hand wrist/hand 
Syu7 [X]Injuries to the hip and thigh hip/thigh 
Syu8 [X]Inj to knee and lower leg knee 
Syu84 [X]Sprn/str oth unsp part knee knee 
Syu9 [X]Injuries to the ankle and foot ankle/foot 
Syu96 [X]Sprn/str oth/unsp part foot foot 
Syu9B [X]Inj oth mus/ten,ank/foot lv ankle/foot 
Syu9C [X]Inj uns mus/ten of ank/foot ankle/foot 
Syu9G [X]Oth specif inj ankle/foot ankle/foot 
SyuB8 [X]Unspecif inj leg lev unsp lower limb 
SyuBJ [X]Inj unsp muscle+tendon trnk trunk 
UNMAPM4AB Muscle strain unspecified 
UNMAPP2R Hamstring injury thigh 
UNMAPPC0 Shoulder injury shoulder 
UNMAPPC4 Wrist injury wrist 
UNMAPPC5 Ankle injury ankle 
UNMAPPC6 Back injury back 
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Sleep problems and tiredness 
Sleep problems and tiredness 
Read code Description 
1662 Night sweats 
1736.   Paroxysmal nocturnal dyspnoea 
173B. Nocturnal cough / wheeze 
173D. Nocturnal dyspnoea 
1B1B. C/O - insomnia 
1B1B0 Initial insomnia 
1B1B1 Middle insomnia 
1B1B2 Late insomnia 
1B1D. Nightmares – symptom 
1B6C. Excessive somnolence 
1BX.. Sleep observations 
1BX0. Delayed onset of sleep 
1BX1. Excessive sleep 
1BX2. Sleeping pattern 
1BX3. Early morning waking 
1BX4. C/O - dreams 
1BX5. C/O - sweet/pleasant dreams 
1BX6. C/O - unpleasant dreams 
1BX7. C/O - bizarre dreams 
1BX8. C/O - vivid dreams 
1BX9. Light sleep 
38D0. Pittsburgh sleep quality index 
663N. Asthma disturbing sleep 
663N0 Asthma causing night waking 
663N1 Asthma disturbs sleep weekly 
663N2 Asthma disturbs sleep frequently 
66Yq. Asthma causes night time symptoms 1 to 2 times per week 
66Yr. Asthma causes symptoms most nights 
7065A Sleep studies NEC 
7P1B0 Polysomnography 
8G9B. Sleep hygiene behaviour education 
8Q0.. Sleep management 
9Ngt. On melatonin for sleep disorder 
c88G. Vantage Pharmacy Sleep Aid 50mg tablet 
c88H. Care Night Time Sleep Aid 25mg tablet 
E205. Tired all the time 
E274. Non-organic sleep disorders 
E2740 Unspecified non-organic sleep disorder 
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E2741 Insomnia NOS 
E2742 Persistent insomnia 
E2743 Hypersomnia NOS 
E2744 Persistent hypersomnia 
E2745 Jet lag – disorder 
E2746 Shifting sleep-work schedule 
E2747 Sleepwalking 
E2748 Night terrors 
E2749 Nightmares 
E274A Sleep drunkenness 
E274B Repeated rapid eye movement sleep interruptions 
E274C Other sleep stage or arousal dysfunction 
E274D Restless sleep 
E274E "Short-sleeper" 
E274F Sleep rhythm inversion 
E274y Other non-organic sleep disorder 
E274z Non-organic sleep disorder NOS 
Eu460 [X]Fatigue syndrome 
Eu51. [X]Nonorganic sleep disorders 
Eu510 Nonorganic insomnia 
Eu511 Nonorganic hypersomnia 
Eu512 Nonorganic disorders of the sleep/wake schedule 
Eu513 [X]Sleepwalking 
Eu514 Sleep terrors 
Eu515 [X]Nightmares 
Eu51y [X]Other nonorganic sleep disorders 
Eu51z [X]Nonorganic sleep disorder, unspecified 
F13z2 Restless legs syndrome 
F270. Cataplexy 
F271. Narcolepsy 
Fy0.. Sleep disorders 
Fy00. Disorders of initiating and maintaining sleep 
Fy01. Disorders of excessive somnolence 
Fy02. Disorders of the sleep-wake schedule 
Fy03. Sleep apnea 
Fy04. Sleep-related respiratory failure 
G3300 Nocturnal angina 
G331. Prinzmetal's angina 
R005. [D]Insomnia - symptom 
R0050  Sleep disturbance, unspecified 
R0051 [D]Insomnia with sleep apnoea 
R0052 Insomnia NOS 
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R0053  Hypersomnia sleep apnoea 
R0054 [D]Hypersomnia NOS 
R0055 [D]Sleep rhythm inversion 
R0056 Sleep rhythm irregular 
R0057 Sleep-wake rhythm non-24-hour cycle 
R0058 Sleep dysfunction with sleep stage disturbance 
R0059 [D]Sleep dysfunction with arousal disturbance 
R005z [D]Sleep dysfunction NOS 
R0084 [D]Night sweats 
ZV1B1 [V]Personal history of unhealthy sleep-wake schedule 
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Psychological diagnosis/problems 
Severe mental illness 
Read code Description 
1464 H/O: schizophrenia  
146D. H/O: manic depressive disorder 
146H. H/O: psychosis 
212T. Psychosis, schizophrenia and bipolar affective disorder resolved 
9H6.. On national service framework mental health  
9H8.. On severe mental illness register  
E02.. Drug psychoses 
E03y3 Unspecified puerperal psychosis 
E1… Non-organic psychoses  
E10.. Schizophrenic disorders  
E100. Simple schizophrenia  
E1000 Unspecified schizophrenia  
E1001 Subchronic schizophrenia  
E1002 Chronic schizophrenic  
E1003 Acute exacerbation of subchronic schizophrenia  
E1004  Acute exacerbation of chronic schizophrenia  
E1005  Schizophrenia in remission  
E100z Simple schizophrenia NOS  
E101. Hebephrenic schizophrenia  
E1010 Unspecified hebephrenic schizophrenia  
E1011 Subchronic hebephrenic schizophrenia  
E1012 Chronic hebephrenic schizophrenia  
E1013 Acute exacerbation of subchronic hebephrenic schizophrenia  
E1014 Acute exacerbation of chronic hebephrenic schizophrenia  
E1015 Hebephrenic schizophrenia in remission 
E101z Hebephrenic schizophrenia NOS 
E102. Catatonic schizophrenia  
E1020  Unspecified catatonic schizophrenia  
E1021 Subchronic catatonic schizophrenia  
E1022  Chronic catatonic schizophrenia  
E1023  Acute exacerbation of subchronic catatonic schizophrenia  
E1024 Acute exacerbation of chronic catatonic schizophrenia  
E1025 Catatonic schizophrenia in remission  
E102z Catatonic schizophrenia NOS  
E103. Paranoid schizophrenia  
E1030  Unspecified paranoid schizophrenia  
E1031 Subchronic paranoid schizophrenia  
E1032  Chronic paranoid schizophrenia  
E1033  Acute exacerbation of subchronic paranoid schizophrenia  
E1034 Acute exacerbation of chronic paranoid schizophrenia  
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E1035  Paranoid schizophrenia in remission  
E103z Paranoid schizophrenia NOS  
E104.  Acute schizophrenic episode  
E105.  Latent schizophrenia  
E1050  Unspecified latent schizophrenia  
E1051 Subchronic latent schizophrenia  
E1052 Chronic latent schizophrenia  
E1053 Acute exacerbation of subchronic latent schizophrenia  
E1054  Acute exacerbation of chronic latent schizophrenia  
E1055 Latent schizophrenia in remission  
E105z Latent schizophrenia NOS  
E106. Residual schizophrenia  
E107. Schizo-affective schizophrenia  
E1070 Unspecified schizo-affective schizophrenia 
E1071 Subchronic schizo-affective schizophrenia 
E1072 Chronic schizo-affective schizophrenia  
E1073 Acute exacerbation subchronic schizo-affective schizophrenia 
E1074 Acute exacerbation of chronic schizo-affective schizophrenia  
E1075 Schizo-affective schizophrenia in remission  
E107z Schizo-affective schizophrenia NOS 
E10y. Other schizophrenia  
E10y0 Atypical schizophrenia 
E10y1 Coenesthopathic schizophrenia  
E10yz  Other schizophrenia NOS  
E10z. Schizophrenia NOS  
E11.. Affective psychoses  
E110. Manic disorder, single episode  
E1100 Single manic episode, unspecified  
E1101  Single manic episode, mild  
E1102  Single manic episode, moderate  
E1103 Single manic episode, severe without mention of psychosis  
E1104 Single manic episode, severe, with psychosis  
E1105 Single manic episode in partial or unspecified remission  
E1106 Single manic episode in full remission  
E110z Manic disorder, single episode NOS  
E111. Recurrent manic episodes  
E1110  Recurrent manic episodes, unspecified  
E1111 Recurrent manic episodes, mild  
E1112  Recurrent manic episodes, moderate  
E1113  Recurrent manic episodes, severe without mention psychosis  
E1114  Recurrent manic episodes, severe, with psychosis  
E1115  Recurrent manic episodes, partial or unspecified remission  
E1116  Recurrent manic episodes, in full remission  
E111z  Recurrent manic episode NOS  
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E112. Single major depressive episode 
E1120 Single major depressive episode, unspecified 
E1121 Single major depressive episode, mild 
E1122 Single major depressive episode, moderate 
E1123 Single major depressive episode, severe, without mention of psychosis 
E1124 Single major depressive episode, severe, with psychosis  
E1125 Single major depressive episode, in partial or unspecified remission 
E1126 Single major depressive episode, in full remission 
E112z Single major depressive episode NOS 
E113. Recurrent major depressive episode 
E1130 Recurrent major depressive episodes, unspecified 
E1131 Recurrent major depressive episodes, mild 
E1132 Recurrent major depressive episodes, moderate 
E1133 Recurrent major depressive episodes, severe, without mention of 
psychosis 
E1134 Recurrent major depressive episodes, severe, with psychosis  
E1135 Recurrent major depressive episodes, in partial or unspecified remission 
E1136 Recurrent major depressive episodes, in full remission 
E1137 Recurrent depression 
E113z Recurrent major depressive episode NOS 
E114. Bipolar affective disorder, currently manic  
E1140 Bipolar affective disorder, currently manic, unspecified  
E1141 Bipolar affective disorder, currently manic, mild  
E1142  Bipolar affective disorder, currently manic, moderate  
E1143 Bipolar affect disord, currently manic, severe, no psychosis  
E1144 Bipolar affect disord, currently manic,severe with psychosis 
E1145 Bipolar affect disord,currently manic, part/unspec remission  
E1146 Bipolar affective disorder, currently manic, full remission 
E114z  Bipolar affective disorder, currently manic, NOS  
E115. Bipolar affective disorder, currently depressed  
E1150 Bipolar affective disorder, currently depressed, unspecified  
E1151 Bipolar affective disorder, currently depressed, mild  
E1152  Bipolar affective disorder, currently depressed, moderate  
E1153 Bipolar affect disord, now depressed, severe, no psychosis  
E1154 Bipolar affect disord, now depressed, severe with psychosis  
E1155  Bipolar affect disord, now depressed, part/unspec remission  
E1156  Bipolar affective disorder, now depressed, in full remission  
E115z  Bipolar affective disorder, currently depressed, NOS  
E116. Mixed bipolar affective disorder 
E1160  Mixed bipolar affective disorder, unspecified  
E1161 Mixed bipolar affective disorder, mild 
E1162  Mixed bipolar affective disorder, moderate  
E1163 Mixed bipolar affective disorder, severe, without psychosis  
E1164  Mixed bipolar affective disorder, severe, with psychosis  
E1165  Mixed bipolar affective disorder, partial/unspec remission  
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E1166 Mixed bipolar affective disorder, in full remission  
E116z  Mixed bipolar affective disorder, NOS  
E117. Unspecified bipolar affective disorder  
E1170 Unspecified bipolar affective disorder, unspecified  
E1171 Unspecified bipolar affective disorder, mild  
E1172 Unspecified bipolar affective disorder, moderate  
E1173 Unspecified bipolar affective disorder, severe, no psychosis 
E1174  Unspecified bipolar affective disorder,severe with psychosis  
E1175  Unspecified bipolar affect disord, partial/unspec remission  
E1176  Unspecified bipolar affective disorder, in full remission  
E117z  Unspecified bipolar affective disorder, NOS  
E11y.  Other and unspecified manic-depressive psychoses  
E11y0  Unspecified manic-depressive psychoses  
E11y1 Atypical manic disorder 
E11y2 Atypical depressive disorder 
E11y3 Other mixed manic-depressive psychoses  
E11yz Other and unspecified manic-depressive psychoses NOS  
E11z. Other and unspecified affective psychoses  
E11z0 Unspecified affective psychoses NOS 
E11z1 Rebound mood swings 
E11z2 Masked depression 
E11zz Other affective psychosis NOS 
E12.. Paranoid states  
E120. Simple paranoid state  
E121. Chronic paranoid psychosis  
E122. Paraphrenia  
E123. Shared paranoid disorder  
E12y.  Other paranoid states  
E12y0 Paranoia querulans  
E12yz  Other paranoid states NOS  
E12z.  Paranoid psychosis NOS  
E13..  Other nonorganic psychoses  
E130.  Psychotic reactive depression  
E131. Acute hysterical psychosis  
E132. Reactive confusion 
E133. Acute paranoid reaction  
E134. Psychogenic paranoid psychosis  
E135. Agitated depression 
E13y.  Other reactive psychoses  
E13y0  Psychogenic stupor  
E13y1  Brief reactive psychosis  
E13yz Other reactive psychoses NOS  
E13z. Nonorganic psychosis NOS  
E14z. Childhood schizophrenia NOS 
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E1y.. Other specified non-organic psychoses  
E1z.. Non-organic psychosis NOS 
Eu02z [X] Senile psychosis NOS 
Eu052 [X]Organic delusional [schizophrenia-like] disorder 
Eu0z. unspecified organic psychosis 
Eu2.. [X]Schizophrenia, schizotypal and delusional disorders  
Eu20. [X]Schizophrenia  
Eu200  [X]Paranoid schizophrenia  
Eu201 [X]Disorganised schizophrenia  
Eu202 [X]Catatonic schizophrenia  
Eu203  [X]Atypical schizophrenia  
Eu204 [X]Post-schizophrenic depression  
Eu205  [X]Residual schizophrenia  
Eu206  [X]Simple schizophrenia  
Eu20y [X]Other schizophrenia  
Eu20z [X]Schizophrenia, unspecified  
Eu21. [X]Schizotypal disorder  
Eu22. [X]Persistent delusional disorders  
Eu220 [X]Delusional disorder  
Eu221 [X]Delusional misidentification syndrome  
Eu222  [X]Cotard syndrome  
Eu22y [X]Other persistent delusional disorders  
Eu22z  [X]Persistent delusional disorder, unspecified  
Eu23. [X]Acute and transient psychotic disorders  
Eu230 [X]Acute polymorphic psychot disord without symp of schizoph  
Eu231 [X]Acute polymorphic psychot disord with symp of schizophren  
Eu232 [X]Brief schizophreniform disorder  
Eu233 [X]Other acute predominantly delusional psychotic disorders  
Eu23y  [X]Other acute and transient psychotic disorders  
Eu23z [X]Acute and transient psychotic disorder, unspecified  
Eu24. [X]Induced psychotic disorder  
Eu25. [X]Schizoaffective disorders  
Eu250 [X]Schizoaffective disorder, manic type  
Eu251 [X]Schizophreniform psychosis, depressive type  
Eu252 [X]Schizoaffective disorder, mixed type  
Eu25y [X]Other schizoaffective disorders 
Eu25z [X]Schizoaffective psychosis NOS 
Eu2y. [X]Other nonorganic psychotic disorders  
Eu2z. [X]Unspecified nonorganic psychosis  
Eu30. [X]Bipolar disorder, single manic episode  
Eu300  [X]Hypomania  
Eu301 [X]Mania without psychotic symptoms  
Eu302 [X]Mania with psychotic symptoms 
Eu30y [X]Other manic episodes  
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Eu30z [X]Manic episode, unspecified  
Eu31. [X]Bipolar affective disorder  
Eu310  [X]Bipolar affective disorder, current episode hypomanic  
Eu311 [X]Bipolar affect disorder cur epi manic wout psychotic symp 
Eu312  [X]Bipolar affect disorder cur epi manic with psychotic symp  
Eu313 [X]Bipolar affect disorder cur epi mild or moderate depressn 
Eu314  [X]Bipol aff disord, curr epis sev depress, no psychot symp  
Eu315  [X]Bipolar affect dis cur epi severe depres with psyc symp  
Eu316 [X]Bipolar affective disorder, current episode mixed 
Eu317 [X]Bipolar affective disorder, currently in remission  
Eu318 [X]Bipolar affective disorder type I 
Eu319 [X]Bipolar affective disorder type II 
Eu31y [X]Other bipolar affective disorders  
Eu31z [X]Bipolar affective disorder, unspecified 
Eu323 [X]Single episode of psychogenic depressive psychosis  
Eu328  [X]Major depression, severe with psychotic symptoms  
Eu329 [X]Single major depressive episode, severe, with psychosis, psychosis in 
remission 
Eu32A [X]Recurrent major depressive episodes, severe, with psychosis, 
psychosis in remission 
Eu332 [X]Manic-depress psychosis,depressd,no psychotic symptoms  
Eu333 [X]Recurrent depress disorder cur epi severe with psyc symp  
Eu3z. [X]Affective psychosis NOS  
Eu44. [X]Hysterical psychosis 
Eu531 [X]Puerperal psychosis NOS 
Eu843 [X]Symbiotic psychosis  
ZV110  [V]Personal history of schizophrenia  
ZV111  [V]Personal history of manic-depressive psy  
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Dementia 
28E..  Cognitive decline (+ daughter codes) 
66h..  Dementia monitoring (+ daughter codes) 
6AB..  Dementia annual review (+ daughter codes) 
8CMZ.  Dementia care plan (+ daughter codes) 
E00 Senile/presenile dementia NOT E00 "Senile and presenile 
organic psychotic conditions" 
E000. Uncomplicated senile dementia (+ daughter codes) 
E001.  Presenile dementia (+ daughter codes) 
E002. Senile dementia with depressive or 
paranoid features 
(+ daughter codes) 
E003.  Senile dementia with delirium (+ daughter codes) 
E004.  Arteriosclerotic dementia (+ daughter codes) 
E041.  Dementia in conditions EC (+ daughter codes) 
Eu00. [X]Dementia in Alzheimer's disease (+ daughter codes) 
Eu01.  [X]Vascular dementia (+ daughter codes) 
Eu02. [X]Dementia in other diseases 
classified elsewhere 
(+ daughter codes) 
Eu041 [X]Delirium superimposed on 
dementia 
 
F110.  Alzheimer's disease (+ daughter codes) 
F111.  Picks disease (+ daughter codes) 
F112.  Senile degeneration of brain (+ daughter codes) 
F116.  Lewy body disease (+ daughter codes) 
F21y2  Binswanger's disease  
Fyu30  [X]Other Alzheimer's disease  
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Schizophrenia/psychosis 
E00y. Other senile psychoses (+ daughter codes) 
E00z. Senile or presenile psychoses NOS (+ daughter codes) 
E01 Alcoholic psychoses  
E010. Alcohol withdrawal delirium (+ daughter codes) 
E013. Alcohol withdrawal hallucinosis (+ daughter codes) 
E015. Alcoholic paranoia (+ daughter codes) 
E01y. Other alcoholic psychosis (+ daughter codes) 
E01z. Alcoholic psychosis NOS (+ daughter codes) 
E02 Drug psychoses  
E020. Drug withdrawal syndrome (+ daughter codes) 
E021. 
Drug-induced paranoia or hallucinatory 
states (+ daughter codes) 
E022. Pathological drug intoxication (+ daughter codes) 
E02yz Other drug psychoses NOS  
E02z. Drug psychosis NOS (+ daughter codes) 
E03y3 Unspecified puerperal psychosis  
E1 Non-organic psychoses  
E10.. Schizophrenic disorders (+ daughter codes)  
E11 Affective psychoses  
E110.. Manic disorder single episode 
(+ daughter codes  EXCEPT E1105 "Single 
manic episode in partial or unspecified 
remission" and E1106 "Single manic 
episode in full remission") 
E111. Recurrent manic episodes 
(+ daughter codes EXCEPT E1115 
"Recurrent manic episodes, partial or  
unspecified remission" and E1116 
"Recurrent manic episodes, in full 
remission") 
E1124 
Single major depressive episode, severe, 
with psychosis  
E1134 
Recurrent major depressive episodes, 
severe, with psychosis  
E114. Bipolar affective disorder, currently manic 
(+ daughter codes EXCEPT E1145 "Bipolar 
affective disorder, currently manic, in 
partial or unspecified remission" and 
E1146 "Bipolar affective disorder, 
currently manic, in full remission" ) 
E115. 
Bipolar affective disorder, currently 
depressed 
(+ daughter codes EXCEPT E1155 "Bipolar 
affective disorder, currently depressed, 
 in partial or unspecified remission" and 
E1156 "Bipolar affective disorder, 
currently depressed,  
in full remission") 
E116. Mixed bipolar affective disorder 
(+ daughter codes EXCEPT E1165 "Mixed 
bipolar affective disorder, in partial or 
unspecified remission" and E1166 "Mixed 
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bipolar affective disorder, in full 
remission" ) 
E117. Unspecified bipolar affective disorder 
(+ daughter codes EXCEPT E1175 
"Unspecified bipolar affective disorder,  
in partial or unspecified remission" and 
E1176 "Unspecified bipolar affective 
disorder,  
in full remission" ) 
E11y 
Other and unspecified manic-depressive 
psychoses  
E11y0 Unspecified manic-depressive psychoses  
E11y1 Atypical manic disorder  
E11y3 Other mixed manic-depressive psychoses  
E11yz 
Other and unspecified manic-depressive 
psychoses NOS  
E11z. Other and unspecified affective psychoses  
E12.. Paranoid states  
E13.. Other nonorganic psychoses  
E1y.. Other specified non-organic psychoses  
E1z.. Non-organic psychosis NOS  
Eu02z [X] Presenile psychosis NOS  
Eu02z [X] Senile psychosis NOS  
Eu20. [X]Schizophrenia  
Eu22. [X]Persistent delusional disorders  
Eu23. 
[X]Acute and transient psychotic 
disorders  
Eu25. [X]Schizoaffective disorders  
Eu2y. [X]Other nonorganic psychotic disorders  
Eu2z. [X]Unspecified nonorganic psychosis  
Eu30. [X]Manic episode  
Eu31. [X]Bipolar affective disorder  
Eu323 
[X]Severe depressive episode with 
psychotic symptoms  
Eu328 
[X]Major depression, severe with 
psychotic symptoms  
Eu329 
[X]Single major depressive episode, 
severe, with psychosis, psychosis in 
remission  
Eu32A 
[X]Recurrent major depressive episodes, 
severe, with psychosis, psychosis in 
remission  
Eu333 
[X]Recurrent depress disorder cur epi 
severe with psyc symp  
Eu3z [X]Affective psychosis NOS  
Eu531 [X]Puerperal psychosis NOS  
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Stress 
13H4 Marital problems  
13H41 Marital breakdown  
13H42 Marital conflict  
13HT1 Stress at home  
13JM. Problems at work (+ daughter codes) 
1B1L. Stress related problem (+ daughter codes) 
1B1T. Feeling stressed (+ daughter codes) 
9ON.. Stress monitoring admin. (+ daughter codes) 
E28.. Acute reaction to stress 
(+ daughter codes EXCEPT E28z 
"Examination fear", E28z "Flying phobia, and 
E28z "Stage fright" but include E28z "Acute 
stress reaction NOS") 
E29y1 
Other post-traumatic stress 
disorder  
Eu43 
[X]Reaction to severe stress, and 
adjustment disorders  
Eu430 [X]Acute reaction to stress  
Eu431 [X]Post - traumatic stress disorder  
Eu433 
[X]Acute post-traumatic stress 
disorder following military 
combat  
Eu434 
[X]Chronic post-traumatic stress 
disorder following military 
combat  
Eu435 
[X]Delayed post-traumatic stress 
disorder following military 
combat  
Eu43y 
[X]Other reactions to severe 
stress  
Eu43z 
[X]Reaction to severe stress, 
unspecified  
R007z [D]Work stress No other synonyms for R007z 
R00zW 
[D]State of emotional shock and 
stress, unspecified  
ZV4B2 [V]Stressful work schedule  
ZVu4E 
[X]Other stressful life events 
affecting family & household 
 
13HT1 Stress at home  
1B1L. Stress-related problem  
1B1T. Feeling stressed  
388Z. 
Depression anxiety stress scales 
depression score  
9ON.. Stress monitoring admin.  
9ON1. Attends stress monitoring  
9ON4. Stress monitoring 1st letter  
9ON5. Stress monitoring 2nd letter  
9ON6. Stress monitoring 3rd letter  
9ON7. Stress monitoring verbal inv.  
9ON8. Stress monitoring phone invite  
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9ONA. Stress monitoring check done  
9ONZ. Stress monitoring admin.NOS  
E28.. Acute reaction to stress  
E280. 
Acute panic state due to acute 
stress reaction  
E281. 
Acute fugue state due to acute 
stress reaction  
E282. 
Acute stupor state due to acute 
stress reaction  
E283. Other acute stress reactions  
E2830 Acute situational disturbance  
E2831 Acute post-trauma stress state  
E283z Other acute stress reaction NOS  
E284. 
Stress reaction causing mixed 
disturbance of emotion and 
conduct 
 
E28z. Acute stress reaction NOS  
E29.. Adjustment disorder  
E291. 
Prolonged depressive adjustment 
reaction  
E292. 
Adjustment reaction with 
predominant disturbance of other 
emotions 
 
E2921 
Adolescent emancipation 
disorder  
E2924 
Adjustment reaction with anxious 
mood  
E292y 
Adjustment reaction with mixed 
disturbance of emotion 
 
E292z 
Adjustment reaction with 
disturbance of other emotion 
NOS 
 
E293. 
Adjustment reaction with 
predominant disturbance of 
conduct 
 
E2930 
Adjustment reaction with 
aggression  
E2931 
Adjustment reaction with 
antisocial behaviour  
E2932 
Adjustment reaction with 
destructiveness  
E293z 
Adjustment reaction with 
predominant disturbance of 
conduct NOS 
 
E294. 
Adjustment reaction with mixed 
disturbance of emotion and 
conduct 
 
E29y. Other adjustment reactions  
E29y1 
Other post-traumatic stress 
disorder  
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E29y2 
Adjustment reaction with physical 
symptoms  
E29yz Other adjustment reactions NOS  
Eu4.. 
[X]Neurotic, stress-related and 
somatoform disorders 
 
Eu430 [X]Acute stress reaction  
Eu43y 
[X]Other reactions to severe 
stress  
Eu43z 
[X]Reaction to severe stress, 
unspecified  
R00zW 
[D]State of emotional shock and 
stress, unspecified 
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Neurosis 
E20 Neurotic disorders  
E201. Hysteria 
(+ daughter codes  
EXCEPT E2019 "Multiple personality") 
E203. 
Obsessive-compulsive 
disorders (+ daughter codes) 
E204 
Neurotic depression reactive 
type (NOT E204 "Postnatal depression") 
E205 
Neurasthenia - nervous 
debility (NOT E205 "Tired all the time") 
E206. Depersonalisation syndrome (+ daughter codes) 
E207. Hypochondriasis (+ daughter codes) 
E20y. Other neurotic disorders (+ daughter codes) 
E20z. Neurotic disorder NOS (+ daughter codes) 
E2C40 Neurotic delinquency  
Eu341 [X]Dysthymia 
(NOT Eu341 "[X]Depressive personality disorder" OR 
Eu341 "[X]Persistent anxiety depression") 
Eu4 
[X]Neurotic, stress - related 
and somoform disorders  
Eu401 [X]Social neurosis 
(NOT Eu401 "[X]Social phobias" OR  
Eu401 "Anthropopobia") 
Eu411 [X]Anxiety neurosis (No other  Eu411) 
Eu42. 
[X]Obsessive - compulsive 
disorder (+ daughter codes) 
Eu44. 
[X]Dissociative [conversion] 
disorders (+ daughter codes) 
Eu45. [X]Somatoform disorders (+ daughter codes) 
Eu460 [X]Neurasthenia (NOT Eu460 "[X]Fatigue syndrome") 
Eu46y 
[X]Other specified neurotic 
disorders  
Eu46z 
[X]Neurotic disorder, 
unspecified  
M184. Dermatitis artefacta (+ daughter codes) 
M240E Alopecia neurotica  
E20.. Neurotic disorders  
E20z. Neurotic disorder NOS  
E21y7 Neurotic personality  
E2C40 Neurotic delinquency  
Eu341 [X]Depressive neurosis  
Eu411 [X]Anxiety neurosis  
Eu42. 
[X]Obsessive-compulsive 
neurosis 
 
Eu420 
[X]Predominantly 
obsessional thoughts or 
ruminations 
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Eu421 
[X]Predominantly 
compulsive acts 
[obsessional rituals] 
 
Eu422 
[X]Mixed obsessional 
thoughts and acts 
 
Eu42y 
[X]Other obsessive-
compulsive disorders 
 
Eu42z 
[X]Obsessive-compulsive 
disorder, unspecified 
 
Eu452 
[X]Hypochondriacal 
neurosis 
 
Eu453 
[X]Somatoform autonomic 
dysfunction 
 
Eu46. 
[X]Other neurotic 
disorders 
 
Eu460 [X]Neurasthenia  
Eu461 
[X]Depersonalization - 
derealization syndrome 
 
Eu46y 
[X]Other specified 
neurotic disorders 
 
Eu46z [X]Neurosis NOS  
M184. Neurotic excoriation  
M240E Alopecia neurotica  
ZV112 
[V]Personal history of 
neurosis 
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Perinatal mental health 
62T1. Puerperal depression (+ daughter codes) 
6G00. Postnatal depression counselling (+ daughter codes) 
E204 Postnatal depression 
(NOT E204 "Neurotic depression 
reactive type") 
Eu530 [X]Postnatal depression NOS 
(NOT Eu530 "[X]Mild mental and 
behavioural disorders associated  
with the puerperium, not elsewhere 
classified") 
Eu530 [X]Postpartum depression NOS 
(NOT Eu530 "[X]Mild mental and 
behavioural disorders associated  
with the puerperium, not elsewhere 
classified") 
Eu531 
[X]Severe mental and behavioural 
disorders associated with the 
puerperium, not elsewhere classified  
 
 
 
Anxiety with depression 
E2003 Anxiety with depression  
Eu341 [X]Persistant anxiety depression (NO other terms for Eu341) 
Eu412 
[X]Mixed anxiety and depressive 
disorder  
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Anxiety 
1B13. Anxiousness (+ daughter codes) 
1B14. Tenseness (+ daughter codes) 
1B16. Agitated (+ daughter codes) 
1B1V. C/O - panic attack (+ daughter codes) 
2258. O/E - anxious (+ daughter codes) 
225J. O/E - panic attack (+ daughter codes) 
E200. Anxiety states (+ daughter codes) 
E202. Phobic disorders (+ daughter codes) 
E280. Acute panic state due to acute stress reaction (+ daughter codes) 
E28z Flying phobia (No other terms for E28z) 
E2920 Separation anxiety disorder  
E2923 Specific academic or work inhibition  
E2924 Adjustment reaction with anxious mood  
E2D0 
Disturbance of anxiety and fearfulness in childhood 
and adolescence  
E2D00 
Childhood and adolescent overanxiousness 
disturbance  
E2D0z 
Disturbance of anxiety and fearfulness in childhood 
and adolescence NOS  
Eu341 [X]Persistant anxiety depression (NO other terms for Eu341) 
Eu40. [X]Phobic anxiety disorders (+ daughter codes) 
Eu41. [X]Other anxiety disorders (+ daughter codes) 
Eu606 [X]Anxious [avoidant] personality disorder  
Eu930 [X]Separation anxiety disorder of childhood  
Eu931 [X]Phobic anxiety disorder of childhood  
Eu932 [X]Social anxiety disorder of childhood  
1288 FH: Anxiety state  
1466 H/O: anxiety state  
2258 O/E - anxious  
2259 O/E nervous  
173f. Anxiety about breathlessness  
1B12.  Nerves, nervousness  
1B13. ANXIOUSNESS  
1B14. Tenseness ` 
1B16. Agitated  
1B1V. C/O - panic attack  
1BK.. WORRIED  
2256 O/E - agitated  
225J. O/E - panic attack  
2J4.. Worried well  
6897 Anxiety screening  
8G52. Antiphobic therapy  
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8G94. Anxiety management training  
E2… 
Neurotic; personality and other nonpsychotic 
disorders  
E20.. Neurotic disorders  
E200. Anxiety disorder  
E2000 Anxiety state unspecified                                                                                                                                                                               
E2001 Panic disorder  
E2002 Generalised anxiety disorder                                                                                                                                                                            
E2003 Anxiety with depression                                                                                                                                                                                
E2004 Chronic anxiety                                                                                                                                                                                        
E2005 Recurrent anxiety                                                                                                                                                                                      
E200z Anxiety state NOS                                                                                                                                                                                      
E201. Hysteria  
E2011 Hysterical blindness  
E2012 Hysterical deafness  
E2013 Hysterical tremor  
E2014 Hysterical paralysis  
E2015 Hysterical seizures  
E2016 Other conversion disorder  
E2017 Hysterical amnesia  
E2018 Hysterical fugue  
E2019 Multiple personality  
E201A Dissociative reaction unspecified  
E201B Compensation neurosis  
E201C Phantom pregnancy  
E201z Hysteria NOS  
E202. Phobic disorders (& [social] or [phobic anxiety])  
E2020 Phobia unspecified  
E2021 Agoraphobia with panic attacks  
E2022 Agoraphobia without mention of panic attacks  
E2023 Social phobia; fear of eating in public  
E2024 Social phobia; fear of public speaking  
E2025 Social phobia; fear of public washing  
E2026 Acrophobia  
E2027 Animal phobia  
E2028 Claustrophobia  
E2029 Fear of crowds  
E202A Fear of flying  
E202B Cancer phobia  
E202C Dental phobia  
E202D Fear of death  
E202E Fear of pregnancy  
E202z Phobic disorder NOS  
E203. Obsessive-compulsive disorder  
E2030 Compulsive neurosis  
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E2031 Obsessional neurosis  
E203z Obsessive-compulsive disorder NOS  
E205. Neurasthenia - nervous debility                                                                                                                                                                         
E206. Depersonalisation syndrome  
E207. Hypochondriasis  
E20y. Other neurotic disorders  
E20y0 Somatization disorder  
E20y1 Writer's cramp neurosis  
E20y2 Other occupational neurosis  
E20y3 Psychasthenic neurosis  
E20yz Other neurotic disorder NOS  
E20z. Neurotic disorder NOS  
E28.. Acute reaction to stress  
E280. Acute panic state due to acute stress reaction  
E281. Acute fugue state due to acute stress reaction  
E282. Acute stupor state due to acute stress reaction  
E283. Other acute stress reactions  
E2830 Acute situational disturbance  
E2831 Acute posttrauma stress state  
E283z Other acute stress reaction NOS  
E284. 
Stress reaction causing mixed disturbance of 
emotion/conduct  
E28z. Acute stress reaction NOS  
E29.. Adjustment reaction  
E2900 Grief reaction  
E291. Prolonged depressive reaction  
E292. 
Adjustment reaction; predominant disturbance 
other emotions  
E2920 Separation anxiety disorder  
E2921 Adolescent emancipation disorder  
E2922 Early adult emancipation disorder  
E2923 Specific academic or work inhibition  
E2924 Adjustment reaction with anxious mood  
E2925 Culture shock  
E292y 
Adjustment reaction with mixed disturbance of 
emotion  
E292z 
Adjustment reaction with disturbance of other 
emotion NOS  
E293. 
Adjustment reaction with predominant 
disturbance of conduct  
E2930 Adjustment reaction with aggression  
E2931 Adjustment reaction with antisocial behaviour  
E2932 Adjustment reaction with destructiveness  
E294. 
Adjustment reaction with disturbance emotion 
and conduct  
E29y. Other adjustment reactions  
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E29y1 Other post-traumatic stress disorder  
E29y2 Adjustment reaction with physical symptoms  
E29y3 Elective mutism due to an adjustment reaction  
E29y4 Adjustment reaction due to hospitalisation  
E29y5 Other adjustment reaction with withdrawal  
E29yz Other adjustment reactions NOS  
E29z. Adjustment reaction NOS  
E2D0.  
Disturbance of anxiety and fearfulness in 
childhood and adolescence  
E2D00 
childhood and adolescent overanxiousness 
disturbance  
E2D0z 
disturbance of anxiety and fearfulness in 
childhood and adolescence NOS  
E2y.. 
Other specified neuroses or other mental 
disorders  
E2z.. Neuroses or other mental disorder NOS  
Eu054 [X]Organic anxiety disorder                                                                                                                                                                            
Eu341 [X]Dysthymia                                                                                                                                                                                           
Eu4.. 
[X]Neurotic; stress - related and somoform 
disorders  
Eu40. [X]Phobic anxiety disorders  
Eu400 
[X] Agoraphobia (& [without history of panic 
disorder] or [with panic disorder])  
Eu401 [X]Social phobias  
Eu402 [X]Specific (isolated) phobias  
Eu403 [X]Needle phobia  
Eu40y [X]Other phobic anxiety disorders  
Eu40z [X]Phobic anxiety disorder, unspecified  
Eu41. [X]Other anxiety disorders  
Eu410 [X]Panic disorder [episodic paroxysmal anxiety]  
Eu411    [X]Generalized anxiety disorder  
Eu412 
[X]Mixed anxiety and depressive disorder (& mild 
anxiety depression)  
Eu413    [X]Other mixed anxiety disorders  
Eu41y 
[X] Anxiety disorders: [other specified] or [anxiety 
hysteria]  
Eu41z    [X]Anxiety disorder, unspecified  
Eu42. [X]Obsessive - compulsive disorder  
Eu420 
[X]Predominantly obsessional thoughts or 
ruminations  
Eu421 
[X]Predominantly compulsive acts [obsessional 
rituals]  
Eu422 [X]Mixed obsessional thoughts and acts  
Eu42y [X]Other obsessive-compulsive disorders  
Eu42z [X]Obsessive-compulsive disorder; unspecified  
Eu43. 
[X]Reaction to severe stress; and adjustment 
disorders  
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Eu430 [X]Acute stress reaction  
Eu431 [X]Post - traumatic stress disorder  
Eu432 [X]Adjustment disorders  
Eu43y [X]Other reactions to severe stress  
Eu43z [X]Reaction to severe stress; unspecified  
Eu44. [X]Dissociative [conversion] disorders  
Eu440 [X]Dissociative amnesia  
Eu441 [X]Dissociative fugue  
Eu442 [X]Dissociative stupor  
Eu443 [X]Trance and possession disorders  
Eu444 [X]Dissociative motor disorders  
Eu445 [X]Dissociative convulsions  
Eu446 [X]Dissociative anaesthesia and sensory loss  
Eu447 [X]Mixed dissociative [conversion] disorders  
Eu44y [X]Other dissociative [conversion] disorders  
Eu44z [X]Dissociative [conversion] disorder; unspecified  
Eu45. [X]Somatoform disorders  
Eu450 [X]Somatization disorder  
Eu451 [X]Undifferentiated somatoform disorder  
Eu452 [X]Hypochondriacal disorder  
Eu453 [X]Somatoform autonomic dysfunction  
Eu454 [X]Persistent somatoform pain disorder  
Eu455 [X]Globus pharyngeus  
Eu45y [X]Other somatoform disorders  
Eu45z [X]Somatoform disorder; unspecified  
Eu46. [X]Other neurotic disorders  
Eu460 [X]Neurasthenia  
Eu461 [X]Depersonalization - derealization syndrome  
Eu46y [X]Other specified neurotic disorders  
Eu46z [X]Neurotic disorder; unspecified  
Eu515 Dream anxiety disorder (nightmrs)  
Eu605 [X]Obsessive-compulsive personality disorder  
Eu606 [X]Anxious [avoidant] personality disorder  
Eu930 [X]Separation anxiety disorder of childhood  
Eu931 [X]Phobic anxiety disorder of childhood  
Eu932 [X]Social anxiety disorder of childhood  
Eu93y [X]Childhood overanxious disorder  
R2y2. (D) nervousness  
ZV655 [V]Worried well  
 
 
  
458 
 
Depression 
1B17. Depressed (+ daughter codes) 
1B1U. Symptoms of depression (+ daughter codes) 
1BT.. Depressed mood (+ daughter codes) 
2257. O/E - depressed (+ daughter codes) 
62T1. Puerperal depression (+ daughter codes) 
6G00. Postnatal depression counselling (+ daughter codes) 
9H90. Depression annual review (+ daughter codes) 
E11 Depressive psychoses (No other terms for E11) 
E112. Single major depressive episode 
(+ daughter codes EXCEPT E1126 "Single 
major depressive episode, in full 
remission") 
E113. Recurrent major depressive episode 
(+ daughter codes EXCEPT E1136 
"Recurrent major depressive episodes, in 
full remission") 
E115. 
Bipolar affective disorder, currently 
depressed (+ daughter codes) 
E118. Seasonal affective disorder (+ daughter codes) 
E11y 
Other and unspecified manic-depressive 
psychoses  
E11y0 Unspecified manic-depressive psychoses  
E11y2 Atypical depressive disorder  
E11y3 
Other mixed manic-depressive 
psychoses  
E11yz 
Other and unspecified manic-depressive 
psychoses NOS  
E11z2 Masked depression  
E135. Agitated depression (+ daughter codes) 
E2003 Anxiety with depression  
E204. Neurotic depression reactive type (+ daughter codes) 
E290 Brief depressive reaction  
E290z Brief depressive reaction NOS  
E291. Prolonged depressive reaction (+ daughter codes) 
E2B.. Depressive disorder NEC (+ daughter codes) 
Eu3 [X]Mood - affective disorders  
Eu31 [X]Manic-depressive illness 
(PLUS all other terms for Eu31  
EXCEPT "[X]Bipolar affective disorder") 
Eu313 
[X]Bipolar affect disorder cur epi mild or 
moderate depressn  
Eu314 
[X]Bipolar affective disorder, current 
episode severe depression without 
psychotic symptoms  
Eu315 
[X]Bipolar affective disorder, current 
episode severe depression with 
psychotic symptoms  
Eu32. [X]Depressive episode (+ daughter codes) 
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Eu33. [X]Recurrent depressive disorder 
(+ daughter codes EXCEPT Eu334 
"[X]Recurrent depressive disorder, currently 
in remission") 
Eu34 [X]Persistent mood affective disorders  
Eu341 [X]Dysthymia  
Eu34y 
[X]Other persistent mood affective 
disorders  
Eu34z 
[X]Persistent mood affective disorder, 
unspecified  
Eu3y. [X]Other mood affective disorders (+ daughter codes) 
Eu3z [X]Unspecified mood affective disorder (NOT Eu3z "Affective psychosis NOS") 
Eu412 
[X]Mixed anxiety and depressive 
disorder  
Eu530 [X]Postnatal depression NOS 
(NOT Eu530 "[X]Mild mental and 
behavioural disorders  
associated with the puerperium, not 
elsewhere classified" 
Eu530 [X]Postpartum depression NOS 
(NOT Eu530 "[X]Mild mental and 
behavioural disorders  
associated with the puerperium, not 
elsewhere classified" 
Eu920 [X]Depressive conduct disorder  
1285 FH: Depression  
1287 FH: Manic depressive state  
1465 H/O: depression  
2257 O/E – depressed  
2258 O/E - anxious  
2259 O/E nervous  
6891 Depression screen  
6896 Depression screening using questions  
12G3. FH: Puerperal depression  
1B12. 'Nerves' - nervousness  
1B13. Anxiousness  
1B17. Depressed  
1B1U. Symptoms of depression  
1BK.. Worried  
1BP0. 
Loss of interest in previously 
enjoyable activity  
1BT.. Depressed mood  
1BU.. Loss of hope for the future  
2J4.. Worried well  
388b. 
Depression anxiety stress scales 
anxiety score  
388g. 
Beck depression inventory second 
edition score  
62T1. Puerperal depression  
6G00. Postnatal depression counselling  
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8BK0. Depression management programme  
8CAa. 
Patient given advice about 
management of depression  
9H90. Depression annual review  
9H91. Depression medication review  
9H92. Depression interim review  
9HA0. On depression register  
9k40. 
Depression - enhanced service 
completed  
9kQ.. 
On full dose long term treatment 
depression - enh serv admin  
E11.. Depressive psychoses  
E112. Single major depressive episode  
E1120 
Single major depressive episode, 
unspecified  
E1121 Single major depressive episode, mild  
E1122 
Single major depressive episode, 
moderate  
E1123 
Single major depressive episode, 
severe, without psychosis  
E1124 
Single major depressive episode; 
severe; with psychosis  
E1125 
Single major depressive episode, 
partial or unspec remission  
E1126 
Single major depressive episode; in 
full remission  
E112z Single major depressive episode NOS  
E113. 
Recurrent depression: [major 
episode] or [endogenous]  
E1130 
Recurrent major depressive episodes, 
unspecified  
E1131 
Recurrent major depressive episodes, 
mild  
E1132 
Recurrent major depressive episodes, 
moderate  
E1133 
Recurrent major depressive episodes, 
severe, no psychosis  
E1134 
Recurrent major depressive episodes; 
severe; with psychosis  
E1135 
Recurrent major depressive 
episodes,partial/unspec remission  
E1136 
Recurrent major depressive episodes; 
in full remission  
E1137 Recurrent depression  
E113z 
Recurrent major depressive episode 
NOS  
E115. Manic-depressive - now depressed  
E1150 
Bipolar affective disorder, currently 
depressed, unspecified  
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E1151 
Bipolar affective disorder, currently 
depressed, mild  
E1152 
Bipolar affective disorder, currently 
depressed, moderate  
E1153 
Bipolar affect disord, now depressed, 
severe, no psychosis  
E1154 
Bipolar affect disord, now depressed, 
severe with psychosis  
E1155 
Bipolar affect disord, now depressed, 
part/unspec remission  
E1156 
Bipolar affective disorder, now 
depressed, in full remission  
E115z 
Bipolar affective disorder, currently 
depressed, NOS  
E118. Seasonal affective disorder  
E11y. 
Other and unspecified manic-
depressive psychoses  
E11y0 
Unspecified manic-depressive 
psychoses  
E11y1 Atypical manic disorder  
E11y2 Atypical depressive disorder  
E11y3 
Other mixed manic-depressive 
psychoses  
E11yz 
Other and unspecified manic-
depressive psychoses NOS  
E11z2 Masked depression  
E130. Reactive depressive psychosis  
E135. Agitated depression  
E2003 Anxiety with depression  
E201. Hysteria  
E2010 Hysteria unspecified  
E201z Hysteria NOS  
E204. Neurotic depression reactive type  
E2112 Depressive personality disorder  
E290. Brief depressive reaction  
E290z Brief depressive reaction NOS  
E291. Prolonged depressive reaction  
E2B.. Depressive disorder NEC  
E2B0. Postviral depression  
E2B1. Chronic depression  
Eu204 [X]Post-schizophrenic depression  
Eu251 
[X]Schizoaffective disorder, 
depressive type  
Eu3.. [X]Mood - affective disorders  
Eu31. [X]Manic-depressive illness  
Eu313 
bipolar affective disorder, current 
epi, mild or mod depression  
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Eu314 
[X]Bipol aff disord, curr epis sev 
depress, no psychot symp  
Eu315 
[X]Bipolar affect dis cur epi severe 
depres with psyc symp  
Eu32. [X]Depressive episode  
Eu320 [X]Mild depressive episode  
Eu321 [X]Moderate depressive episode  
Eu322 
[X] Severe depressive episode 
without psychotic symptoms:  
(& [single episode agitated 
depression] or [single episode major 
depression] or [single episode vital 
depression])  
Eu323 
[X] Severe depressive episode with 
psychotic symptoms: (& single 
episode of [major depression] or 
[psychogenic depressive psychosis] or 
[psychotic depression] or [reactive 
depressive psychosis])  
Eu324 [X]Mild depression  
Eu325 [X]Major depression, mild  
Eu326 
[X]Major depression, moderately 
severe  
Eu327 
[X]Major depression, severe without 
psychotic symptoms  
Eu328 
[X]Major depression; severe with 
psychotic symptoms  
Eu329 
[X]Single major depr ep; severe with 
psych; psych in remiss  
Eu32A 
[X]Recurr major depr ep; severe with 
psych; psych in remiss  
Eu32y 
[X] Depression: [other episodes] or 
[atypical] or [single episode masked 
NOS]  
Eu32z 
[X] (Depression: [episode, 
unspecified] or [NOS (& reactive)] or 
[depressive disorder NOS]  
Eu33. [X]Recurrent depressive disorder  
Eu330 
[X]Recurrent depressive disorder, 
current episode mild  
Eu331 
[X]Recurrent depressive disorder, 
current episode moderate  
Eu332 
[X]Depression without psychotic 
symptoms: [recurrent: [major] or  
[manic-depressive psychosis, 
depressed type] or [vital] or [current 
severe episode]] or  
[endogenous]  
Eu333 
[X]Recurrent depress disorder cur epi 
severe with psyc symp  
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Eu334 
[X]Recurrent depressive disorder; 
currently in remission  
Eu33y 
[X]Other recurrent depressive 
disorders  
Eu33z 
[X]Recurrent depressive disorder, 
unspecified  
Eu34. 
[X]Persistent mood affective 
disorders  
Eu341 [X]Persistant anxiety depression  
Eu34y 
[X]Other persistent mood affective 
disorders  
Eu34z 
[X]Persistent mood affective 
disorder, unspecified  
Eu3y1 
[X]Recurrent brief depressive 
episodes  
Eu3z. 
[X]Unspecified mood affective 
disorder  
Eu412 
[X]Mixed anxiety and depressive 
disorder  
Eu43. 
[X]Reaction to severe stress, and 
adjustment disorders  
Eu430 [X]Acute stress reaction  
Eu431 [X]Post - traumatic stress disorder  
Eu432 [X]Adjustment disorders  
Eu43y [X]Other reactions to severe stress  
Eu43z 
[X]Reaction to severe stress, 
unspecified  
Eu530 [X]Postnatal depression NOS  
Eu53z 
[X]Puerperal mental disorder, 
unspecified  
Eu920 [X]Depressive conduct disorder  
R007z [D]Postoperative depression  
R2y2. [D]Nervousness  
ZV655 [V]Worried well  
ZV790 [V]Screening for depression  
 
 
Suicide/self-harm 
TK… Suicide and selfinflicted injury 
TK0.. Suicide + selfinflicted poisoning by solid/liquid substances 
TK00. Suicide + selfinflicted poisoning by analgesic/antipyretic 
TK01. Suicide + selfinflicted poisoning by barbiturates 
TK010 Suicide and self inflicted injury by Amylobarbitone 
TK011 Suicide and self inflicted injury by Barbitone 
TK014 Suicide and self inflicted injury by Phenobarbitone 
TK01z Suicide and self inflicted injury by barbiturates 
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TK02. Suicide + selfinflicted poisoning by oth sedatives/hypnotics 
TK03. Suicide + selfinflicted poisoning tranquilliser/psychotropic 
TK04. Suicide + selfinflicted poisoning by other drugs/medicines 
TK05. Suicide + selfinflicted poisoning by drug or medicine NOS 
TK06. Suicide + selfinflicted poisoning by agricultural chemical 
TK07. Suicide + selfinflicted poisoning by corrosive/caustic subst 
TK08. Suicide and selfinflicted poisoning by arsenic and its compounds 
TK0z. Suicide + selfinflicted poisoning by solid/liquid subst NOS 
TK1.. Suicide + selfinflicted poisoning by gases in domestic use 
TK10. Suicide + selfinflicted poisoning by gas via pipeline 
TK11. Suicide + selfinflicted poisoning by liquified petrol gas 
TK1y. Suicide and selfinflicted poisoning by other utility gas 
TK1z. Suicide + selfinflicted poisoning by domestic gases NOS 
TK2.. Suicide + selfinflicted poisoning by other gases and vapours 
TK20. Suicide + selfinflicted poisoning by motor veh exhaust gas 
TK21. Suicide and selfinflicted poisoning by other carbon monoxide 
TK2y. Suicide + selfinflicted poisoning by other gases and vapours 
TK2z. Suicide + selfinflicted poisoning by gases and vapours NOS 
TK3.. Suicide + selfinflicted injury by hang/strangulate/suffocate 
TK30. Suicide and selfinflicted injury by hanging 
TK31. Suicide + selfinflicted injury by suffocation by plastic bag 
TK3y. Suicide + selfinflicted inj oth mean hang/strangle/suffocate 
TK3z. Suicide + selfinflicted inj by hang/strangle/suffocate NOS 
TK4.. Suicide and selfinflicted injury by drowning 
TK5.. Suicide and selfinflicted injury by firearms and explosives 
TK50. Suicide and selfinflicted injury by handgun 
TK51. Suicide and selfinflicted injury by shotgun 
TK52. Suicide and selfinflicted injury by hunting rifle 
TK54. Suicide and selfinflicted injury by other firearm 
TK5z. Suicide and selfinflicted injury by firearms/explosives NOS 
TK6.. Suicide and selfinflicted injury by cutting and stabbing 
TK60. Suicide and selfinflicted injury by cutting 
TK61. Suicide and selfinflicted injury by stabbing 
TK6z. Suicide and selfinflicted injury by cutting and stabbing NOS 
TK7.. Suicide and selfinflicted injury by jumping from high place 
TK70. Suicide+selfinflicted injury-jump from residential premises 
TK71. Suicide+selfinflicted injury-jump from oth manmade structure 
TK72. Suicide+selfinflicted injury-jump from natural sites 
TK7z. Suicide+selfinflicted injury-jump from high place NOS 
TKx.. Suicide and selfinflicted injury by other means 
TKx0. Suicide + selfinflicted injury-jump/lie before moving object 
TKx00 Suicide + selfinflicted injury-jumping before moving object 
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TKx0z Suicide + selfinflicted inj-jump/lie before moving obj NOS 
TKx1. Suicide and selfinflicted injury by burns or fire 
TKx2. Suicide and selfinflicted injury by scald 
TKx3. Suicide and selfinflicted injury by extremes of cold 
TKx4. Suicide and selfinflicted injury by electrocution 
TKx5. Suicide and selfinflicted injury by crashing motor vehicle 
TKx6. Suicide and selfinflicted injury by crashing of aircraft 
TKx7. Suicide and selfinflicted injury caustic subst, excl poison 
TKxy. Suicide and selfinflicted injury by other specified means 
TKxz. Suicide and selfinflicted injury by other means NOS 
TKz.. Suicide and selfinflicted injury NOS 
U2… [X]Suicide 
 
 
ADHD 
1P00. Hyperactive behaviour 
6A61. Attention deficit hyperactivity disorder annual review 
8BPT. Drug therapy for ADHD (attention deficit hyperactivity disorder) 
8BPT0 Stimulant drug therapy for ADHD (attention deficit hyperactivity disorder) 
8BPT1 
Non-stimulant drug therapy for ADHD (attention deficit hyperactivity 
disorder) 
9Ol8. Attention deficit hyperactivity disorder monitoring invitation first letter 
9Ol9. Attention deficit hyperactivity disorder monitoring invitation second letter 
9OlA. Attention deficit hyperactivity disorder monitoring invitation third letter 
dc1.. DEXAMFETAMINE SULFATE 
dc11. *DEXEDRINE 5mg tablets 
dc12. *DUROPHET 7.5mg m/r capsules 
dc13. *DUROPHET 12.5mg m/r capsules 
dc14. *DUROPHET 20mg m/r capsules 
dc1v. DEXAMFETAMINE SULFATE 1mg/mL oral solution 
dc1w. DEXAMFETAMINE SULFATE 5mg tablets 
dc1x. DEXAMPHETAMINE SULPHATE 7.5mg m/r capsules 
dc1y. DEXAMPHETAMINE SULPHATE 12.5mg m/r capsules 
dc1z. DEXAMPHETAMINE SULPHATE 20mg m/r capsules 
dw11. METHYLPHENIDATE HYDROCHLORIDE 10mg tablets 
dw12. RITALIN 10mg tablets 
dw16. EQUASYM XL 20mg m/r capsules 
dw17. CONCERTA XL 18mg m/r tablets 
dw18. CONCERTA XL 36mg m/r tablets 
dw1C. EQUASYM XL 10mg m/r capsules 
dw1D. EQUASYM XL 30mg m/r capsules 
dw1E. MEDIKINET XL 10mg m/r capsules 
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dw1F. MEDIKINET XL 20mg m/r capsules 
dw1G. MEDIKINET XL 30mg m/r capsules 
dw1H. MEDIKINET XL 40mg m/r capsules 
dw1I. CONCERTA XL 27mg m/r tablets 
dw1J. MEDIKINET 5mg tablets 
dw1K. MEDIKINET 10mg tablets 
dw1L. MEDIKINET 20mg tablets 
dw1M. MEDIKINET XL 5mg m/r capsules 
dw1n. METHYLPHENIDATE HYDROCHLORIDE 54mg m/r tablets 
dw1q. METHYLPHENIDATE HYDROCHLORIDE 5mg m/r capsules 
dw1r. METHYLPHENIDATE HYDROCHLORIDE 27mg m/r tablets 
dw1s. METHYLPHENIDATE HYDROCHLORIDE 40mg m/r capsules 
dw1t. METHYLPHENIDATE HYDROCHLORIDE 10mg m/r capsules 
dw1u. METHYLPHENIDATE HYDROCHLORIDE 30mg m/r capsules 
dw1v. METHYLPHENIDATE HYDROCHLORIDE 36mg m/r tablets 
dw1w. METHYLPHENIDATE HYDROCHLORIDE 18mg m/r tablets 
dw1x. METHYLPHENIDATE HYDROCHLORIDE 20mg m/r capsules 
dw1y. METHYLPHENIDATE HYDROCHLORIDE 5mg tablets 
dw1z. METHYLPHENIDATE HYDROCHLORIDE 20mg tablets 
dw21. STRATTERA 10mg capsules 
dw22. STRATTERA 18mg capsules 
dw23. STRATTERA 25mg capsules 
dw24. STRATTERA 40mg capsules 
dw25. STRATTERA 60mg capsules 
dw26. STRATTERA 80mg capsules 
dw27. STRATTERA 100mg capsules 
dw2t. ATOMOXETINE 100mg capsules 
dw2u. ATOMOXETINE 80mg capsules 
dw2v. ATOMOXETINE 60mg capsules 
dw2w. ATOMOXETINE 40mg capsules 
dw2x. ATOMOXETINE 25mg capsules 
dw2y. ATOMOXETINE 18mg capsules 
dw2z. ATOMOXETINE 10mg capsules 
dw31. ELVANSE 30mg capsules 
dw32. ELVANSE 50mg capsules 
dw33. ELVANSE 70mg capsules 
dw3x. LISDEXAMFETAMINE DIMESYLATE 70mg capsules 
dw3y. LISDEXAMFETAMINE DIMESYLATE 50mg capsules 
dw3z. LISDEXAMFETAMINE DIMESYLATE 30mg capsules 
E2E.. Overactive child syndrome 
E2E0. Child attention deficit disorder 
E2E00 Attention deficit without hyperactivity 
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E2E01 Attention deficit with hyperactivity 
E2E0z Child attention deficit disorder NOS 
E2E1. Hyperkinesis with developmental delay 
E2E2. Hyperkinetic conduct disorder 
E2Ey. Other hyperkinetic manifestation 
E2Ez. Hyperkinetic syndrome NOS 
Eu90. [X]Hyperkinetic disorders 
Eu900 [X]Attention deficit hyperactivity disorder 
Eu901 [X]Hyperkinetic conduct disorder 
Eu902 [X]Deficits in attention, motor control and perception 
Eu90y [X]Other hyperkinetic disorders 
Eu90z [X]Hyperkinetic disorder, unspecified 
Eu9y7 [X]Attention deficit disorder 
 
 
Conduct problems 
13HN. Vandalism record 
13HN0 Theft 
13HN1 Shoplifting 
13HN2 Forged/altered prescription 
13Z4C Behavioural problems at school 
13Zb. Bullies children 
13Zc. Bullies adults 
1B1X. Behavioural problem 
1P5.. Aggressive behaviour 
1P50. Violent acts towards others 
1P51. Physically abusive behaviour 
1P52. Verbally abusive behaviour 
1P53. Argumentative behaviour 
38G01 Strengths and Difficulties Questionnaire - conduct problems score 
38G03 Strengths and Difficulties Questionnaire - peer problems score 
E213. Aggressive personality 
E2C.. Behaviour disorder 
E2C0. Aggressive unsocial conduct disorder 
E2C00 Aggressive outburst 
E2C01 Anger reaction 
E2C0z Aggressive unsocial conduct disorder NOS 
E2C1. Nonaggressive unsocial conduct disorder 
E2C10 Unsocial childhood truancy 
E2C11 Solitary stealing 
E2C12 Tantrums 
E2C1z Nonaggressive unsocial conduct disorder NOS 
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E2C2. Socialised conduct disorder 
E2C20 Socialised childhood truancy 
E2C23 Group delinquency 
E2C2z Socialised conduct disorder NOS 
E2C4. Mixed disturbance of conduct and emotion 
E2C40 Neurotic delinquency 
E2C4z Mixed disturbance of conduct and emotion NOS 
E2Cy. Other conduct disturbances 
E2Cy0 Breath holder 
E2Cyz Other conduct disturbances NOS 
E2Cz. Unspecified disturbance of conduct 
E2Cz0 Juvenile delinquency unspecified 
E2Czz Disturbance of conduct NOS 
E2930 Adjustment reaction with aggression 
E2931 Adjustment reaction with antisocial behaviour 
Eu603 [X]Aggressive personality disorder 
Eu911 [X]Unsocialised aggressive disorder 
Eu912 [X]Group delinquency 
Eu92. [X]Emotional behavioural problems 
R06z0 [D]Breath-holding spell 
U3E.. [X]Stabbing 
ZV4G7 [V] Bullying of child 
 
 
Hyperactivity 
1P00. Hyperactive behaviour 
38G02 Strengths and Difficulties Questionnaire - hyperactivity score 
6A61. Attention deficit hyperactivity disorder annual review 
8BPT. Drug therapy for ADHD (attention deficit hyperactivity disorder) 
8BPT0 Stimulant drug therapy for ADHD (attention deficit hyperactivity disorder) 
8BPT1 
Non-stimulant drug therapy for ADHD (attention deficit hyperactivity 
disorder) 
9Ol8. Attention deficit hyperactivity disorder monitoring invitation first letter 
9Ol9. Attention deficit hyperactivity disorder monitoring invitation second letter 
9OlA. Attention deficit hyperactivity disorder monitoring invitation third letter 
dw... Drugs used to treat hyperactivity disorders 
dw3.. LISDEXAMFETAMINE 
dw31. ELVANSE 30mg capsules 
dw32. ELVANSE 50mg capsules 
dw33. ELVANSE 70mg capsules 
dw3x. LISDEXAMFETAMINE DIMESYLATE 70mg capsules 
dw3y. LISDEXAMFETAMINE DIMESYLATE 50mg capsules 
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dw3z. LISDEXAMFETAMINE DIMESYLATE 30mg capsules 
E2E0. Child attention deficit disorder 
E2E0z Child attention deficit disorder NOS 
Eu900 [X]Disturbance of activity and attention 
 
Nervous 
1B12. Nerves - nervousness 
E205. Nervous exhaustion 
E20z. Nervous breakdown 
 
Grief and bereavement 
675.. Grieving counselling 
6751 Bereavement counselling 
675Z. Grieving counselling NOS 
13M.. Family bereavement 
13MZ. Family bereavement NOS 
E2900 Grief reaction                                                                                                                                                                                         
Eu432 adjustment disorders 
ZV628 [V]Uncomplicated bereavement 
 
Anorexia 
1612 Anorexia symptom 
1467 H/O: anorexia nervosa 
E271. AN - Anorexia nervosa 
E2756 Non-organic loss of appetite 
Eu500 [X]Anorexia nervosa 
Eu501 [X]Atypical anorexia nervosa 
Eu50y [X]Psychogenic loss of appetite 
R030. [D]Anorexia 
R0300 [D]Appetite loss 
R030z [D]Anorexia NOS 
 
Bulimia 
E2751 Bulimia (non-organic overeating) 
Eu502 [X]Bulimia NOS 
Eu503 [X]Atypical bulimia nervosa 
 
